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IAbstract
Heart muscle cells (cardiomyocytes) have to fulfill a demanding task. They
have to ensure continuous and regular heartbeat and maintain their integrity
despite undergoing constant mechanical stress during muscle contraction. To
accomplish this, they feature a characteristic membrane architecture: the Trans-
verse-Axial Tubular System (TATS), a network of membrane invaginations –
the Transverse Tubules (TT) – which allows the fast translation of an electrical
stimulus into a mechanical response. Further, specialized membrane protein
complexes ensure membrane flexibility and stability during cycles of contrac-
tion and relaxation. Structural alterations of the TATS and the membrane pro-
tein complexes are linked to cardiac pathologies.
This thesis presents the subdiffraction image based investigations of the car-
diac membrane architecture and membrane nanodomains using STimulated
Emission Depletion (STED) microscopy of mouse ventricular cardiomyocytes
(VM). Experimental and analytical methods comprising single- and multicolor,
one- and two-photon-excitation STED microscopy are developed and applied.
Special focus is laid on the three-dimensional (3D) TATS topology, on the mem-
brane lipids Cholesterol (Chol) and Ganglioside GM1 (GM1), and on the mem-
brane associated proteins Caveolin-3 (Cav-3) and Dystrophin (Dyst).
Novel fluorescent Chol analogs are characterized and established as a class of
membrane labels with superior properties for STED microscopy of living VM.
These dye compounds allow the visualization of the TATS with an unprece-
dented lateral resolution of below 35 nm and can be used for both membrane
bulk staining and labeling of nanoscopic membrane compartments.
Using a custom-built two-photon-excitation-STED (2P-Exc-STED) microscope,
the new Chol dyes enable the acquisition of 3D subdiffraction images of the
TATS of living VM. These 3D images reveal that TT bud from Chol rich mem-
brane domains and that these Chol rich domains can also form shallow mem-
brane invaginations which are hypothesized to be caveolae.
The signal patterns of the caveolae-associated protein Cav-3 and of Chol are
comparatively investigated and their similarities quantitatively evaluated. The
dramatic effect of membrane Chol depletion on the nanoscopic Cav-3 signal
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distribution is assessed. The correlation between the Cav-3 and Chol mem-
brane patterns is further supported by two-color STED microscopy of VM la-
beled for Cav-3 and GM1, and Chol and GM1.
Finally, the spatial association between Cav-3 and the cytoskeletal protein Dyst
is studied in detail. For this, two- and three-color STED imaging protocols and
image analysis procedures are developed. To determine the molecular orien-
tation of the Dyst protein with respect to Cav-3 and with respect to the cardiac
membrane, a multicolor “intra-protein” labeling protocol is developed that is
based on immunofluorescence staining using different primary antibodies that
target specific epitopes along the Dyst protein.
A cardiac membrane nanodomain model summarizing the presented observa-
tions and findings is derived, validated, and discussed in detail.
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Zusammenfassung
Herzmuskelzellen (Kardiomyozyten) müssen einer sehr anspruchsvollen Auf-
gabe gerecht werden. Sie müssen für einen kontinuierlichen und wohlgetak-
teten Herzschlag sorgen und gleichsam unversehrt bleiben trotz konstanter
auf sie wirkender Scherkräfte während der Muskelkontraktion. Aufgrund die-
ser Anforderungen weisen Kardiomyozyten eine charakteristische Membran-
architektur auf: das Transversal-Axiale Tubuläre System (TATS), ein verzweig-
tes Netzwerk gebildet von Einstülpungen der Zellmembran, den Transversen
Tubuli (TT), welches die rasche Umsetzung eines elektrischen Reizes in eine
mechanische Reaktion ermöglicht. Desweiteren erhalten spezielle Membran-
protein-Komplexe sowohl die Flexibilität, als auch die Stabilität der Zellmem-
bran während der immerwährenden Abfolge von Zellkontraktion und Rela-
xation. Strukturelle Veränderungen des TATS und der Membranprotein-Kom-
plexe stehen in Verbindung mit herzspezifischen Krankheitsbildern.
In dieser Doktorarbeit werden die Membranarchitektur und Membran-Nano-
domänen in ventrikulären Kardiomyozyten aus der Maus (VM) mithilfe der
nicht durch die Beugung limitierten “STimulated Emission Depletion” (STED)
Mikroskopie untersucht. Experimentelle und analytische Methoden für die
Ein- und Mehrfarben-, Ein- und Zwei-Photonen-Anregungs-STED Mikrosko-
pie werden entwickelt und angewendet. Besonderes Augenmerk wird auf
die dreidimensionale (3D) Topologie des TATS gelegt, sowie auf die Mem-
branlipide Cholesterin (Chol) und GM1-Gangliosid (GM1) und die mit der
Zellmembran in Verbindung stehenden Proteine Caveolin-3 (Cav-3) und Dys-
trophin (Dyst).
Neuartige fluoreszente Chol-Derivate werden beschrieben und als Membran-
indikatoren mit hervorragenden Eigenschaften für die STED Mikroskopie von
lebenden VM etabliert. Diese Farbstoffverbindungen ermöglichen die Visual-
isierung des TATS mit nie zuvor dagewesener lateraler Auflösung von unter
35 nm und können sowohl für die Markierung der gesamten Membran, als
auch für die Markierung einzelner nanoskopischer Membran-Kompartimente
eingesetzt werden.
Die Verwendung der neuen Chol-Farbstoffe zusammen mit einem im Rah-
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men dieser Doktorarbeit aufgebauten und detailliert beschriebenen Zwei-Pho-
tonen-Anregungs-STED Mikroskop ermöglicht die Aufnahme von hochaufge-
lösten 3D-Bildern des TATS in lebenden VM. Diese 3D-Bilder zeigen, dass TT
aus mit Chol angereicherten Strukturen entlang der zellulären Oberflächen-
membran entspringen und dass ein Teil dieser mit Chol angereicherten Struk-
turen flachere Einstülpungen der Membran markiert. Es wird hypothetisiert,
dass diese flacheren Einstülpungen den Caveolae der Zellmembran entspre-
chen.
Die Signalmuster des mit den Caveolae assoziierten Proteins Cav-3 und des
Membranlipids Chol werden vergleichend untersucht und ihre Übereinstim-
mungen quantifiziert. Der dramatische Effekt, den die Extraktion von Mem-
bran ansässigem Chol auf das nanoskopische Cav-3 Signalmuster hat, wird
herausgearbeitet. Die Korrelation zwischen dem Cav-3 und dem Chol Mem-
branmuster wird zusätzlich bestätigt durch Zweifarben-STED mikroskopische
Aufnahmen von VM-Proben, in denen jeweils GM1 und Cav-3, sowie GM1
und Chol fluoreszent markiert sind.
Abschließend wird die räumliche Anordnung von Cav-3 und dem mit dem Zy-
toskelett verbundenen Protein Dyst im Detail untersucht. Dafür werden Pro-
tokolle für Bildaufnahmen mit Zwei- und Dreifarben-STED Mikroskopie und
zugehörige Strategien der Bildanalyse entwickelt. Um die molekulare Orien-
tierung des Dyst Proteins bezüglich Cav-3 und entlang der kardialen Zellmem-
bran zu bestimmen, wird ein Protokoll für die mehrfarbige “Intra-Protein”-
Markierung etabliert. Dieses Protokoll basiert auf der indirekten Immunfluo-
reszenz-Markierung verschiedener Domänen des Dyst Proteins mithilfe unter-
schiedlicher epitopspezifischer Primärantikörper.
Ein herzspezifisches Membran-Nanodomänen Modell, welches die in dieser
Doktorarbeit gemachten Beobachtungen und die daraus gewonnenen Erkennt-
nisse zusammenfasst, wird abgeleitet, überprüft und im Detail diskutiert.
VList of Abbreviations
Note: the most frequently used abbreviations are listed here. Less frequently
used abbreviations are introduced in place in the respective sections.
2P-Exc Two-photon excitation
2P-Exc-CWSTED Two-photon-excitation-continuous-wave-STED
3D Three-dimensional
AF594 Alexa Fluor 594 (fluorescent dye)
AP Action potential
Cav-3 Caveolin-3
Chol Cholesterol
Chol depl. Cholesterol depletion
Chol-KK114 Fluorescent Chol analog (PEG-linker; dye: KK114)
Chol-OG488 Fluorescent Chol analog (PEG-linker; dye: Oregon Green 488)
CtB Cholera toxin subunit B
CtB-AF594 Fluorescent recombinant CtB (dye: AF594)
CVD Cardiovascular disease
Dyst Dystrophin
ECC Excitation-contraction coupling
F-Actin Filamentous Actin
GM1 Ganglioside GM1
HAd Human adipocyte (derived from adipose heart tissue)
KK114 Fluorescent dye
M-β-CD Methyl-β-cyclodextrin
NND Nearest neighbor distance
OG488 Oregon Green 488 (fluorescent dye)
PEG Polyethylene glycol
SR Sarcoplasmic reticulum
STAR635P Fluorescent dye (Abberior STAR 635P)
STED Stimulated emission depletion
TATS Transverse-axial tubular system
TT Transverse tubule
ViPSC Ventricular induced pluripotent stem cell
VM Mouse ventricular cardiomyocyte
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11. Introduction
1.1. The cardiac membrane system
The heart is undoubtedly the most romanticized and stylized organ in the body
and is perhaps the most recognizable pictogram throughout the world. Even if
hidden and well-sheltered in the chest, it readily comes back to mind; beating
tirelessly - directly heard and felt at any time. The heart is a symbol. It has
almost become an independent-minded, autonomously acting personality.
The heart is also an organ. It is part of the machinery which is responsible for
maintaining the necessary order defined as life. And as part of this machinery,
it is clocked by the basic principles of science: cause and effect. This is the
actual magic which provokes fascination and makes the heart one of the organs
studied in greatest detail across all life sciences ranging from physiology to
biology and physics.
The average human heart is made up of about 2 to 3 billion individual heart
muscle cells - the cardiomyocytes - that share the space with other 3 to 6 billion
cells of other types [1]. The cardiomyocytes are connected with each other at
the intercalated disc and embedded in a wickerwork of extracellular matrix.
Together, these cells form the four chambers of the mammalian heart: the left
and the right atrium, and the left and the right ventricle. Arriving at the right
atrium, deoxygenated blood is directed to the right ventricle, and to the lungs
to be oxygenated. The oxygenated blood re-enters the heart via the left atrium
to the left ventricle, and from there pumped into the bloodstream to supply the
organism’s cells with fresh oxygen for the maintenance of cellular homeostasis
[2].
Being at the node of an organism’s oxygen distribution, the heart is a veritable
working horse. Under normal conditions, i.e. 60 to 70 heart beats per minute,
the human heart - assuming it to be a mechanical pump - has to generate about
2 W of power - and this for a whole lifetime. Under extreme conditions, the
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power output demand of the heart can even rise up to about 10 W [3]. Thus,
even under normal conditions, the heart consumes a lot of oxygen: 20 times
more than skeletal muscle at rest (normalized to tissue mass) [4]. To meet this
high demand in oxygen, the heart has an oxygen extraction level of between 70
and 80 %.
Impairment of the cardiac function results in a cascade of consequences: the
systemic oxygen demand cannot be met any more - and this holds true for all
organs, including the heart itself. This is the onset of heart failure which is
defined as the progressive and typically lethal syndrome being the common
consequence of CardioVascular Diseases (CVD) arising from various underly-
ing origins [5, 2].
The vital importance of proper heart function manifests itself in the fact that
since data is collected on the statistics of mortality, CVD ranks top as the un-
derlying cause of death. Based on the 2013 mortality data, one third of all
deaths in the United States are caused by CVD with about 2200 Americans dy-
ing of CVD every day - which is equal to 1 death every 40 seconds. On a global
scale, over 17 million deaths in 2013 were of CVD. Additionally, CVD related
diseases pose a tremendous financial burden regarding prevention, treatment,
and aftercare [6]. Basic research investigating the molecular changes involved
in CVD and aiming at translating findings into clinical studies is hence of great
importance.
To ensure regular, robust, and continuous heartbeat, cardiomyocytes have to
contract and relax with precise timing. The initial triggering signal for contrac-
tion is electrical: the depolarization of the cardiomyocyte plasma membrane
(the sarcolemma) by a propagating action potential (AP) [2, 7]. Unlike skele-
tal muscle, the heart muscle as a whole does not need external stimulation to
rhythmically initiate its AP. This ability is know as cardiac automaticity and is
mediated by pacemaker cells situated in a region of the right atrium known
as the sinoatrial node. These pacemaker cells constantly have a higher trans-
membrane potential than other cardiomyocytes and can undergo spontaneous
depolarization [8, 9]. Since all cardiomyocytes are electrically coupled, an AP
in one cell will dominantly cause all neighboring cells to depolarize and gener-
ate a propagating AP. Along the sarcolemma, this propagating AP induces the
opening of membrane resident voltage-gated Calcium ion channels (Cav1.2),
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resulting in an influx of Calcium ions (Ca2+) into the sarcoplasm (i.e. the cy-
tosol). This Ca2+ influx leads to an increase in the permeability of the Sar-
coplasmic Reticulum (SR) to Ca2+ - a process mediated by the Ryanodine Re-
ceptors type 2 (RyR2) which are SR resident Ca2+ release channels and which
open upon Ca2+ influx through Cav1.2 [10]. The SR is the cell’s main store of
Ca2+ and the opening of RyR2s leads to the release of the stored Ca2+ from
inside the SR into the sarcoplasm. Thus, the Ca2+ concentration inside the
cell is potentiated. This cascade is called Calcium Induced Calcium Release
(CICR) [11, 12, 13, 14]. Ca2+ will reach the myofibrils via diffusion. There,
long filamentous Tropomyosin proteins lie on two sides of the Actin myofil-
ament, covering up the sites where the Myosin can bind. Globular Troponin
proteins are attached to the Tropomyosin. When Ca2+ binds to Troponin, the
protein undergoes a conformational change and moves the Tropomyosin. This
again uncovers the Myosin binding sites on the Actin, allowing Myosin heads
to bind and form cross-bridges which results in the movement of Myosin along
the Actin filaments and thus in muscle contraction [15, 2].
The translation between AP, i.e. electrical stimulus, and contraction, i.e. me-
chanical response, is called Excitation-Contraction Coupling (ECC). The ECC
in cardiomyocytes must be reliable, synchronous, repetitive and - most of all -
fast. In this context, it is important to note that cardiomyocytes are rather large
cells: e.g. mouse ventricular cardiomyocytes (VM) measure about 20 µm ×
20 µm × 80 µm. A rough estimate assuming a cardiomyocyte to be a cuboid
yields a surface area of 7200 µm2 and a volume of 32,000 µm3. The propa-
gating AP has a velocity of about vAP ≈ 50 m/s [16, 17] while the diffusion
constant of Ca2+ in the sarcoplasm amounts to about D ≈ 2× 10−7 cm2/s [18].
In this “gedankenexperiment”, we will assume that the initial AP at the most
has to cover the distance along one of the short axes of the cell and along the
long axis because in a cascade, the AP triggers membrane depolarization along
its way. Thus, it would take the AP a time of tAP ≈ 2× 10−6 s = 2 µs to travel
across the cell surface once and open the membrane resident Cav1.2 channels.
For the Ca2+ released from the SR, we will assume that it has to traverse (at
least) the cuboid cell’s diagonal d = 7200 µm by diffusion. Making use of
Einstein’s approximation equation [19], the time it will take the Ca2+ to diffuse
across this area amounts to tCa2+ ≈ ((7200 µm)2)/(2 × 2 × 10−7cm2s−1) ≈
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1.3× 106 s. This is equivalent to 15 days that it would take the Ca2+ to reach
every myofibril to initiate contraction of the whole cell. Even when taking into
account that there is an accelerating effect on the stimulus conduction by the
Ca2+ concentration amplifying and Ca2+ distributing function of SR, this is
still much too slow. The human heart beats about 65 times per minute, ECC
can obviously not rely on intracellular diffusion of Ca2+ alone.
Hence, in order to meet the demand of fast ECC, cardiomyocytes feature a spe-
cialized membrane architecture: the Transverse-Axial Tubular System (TATS)
[20]. The TATS is a cell wide network or membrane invaginations - the so
called Transverse Tubules (TT). The basic functionality of TT is to connect re-
gions buried deep inside the large cells with the extracellular space, thus pro-
viding for a cell spanning spatial association between the electrically excitable
cell membrane and the SR inside the cell. The TATS of a VM is visualized in
Fig. 1.1.
Fig. 1.1 A shows a widefield image of a living, resting VM of typical size with
evenly spaced sarcomeres of a length of about 2 µm. In Fig. 1.1 B, a living VM
was fluorescently stained with the membrane dye Cholesterol-PEG-OG488 and
imaged using two-photon-excitation microscopy to obtain a whole-cell three-
dimensional image. Both images were obtained in the course of this thesis
(see also section 3.4). The highly interconnected TATS is to the biggest extent
composed of tubules oriented parallel to the short (transverse) cell axes. These
TT are evenly spaced corresponding to the sarcomere lengths of about 2 µm.
There are also, albeit fewer, longitudinal tubules. From two-photon-excitation
microscopy of rat cardiomyocytes, the average TT diameter was estimated to
be about 250 nm [21] while recent subdiffraction STED microscopy of the fluo-
rescently labeled TATS of VM determined the average TT diameter to be about
198 nm [22, 23] and electron microscopy based studies found the TT diameter
to be between 70 and 100 nm [24] in rat cardiomyocytes.
Although the TATS is structurally formed by invaginations of the surface sar-
colemma, it has been found that the density and distribution of proteins - pre-
dominantly those proteins involved in Calcium in- and efflux - differ between
the surface sarcolemma and the TT membrane composing the TATS [25, 26, 27].
The Cav1.2 channels, for example, occur in higher abundance at the TT mem-
brane than at the surface sarcolemma [28]. On the other hand, in the absence of
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Figure 1.1.: Micrographs of living mouse ventricular cardimyocytes (VM). Coordinate systems indicate the longitudi-
nal cell axis (X) and the transverse cell axes (Y and Z), respectively. A Widefield image of a living VM. B
two-photon-excitation microscopy image of the Transverse-Axial Tubular System (TATS) of a living VM
stained with the fluorescent membrane dye Cholesterol-PEG-OG488 (see section 3.4). Scale bars: 5 µm.
TT, the β-adrenergic pathway was found to stay functional and that the phos-
phorylation of Phospholamban, a protein involved in the initiation of muscle
relaxation, was not changed upon loss of TT [29, 30].
Further, the membrane capacitance is assumed to be lower for the TT mem-
brane than for the surface sarcolemma [28] - an effect which might be due to
the specific membrane content of Cholesterol and caveolae (see also sections
1.1.1, 1.1.2, and 3.3).
Changes of surface sarcolemma and TT membrane architecture are linked to
cardiac pathophysiology. Heart failure is linked to cardiac hypertrophy, espe-
cially an increase in mass and wall thickness of the left ventricle [2, 31]. The
size of VM increases as well and, with it, the area of the surface sarcolemma
[23]. This results in morphological changes of the surface sarcolemma, pre-
dominantly flattening of the surface and loss of the typical “Z-grooves” at the
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cardiomyocyte surface [32] which has been shown to lead to reduction in car-
diomyocyte contraction amplitudes [33]. Further, combined atomic force mi-
croscopy and electron microscopy studies of a mouse model of myocardial in-
farction revealed a loss of sarcolemmal stiffness already in the early stages of
heart failure [34].
In several animal disease models and also based on biopsies from diseased
and healthy human hearts, the loss and geometric rearrangement of TT struc-
tures has been reported. In animal models of heart failure a loss of TT and a
concomitant loss in Cav1.2 channels has been reported [35, 36]. There, the TT
depletion led to a loss of between 28 and 41 % of TT membrane area [37, 38].
Based on a computational model, structural changes of the TT architecture in
cells depleted of TT resulted in AP propagation inhibition [39]. In the failing
human heart, a loss of the rectangular arrangement, an increase in the number
of longitudinally oriented TT, and an increase in TT diameter was observed
[40, 41]. These pathological changes were have also been confirmed in a mouse
model of myocardial infarction using subdiffraction STED microscopy [22].
Consequently, it is likely that the surface sarcolemma and the TT membrane
serve different - yet equally important - functions that are specifically tailored
for different processes of cell excitation and signaling events. After all, the total
cardiomyocyte membrane area is composed of the surface sarcolemma and the
TT membrane in roughly equal shares [42, 43].
Concluding, the sarcolemma of cardiomyocytes can essentially be divided into
two parts based on their structure and molecular composition: the surface sar-
colemma and the TT membrane. These two components feature some charac-
teristics that make them distinguishable. Throughout this thesis, for simplicity,
the surface sarcolemma will be referred to as the sarcolemma while the TT
membrane will be addressed as such. Both sarcolemma and TT membrane
have an equally important impact on cardiac electrophysiology, signaling and
cellular integrity. The specific electro- and biomechanical demands on cardiac
myocytes and the therefrom arising distinct cellular membrane topology moti-
vates the worthwhile closer look at the concept of the “cell membrane” itself.
When in the mid-seventeenth century the English polymath Robert Hooke first
looked at the microscopic structure of thinly cut slices of cork, he was imme-
diately reminded of the small dwellings of Italian cenobites, the cells. With
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this catchy term that he established in his bestselling book Micrographia [44], he
stressed one of the most important and defining properties of these elementary
biological building blocks: the existence of a cell wall. A cell wall that defines
the “inside” and “outside” of a cell and thus identifies a self-contained unit. In
eukaryotes, the development of a cell membrane - i.e. a selectively permeable
and flexible cell boundary - can be considered to be a tremendously advanta-
geous evolutionary step beyond the concept of the stiff and impermeable cell
wall found in plant cells, bacteria, and other prokaryotes [45]. Cell membranes
create a Ca2+ gradient of roughly a factor of 10,000 between the extra- and the
intracellular space [46]. Since the tight control of intracellular Ca2+ concentra-
tion is key for cell homeostasis, the integrity and functionality of the eukary-
otic membrane are vital. This is especially the case for terminally differentiated
cells like cardiomyocytes which don’t have high self-renewal capability and
hence need tightly regulated mechanisms of membrane maintenance and re-
pair [47].
A characteristic feature of the eukaryotic cell membrane is the assembly of
phospholipids, glycolipids, cholesterol and membrane proteins that together
form a bilayer sheet of about 5 - 6 nm thickness [48] covering the entire cy-
tosol - and sometimes, in the case of striated muscle cells, even penetrating
the complete cellular volume in a network-like fashion and thus letting re-
gions normally buried deep inside the cell come into close contact with the
extracellular space [21]. The lipid bilayer sheet provides cellular membranes
with unique properties. First, the cell membrane is plastic and flexible, thus al-
lowing the cells to change shape according to its momentary functional need,
e.g. the necessity to reversible contract and relax as is the case in a muscle
cell [49]. Second, the eukaryotic cell membrane is both permeable and im-
penetrable, thus providing the cell with protection against possibly harmful
molecules or organisms while at the same time allowing control over chem-
ical gradients and the uptake of nutrients to maintain cellular homeostasis.
Indeed, the cellular membrane is more than a pragmatic or minimalist evo-
lutionary approach to simply delimit intracellular vs. extracellular territory:
the cell membrane of eukaryotes is made up of far more different kinds of
lipids than would be necessary to form a basic bilayer [50]. It is this surplus
complexity and sophistication in lipid structure which enables the opening of
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various pathways for differently-natured exchange and signaling mechanisms
across the cellular membrane. And there are many different transmembrane
pathways - based on a broad variety of principles and mechanisms - that cells
utilize to communicate with their “outside world”: endocytosis [51], exocyto-
sis [52], caveolae [53, 54] (see also section 1.1.2), pits [55], tubules [56, 57, 49],
protrusions [58, 59, 60], and channels [61, 62, 63], just to name a few promi-
nent examples. Given this plethora of specific tasks that a functional cellu-
lar membrane can perform - and has to perform - it is hardly surprising that
the cellular membrane is not a chemically isotropic sheet but features a very
heterogeneous and complex arrangement of different lipids and proteins in
various stoichiometries and assemblies. For a long time, the predominant fo-
cus had been laid on the investigation of the distribution and the therefrom
deduced functionality of membrane proteins. The membrane lipid composi-
tion, however, albeit being an ever present parameter in every investigation
of the functional implications of a certain membrane organization, was much
less in the spotlight [64]. After the 1980s, more and more studies started rec-
ognizing the influence of lipids in cellular signaling processes and the spatial
interaction of lipids and proteins [65, 66, 67], hence commencing the field of
lipid biochemistry. The observation that there is an asymmetry of the lipid
composition at the apical vs. the basolateral membrane of polarized epithelial
cells lead to the proposition that this asymmetry helps in the precise shipment
and sorting of function-specific lipids and proteins from the Golgi complex
to select locations in the cellular membranes (i.e. either the apical or basolat-
eral membrane where different functional requirements have to be met) and
from there to the proposition of membrane microdomains featuring a specific
heterogeneous composition that would define their functionality [68]. These
heterogeneous, function-specific membrane microdomains laid the foundation
of the concept of “lipid rafts” which was first proposed and propagated by
Simons and Ikonen in 1997 [69]. According to their “raft hypothesis”, sphin-
golipids and Cholesterol assemble into membrane domains (the “rafts”) along
the lipid bilayer and float laterally in a “sea” of phospholipids. The postu-
late of lipid rafts immediately triggered profound excitement in the scientific
community - in fields ranging from biochemistry over biophysics to molecu-
lar medicine. Studies regarding the visualization and characterization of lipid
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rafts and their properties - sometimes quite contradictory studies - accumu-
lated (for review see [70, 71, 72]), soon demanding a generalized definition of
what a lipid raft actually is - if it actually is. In the “Keystone Symposium
on Lipid Rafts and Cell Function” in 2006 - about 10 years after the proposi-
tion of the lipid raft principle - the terminology of membrane rafts (note that
the expression “lipid raft” was abandoned in favor of the more general “mem-
brane raft”) was established as follows: “Membrane rafts are small (10 - 200
nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched do-
mains that compartmentalize cellular processes. Small rafts can sometimes be
stabilized to form larger platforms through protein-protein and protein-lipid
interactions” (cf. [73]). This formalism was intentionally broadly and carefully
defined since the corresponding area of lipid research was and is still develop-
ing. The existence of membrane rafts has been met with support [74, 75, 76]
- and it has been questioned [77, 78]. Albeit the fact that it is quite an ap-
pealing concept that provides explanations of many robust and specific cellu-
lar transport and signaling processes [79, 80, 81, 82], the controversy still re-
mains. This is mostly because membrane rafts have not yet been directly and
unequivocally detected or visualized. And such a visualization remains a chal-
lenging task - because of three of the main defining properties of membrane
rafts: 1.) they are small, 2.) they are dynamic, and 3.) they are heterogeneous.
To unravel the heterogeneity of a small and fast object, a probing mechanism
with both a spatially and temporally sufficient resolution is necessary - oth-
erwise, the object will appear homogeneous and its structural and functional
uniqueness cannot be pinpointed. There are many different approaches to de-
tect and characterize membrane rafts. Regarding biochemical methods, there is
for example the determination of the molecular content of membrane domains
that survive the solubilizing effects of certain detergents (e.g. Triton X-100 or
Saponin) [83, 84, 85] - typically resulting in the classification of the insoluble
protein and lipid fraction to be membrane raft associated. However, it has
been argued that detergent insolubility of a specific protein or lipid does not
necessarily indicate its association to membrane rafts [86, 87]. Microscopic ap-
proaches like electron microscopy or Atomic Force Microscopy (AFM) suffer
from an unphysiological sample preparation or from the necessary reduction-
ist approach of studying artificially prepared model membranes [88, 89, 90].
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Microscopic approaches like confocal fluorescence microscopy or Fluorescence
Correlation Spectroscopy (FCS) suffer from their diffraction limited spatial res-
olution [91, 92, 93, 94, 72]. Further, there is always the issue of the experimental
bias introduced by a specific lipid or protein marker needed for molecular la-
beling - cross-linking effects caused by standardly used toxin or antibody based
lipid markers can lead to the misinterpretation of the actual degree of lipid or
protein clustering [95, 96, 97].
Recent advances in subdiffraction fluorescence light microscopy - namely STim-
ulated Emission Depletion (STED) microscopy (see section 1.2) and STED-FCS -
in conjunction with novel techniques to fluorescently label specific lipids have,
however, revitalized the search for membrane rafts and extended the scope of
lipid biochemistry [98, 99, 100, 101, 72]. So far, the majority of the conducted
subdiffraction investigations of the properties of membrane domains are based
on STED-FCS, i.e. inferring the size of these membrane domains from the dif-
fusion behavior of fluorescently labeled proteins or lipids. Yet, diffusion based
measurements are not the definite answer to the question about the existence
of lipid rafts and their properties because the diffusion properties of cellular
membranes are certainly not restricted to the clustering of membrane lipids
[102] but are likely influenced and mediated by membrane associated proteins,
e.g. cytoskeletal structures [100]. Hence, the explicit visualization and charac-
terization of subdiffraction membrane clusters and domains is of great interest
to accompany and complement the so far available data on the nature of mem-
brane domains.
This thesis focuses on cardiac membrane nanodomains, their spatial associa-
tion and the therefrom arising functional implications. Four key players asso-
ciated with the cardiac sarcolemma and the TT membrane will be investigated
using STED microscopy: the lipid Cholesterol, the membrane assciated protein
Caveolin-3, the glyocsphingolipid Ganglioside GM1, and the cytoskeletal pro-
tein Dystrophin. These four molecules and their relevance for cardiac function
will be introduced in the next sections.
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1.1.1. Cholesterol
Cholesterol (C27H46O; in the following abbreviated as Chol) is a lipid molecule
- a sterol - that is both endogenously synthesized and internalized via receptor
mediated endocytosis by all eukaryotic cells in a ratio of about 2:1 [103, 104].
Chol is an essential component of the lipid bilayer sheet of eukaryotic mem-
branes and is the precursor of bile salts [105], vitamin D, and all steroid hor-
mones [106, 107].
Since its discovery in 1815 by the French chemist M. E. Chevreul who isolated
Chol from human gallstones [108], it has been subject to extended research
across many scientific fields, earning H. O. Wieland the Nobel Prize in Chem-
istry in 1927 for pioneering studies in deciphering its chemical structure, earn-
ing K. Bloch and F. Lynen the Nobel Prize in Physiology or Medicine in 1964
for elucidating the processes of the Chol metabolism, and earning M. S. Brown
and J. L. Goldstein the Nobel Prize in Physiology or Medicine in 1985 for clar-
ification of the regulation of the Chol metabolism. Chol has by now become
one of the pets of popular science. Most prominently, Chol is widely known -
and dreaded - for its connection to arterial plaques and cardiovascular disease
[109, 110, 111]. But despite Chol’s somewhat bad reputation, proper function
of eukaryotic cells is not possible without it because of its vital role in diverse
cellular processes.
Chol is an integral component of the plasma membrane of eukaryotes, account-
ing for 20 - 50 mol% of the membrane’s lipid content [112, 113, 76]. It is thus the
most abundant molecule in the plasma membrane - and this applies to all eu-
karyotes [76]. Just like the development of the eurkaryotic cell membrane (see
section 1.1), the cellular synthesis of Chol as the “sterol of choice” [114] was
a concomitant evolutionary process towards the improvement of membrane
functionality under the pressure of selection [115, 116].
Chol features a rather small hydrophilic polar domain that consists of merely
one -OH headgroup which is facing either the extracellular or the cytosolic
space (shaded in pink in Fig. 1.2 A), and a hydrophobic domain that is buried
between the hydrocarbon chains of the membrane phospholipids and that con-
sists of a steroid nucleus and a hydrocarbon side chain (shaded in blue in Fig.
1.2 A) [117, 118, 119]. Chol provides for membrane stiffness, reducing mem-
brane permeability [116], increasing membrane viscosity [120], reducing the
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Figure 1.2.: Schematic of the structure of Cholesterol
(Chol). A The hydrophilic, polar -OH
headgroup that is facing either the extra-
cellular or the cytosolic space is shaded
in pink; the hydrophobic tail that inserts
itself in-between the hydrocarbon chains
of the membrane phospholipids and that
consists of a steroid nucleus and a hydro-
carbon side chain is shaded in blue. B Pic-
tographic illustration of Chol as it will be
used throughout this thesis.
lateral diffusion along the membrane [121], and decreasing the membrane’s
compressibility [122]. Additional to these Chol dependent biophysical proper-
ties of cell membranes, Chol is involved in many biochemical processes such as
cellular transport [123], cell signaling [124, 125], and gene expression [126, 127]
(also well reviewed in [128]). In fact, Chol plays such a crucial role in cellular
homeostasis that its concentration in different cellular organelles is very sen-
sitively and precisely regulated by the interplay of many proteins that allow a
“switch-like” control of cellular Chol levels [129, 130, 131].
Further, Chol tends to induce and organize sphingolipid and Chol rich do-
mains along the membrane bilayer - the so called “membrane rafts” (see sec-
tion 1.1 and [69]). The existence and precise nature of membrane rafts are still
unanswered questions whose elucidation will require the unequivocal visu-
alization of the rafts and a consensus about the specific interactions between
Chol and other membrane lipids. There are three major models that were pro-
posed to describe and explain these interactions: 1.) the “Condensed Complex
Model, 2.) the “Superlattice Model”, and 3.) the “Umbrella” Model. The Con-
densed Complex Model hypothesizes Chol-lipid complexes that are so densely
packed that they together would occupy smaller areas in the bilayer than the
individual components of the complex would - an effect caused by the lower
free energy of the complex [132]. The Superlattice Model hypothesizes that
sterols in membranes maximize their inter-molecular spacing by forming long
range superlattices of different geometries [133]. The Umbrella Model hypoth-
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esizes that since Chol’s hydrophilic -OH headgroup is too small to shield its
bulky hydrophobic steroid nucleus and hydrocarbon side chain from the aque-
ous phase, Chol tends to “seek shelter” under the larger hydrophilic head-
groups of glycosphingolipids - e.g. sphingomyelin and Ganglioside GM1 (see
also section 1.1.3) [134, 135]. The glycosphingolipids thus provide an “um-
brella” for Chol’s sterol group. The Umbrella Model can adequately - probably
most adequately of the three here introduced models - explain the formation of
Chol/glycosphingolipid clusters in the membrane [136] and also predicts that
a cluster of only Chol would result in an inward bend of the membrane as a
result of the preferred reduction of the interface area with the aqueous phase
to which Chol’s hydrophobic tail would be exposed [135].
Indeed, due to the size difference between the hydrophilic headgroup and
the hydrophobic tail, Chol has a reported highly negative intrinsic curvature
[137, 138, 118, 139], featuring a spontaneous curvature of about -0.45 nm−1 (at
20 °C) and about -0.5 nm−1 (at 35 °C) which is about at least a factor 2 more
negative than that of phosphatidylcholines [139]. Chol thus tends to form in-
wardly curved membrane structures, i.e. concave formations that bend away
from the aqueous phase and cause dents or pits in the membrane. A very
prominent example of such Chol enriched pits along the membranes of many
cell types are caveolae [140, 54] which will be discussed in detail in the next sec-
tion (section 1.1.2), thereby focusing on the association of Chol and the muscle
cell specific caveolae scaffolding protein Caveolin-3 (Cav-3) which will be one
of the main subjects of investigation of this thesis. This is because the Chol
rich caveolae are abundant in cardiomyocytes and are assumed to serve as a
membrane surface area reservoir to enable the reversible geometrical changes
of the cardiomyocyte sarcolemma during the cycles of contraction and relax-
ation [141, 142] (see also section 1.1).
Here, a brief outline of the functional relevance of Chol in cardiomyocytes shall
conclude this introductory section about Chol. Especially the membrane of car-
diomyocytes features high amounts of free Chol (note that free Chol - opposed
to esterified Chol - is mobile and accessible in the respective cell organelles
and not confined to and stored in lipid droplets [143]). When estimating the
Chol content in the cardiac membrane system and its influence on the prop-
erties of cardiomyocytes, three factors should be taken into account. First, in
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cultured rat cardiomyocytes, the free Chol content of the whole sarcolemma
(i.e. surface sarcolemma and Transverse tubule (TT) associated membranes)
was determined to amount to about 53 % of the total cellular Chol content
[144]. Note here that according to the terminological convention used in this
thesis, i.e. generally referring to the surface sarcolemma as “sarcolemma” vs.
the TT membranes (see section 1.1), this means that about half the cellular Chol
content is distributed among the sarcolemma and the TT membrane. Second,
the fraction of the TT membrane area is estimated to amount to about 50 % of
the total cardiac membrane area [21, 42]. And third, from data obtained from
skeletal muscle, it was found that the TT membrane contain an about 2 fold
higher amount of Chol than the sarcolemmal membrane [145]. Conclusively,
this means that the cardiac membrane contains high amounts of Chol and that
there is a difference in Chol content between the TT associated membrane and
the sarcolemmal membrane which shapes the functional properties of these
two specific types of cardiac membrane.
Regarding the electrophysiological properties of cardiomyocytes, an increase
in Chol content is assumed to decrease the specific membrane capacitance due
to the increase in membrane thickness caused by the additional insertion of
Chol [42]. For example, Chol depleted cultured rat cardiomyocytes showed a
faster rate of depolarization than controls (which might again indicate an in-
crease in Calcium influx during depolarization) [146]. Since TT membranes
contain higher levels of Chol, it is assumed that they feature a lower capaci-
tance than the sarcolemma [42] (for example, it has been shown that the capac-
itance of cardiomyocytes proportionally depends on the developmental stage
of the cells which correlates with their degree of tubulation [147]). Thus, Chol
content in the cardiac membrane influences its specific capacitance.
Further, studies about the influence of the acute alteration of cellular Chol lev-
els on the intracellular Ca2+ ion concentration [Ca2+]i showed the significant
effect of Chol concentration - yet, the results were very contradictory, either
stating a positive dependence between Chol levels and [Ca2+]i [144, 148], or a
negative one [149].
Regarding the structural properties and the integrity of cardiomyocytes, Chol
is involved in cardiac membrane repair mechanisms: upon rupture of the plasma
membrane, the Chol that is release from the site of membrane injury triggers
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the relocation of the repair protein MG53 to the site of membrane rupture [46].
The initiation of repair mechanisms is especially important in cardiomyocytes
because they are terminally differentiated cells that have only minimal possi-
bilities for self-renewal [47]. In addition, lowering of Chol content has been
reported to lead to a loss of TT integrity in cultured mouse ventricular car-
diomyocytes [150]. However, these findings could not be reproduced in the
experiments conducted in this thesis using freshly isolated mouse ventricular
cardiomyocytes (see section 3.5.1) and showing that Chol depletion did not
compromise the cardiac TT architecture. This discrepancy could be explained
by the fact that upon culture, mouse cardiomyocytes tend to lose TT structures
which has been reported oftentimes in the literature [151, 152, 153, 32].
Finally, on a clinical scale, the influence of Chol on health and longevity re-
mains controversial. Some studies indicate that lower levels of serum Chol
correlate with a lower risk of arterosclerotic cardiovascular disease [154, 111]
(although the decrease of blood Chol levels also correlated with a higher risk
of diabetes [154]). Then again, some studies report that low levels of serum
total Chol correlate with and increased risk of heart failure [155, 156]. Also, in
meta-analysis of 40 Chol associated studies, dietary Chol intake could not be
found to be statistically significantly linked to a number of cardiovascular dis-
eases [110]. Further, unbiased clinical trials accompanied by new insights from
molecular biology will be needed to resolve the decade old question whether
Cholesterol is “good or bad for you”.
In this thesis, I will not try to make a statement regarding this ongoing debate.
Rather, I will concentrate on the association between Chol and membrane cave-
olae since many of the Chol dependent cellular processes - generally in many
cell types and specifically in cardiomyocytes - can be traced back to caveolae
that seem to provide membrane-resident signaling hubs, reservoirs of mem-
brane surface area, and stores of membrane integral proteins. The next section
will thus introduce the muscle specific caveolae scaffolding protein Caveolin-3
(Cav-3) and discuss its functional connection to Chol.
1.1.2. Caveolin-3
Caveolin-3 (Cav-3) is a 21 kDa protein [157] and was identified as the muscle
specific isoform of the caveolin protein family [158, 159]. The caveolins - i.e.
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Caveolin-1, Caveolin-2, and Cav-3 - are the major scaffolding proteins of mem-
brane caveolae [160, 140]. Accordingly, Cav-3 is the caveolae forming protein
of sarcolemmal caveolae in muscle cells and is highly expressed in cardiac my-
ocytes [161].
Cav-3 consists of 151 amino acids (aa) that can be classified into an amino
terminus (N-terminus or “N”, aa 1-73), a hydrophobic transmembrane do-
main (aa 75-106, assumed to form a hairpin loop), and a carboxyl terminus
(C-terminus or “C”, aa 107-151) [162, 163, 164]. The N-terminus contains a
scaffolding domain (aa 55-74) that is known to bind various signaling pro-
teins [165]; the C-terminus contains three palmitoylation sites [166]. Fig. 1.3
schematically depicts the estimated structure and conformation and its loca-
tion in the membrane lipid bilayer. The shown schematic structure of Cav-3
summarizes the possible appearance and membrane association of Cav-3 that
are proposed in [167, 168, 169, 170, 140, 164, 166]. Cav-3 has been shown to be
Figure 1.3.: Schematic of the protein Caveolin-3 (Cav-3). The depiction summarizes the assumed structure and mem-
brane location of Cav-3 that are proposed in [167, 168, 169, 170, 140, 164, 166]. Abbreviations: C - carboxyl
terminus; Chol - Cholesterol; N - amino terminus. Red triangles indicate possible Chol binding site(s).
a Cholesterol (Chol) binding protein and supposedly binds tightly to Chol in
a ratio of at least 1:1 lipid:protein [171, 172]. A study involving the artificial
expression of caveolin in a cell system normally lacking caveolae, however,
showed that the additional caveolin expression led to a Chol enrichment by a
factor of ≥ 2 [173]. The exact binding site (or binding sites) of Chol along the
Cav-3 protein is not yet unequivocally determined but it is most likely located
within the scaffolding domain of the N-terminus [170]. This scaffoldinig re-
gion is supposed to bind to the membrane via electrostatic and hydrophobic
interactions [167]. In Fig. 1.3, three possible Chol binding sites along the Cav-3
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protein are indicated by red triangles.
The Chol binding properties of Cav-3 predict the promotion of Cav-3 protein
oligomerization [171]. Indeed, Cav-3 has been shown - based on transmis-
sion electron microscopy and single particle analysis - to form nonamers with
a radial symmetry (similar to a cartwheel with the C-termini at the axle, the
transmembrane domains forming the spokes, and the N-termini forming the
wheel’s rim) [164]. The Cav-3 nonamers partly reside in the intracellular leaflet
of the lipid bilayer, are ≈ 16.5 nm in diameter and ≈ 5.5 nm in height, with the
C-terminus and the N-terminus extending about 1.8 nm and 2.8 nm into the
cytosol, respectively.
Many Cav-3 molecules (i.e. between 100 and 200 molecules per caveola [174,
175]) assemble to form (sarcolemmmal) membrane caveolae. Caveolae are
shallow membrane invaginations that were first discovered in the 1950s in
electron micrographs of blood capillaries and epithelial tissue [176, 177]. After
synthesis, Cav-3 oligomerizes in the sarcoplasmatic reticulum, is transported
to the Golgi apparatus, then interacts with Chol - eventually, the thus prepared
Cav-3/Chol assembly is transported to and integrated into the plasma mem-
brane (being stabilized, among other proteins, by cavin) [178, 179, 180]. Cave-
olae are very characteristic and easily recognizable membrane structures: they
are omega-shaped pits with their neck region featuring a diameter of about 45
nm and their bulbous body being between about 60 - 80 nm in diameter [170].
Both the arrangement of single caveolae that are either in close proximity or
that fuse together to form “grape-like” structures have been reported based on
electron micrographs and fluorescence microscopy [175, 140] (see also section
3.5 and the Appendix K). Further, regarding striated muscle cells, caveolae are
assumed to be the precursor structures for Transverse Tubules (TT) in develop-
ing muscle cells [20, 181]. In adult skeletal muscle fibers, Cav-3 has been shown
to be present at the TT membrane although the protein is most abundant at the
surface sarcolemma [182] and Cav-3 predominantly occurs at the neck regions
of TT [183] which might indicate that in mature myocytes the generation of
new TT is already terminally concluded.
Caveolae are strongly involved in many specific cellular signaling processes.
For example (and especially interesting regarding cardiomyocytes), caveolae
are involved in Calcium signaling [184, 185] and endothelial and neuronal Ni-
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tric Oxide Synthase (eNOS and nNOS, respectively) signaling [186, 187] (also
well reviewed in [165, 188]).
The connection of caveolae to many cellular signaling events is in unison with
the enrichment of caveolae with Chol and Chol also being a well-known reg-
ulative molecule for signaling processes. Since each Cav-3 molecule tightly
binds to one or more Chol molecules, caveolae feature high concentrations of
Chol. As mentioned in the last section (section 1.1.1), the highly negative spon-
taneous curvature of Cholesterol (Chol) causes clusters of Chol to form mem-
brane invaginations, e.g. caveolae. Cav-3 then serves as a scaffolding protein
to maintain the integrity of the Chol rich caveolae. Interestingly, in vascular
epithelial tissue, the portion of free (i.e. unesterified) Chol that is associated to
caveolae (amounting to about 2-5 % of the entire free Chol in the plasma mem-
brane) is exclusively contained in the extracellular leaflet of the lipid bilayer
[160] (cf. section 3.1, Fig. 3.2).
The enrichment of Chol in caveolae is typically shown by using a standard pro-
tocol for the extraction of Chol from membranes: Chol depletion by Methyl-β-
Cyclodextrin [189, 190] (see also section 3.5.1). Chol depletion leads to a dis-
ruption of caveolar structures [191] (and other Chol rich membrane structures,
e.g. clathrin coated pits [192]) and flattening of the caveolae and thus of the
plasma membrane [193, 194]. This effect of caveolar flattening was reported to
be reversible by the addition of exogenous Chol [193]. Hence, there is reason to
believe that the Chol enriched caveolae at the cellular plasma membrane serve
as a membrane (and Chol) reservoir providing additional surface area to allow
the cell to expand as a fast response to an external stimulus such as membrane
tension caused by cell stretching or cell swelling [195, 142]. This is of particular
interest in the study of cardiomyocytes that undergo constant contraction and
relaxation cycles. Indeed, caveolae have been shown to be crucially involved
in mechanosensation and mechanoprotection, i.e. regulatory mechanisms trig-
gered by the geometrical alteration of a cell’s surface [196, 188].
Likewise, membrane repair mechanisms are also potentially mediated by cave-
olae. In mechanically injured muscle cells, it seems that there is a subsarcolem-
mal abundance of vesicles that strongly resemble assemblies of fused caveo-
lae [197]. This motivates the hypothesis that myocytes contain an intracellular
reservoir of caveolae associated proteins that can be mobilized fast upon in-
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cidents of mechanical injury [198, 199]. Since many incidents of heart failure
can essentially be traced back to hypertrophy of cardiomyocytes and thus an
increased demand of membrane extensibility, caveolae and the proteins and
lipids they contain are interesting starting points for therapeutic targeting in
the field of molecular medicine [142].
Finally, both over- and under-expression of Cav-3 and thus surplus or lack of
caveolae are involved in many pathologies: in cardiac arrhythmias [200, 201]
(although cardiac specific overexpression of Cav-3 could also show potential
for cardiac protection [202, 203]) and, most prominently, in muscular dystro-
phies [204, 205, 206, 188]. Regarding muscular dystrophies, an upregulation
of Cav-3 expression and an increase in abundance of caveolae have been re-
ported [207, 208, 209]. A fraction (not all) of the cellular Cav-3 content has been
shown to co-purify with Dystrophin [204], a product of the Duchenne Muscu-
lar Dystrophy gene. Further, (probably also only a fraction of the total) Cav-3 is
part of the Dystrophin-Glycoprotein Complex (DGC) [206]. In dystrophic my-
ocytes, the interaction between Cav-3 and the DGC is compromised [208]. The
eponymous protein involved in muscular dystrophies, Dystrophin, its connec-
tion to Cav-3 and Chol and its association to the cardiac sarcolemma will be
introduced in detail in section 1.1.4, together with the most common forms of
muscular dystrophies, i.e. Duchenne and Becker Muscular Dystrophy - DMD
and BMD, respectively - and their phenotypes.
In the next section, another typically raft-associated lipid shall be introduced
first: Ganglioside GM1 (GM1). In the scope of this thesis, to show the asso-
ciation between Chol and Cav-3 nanostructures at the cardiac sarcolemma, an
association that has so far been shown mostly biochemically (see this section
and section 1.1.1), I will make use of the visualization of GM1 in two-color
imaging protocols together with Chol and Cav-3, respectively. Therefore, fo-
cus shall be laid first on this lipid which will be called on for the combined
sarcolemmal localization of Cav-2 and Chol later on (see also section 3.6).
1.1.3. Ganglioside GM1
Ganglioside GM1 (monosialotetrahexosylganglioside, C77H139N3O31; in the fol-
lowing abbreviated as GM1) is a ≈ 1.6 kDa [210] glycosphingolipid, i.e. fea-
turing a hydrophilic oligosaccharide headgroup and a hydrophobic ceramide
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tail [211]. Gangliosides were first isolated from ganglion cells of the human
brain by the German biochemist Ernst Klenk [212]. Brain tissue is abundant
in gangliosides (about 1 - 2 g per kg of brain tissue [213]) but also other types
of mammalian cells feature gangliosides as general and intergral part of their
plasma membrane [214, 215]. GM1 is considered the “parent” or “prototype”
ganglioside because most of the various types of different gangliosides can
be chemically derived from GM1 [216, 217]. GM1 is resident in the extracel-
lular leaflet of the mammalian membrane bilayer [218, 219, 220, 221]. From
there, its charged polar sugar headgroup protrudes about 2.5 nm into the ex-
tracellular space, creating an electric potential with a Debye length of about
1 nm [222, 223]. Fig. 1.4 A schematically depicts the chemical structure of
GM1 with its hydrophilic oligosaccharide headgroup facing the extracellular
space (highlighted in pink) and its hydrophobic ceramide tail that is buried
within the plasma membrane (highlighted in blue). A pictographic illustra-
tion of GM1 is given in Fig. 1.4 B; this illustration will be used to conceptu-
ally and schematically visualize GM1 in the specific cardiac membrane models
proposed in this thesis (see e.g. section 1.4). Together with other glycolipids
Figure 1.4.: Schematic of the structure of Ganglioside
GM1 (GM1). A The hydrophilic, polar
oligosaccharide headgroup that is facing
the extracellular space is shaded in pink;
the hydrophobic ceramide tail is shaded in
blue. B Pictographic illustration of GM1 as
it will be used throughout this thesis.
and glycoproteins, GM1 contributes to the formation of the cellular glycoca-
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lyx - a nanometer thick coat surrounding many cell types and presenting a
unique and cell type specific composition [223, 212]. The glycocalyx of a cell
functions like a cellular fingerprint and allows the specialized mutual recogni-
tion and the communication between cells. A variety of these communication
and signaling processes are mediated by membrane clusters that contain large
fractions of GM1 and Cholesterol. These clusters - generally enriched in sphin-
golipids and Cholesterol [91] and oftentimes referred to as lipid rafts (see also
section 1.1) - contribute to the heterogeneous distribution of lipids and proteins
along the membrane bilayer and associate to the liquid ordered phase of the
lipid bilayer. Effectively, GM1 clusters that associate with the membrane liq-
uid ordered phase summarize highly functional units that are involved in the
binding of hormones [224, 225], lectins [88, 226, 212], monoclonal antibodies
[227, 228, 215] - but also viruses [229] and toxins [230] (also well summarized in
[214]). Specifically, GM1 is the natural receptor of the Choleratoxin [231]: each
one of the pentameric Choleratoxin subunit B (CtB) binds with high specificity
and affinity [232, 233] to two sugars of the GM1 oligosaccharide headgroup (i.e.
sialic acid and galactose [234, 235, 236]). Effectively, one molecule of CtB can
bind five molecules of GM1 [97, 221]. Using CtB - in some cases in conjunction
with an anti-CtB antibody - is the most common procedure to label membrane
GM1, e.g. for immuno-electron microscopy [237] or Atomic Force Microscopy
(AFM). As an example, AFM studies of the assembly of GM1 crosslinked by
CtB could show that GM1 forms raised domains of 30 - 200 nm diameter in
experimental systems of supported lipid bilayers of controlled lipid composi-
tions [89, 90]. Analogous GM1 clustering could be visualized using fluores-
cence light microscopy via the standard protocol of labeling GM1 by using
fluorescently tagged recombinant, i.e. non-toxic, CtB (in combination with an
anti-CtB antibody) [92, 219, 95]. Yet, due to the diffraction limited resolution of
this imaging approach, the lower limit of the observed GM1 cluster size was
typically found to be ≈ 300 nm.
In this thesis, however, the application of subdiffraction STED microscopy of
GM1 clusters labeled with fluorescent CtB, revealed variously shaped GM1
clusters at the sarcolemma of living and fixed mouse ventricular cardiomy-
ocytes (VM). These clusters ranged in size between 70 nm up to 1 µm and
showed a distinct substructure. Note that although GM1 is typically consid-
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ered to be a marker of the liquid ordered membrane phase, it has been pro-
posed that only upon binding of CtB to GM1, the GM1 is redistributed from the
liquid disordered phase to the liquid ordered phase [95, 238]. This might be due
to the above mentioned cross-linking effect induced by the combination of CtB
and anti-CtB for fluorescence tagging of GM1. Nevertheless, since CtB alone
can only crosslink GM1 to form at most pentamers, there is reason to assume
that the observed > 100 nm large GM1 membrane clusters require a certain
degree of pre-existing GM1 clustering - an assembly that is likely Cholesterol
mediated [239, 240]. This again would reconstitute the association of GM1 to
the Cholesterol rich liquid ordered phase. Further, within the scope of this the-
sis, fluorescence labeling of GM1 via CtB will be used as a strategy to identify
regions of the densely packed Cholesterol rich liquid ordered phase at the sar-
colemma of living and fixed VM. Hence, the question whether GM1 naturally
resides in the liquid ordered or liquid disordered phase is thus neither directly
relevant nor challenging the reliability of the localization of the sarcolemmal
liquid ordered phase. Additionally, studies based on immunogold labeling
electron microscopy and total internal reflection microscopy have shown that
GM1 is concentrated in membrane caveolae [241, 242, 243] (see section 1.1.2).
This association of GM1 to both Cholesterol rich membrane domains and cave-
olae makes the fluorescent GM1-CtB complex a preferred reporter to motivate
similarity of Cholesterol clusters in living cardiomyocytes to Caveolin-3 clus-
ters in fixed cardiomyocytes (see section 3.6).
1.1.4. Dystrophin
Dystrophin (Dyst) is a large cytoskeletal and membrane associated protein of
427 kDa which constitutes about 0.002 % of the total protein in striated mus-
cle cells [244, 245]. Dyst is the 3685 amino acid (aa) protein product of the
Duchenne Muscular Dystrophy (DMD) gene which is located at band Xp21 on
the short arm of the X chromosome and which - with 2.5 Mb - is the largest
human gene [246, 245, 247]. Dyst is assumed to be of an elongated, flexible rod
shape with an approximate folded contour length of 150 nm [245, 248].
Fig. 1.5 schematically shows the Dyst protein how it is currently perceived in
the scientific field. The schematic summarizes the specific protein domains and
structure proposed in [245, 249, 250, 251, 247, 252, 253, 254].
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Figure 1.5.: Schematic of the protein Dystrophin (Dyst) summarizing the specific protein domains and structure pro-
posed in [245, 249, 250, 251, 247, 252, 253, 254]. The specific protein domains and binding motifs are
denoted in the figure key.
Dyst can be structurally subdivided into four major domains:
1.) The amino terminus (N-terminus or N in Fig. 1.5) comprising aa 1-240
[245] and featuring an (F-)Actin Binding Domain (ABD1) in the region of
aa 14-240 [255].
2.) The central rod domain (H1-H4 and R1-R24 in Fig. 1.5) approximately
comprising aa 253-3112 and featuring 24 triple helical repeats that resem-
ble the protein Spectrin (R1-R24) [245, 253]. In between the Spectrin like
repeats, 4 hinge regions (H1-H4) are distributed: H1 right in front of R1;
H2 between R3 and R4; H4 between R19 and R20; H4 behind R24. These
hinge regions are assumed to provide the flexibility of the Dyst protein
along the region of the rather rigid 24 helical repeats [256]. A second
Actin Binding Domain (ABD2) is located along R11-R17 and is supposed
to bind Filamentous Actin (F-Actin) monomers in a stoichiometry of 1:24
Dyst:F-Actin - ABD2 is thought to bind F-Actin with a lower affinity than
ABD1 in the N-terminus [250, 257, 251, 253]. Further, the Spectrin like
repeats R16 and R17 are supposed to bind Nitric Oxide Synthase (NOS)
and anchor it to the sarcolemma [258], possible via the interaction of NOS
with Caveolin-3 (Cav-3) which is assumed to interact with both endothe-
lial NOS (eNOS) and neuronal NOS (nNOS) [259, 260, 261] and which re-
sides in the intracellular leaflet of the sarcolemma (see section 1.1.2). Note
that both eNOS and nNOS are expressed in cardiomyocytes [262, 263].
Further, the Dyst rod domain presents a possible binding motif for mi-
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crotubules. This motif is assumed to lie between R20 and H4 but has
also been proposed to extend as far as the Cystein rich Dyst domain (see
3.)) [264, 265, 253, 266]; generally, the microtubule binding site(s) can be
assumed to lie somewhere between aa 2471-3092.
3.) The Cystein rich domain (Cyst in Fig. 1.5) approximately comprising aa
3080-3360 and carrying a structural motif that binds to β-Dystroglycan
of the Dystroglycan complex that resides in the sarcolemma [267, 268].
β-Dystroglycan is connected, via its α domain, to Laminin-2 - an extra-
cellular matrix protein - that in turn binds Collagen. Thus, the Cyst rich
domain is anchoring Dyst to the sarcolemma and from there to the extra-
cellular matrix.
4.) The carboxy-terminus (C-terminus or C in Fig. 1.5) approximately com-
prising aa 3361-3685 and featuring an α1-Syntrophin and a β1-Syntrophin
binding site [269, 268]. α1-Syntrophin is assumed to bind NOS [270, 271]
which in turn is supposed to interact with Cav-3 (see also 2.).
Summarizing, by binding F-Actin and binding to the Dystroglycan complex,
Dyst connects the muscle cytoskeleton to the sarcolemma and, from there, to
the extracellular matrix. This makes Dyst an important protein of the costamere
- a large protein complex that connects the myofibrils to the plasma membrane
[272, 273, 274]. Dyst thus helps provide the transmission of contractile forces
originating in the myofibrils to the sarcolemma and is vital for sarcolemmal
stability.
Malexpression of Dyst leads to the class of pathologies that gave the protein
its name: the (muscular) dystrophies, i.e. muscle-wasting diseases. The most
severe form, Duchenne Muscular Dystrophy (DMD), is caused by a complete
absence of Dyst expression. DMD affects about 1 in 3,500 newborn boys (since
the disease is linked to the X chromosome) [275, 276], leading to confinement
of patients to a wheelchair by the age of about 13 and death by the age of about
20 (typically due to respiratory or cardiac failure) [277, 278]. A less pronounced
form of muscular dystrophy - Becker Muscular Dystrophy (BMD) - is caused
by the expression of smaller, truncated Dyst variants. BMD affects about 1 in
12,000 newborn boys and shows many different pathological phenotypes with
varying severity of the disease [279, 280]. Typically, affected individuals show
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first symptoms around the age of 17 and have almost average life expectan-
cies [268]. Myocardial pathologies emerge for the majority of both DMD and
BMD patients and most often manifest themselves as dilated cardiomyopathy,
predominantly left-ventricle dilation [281, 282, 283, 284, 285].
The localization of the DMD gene on the X chromosome was of tremendous im-
portance for the muscular dystrophy research [269]. For both DMD and BMD
many possible mutation sites along the DMD gene have now been identified
[286, 268]. Investigating the effect of these specific mutations on the Dyst pro-
tein functionality is a powerful starting point for the prevention and treatment
of muscular dystrophy. Generally, studies of Dyst related pathologies are com-
plicated by the unusually large size of the DMD gene. The pathological effects
of Dyst malexpression are typically studied by partial deletion or mutation of
specific regions of the gene [254, 287]. Widely used animal models are for ex-
ample the mdx mouse strains that feature different mutations of the DMD gene
([288], see also sections 2.3.4 and 3.8).
Studies of this kind have revealed that there is a relatively large margin of the
extent of Dyst expression regarding the proper functionality of the resulting
protein product albeit being a truncated variant of the full-length Dyst pro-
tein. These findings have opened a fruitful approach to gene therapy based
on the generation (and induced cellular expression) of “mini-” and “micro-
Dystrophins” that - despite not mimicking the complete Dyst protein (explic-
itly, they are missing a portion of the Spectrin like repeats) - are capable to
adopt the function of Dyst. In mouse models, these Dyst variants have been
shown to potentially alleviate dystrophic phenotypes by compensating for the
Dyst deficiency [289, 290, 291, 254, 287]. However, such gene therapy might
require the introduction of adeno-associated viral vectors to the dystrophic or-
ganism in order to deliver the mini-Dystrophin encoding genes (this introduc-
tion would be performed by intramuscular injection) [292] - a procedure that
could not only result in a profound immune response [293] but would also
require tight ethical control.
Further, it is estimated that exon skipping would offer possible gene therapy
because although it would result in the expression of truncated (yet, still func-
tional) Dyst variants, it would reconstitute the reading frame of the DMD gene
[292]. Other, pharmacological, interventions that have shown some success
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to compensate for Dyst malexpression included administration of Gentamicin
to patients with mutations in the Dyst gene based on premature stop codons
[294], and the pharmacological prevention of the loss of Nitric Oxide which is
typically involved in DMD [295].
In addition to Dyst, it has been reported that also the membrane resident pro-
tein Cav-3 (see section 1.1.2) is associated with muscular dystrophies. In both
DMD patients and in mice of the mdx, i.e. dystrophic, strains, Cav-3 is ex-
pressed in surplus [207, 296, 209]. This Cav-3 upregulation is assumed to
distort the connection between Dyst and the sarcolemma interrupting the sar-
colemmal Dyst distribution [205]. On the other hand, however, different mus-
cular dystrophies are associated with a downregulation of Cav-3, e.g. Limb
Girdle Muscular Dystrophy Type 1C [297, 298]. All in all, the proper expres-
sion of the Dyst protein and the tight regulation of Cav-3 expression seem to be
essential for the functional Dyst mediated connection between the myofibrils
and the sarcolemma.
In this thesis, the spatial association between Dyst and Cav-3 will be inves-
tigated using STED microscopy. The reported association between Dyst and
NOS - either via direct binding or mediated by α1-Syntrophin - and the inter-
action of Cav-3 and NOS serves as the starting point for the here presented
nanoscopic investigations of the mutual spatial arrangement of Dyst and Cav-
3 along the cardiac sarcolemma (see also Fig. 1.10 in section 1.4). It has been
shown that Dyst is localized to plasma membrane caveolae [208] and recently,
Dyst has evolved from being considered to have merely mechanical function
in myocytes to actually comprise signaling function as well [271]. This moti-
vates the association of Dyst and sarcolemmal caveolae which are assumed to
be cellular signaling hubs. Yet, Cav-3 has also been reported to interact with
other membrane associated proteins, e.g. with β-Dystroglycan [299, 300]. The
fact that there are different populations of Cav-3 present at the sarcolemma
that can be discriminated by the spatial association with certain proteins will
be discussed in section 3.7. Finally, this work will present and discuss a possi-
ble strategy to visualize the molecular orientation of the Dyst protein along the
cardiac sarcolemma by immunofluorescence labeling of different protein do-
mains using specific primary antibodies directed against distinct amino acid
sequences of the Dyst protein.
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At the end of the day, many questions about the cardiomyocyte-specific, na-
noscopic spatial arrangement of the two prominent membrane-associated pro-
teins Cav-3 and Dyst, and the two membrane lipids Chol and GM1 remain.
Biochemical methods, for example co-immunoprecipitation (and Western blot-
ting) or mass spectrometry (e.g. SILAC [301]), are precise and powerful tech-
niques to detect that specific molecules are associated - but not how this associ-
ation is actually structured and oriented in the cell. Neither do these methods
supply information if there is one or more bridging molecules that mediate a
certain protein protein association. Thus, biochemical analysis is not enough
to shed light on questions about the architecture and topology of associated
protein and lipid complexes. Answers will only be found using a combined
approach together with imaging, i.e. microscopy, techniques. There exist many
different types of microscopy, each of them having their advantages and dis-
advantages. Generally, for the investigation of membrane domains in living
cardiomyocytes, fluorescence light microscopy is the method of choice. This is
because fluorescence microscopy is live-cell compatible, can cover large fields
of view in all three dimensions, and is highly target-specific when used to-
gether with immunolabeling. However, the seemingly perfect match of biolog-
ical specimen and far-field fluorescence microscopy has a major drawback: res-
olution. The object resolution that can be achieved using confocal fluorescence
microscopy - which is, so far, the sharpest lens-based, and thus diffraction-
limited, method in light microscopy - lies roughly at about 200 nm, depending
on the wavelengths of fluorescence excitation and detection. This is insufficient
to reveal the details of the mosaic of the proteins and lipids that line and shape
the cardiac sarcolemma.
As mentioned, the proteins and lipids within and along the cardiac sarcolem-
mal membrane are nanoscopic, and partially highly dynamic, complexes: a
single molecule of Chol has a hydrodynamic radius R ≈ 5 Å [302], an area
of about 32 Å
2
[303, 304] when crystallized, and forms aggregates of R ≈ 10 Å
when at 35 °C at a concentration of 400 mM which corresponds to the standard
concentration of ≈ 30 mol % of Chol in the plasma membrane [302]. GM1 mi-
celles have a hydrodynamic radius of about 6 nm [305, 306] and, in supported
lipid bilayers, form domains of ≈ 100 nm diameter [90]. Cav-3 is supposed
to form nonamers of 16.5 nm diameter [164]. And Dyst, quite large with its
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molecular weight of 427 kDa [307], is assumed to have a folded contour length
of ≈ 150 nm [245, 248].
Yet, abandoning far-field optical microscopy in favor of methods with a much
higher resolution but with much harsher sample preparation steps, for exam-
ple electron microscopy or near-field microscopy, is a great sacrifice for the
study of the dynamic and diverse processes in a living cell.
Until the early 1990s, this dilemma remained. A new class of fluorescence-
based microscopes made its appearance thereafter. These novel microscopes
moved on from the previous endeavors of pushing the diffraction barrier by
solely working with its fundamental physical parameters - wavelength, angle
of incidence, and index of refraction. In what from the purely physical point
of view might almost seem like a hack coming from chemistry, their concept
was to exploit the molecular states of fluorophores - “bright” vs. “dark” - by
photophysically switching between them and thus markedly reducing the vol-
ume of the effective detectable fluorescence, and thereby locating single fluo-
rophores with much higher precision. The principle fundamentally challenged
the diffraction barrier - until it crumbled, giving way to unprecedented fluores-
cence image resolution and coining the term “nanoscopy”. By 2014, these for-
mer “underdog” methods of super-resolved microscopy had established them-
selves in the scientific community, had been broadly commercialized and had
earned their major developers - Stefan W. Hell, William E. Moerner, and Eric
Betzig - the Nobel Prize in Chemistry. Pioneering the field, one of the meth-
ods was STimulated Emission Depletion (STED) microscopy which is based on
the targeted silencing of excited fluorophores. Since STED microscopy makes
use of the most basic molecular transition, i.e. from the ground state to the
excited state, it is compatible with many organic fluorophores, fluorescent pro-
teins, and with standard immunofluorescence protocols - without the need
for any special sample preparation or treatment with detrimental chemicals.
In this thesis, the nanoscopic cardiac membrane composition will be investi-
gated using STED microscopy. The next section will give a detailed introduc-
tion to diffraction-limited and subdiffraction fluorescence light microscopy and
demonstrate how the field of optical microscopy was revolutionized by subd-
iffraction imaging techniques, with STED microscopy leading the way.
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1.2. STED microscopy
Understanding biological processes and relationships has always relied on vi-
sualization. From the depiction of organisms (of the size of ≈ 1 m - 1 cm)
and cells (≈ 1 µm) to eventually modeling the various shapes of proteins (≈ 1
nm), the scale of biological considerations became smaller and smaller. This ex-
tension of the accessible length scales naturally happened in synergy with the
technical advancement of the possibilities at hand to image and map, i.e. the
resolving power of the available microscopes. By better design, more careful
engineering, and more precise manufacturing, the resolving power of optical
microscopes could historically be improved more and more.
This is because the resolution of all microscope systems that depend on inter-
rogating the structure of a sample by a focused beam of electromagnetic waves
is fundamentally limited by diffraction. Diffraction summarizes the complex
alterations of the spatial and frequency pattern of the incident light that oc-
cur upon its interaction with an obstacle [308]. Even a small point light source
(e.g. a laser beam), after hitting an obstacle, will form a diffraction pattern that
will contain additional information about the obstacle - the light source will
hence not be point-like any more. Every aperture, lens, mirror etc. within an
optical microscope system is such an obstacle. Due to diffraction, it is thus im-
possible to focus light to an infinitesimally small spot within the investigated
sample. Likewise, the signal stemming from an ideal point-like object within
the sample will not reach the microscope’s signal detecting unit (e.g. the eye,
a camera, an avalanche photodiode) as an ideal point-like object be but will
smear out in all three dimensions and appear larger than it actually is. The
specific three-dimensional diffraction pattern that a point-like object displays
when being imaged by a microscope is called the Point Spread Function (PSF).
The PSF is a microscope’s characteristic response function. In the lateral imag-
ing plane (i.e. the X-Y plane), the PSF corresponds to a circular Airy diffraction
image whose central intensity maximum is called the Airy disk. Now, if two
equally bright point objects within the imaged sample are very close together,
the overlap of their Airy disks at the microscope’s detector can result in the
two objects to appear as a single one. According to the Rayleigh criterion for
minimum resolvable detail [309, 310], a microscope can resolve only those in-
dividual features that are at a distance from each other of at least the radius of
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the Airy disk.
This immutable barrier that diffraction imposes on the possible resolution of a
microscope was formulated by the German physicist Ernst Abbe in 1873 [311].
In 1866, Ernst Abbe had been hired by the entrepreneur and optical manufac-
turer Carl Zeiss to formulate a theoretical framework, a recipe, how to design
and build the highest quality light microscope [312]. In addition to being very
successful at his assigned task, he came up with a fundamental law that - ad-
mittedly - would nowadays be considered to have “low advertising appeal”
for the microscope industry: Abbe’s diffraction limit. In a nutshell, it states
that two objects can only be discerned by a microscope if they are further apart
than about half the wavelength of the particle (including photons) that they
are examined with. Explicitly formulated, the approximate lateral resolution
∆x and ∆y, respectively, and the axial resolution ∆z of a microscope are subject
to the following relations:
∆x,∆y ≈ λ
2 · n · sin(α)
∆z ≈ λ
2 · n · sin2(α) .
(1.1)
Therein, ∆x and ∆y denote the full width at half maximum (FWHM) of the two
lateral directions, i.e. the directions spanning the focal plane, and ∆z denotes
the FWHM along the axial direction, i.e. the direction of the propagation of the
illuminating light. λ denotes the wavelength of the light used for the investiga-
tion of the sample, n is the refractive index of the immersion medium between
the objective lens and the sample, and α refers to half of the angular aperture
of the objective. In practice, the specific ability of the objective to collect light is
given by its Numerical Aperture (NA) which is defined as NA = n sin(α).
Examining Abbe’s formulation of the diffraction limit, two parameters can be
optimized to achieve better resolution. First, maximization of the numerical
aperture NA: the value of NA depends on the refractive index of the immer-
sion medium. The immersion media with the highest refractive indices avail-
able are immersion oils reaching n ≈ 1.51 which would lead to NA ≈ 1.3 and
thus not a profound increase in resolution compared to a dry objective (with
NA ≈ 0.95). Note that the concept of 4Pi-microscopy introduced by S. W. Hell
in 1990 [313] which achieves an effective doubling of the numerical aperture by
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mounting the sample between two opposing objectives can yield a profound
increase of the axial resolution ∆z by making use of the interference pattern
of the detected signal stemming from the sample. The lateral resolution, how-
ever, is not significantly improved in this approach. Second, minimization of
the wavelength λ of the employed light. Using short wavelengths, e.g. 400
nm UV light would, under ideal conditions (i.e. NA ≈ 1.3), lead to a possi-
ble object resolution of d ≈ 150nm - this is not sufficient to resolve subcellular
features. Also, for living biological systems, this UV light would be extremely
detrimental. Further, UV light needs special optical components to ensure high
transmission along the microscope’s beam paths.
Also based on the reduction of the sample interrogation wavelength, a ma-
jor step in increasing image resolution was the introduction of Electron Mi-
croscopy (EM) by Ernst Ruska in 1931 [314, 315]. Electrons feature a de Broglie
wavelength of about 2.5 pm when accelerated by about 200 keV. And despite
the fact that focusing electron beams by electrostatic and electromagnetic lenses
results in very small numerical apertures (NA ≈ 10−2 in transmission electron
microscopy), a resolution of about 0.1 nm can be achieved with EM; this is
imaging on the atomic scale. Yet, sample preparation for EM includes treat-
ments that are very harsh for the biological system, e.g. fixation with glu-
taraldehyde, then ultra-thin slicing (cf section 2.10.3) - hence, imaging con-
ditions in EM are certainly no longer physiological. Further, in electron mi-
croscopy, image contrast is based on the density of the scattering electrons
within the sample. Thus, targeting and highlighting specific structures is not
possible. A solution to this is immunoelectron microscopy [316] which is, how-
ever, a rather expensive and definitely challenging technique that requires a lot
of effort regarding protocol optimization and control experiments.
For completeness, a third strategy to increase the resolution shall be mentioned
here: scanning near-field optical microscopy (SNOM) [308]. SNOM is based on
avoiding the effect of diffraction by placing the probe (i.e. the light source or a
force sensor) closer to the sample surface than half the wavelength. That way,
effectively creating the focus next to the structure, there is not enough space
for the light waves to spread out due to diffraction and no diffraction pattern
is created. However, since they depend on the almost direct contact to the
sample, near field methods are restricted to surface sampling and need very
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complicated feedback controls to keep the distance from the sample constant.
Conclusively, there are very powerful approaches available that can achieve
much higher detail resolution than diffraction-limited light microscopy. Nev-
ertheless, (far-field) light microscopy is still the most frequently used imaging
modality to study biological systems. With the development of stable running
and powerful laser sources, especially fluorescence light microscopy has estab-
lished itself firmly in the life sciences. This has many convincing reasons:
• Light microscopy is minimally invasive to the sample and thus allows
imaging living, dynamic systems.
• Light microscopy is easy to implement at ambient conditions (i.e. tem-
perature, pressure etc.).
• Using fluorescence microscopy in conjunction with fluorescent proteins
allows the visualization of specifically tagged proteins in living systems.
• Using fluorescence microscopy in conjunction with immunolabeling al-
lows the visualization of specifically targeted proteins.
• Using fluorescence microscopy allows the simultaneous imaging of dif-
ferent structures in multi-color assays.
Nowadays, one of the most advanced systems in light microscopy - the laser-
scanning confocal fluorescence microscope - can almost standardly be found in
most life science laboratories. The principle of fluorescence microscopy makes
use of the properties of fluorescent dyes (fluorophores): they can be excited
with a certain laser wavelength, they will fluoresce at a more red-shifted wave-
length which can be detected, and this cycle of excitation and fluorescence can
be repeated multiple times.
With the invention of the general concept of immunofluorescence by Coons et
al. [317, 318] in 1941 which is based on coupling fluorescent dyes to protein spe-
cific antibodies to achieve the targeted fluorescent readout of the respectively
labeled proteins, fluorescence microscopy quickly became a widely used imag-
ing technique for diagnostics and in the basic research of protein localization
and interactions.
Another pioneering advancement in the field was the introduction of the scan-
ning confocal microscope by Marvin Minsky in 1957 [319, 320, 310]. Together
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with the appearance of high performance, highly focused laser systems and
precise, stable beam and sample stage scanning devices, Minsky’s prototype
of the confocal microscopy evolved to the phenotype that is predominantly
used today and that is displayed schematically in Fig. 1.6. In laser-scanning
Figure 1.6.: Schematic of a laser-scanning confocal microscope. Abbreviations (in alphabetical order): DM - Dichroic
Mirror; Exc - Excitation; F - Filter; L - Lens; PH - Pinhole; BS - Beam Scanner. The fluorescently labeled
sample is scanned and excited by a focused laser beam (red beam path) and fluorescence is collected by
a detector (green beam path). Fluorescence signal stemming from the out-of-focus regions (black beam
paths) are rejected before they enter the aperture of the detector by a pinhole placed in a plane conjugate
to the focal plane within the sample. The depicted coordinate system respectively indicates the lateral (X
and Y) and axial (Z) directions within the sample with respect to the optical axis.
confocal fluorescence microscopy, the fluorescently labeled sample is scanned
and excited by a focused laser beam (displayed in red in Fig. 1.6). The focal
spot in the sample is diffraction-limited. Thus, fluorescence signal stemming
from both the ideally focused plane (displayed in green in Fig. 1.6) as well
as from out-of-focus planes (displayed in black in Fig. 1.6) will propagate to-
wards the detector. However, the confocal pinhole (PH) before the detector in
a plane conjugate to the focal plane within the sample, will reject every fluo-
rescence signal stemming from out-of-focus regions. This readily provides for
optical sectioning. The procedure of scanning the laser beam over the sample
(or moving the sample through the laser focus by stage-scanning, respectively)
allows for the pixel based readout of the sample’s fluorescence signal.
In summary, the advantages of the labeling specificity, the possibility to image
living systems, and the relatively easy implementation make laser-scanning
confocal fluorescence microscopy the preferred method to image biological
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samples. Of course, it is just as diffraction-limited as every other thus far dis-
cussed microscopic technique. But the stated advantages justify why the sci-
entific field was and is so eager to refine fluorescence microscopy to its full
potential. Since knowledge is power, it is vital to understand the principles
of fluorescence excitation and emission in order to design the optimal fluo-
rescence microscope. After all, it was the knowledge about the energy levels
of fluorescent dyes and the knowledge how the transition between these lev-
els can be provoked that, 120 years after Abbe’s formulation of the diffraction
limit, would give optical microscopy another boost at nanometer resolution.
There exist three basic processes describing the possible interactions between
light and atoms or molecules: 1.) absorption, 2.) spontaneous emission, and
3.) induced (or stimulated) emission. These three concepts were formulated
within the framework of quantum theory by Einstein in 1916 [321]. In each of
the three cases, the energetic state of the atom or molecule is changed, resulting,
because of the conservation of energy, in the “consumption” or “production”
of photons. When a photon is emitted by a molecule due to its radiative tran-
sition from a higher (excited) energy level to a lower energy level, one speaks
of photoluminescence. Fluorescence is a special case of photoluminescence in
which the radiative transitions occur between molecular energy levels of the
same spin multiplicity [308]. Typical organic fluorophores generally make an
electronic transition between their singlet ground state and their first excited
singlet state when absorbing a photon [322] - and then make a transition back
from the first excited singlet state to the singlet ground state via spontaneous
emission of a photon, known as fluorescence. Another possible process caus-
ing the fluorophore to transition from its first excited singlet state back to its
singlet ground state is by stimulated emission.
Fig. 1.7 schematically displays the basic principle of photon absorption (i.e.
excitation), spontaneous emission (i.e. fluorescence) and stimulated emission.
To demonstrate these principles, a simplified model of a fluorescent molecule
is shown consisting of two energy levels: the dark ground state (the molecular
“Off” state) S0 and the fluorescent first excited state (the molecular “On” state)
S1. The ground and the first excited state are both accompanied by higher
energy vibrational levels (Svib0 and S
vib
1 in Fig. 1.7, respectively). The energy
difference between the ground state S0 and its corresponding vibrational lev-
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els Svib0 is very small. Likewise, the energy difference between the first excited
state S1 and its corresponding vibrational levels Svib1 is very small as well. The
fluorescent molecule can thus transition between Svib0 and S0 (and between S
vib
1
and S1, respectively) via nonradiative relaxation - a process called “internal
conversion”. This typically happens on a time scale on the order of a few pi-
coseconds [323]. In Fig. 1.7, the nonradiative relaxation is indicated by black
arrows.
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Figure 1.7.: Schematic energy level diagram of the processes of excitation, fluorescence and stimulated emission. The
schematic shows the simplified model of a fluorescent molecule assumed to comprise two (singlet) energy
levels. S0 and Svib0 denote the ground state and higher vibrational levels of the ground state, respectively.
S1 and Svib1 denote the first excited state and higher vibrational levels of the first excited state, respec-
tively. Black arrows indicate nonradiative relaxation. A The principles of molecular excitation (in blue)
and fluorescence (in green). B The principles of molecular excitation (in blue) and stimulated emission (in
red).
Fig. 1.7 A summarizes one complete excitation-emission duty cycle of a fluo-
rescent molecule. First, via absorption of a photon, the molecule is excited and
transitions from its ground state S0 to one of the short-lived vibrational levels
of the first excited state, i.e. to Svib1 . In this process (shown in blue in Fig. 1.7 A),
the energy of the absorbed photon matches the energetic gap between S0 and
Svib1 . After the fast nonradiative relaxation from S
vib
1 to S1, the molecule will
spontaneously and radiatively transition from S1 back to one of the vibrational
levels of the ground state, i.e. to Svib0 . This transition comprises the process of
fluorescence in which bridging the energy gap between S1 and Svib0 results in
the emission of a photon carrying this energy difference. The photon is emitted
in a random direction (depicted in green in Fig. 1.7 A). Since the energy gap
between S1 and Svib0 is smaller than that between S0 and S
vib
1 , the fluorescence
photon has a longer wavelength than the initial, exciting photon. From the
state Svib0 , the fluorescent molecule will now - again via nonradiative relaxation
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- return to its ground state S0 and is in princinple ready to be excited again.
The fluorescence life time of a typical organic fluorophore, i.e. the character-
istic time it takes for an excited molecule to emit the fluorescence photon, is
generally on the order of 2 - 10 ns [308].
The number of possible duty cycles that a fluorophore can perform is limited
by the process of photobleaching. Photobleaching occurs when the popula-
tion of fluorophores that can return to the energetic ground state is decimated
by permanent photochemical destruction of individual fluorescent molecules
[324]. Photochemical destruction can happen to the molecule from one of its
excited singlet energy levels and also from one of its excited triplet energy level
(which is usually reached by a molecule in the excited singlet state via intersys-
tem crossing). Photochemical destruction will not happen to fluorophores in
the energetic ground state. After photobleaching, fluorescent molecules are ir-
reversibly excluded from the excitation-emission cycle. Thus, for fluorescence
microscopy, the number of duty cycles that a fluorescent molecule can undergo
before it succumbs to photobleaching is an important sign of quality: the more
often a dye can be excited - and thus emit fluorescence and thus yield fluores-
cence signal - the better suited it is for imaging.
To complete the set of the three possible optical transition processes that Ein-
stein described in 1916, Fig. 1.7 B schematically displays the process of stim-
ulated emission. In stimulated emission, the interaction of a photon within
an already excited molecule results in the induced transition of that molecule
back into its energetic ground state. For stimulated emission to happen, the
molecular system has to be already prepared to be in the excited state. That
is after excitation from S0 to Svib1 and after nonradiative relaxation from S
vib
1 ,
the molecule is prepared in the state S1. Now, instead of spontaneously re-
turning back from S1 to Svib0 , the transient interaction with another photon can
instantaneously induce this transition. In this case, the photon needs to have
the necessary energy to bridge the gap between S1 and Svib0 . Then, if the addi-
tional photon transiently interacts with the molecule, the molecule will return
to Svib0 , thereby emitting a photon of the energy that matches the energetic gap
between the states S1 and Svib0 . Explicitly, the emitted photon will be of the
same wavelength as the one that initialized the process of stimulated emis-
sion. Since the emission stimulating photon only transiently interacts with the
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molecule, it will leave the molecule along the same direction of propagation
along which it arrived. The photon emitted by the molecule will be coherent
to the incident photon and propagate in the same direction. In Fig. 1.7 B, the
process of stimulated emission is displayed in red. Effectively, one will be left
with two coherent photons that propagate in the same direction: stimulated
emission is the underlying working principle of a laser.
These are the three basic tools at hand to harvest the chemical properties of
fluorescent molecules for light microscopy: excitation, fluorescence, and stim-
ulated emission. Ingeniously combining these three tools to manipulate and
influence the energy state that a dye is in during the time of fluorescence read-
out by a microscope lead to the clever de facto circumvention of the diffraction
limit and to the advent of superresolution optical microscopy.
In 1994, Hell and Wichmann envisioned using the process of stimulated emis-
sion to design a fluorescence microscope that would eventually break Abbe’s
diffraction barrier - not by bending the laws of Physics but by employing the
basic chemical properties of fluorescent molecules: the fact, that they can be
switched “On” and “Off” [325]. The idea of the targeted photoswitching of
fluorophores resulted in the concept of STimulated Emission Depletion (STED)
microscopy.
STED microscopy is a special case of the concept of Reversible Saturable Op-
tical Fluorescence Transition (RESOLFT) microscopy [326, 327]. As the name
implies, the principle of RESOLFT microscopy is based on the reversible sat-
uration of one of the specific energy levels of the fluorophores in a specimen.
The molecular energy level can correspond to a dark state (the “Off” state) or
a state from which a radiative transition would be possible (the “On” state). In
any case, the saturated molecular state is externally induced while the depleted
state serves as the information read-out channel. Typically, the molecular dark
state is saturated [328, 329, 330, 331, 332] because saturation of the excited state
[333, 334] is more vulnerable to increased levels of noise.
In essence, by the controlled saturation of specific molecular states, the concept
of RESOLFT allows the targeted preparation of the ensemble of fluorophores in
a specimen into a portion that is “Off” and a portion that is “On” - like a light
switch. The degree of saturation of the molecular state - i.e. the effectiveness
of the light switch - depends on the energy that is added to or taken from the
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molecular system. This energy can be controlled by adjusting the power of the
illuminating light sources that can induce specific state transitions, i.e. by the
intensity of the laser light with which the sample is irradiated. Further, the
region in which the optical state transitions are induced can be controlled by
spatially modulating the illumination pattern.
STED microscopy is the first and the most straightforward implementation of
RESOLFT type microscopy. In STED microscopy, the molecular ground state
(i.e. the dark state) of a fluorophore is saturated by making use of the principle
of stimulated emission. A STED microscope is basically an enhanced laser-
scanning confocal microscope (see Fig. 1.6). Because to achieve the satura-
tion of the molecular dark state, an additional laser beam (hereafter referred
to as the STED laser) is overlaid with the excitation laser beam of the confocal
microscope, both laser beams are focused into the sample, and the sample is
scanned. The circularly polarized STED laser features a spatially modulated
light pattern: a helical phase ramp from 0 to 2pi, typically created by a vortex
phase plate placed in the STED laser beam path, shapes the lateral intensity
distribution of the STED laser into a ring with an intensity zero in the center.
This characteristic intensity distribution is the so-called STED “doughnut” - an
expression that has gained some popularity and which will be used hereafter as
well to describe the specific appearance of the STED laser beam (in the lateral
direction).
Fig. 1.8 shows the calculated PSFs for a typical STED microscope featuring a
helical phase ramp from 0 to 2pi in the STED laser beam path. The PSFs are
displayed in the lateral plane (X-Y-plane) and in one of the axial planes (X-Z-
plane), respectively. Fig. 1.8 C shows the ideal spatial alignment of the exci-
tation and STED laser beam in all three dimensions that is generally pursued
when building and aligning a STED microscope.
Both the excitation and the STED laser beam PSFs are diffraction-limited. How-
ever, aligning excitation and STED laser beam and simultaneously scanning
the fluorescent sample with both focused lasers results in an effective STED
PSF that is diffraction-unlimited. The effective STED PSF is displayed in Fig.
1.8 D and features a FWHM of about 40 nm, i.e. a factor 6 smaller than in the
confocal case.
This remarkable increase in resolution beyond Abbe’s diffraction limit (see
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Figure 1.8.: Calculated Point Spread Functions (PSF) for a STED microscope featuring a helical phase ramp from 0 to
2pi in the STED laser beam path, i.e. a doughnut shaped light distribution in the lateral imaging plane
(X-Y-plane). The calculated PSFs in the lateral plane (X-Y-plane) and in one of the axial planes (X-Z-plane)
are displayed, respectively. The PSFs are radially symmetrical along the axial direction. A The calculated
PSF of the Gaussian shaped excitation laser beam, assuming an excitation wavelength of 532 nm. B The
calculated PSF of the initially Gaussian shaped, circularly polarized STED laser beam, assuming a wave-
length of 775 nm. C Overlay of the excitation and STED laser beams from A and B. D Effective PSF of
the STED microscope, assuming fluorescence detection at 580 nm, a numerical aperture of the objective of
NA ≈ 1.2 and a saturation factor of ζ = 50. Scale bars: 200 nm.
Eqs. 1.1) stems from the forced optical transition from the excited to the ground
state of those fluorophores within the diffraction limited focal spot of the ex-
citation laser that are at the same time (in fact, within a certain time frame
after the arrival of the excitation laser pulse at the sample) illuminated with
the STED laser beam. A portion of the fluorophores in the “On” state will be
switched into the “Off” state - and another portion of fluorophores will not be
switched off and thus stay in the “On” state. The efficiency of the switch-off de-
pends on the STED laser intensity: The higher the intensity of the STED laser
light, the higher is the probability of stimulated emission and the more fluo-
rophores will be switched off. Since the STED doughnut features an intensity
zero at its center, no fluorophores will be switched off there - those fluorophores
are the ones recorded by the fluorescence detection; those fluorophores are the
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ones that yield the effective information for the image acquisition.
Thus, the combination of two diffraction-limited focused laser beams results in
the STED laser intensity dependent reduction of the sample volume contribut-
ing to the fluorescence signal. Summarizing, the effective lateral resolution of
a STED microscope (along the X-direction) can be expressed by [335]
∆xSTED ≈ ∆x√
1+ (∆x)2a2(ISTED/ISat)
=
∆x√
1+ (∆x)2a2ζ
(1.2)
where ∆xSTED is the FWHM along the X-direction in STED illumination mode,
∆x is the FWHM along the X-direction in confocal mode (see also Eqs. 1.1),
and a is the steepness of the intensity distribution between the doughnut rim
and the doughnut zero along the X-direction. ISTED denotes the intensity of
the STED laser beam in the sample and ISat denotes the effective saturation
intensity, i.e. the STED laser intensity that is necessary to switch off half of
the fluorophores in an ensemble (ISat is an intrinsic property of a given fluo-
rophore; a low ISat typically results in a favorable switch-off behavior of a dye
for STED microscopy applications). These two figures can be summarized by
the saturation factor ζ = ISTED/ISat. In Fig. 1.8 D, the effective STED PSF was
calculated for an assumed saturation factor ζ = 50. For large saturation factors,
∆xSTED becomes independent of ∆x and one can write [335]:
∆xSTED ≈ 1a√ζ . (1.3)
As can be seen from Eq. 1.2, the achievable lateral resolution in STED mi-
croscopy is in principle unlimited. Factors influencing the achievable resolu-
tion in reality are the switch-off behavior of the used fluorophores, the avail-
able STED laser intensities, the photobleaching behavior of the fluorophores,
and the steepness of the pattern used for spatial light modulations - but none
of these factors pose a fundamental limit. Regarding the STED laser source, us-
ing STED lasers operated in both pulsed mode [330, 336] and continuous wave
(CW) mode [337, 338] has resulted in high quality subdiffraction images. Typi-
cally, to achieve the same spatial resolution, the laser power in CW mode has to
be larger by about a factor of 3 than the time-averaged power in pulsed mode
(assuming a laser repetition rate of about 80 MHz and a pulse length of 250
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ps) [337, 339, 340]. Both the application of pulsed and CW STED lasers has its
advantages and disadvantages: CW STED lasers are easier to implement in an
optical setup, are easier to maintain, and offer larger flexibility regarding avail-
able wavelengths. Pulsed STED lasers on the other hand typically yield better
image resolution at lower time-averaged intensities and are thus less invasive
with respect to photobleaching of fluorophores and heat induced damage to
the specimen. The implementation of fluorescence time gating for CW STED
applications has, however, proven to be a very feasible strategy to achieve high
resolution at lower STED powers [338, 341]. The principle and implementation
of fluorescence time gating for CW STED microscopy is described in more de-
tail in section 1.3.
Beside the choice of the STED laser source, many other successful approaches
to optimize the implementation of STED microscopy have been and are be-
ing investigated across various scientific areas, i.e. the development of refined
imaging setups [342], new fluorophores [343, 344], and staining protocols [345].
So far, the focus has been on the explicit improvement in lateral resolution in
STED microscopy. Note that by using a helical phase ramp, the axial resolution
of the STED microscope is not enhanced but equals that of the corresponding
confocal image. A 3D STED “doughnut” is typically realized by splitting the
STED beam into two perpendicularly polarized beams using a polarizing beam
splitter [339, 346, 347]. One beam is then directed through a vortex phase plate,
the other beam is directed through an axial phase plate which features a layer
of mineral (typically cryolite) of a certain thickness that causes a phase shift
of the STED beam along the optical axis. After passing the respective phase
plates, the two STED beams are recombined by another polarizing beam split-
ter. The resulting STED beam profile has an intensity zero both in the lateral
plane and along the optical axis. The combination of the lateral and the axial
phase plates results in a trade-off between achievable lateral and axial resolu-
tion since the intensity of the initial STED beam has to be split between the
lateral doughnut and the axial doughnut. This splitting can be adjusted by a
half-wave retarder plate in front of the first polarizing beam splitter to tune the
ratio of the intensity of the vertically and the horizontally polarized portion of
the STED laser beam. The optimal intensity distribution is about 70 % vs. 30 %
for helical phase plate vs. axial phase plate [348]. An alternative approach to
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achieve a 3D STED effect included the implementation of adaptive optics for
wave front shaping [349].
Apart from the targeted read-out approach in STED microscopy, there are also
other types of subdiffraction optical microscopy.
One alternative relies on the stochastic read-out of fluorophores or subdiffrac-
tion proteins. Here, the superresolution is achieved by “thinning out” the pop-
ulation of simultaneously emitting fluorophores. This is done by using only
low light intensities to excite the fluorophores such that only a fraction of the
whole ensemble of possible emitters transitions to the excited energy state. The
cycle of partial activation and read-out is repeated until every fluorophore is
terminally photobleached. The final image is then reconstructed by consider-
ing the signal from every cycle of excitation and read-out and assigning every
detected signal per cycle a location within the field of view. Thus, the achiev-
able resolution with these techniques depends on the accuracy of the local-
ization of individual fluorescent molecules and hence on the number of duty
cycles a fluorophore can undergo before photobleaching, i.e. on the number
of emitted photons per molecule. Examples of these stochastic approaches are
PhotoActivated Localization Microscopy (PALM) invented by Betzig et al. in
2006 [350], STochastic Optical Reconstruction Microscopy (STORM) developed
by Rust et al. in 2006 [351], and (GSDIM) introduced by Hell et al. in 1995
[352, 353]. As opposed to STED microscopy which is a direct imaging tech-
nique, the stochastic read-out methods have the drawback that in addition to
a quite extended image acquisition time, they require algorithm based image
post-processing to reconstruct the image.
Finally, another option of subdiffraction optical microscopy, the concept of sat-
urated structured illumination (SSIM), put forward by Gustafsson in 2005 [333],
shall be mentioned here in brief. Here, the fluorophores in the sample are
illuminated with a spatially modulated light pattern in the wide-field mode
and tuning the excitation to the level of fluorophore excitation. The overlay of
the actual sample structure and the patterned illumination will lead to Moiré
fringes between the two structures that encode higher spatial frequencies, i.e.
structural detail. The direct image read-out is the outline of the sample struc-
ture (a “negative” image) which then has to be deconvolved to yield the actual
sample structure. While this concept has the advantage of not relying on fo-
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cused light and hence being a parallelized method, it also has the drawback of
necessary algorithm-based image post-processing.
Just like the above mentioned subdiffraction imaging methods, STED micros-
copy has now officially arrived in the scientific community as well as in the in-
dustrial sector. There is no longer the need to simultaneously show a STED im-
age with its confocal counterpart to justify the data’s scientific reliability or to
stress the increase in object resolution. The coming of age of STED microscopy
is ushering in a new era of formulating new biological questions - and of revis-
iting already decade old ones - under the light of subdiffraction resolution and
the possibilities that it brings about. Some very impressive and biologically rel-
evant results arising from STED microscopy investigations shall be mentioned
in the following.
In the field of virology and the basic research on the Human Immunodeficiency
Virus type 1 (HIV-1), the application of STED microscopy unraveled that upon
maturation, the viral envelope glycoprotein will cluster, thereby augmenting
the capability of the virus to invade the host cell [354].
In structural biology, the eight fold symmetry of proteins of the cellular Nuclear
Pore Complex (NPC) could be visualized [336], thus enabling the protein tar-
geted structure resolution of the NPC in unison with and to accompany studies
based on, for example, cryoelectron tomography, X-ray crystallography, and
Nuclear Magnetic Resonance (NMR) spectroscopy [355, 356, 357].
In structural neuroscience, the striped arrangement of axonal Actin structures
in living cultured rat neurons could be revealed [345, 358], an arrangement that
had so far only been shown in fixed cells [359] or could only be hypothesized
based on electron micrographs [360].
In live-organism neuroscience, STED microscopy could be applied to visualize
the structurally dynamic behavior of dendritic spines and the rearrangement
of Actin structures in the brain of living mice in real time [361, 362, 363].
Of special importance for this thesis, in the field of cardiovascular research,
STED microscopy was successfully applied to study the remodeling of Trans-
verse Tubules in living mouse ventricular cardiomyocytes in a disease model
of myocardial infarction [22, 23] (see also section 1.1 for more detail).
Note that this is by far not a comprehensive listing since many new insights
made possible by STED microscopy are constantly being published.
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Further, STED microscopy has been successfully combined with other pow-
erful imaging techniques such as Atomic Force Microscopy (AFM) [364, 365],
Electron Microscopy (EM) [366], Fluorescence Correlation Spectroscopy (FCS)
[98, 367] (see also section 1.1), and Two-Photon-Excitation (2P-Exc) microscopy
[368, 369].
Hence, with an ingenious and basically more and more refinable underlying
principle, a rapidly evolving field of convincing and impressive applications,
and the possibility to match and control experimental findings with other pow-
erful imaging approaches, STED microscopy has established itself firmly among
the staple techniques of biological imaging.
In this thesis, the subdiffraction imaging and study of membrane lipid and
membrane protein clusters in cardiomyocytes were of particular interest. The
conducted studies brought about new labeling, imaging and image analysis
techniques. The advantages of 2P-Exc microscopy in conjunction with STED
microscopy were explored and utilized to achieve three-dimensional (3D) imag-
ing of membrane structures in living mouse ventricular cardiomyocytes (see
also sections 3.4 and 3.4.3).
1.3. Two-Photon-Excitation-STED microscopy
The theoretical foundation of two-photon excitation dates back to 1931 when
the physicist Maria Göppert-Mayer in her doctoral dissertation theoretically
predicted that in one quantum event, a molecule could absorb two photons,
thereby being excited to an energy level which is the sum of the energy of
the two photons. Göppert-Mayer gave her thesis the wonderful title - here
freely translated from German - “About elementary processes with two quan-
tum leaps” [370].
In Fig. 1.9, the principle of Two-Photon Excitation (2P-Exc) and the ensuing
process of fluorescence (i.e. spontaneous emission) are schematically depicted
for a fluorescent molecule comprising two energy levels: the dark ground state
level (S0, the molecular “Off” state) and the fluorescent first excited state (S1,
the molecular “On” state). Svib0 and S
vib
1 denote the higher vibrational levels of
the ground state and the first excited state, respectively. The 2P-Exc process is
depicted in red, the process of fluorescence is depicted in green, and black ar-
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Figure 1.9.: Schematic energy level diagram of the
process of Two-Photon Excitation (2P-Exc)
and the ensuing fluorescence relaxation of
a fluorescent molecule. A two-level en-
ergy system was assumed for the fluores-
cent molecule. S0 and Svib0 denote the sin-
gle ground state and higher vibrational
levels of the singlet ground state, respec-
tively. S1 and Svib1 denote the singlet first
excited state and higher vibrational lev-
els of the singlet first excited state, respec-
tively. The 2P-Exc process is displayed in
red, the fluorescence process (i.e. sponta-
neous emission) is depicted in green; black
arrows indicate vibrational energy relax-
ation.
rows indicate vibrational energy relaxation from higher vibrational levels back
to the first excited state or back to the ground state, respectively. For the fluo-
rophore transition from the ground state to the excited state, the two simulta-
neously absorbed photons have to deliver an energy of
∆E = ES1 − ES0 ≈ 2
hc
λ2P
(1.4)
with ES1 and ES0 being the first excited state and ground state energy, respec-
tively, h being Planck’s constant, c being the speed of light, and λ2P being the
wavelength of each of the two photons absorbed in the 2P-Exc process.
In a microscope setup making use of 2P-Exc, the following relationship for the
number of absorbed photons per fluorophore per laser pulse, Nabs would apply
[371, 372]:
Nabs ≈
P20 δ
τP f 2P
(
pi (NA)2
hcλ2P
)2
(1.5)
with P0 being the average laser intensity, δ being the fluorophore’s two-photon
absorption cross section at the 2P-Exc wavelength λ2P, τP and fP being the
pulse duration and the repetition rate of the excitation laser source, respec-
tively, and NA being the numerical aperture of the microscope’s objective lens.
h and c are Planck’s constant and the speed of light, respectively. From equa-
tion 1.5, it follows that in 2P-Exc microscopy, the intensity of the emitted flu-
orescence of a dye molecule depends quadratically on the excitation intensity
[373].
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The simultaneity of the two-photon absorption process requires the two pho-
tons to be absorbed during the Heisenberg uncertainty principle time of ≈
10−16 s. Thus, efficient 2P-Exc requires very high photon densities of about
1032/cm² [374]. For practical fluorescence imaging applications, this puts a vi-
tal demand on the illumination source: providing extremely high peak powers
per sample area - typically in the range of about 10 GW/cm² [375] - while at the
same time avoiding damage of the sample. Pulsed lasers with pulse lengths in
the region of≈ 100 fs and≈ 80-100 MHz repetition rate (e.g. Titanium:Sapphire
lasers) can supply the necessary peak powers without delivering the detrimen-
tal thermal load to the samples.
Therefore, the application of the proposed principle of 2P-Exc for fluorescence
microscopy needed to await the advent of bright and stable laser sources sup-
plying the necessary photon density to achieve a sufficient two-photon absorp-
tion cross section [374]. Then, in 1990, combining laser scanning microscopy
and a femtosecond pulsed laser, Denk, Strickler, and Webb first applied the tech-
nique of two-photon laser scanning fluorescence microscopy to image DNA in
living pig kidney cells [371].
Since then, Two-Photon Excitation (2P-Exc) microscopy has become widely
used and favored in the life sciences, especially for 3D imaging deep inside
living cells. This is due to the three major advantages of 2P-Exc microscopy:
1.) In 2P-Exc microscopy, the optical sectioning effect which in confocal mi-
croscopy can only be achieved via the confocal pinhole (see section 1.2),
comes for free since the quadratic dependence of the fluorescence sig-
nal on the excitation intensity substantially decreases the effectively flu-
orescing sample volume. Hence, background signal from out-of-focus
planes is eliminated without having to sacrifice precious fluorescence sig-
nal [376].
2.) Second, due the “virtual pinhole” inside the focal plane caused by the 2P
effect, also those fluorescence photons that are scattered within the spec-
imen on their way back through the objective lens can be detected and
are not rejected by a physical confocal pinhole [376]. This is particularly
useful for imaging deep within thick and strongly scattering samples, e.g.
biological tissues, and additionally supported by the longer illumination
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wavelengths used in 2P-Exc applications because the degree of scattering
is inversely proportional to the wavelength.
3.) Third, photobleaching of the used fluorophores and photodamage to the
specimen are reduced because longer wavelengths are used for fluoro-
phore excitation and because the region of laser light absorption is con-
fined to the focal plane since only there, at the excitation laser focus, the
absorption cross section is large enough to provide fluorophore excitation
[371].
Of course, the concept of fluorophore excitation by the simultaneous absorp-
tion of multiple photons can and has already been extended to three-photon
absorption processes for biological imaging [377, 378] and even four-photon
absorption [379], although the latter has so far remained rather exotic but may
prove useful for the investigation of the properties of semiconductors.
Regarding the usable fluorophores for 2P-Exc microscopy applications, basi-
cally all dyes that are standardly used for one-photon excitation microscopy
can be used under 2P-Exc conditions - of course, more or less efficiently, de-
pending on their 2P absorption efficiency, i.e. the 2P cross section of the re-
spective dye. While the emission spectra of fluorophores are essentially un-
changed under one-photon vs. 2P-Exc conditions, the absorption spectra can
show profound blue-shifts in the 2P-Exc case compared to one-photon excita-
tion [380, 381, 382]. It can thus not be readily assumed that the optimal 2P-Exc
wavelength for a given fluorophore whose one-photon absorption spectrum is
known simply corresponds to twice the wavelength of the one-photon absorp-
tion maximum. The optimal 2P-Exc wavelength for a given fluorophore in a
given specimen thus has to be determined experimentally.
2P-Exc microscopy could successfully be applied to visualize and unravel as-
tonishing biological relations [383, 384]. Especially in the neurosciences, 2P-Exc
microscopy is a staple method for imaging all the intricate details deep inside
the brain - partly even in live, freely moving animals [385, 386, 387, 388]. But
also in developmental biology [389, 390, 391] and in materials science [392, 393,
394] 2P-Exc microscopy are now a standard method.
However, it has to be kept in mind that the resolution of a 2P-Exc microscope
is about the same as that of a standard “perfect” (i.e. pinhole  one Airy
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Unit diameter) confocal microscope. In fact, 2P-Exc microscopy features even
worse resolution because of the necessary application of longer wavelengths
for fluorophore excitation (see also the equations 1.1 in section 1.2). If an ob-
ject cannot be resolved by a confocal microscope, then the 2P-Exc microscope
will not resolve it either. Nevertheless, because of the above mentioned three
major advantages of 2P-Exc microscopy, it is still better suited than confocal
microscopy for imaging specific biological samples.
Note also that the excitation power densities necessary for a sufficient absorp-
tion cross section are significantly higher for 2P-Exc than for one-photon ex-
citation, corresponding to ≈ 10 GW/cm² as compared to ≈ 1 MW/cm² [373]
(also observed from one-photon excitation vs. 2P-Exc experiments of the same
specimen conducted in this thesis). This can undo the benefits of reduced sam-
ple bleaching in out-of-focus planes and, in the worst case, lead to increased
photobleaching and photodamage. Several studies have thus investigated the
effect of the relatively high 2P illumination intensities on the sample quality,
especially cell/organism longevity in live-cell experiments using 2P-Exc mi-
croscopy. Generally, the parameters that actually define the fitness or quality
of a biological sample have to be determined very specifically with respect to
the specimen under consideration and then lay the foundation for appropriate
control experiments. For example, examining the continued normal develop-
ment of mammalian embryos, Squirrell et al. could show that repetitive sample
scanning with 2P-Exc even over a period of 24 h did not compromise the de-
velopmental stages - opposed to analogously performed one-photon excitation
scanning which lead to the inhibition of embryo development already after 8 h
[395]. Likewise, the unimpaired function of pancreatic islets [396] and the via-
bility of cultured cells [397] in 2P-Exc imaging experiments could be verified.
However, 2P-Exc processes are assumed to be the major cause of photodam-
age to a specimen scanned with laser radiation within the wavelength range
between 700 and 1000 nm [398]. All in all, it is important to find the lowest 2P-
Exc illumination power that yields both a sufficiently high signal-to-noise ratio
and at the same time limits damage to the biological system - typically em-
ployed 2P-Exc powers (≈ 5 mW measured right at the sample) can fulfill both
these prerequisites [399]. And since the fluorophores in the out-of-focus sam-
ple planes do not interact with the 2P-Exc light, they are spared the detrimental
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effects of photobleaching and possible photodamage. This will be of particular
importance when combining 2P-Exc microscopy and STED microscopy which
will be discussed next.
Regarding the further improvement of spatial resolution in 2P-Exc microscopy,
several successful approaches have been demonstrated. For example, 2P-Exc
microscopy has been combined with structured illumination microscopy (SIM)
and thus achieved an improvement in the lateral resolution by a factor of ≈ 2
[400]. In 2009, the combination of 2P-Exc and STED microscopy (from here on
referred to as 2P-Exc-STED) was first reported by Moneron et al. who could
show lateral structure resolutions down to 80 nm in fixed mammalian cells
immunofluorescently labeled for the protein complex NF-κB [368]. This corre-
sponds to an improvement in lateral resolution by a factor of 4 compared to
conventional 2P-Exc microscopy. Also in 2009, 2P-Exc-STED imaging of pyra-
midal neurons identified within hippocampal brain slices, loaded with a flu-
orescent dye solution, and recorded at an imaging depth of between 45 and
80 µm, Ding et al. could show lateral structure resolutions of ≈ 280 nm, cor-
responding to a 3-fold resolution improvement over 2P-Exc microscopy [369].
Further, 2P-Exc-STED could be shown to also be used in conjunction with flu-
orescent proteins. In 2009, Li et al. tagged the protein Caveolin-1 in Chinese
Hamster Ovary cells with the green fluorescent protein derivative EGFP and,
using 2P-Exc-STED, achieved a structural resolution of about 70 nm [401].
Since these first applications of 2P-Exc-STED microscopy in biological imag-
ing, 2P-Exc-STED microscopy has been successfully applied predominantly to
visualize topological features in the mammalian brain: axons, dendrites, pyra-
midal neurons - all under physiological conditions [402, 403, 404].
When designing a 2P-Exc-STED microscope, the researcher can typically make
a choice whether to use a STED laser operated in pulsed or continuous wave
(CW) mode. Deciding for a pulsed STED laser has the advantage that it pro-
vides a higher signal-to-noise ratio and leads to a more confined focal spot in
which fluorescence is still possible compared to using a CW STED laser [348].
This effectively results in a more efficient fluorescence switch-off of the dye
molecules and thus comparatively lower illumination intensities focused into
the sample in the case of a pulsed STED laser as compared to a CW STED
laser (see also section 1.2). However, pulsed lasers are more expensive than
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CW lasers. Further, incorporating a pulsed STED laser in a 2P-Exc microscope
can be quite challenging since both the laser pulses stemming from the 2P-Exc
source as well as the STED laser pulses have to be temporally synchronized,
a procedure that has to be performed as a part of the daily microscope align-
ment. Also, the optimal synchronization depends on factors like the lifetime
of the used dye in a specific sample - a property that is influenced by the dye
environment, i.e. the sample medium or the sample substrate, resulting in hav-
ing to adjust the proper laser pulse synchronization using the actual sample; at
least when wanting to ensure optimal sample imaging conditions [402].
In contrast, the technical realization of combining 2P-Exc and STED microscopy
using a CW STED laser (an imaging modality from here on referred to as 2P-
Exc-CWSTED) is very straightforward: starting from a standard designed 2P-
Exc microscope, an additional CW STED laser featuring the distinct “doughnut-
shape” (see section 1.2) is coaligned with the 2P-Exc laser and the sample si-
multaneously scanned with the two focused laser beams (see also section 2.1.1
for the 2P-Exc-CWSTED system custom-built in this thesis). However, as men-
tioned in section 1.2 and in the last paragraph, using a STED laser operated in
CW mode results in having to apply higher illumination powers to the sample
compared to the case of using a pulsed STED laser to achieve the same gain in
resolution. Additionally, the recorded images feature a lower signal-to-noise
ratio [341].
Therefore, it has been found that time gating of the detected fluorescence signal
stemming from the scanned sample brings about a tremendous improvement
in both image resolution and background noise suppression [405, 338, 406, 341,
407] - and this applies to both one-photon-excitation-CW-STED as well as 2P-
Exc-CWSTED applications. In brief, the concept of time gating makes use of the
fact that the effective excited-state life time of a dye molecule depends on its
position within the STED “doughnut’s” illumination pattern, i.e. on the inten-
sity of the light that leads to stimulated emission. The higher the STED laser
intensity “seen” by the fluorophore, the longer its effective excited-state life
time. Accordingly: the closer a fluorophore is located to the center of the STED
laser, the longer its effective excited-state life time. Selecting for the long-lived
excited-state dye molecules for fluorescence recording means selecting for the
dye molecules close to the center of the STED beam - thus spatially confin-
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ing the spot from which the fluorescence is recorded and thereby enhancing
resolution (and decreasing unspecific background signal). In principle, a flu-
orescence time gate is implemented by first setting the time of arrival of the
excitation laser pulses as a relative and periodic reference point for the fluo-
rescence photons recorded by the detection device. With respect to this refer-
ence point, only those photons that were detected after a certain time TGate (the
“gate delay”) after the excitation laser pulse are accepted to contain informa-
tion for image acquisition. The photons that arrive before TGate are rejected.
Note here that fluorescence time gating will sacrifice a portion of the detected
fluorescence photons. It is therefore important and highly advisable to adjust
the fluorescence time gate precisely . This is typically done by aiming to set
the time gate such that optimal image resolution and signal-to-noise ratio are
achieved. The gate delays for many of the organic fluorophores in this thesis
that have proven to be suitable for 2P-Exc-CWSTED are within the range of
2 - 3 ns (see also section 3.4.2).
Finally, regarding the choice of suitable fluorophores for 2P-Exc-CWSTED, no
comprehensive studies stating the ideal 2P-Exc wavelength and illumination
conditions, and the performance under 2P-Exc-CWSTED conditions of stan-
dard used STED microscopy compatible dyes has been conducted until now -
a shortcoming that will be remedied in this thesis (see section 3.4.2).
Conclusively, 2P-Exc-CWSTED microscopy is also a promising approach to im-
age living isolated cardiomyocytes in 3D. First, because cardiomyocytes are
quite large cells, e.g. mouse ventricular myocytes measure about 20 µm ×
20 µm × 80 µm – 3D imaging of whole cardiomyocytes thus necessarily re-
sults in deep-tissue imaging. Second, because cardiomyocytes feature their
Transverse-Axial Tubular System (TATS, see section 1.1) that basically presents
channels that are filled with aqueous culture medium, and because they also
feature an abundance of mitochondria. This results in many interfaces inside
the cells at which scattering events are very likely. These limitations regarding
image quality are best compensated for by the 2P-Exc-CWSTED imaging pro-
tocol. Based on the known facts as well as the hypotheses about the distinct car-
diac membrane organization and based on the two types of STED microscopy
techniques (i.e. STED and 2P-Exc-CWSTED) that have here been introduced in
brief, the overall aim of this thesis shall be formulated in the next section.
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1.4. Aim of this thesis
The aim of this thesis is the generation of a comprehensive cardiac sarcolem-
mal membrane model localizing and structurally relating Cholesterol (Chol),
Caveolin-3 (Cav-3), Ganglioside GM1 (GM1), and Dystrophin (Dyst), thereby
focusing on the specific membrane architectures and sarcolemmal nanopat-
terns that these lipids and proteins form - individually and mutually associ-
ated. The generation of this cardiac membrane model is based on, will be
investigated with and verified by single- and multi-color STED and 2P-Exc-
CWSTED microscopy.
The here proposed cardiac sarcolemmal membrane model is summarized in
Fig. 1.10. This model comprises the cardiac membrane structures of caveolae
and Transverse Tubules (T-Tubules) as well as the possible mutual arrange-
ment of Chol, Cav-3, GM1, and Dyst at the sarcolemma. Note that the model
is not drawn to actual proportions nor correct stoichiometry. The enrichment
of Chol and GM1 at the membrane of caveolae lined by Cav-3 is schematically
depicted; possible binding sites for Chol along the Cav-3 protein are indicated
by red triangles (see also sections 1.1.1, 1.1.2, and 1.1.3). The location of possi-
ble F-Actin, Nitric Oxide Synthase (NOS), Dystroglycan (including the α and
β subunit), and Syntrophins (Syntr., including α1− and β1−Syntr.) binding
sites along the Dyst protein are shown based on the information presented in
section 1.1.4. Note here that in this model, NOS comprises both endothelial
NOS as well as neuronal NOS since they are both expressed in cardiac tissue
(see section 1.1.4). The possible association between Dyst and Cav-3 mediated
via interaction with NOS and located to the Dyst rod domain and the Dyst
C-terminus (C) are suggested (question marks). The potential binding sites
for microtubules at different locations long the Dyst protein (see section 1.1.4)
are depicted (question marks) but will not be investigated within the scope of
this thesis. Finally, the following molecular orientation of the Dyst molecule is
proposed and displayed in the model: a) the Cystein rich and the C-terminal
protein domains are located closest to the sarcolemma (and to Cav-3), b) there
is a possible close proximity between the rod domain (at the Spectrin like re-
peats R17-R18, i.e. the potential NOS binding site, see section 1.1.4) and Cav-3
at the sarcolemma, and c) the N-terminus (N) of the Dyst protein is located
further away from the sarcolemma (and the therein residing Cav-3).
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In summary, this thesis will address the following topics and present strategies
for their investigation:
1.) To allow fluorescent labeling of Chol rich membrane nanodomains for
STED and 2P-Exc-CWSTED microscopy imaging, a new class of variously
colored fluorescent Cholesterol analogs will be introduced and a general
protocol for cardiomyocyte labeling will be established.
2.) To enable three-dimensional subdiffraction imaging of whole mouse ven-
tricular cardiomyocytes (VM), the design and construction of a 2P-Exc-
CWSTED microscope will be outlined together with an overview of suit-
able fluorophores.
3.) To relate the sarcolemmal signal structures of the associated proteins and
lipids Chol/GM1, Cav-3/GM1, and Cav-3/Dyst, two-color imaging pro-
tocols for STED microscopy will be established and analyzed quantita-
tively.
4.) To develop a model for the molecular orientation between Cav-3 and
Dyst, and to resolve the molecular orientation of the complete Dyst pro-
tein along the sarcolemma, three-color imaging protocols for STED mi-
croscopy with a single STED laser wavelength will be established based
on the targeted labeling of specific protein epitopes via different primary
antibodies.
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2. Experimental methods and
techniques
For providers and order numbers of used chemicals, equipment, and antibod-
ies, please refer to Appendix A. Appendix B contains a comprehensive, tabular
overview over all the images presented throughout this thesis; the table explic-
itly summarizes which microscopes were used and which parameters were set
for image acquisition.
2.1. Microscope setups
2.1.1. Custom-built Two-Photon-Excitation-CW-STED
(2P-Exc-CWSTED) microscope
The following experiments were conducted using a Two-Photon-Excitation-
CW-STED (2P-Exc-CWSTED) microscope setup that was custom-built within
the scope of this thesis:
• Investigation of the effect of the repetition rate (rep rate) of the 2P-Exc
laser on the photobleaching behavior of fluorophores in 2P-Exc and 2P-
Exc-CWSTED applications (specifically: 1 GHz vs. 800 MHz rep rate, see
section 3.4.1).
• Screening and evaluation of organic fluorophores for their suitability in
Two-Photon-Excitation-CW-STED microscopy applications (see section
3.4.2).
• Three-dimensional (3D) imaging of membrane and Cholesterol structures
in living mouse ventricular cardiomyocytes (VM) (see section 3.4.3).
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Figure 2.1.: Scheme of the custom-built, Two-Photon-Excitation-CWSTED (2P-Exc-CWSTED) microscope (see also sec-
tion 3.4.3). Abbreviations (in alphabetical order): 2P-Exc - Two-Photon-Excitation; APD - Avalanche Photo
Diode; BF - Bright Field; BS - Beam Scanner; DM - Dichroic Mirror; F - Filter; FI - Faraday Isolator; FL - Flu-
orescence Lamp; Fluo - Fluorescence; FO - Fluorescence Objective; FPH - Flippable Pinhole; FPS - Flippable
Pellicle Beam Splitter; GM - Galvanometer Mirror; λ/2 - Half-Wave Retarder Plate; λ/4 - Quarter-Wave
Retarder Plate; L - Lens; M - Mirror; MMF - Multi Mode Fiber; MO - Mirror for beam Overlay; Obj -
Objective; P - Periscope; PBS - Polarizing Beam Splitter Cube; PH - Pinhole; PM - Phase Mask; PMT -
Photomultiplier Tube; SL - Scan Lens; SM - Spherical Mirror; SMF - Single Mode Fiber (polarization main-
taining); Ti:Sa - Titanium Sapphire; TL - Tube Lens.
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The 2P-Exc-CWSTED microscope is schematically depicted in Fig. 2.1 and de-
scribed in the following, making implicit use of the nomenclature and abbrevi-
ations introduced in the scheme.
The setup was built from scratch and designed to meet the specific require-
ments imposed by live cardiomyocyte imaging for biological studies. Special
attention was paid to the provision of fast workflow for the experimenter. This
was done to ensure optimal cell quality within the physiologically relevant
time window of approximately 5 hours after cardiomyocyte isolation (see sec-
tion 2.3.1), and to achieve high throughput of investigated cells per prepared
sample. Further, the 2P-Exc-CWSTED setup comprised both bright field as
well as fluorescence widefield imaging channels that could be operated simul-
taneously. This allowed direct feedback to control the cardiomyocyte quality:
regular striations and sharp cell edges could be confirmed in the bright field
channel, and even distribution of the membrane stain and the absence of vesi-
cle formation could be confirmed in the fluorescence widefield channel. Both
the bright field and the fluorescence widefield channels were realized by fo-
cusing the light from a fluorescence lamp (FL, Leica EL6000 LQ-HXP 120, Leica
Microsystems, Wetzlar, Germany) into the sample in an upright fashion using a
10x, 0.25 NA air objective (FO, 038712, Spindler & Hoyer, now Qioptiq Photon-
ics GmbH, Goettingen, Germany). For the bright field channel, after passing
the microscope objective (Obj), a portion of the light was reflected onto a CCD
camera chip (Camera BF) via a flippable pellicle beam splitter (FPS1, BP145B1,
Thorlabs, Munich, Germany). For the fluorescence widefield channel, the light
from the fluorescence lamp first passed a bandpass filter (F4, 488/50 BrightLine
HC, F39-486, AHF Analysentechnik, Tuebingen, Germany) and a short pass
dichroic beam splitter (DM3, T500SPXR, F48-499, AHF Analysentechnik, Tue-
bingen, Germany) before entering the air objective. The fluorescence from the
sample was collected by the air objective and reflected by the above mentioned
dichroic beam splitter (DM3). The fluorescence light then passed a bandpass
filter (F5, ET535/70m, Chroma Technology, Bellows Falls, VT, USA) and was
focused onto a CMOS camera (Camera Fluo, DMK 72BUC02, The Imaging
Source GmbH, Bremen, Germany). With both the bright field and the fluo-
rescence widefield channels, intact cells could be found fast and positioned
coarsely using a motorized XY-translation stage for inverse microscope setups
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(SCAN IM 130 × 100-1 mm with TANGO controller, 00-24-546-0000 and 00-76-
150-1802, Maerzhaeuser Wetzlar GmbH, Wetzlar, Germany).
The 2P-Exc-CWSTED microscope setup was designed as an inverse micro-
scope. Two-Photon Excitation (2P-Exc) was provided by a tunable, mode-
locked Titanium:Sapphire laser (2P-Exc Laser Ti:Sa, Mai Tai, Newport Spectra-
Physics, Darmstadt, Germany) with a pulse width of 100 fs and a repetition
rate of 80 MHz. The total of all optical components in the laser beam path in-
troduced positive group velocity dispersion and thus resulted in pulse spread-
ing. Therefore, the 2P-Exc laser pulse width was controlled right before enter-
ing the microscope objective with an autocorrelator (pulseCheck, APE Ange-
wandte Physik & Elektronik GmbH, Berlin, Germany) and amounted to 300
fs which provided a sufficient two-photon absorption cross section. The laser
was operated within the wavelength range of 730 - 850 nm. A Faraday Isolator
(FI, FI-820-5SV-BB, Linos via Qioptiq Photonics GmbH, Goettingen, Germany)
was placed in front of the laser output aperture to avoid back reflections into
the laser head. The 2P-Exc laser light was operated in a free beam mode to pro-
vide the high illumination peak powers necessary for efficient 2P-Exc. Hence,
the beam profile was laterally cleaned up with a 100 µm mechanical pinhole
(PH) positioned at the focus of a telescope lens system (L1 and L2) and con-
trolled to have a Gaussian profile using a CCD camera beam profiler (BC106N-
VIS/M, Thorlabs, Munich, Germany). Vertical linear polarization of the 2P-Exc
laser beam as well as laser power control was provided by a combination of a
half-wave retarder plate (λ/2, RAC 4.2.15, B. Halle Nachfl. GmbH, Berlin, Ger-
many) and a polarizing beam splitter (PBS, PTW 1.20, B. Halle Nachfl. GmbH,
Berlin, Germany). The 2P-Exc laser beam could be precisely aligned with the
STED laser beam using a dielectric mirror positioned in a conjugated plane
of the focus of the microscope objective (conjugated planes are indicated by
dashed yellow lines in Fig. 2.1).
The STED light was provided by a continuous wave visible fiber laser at a
wavelength of 592 nm (STED Laser 592 nm CW, 2RU-VFL-P-1500-592, MPB
Communications Inc., Montreal, Quebec, Canada). The polarization of the
STED laser beam was adjusted with a half-wave retarder plate (λ/2, RAC
3.2.15, B. Halle Nachfl. GmbH, Berlin, Germany) before being coupled into
a polarization maintaining single mode fiber (SMF, P3-488PM-FC-2, Thorlabs,
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Munich, Germany). After the fiber, the beam was collimated by an achromatic
lens (L4). Vertical linear polarization and and laser power control were pro-
vided by a combination of a half-wave retarder plate (λ/2, RAC 3.2.15, B. Halle
Nachfl. GmbH, Berlin, Germany) and a polarizing beam splitter (PBS, PTW 20,
B. Halle Nachfl. GmbH, Berlin, Germany). The STED beam then passed a
vortex phase plate (PM, VPP-A1, RPC Photonics, Rochester, NY, USA) which
generated the typical toroidal lateral intensity distribution used in STED mi-
croscopy (the so-called “STED Doughnut”). The STED laser beam could be
precisely aligned with the 2P-Exc laser beam using a dielectric mirror posi-
tioned in a conjugated plane of the focus of the microscope objective (conju-
gated planes are indicated by dashed yellow lines in Fig. 2.1). The STED laser
beam was coupled into the common beam path with the 2P-Exc beam by a
dichroic mirror (DM1, DCLP660DCXR, F25-660, AHF Analysentechnik, Tue-
bingen, Germany).
The spatial alignment of the 2P-Exc and the STED beam was performed on
a daily basis prior to an experiment as described in section 2.10.1. In brief,
a calibration sample of  80 nm gold beads was illuminated with the two
laser beams and the back-scattered signal from an individual bead recorded
with a photomultiplier tube (PMT, H10723-20, Hamamatsu, Herrsching am
Ammersee, Germany). To that end, a flippable pellicle beam splitter (FPS2,
BP145B1, Thorlabs, Munich, Germany) was placed in the reflection path of the
optical setup and the gold bead signal focused onto the PMT. The aligned 2P-
Exc and STED beam passed another telescope lens arrangement (L5 and L6)
and were vertically shifted by a custom-built mirror periscope (P) to enter the
input aperture of the beam scanning unit (BS, YANUS IV, Till Photonics via FEI
Munich, Graefelfing, Germany) without angular tilt. The beam scanning unit
deflected the beams in two directions using two galvanometer mirrors (GM).
The two galvanometer mirrors and two additional spherical mirrors (SM) were
arranged in a 4f-configuration inside the beam scanner. The galvanometer mir-
rors are thus imaged onto each other which prevents a lateral shift of the laser
beams during scanning. After the beam scanning unit, a matched pair of a scan
and a tube lens (obtained from Leica Microsystems, Wetzlar, Germany), and the
microscope objective were positioned such that the second galvanometer mir-
ror of the beam scanning unit is imaged into the back aperture of the objective.
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Circular polarization of both beams was adjusted with a quarter-wave retarder
plate (λ/4, 4.4.15, B. Halle Nachfl. GmbH, Berlin, Germany) right in front of
the microscope objective. The circular laser beam polarization, especially for
the STED laser beam, was checked with a polarization analyzer (SK010PA-VIS,
Schaefter + Kirchhoff GmbH, Hamburg, Germany) positioned in the backfocal
plane of the objective. The 2P-Exc laser beam and the STED laser beam were
focused into the sample by a water immersion objective equipped with a cor-
rection collar (HCX PL APO 63x/1.20 W Corr CS, Leica Microsystems, Wetzlar,
Germany). The correction collar was adjusted for the # 1.0 coverslips on which
the ventricular mouse cardiomyocytes were typically plated for imaging (see
sections 2.3 and 2.10.1). Coarse axial positioning of the objective was provided
by a custom-built socket equipped with a micrometer screw. For axial fine po-
sitioning and axial scanning of the sample, the objective was mounted into a
(MIPOS 100 SG, piezosystem jena GmbH, Jena, Germany).
The fluorescence signal from the sample was collected by the objective and
reversely passed through the above described laser beam path, thus being des-
canned by the beam scanning unit, and was coupled out of the beam path
by a dichroic mirror (DM2, DCXR580DCXRU, on request, Chroma Technol-
ogy, Bellows Falls, VT, USA). A notch filter and a shortpass filter were placed
in the fluorescence signal path to filter possible residual laser light stemming
from STED and/or excitation beam (F1, 612/SP, F37-612, and F2, F40-593, AHF
Analysentechnik, Tuebingen, Germany). After passing a fluorescence band-
pass filter (F3) that could be adjusted according to the respectively used flu-
orescent dye in the sample, the fluorescence signal was focused into a multi
mode optical fiber (MMF, M42L01, Thorlabs, Munich, Germany) that was con-
nected to an avalanche photo diode (APD, SPCM-AQRH-13-FC, Perkin Elmer,
Fremont, CA, USA) for detection. The fluorescence signal was recorded using
time gated detection (see section 1.3). For the realization of the time gated de-
tection, a home-built constant fraction discriminator (CFD) was triggered by
a reflection of the pulsed 2P-Exc laser beam directly at the laser output, thus
picking up the temporal information about the 2P-Exc pulse arrival time. The
temporal information from the CFD served as a reference input signal for a
home-built time delay unit. The time delay unit was installed downstream
of the APD output signal, i.e. the detected fluorescence photons. Thus, the
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time delay unit imposed a time gate on the fluorescence signal that could be
adjusted regarding both the time delay with respect to the 2P-Exc pulses, and
the width of the time gate. For the coarse adjustment of the appropriate time
gate settings, the fluorescence signal from a dye solution (Alexa Fluor 488, see
section 2.5.2) was detected and visualized by a Time-Correlated Single Photon
Counting (TCSPC) system (PicoHarp 300, PicoQuant, Berlin, Germany) and
set to a time delay of approximately 1.5 ns and a gate width of 9 ns. The fine
adjustment of the gated detection was performed for each respective experi-
mental sample and is stated explicitly in the corresponding sections.
2.1.2. Custom-built fast scanning STED microscope
The following experiments were carried out using a custom-built, fast scanning
STED microscope setup:
• STED imaging of sarcolemmal Cholesterol structures in living VM (see
section 3.5).
• STED imaging of sarcolemmal Caveolin-3 structures in fixed VM (see sec-
tion 3.5).
• Two-color STED imaging of Caveolin-3 and Dystrophin structures in fixed
VM (see section 3.7).
This fast scanning microscope setup has, in its basics, been first described in
[408, 330, 409]. For this thesis, the setup was equipped with an additional ex-
citation laser with a wavelength of 532 nm, as well as with an additional fluo-
rescence detection channel covering the wavelength range of (630 ± 20) nm.
Also, the wavelength range of the de-exciting STED pulses was extended to
an effectively usable region of 740 to 800 nm provided by a tunable, mode-
locked Titanium:Sapphire (Ti:Sa) laser. These changes were made to enable
two-color STED imaging of Caveolin-3 and Dystrophin structures in fixed car-
diomyocytes labeled with spectrally appropriate organic dyes via indirect im-
munofluorescence as described in detail in section 2.3.3. This modified STED
setup described in the following is schematically illustrated in Fig. 2.2.
All lasers in the setup were operated in the pulsed mode and their pulse trains
synchronized using the STED laser pulses as trigger signals by recording their
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reflection with a fast photo diode (s5973-01, Hamamatsu, Herrsching am Am-
mersee, Germany), converting the laser signals into NIM (Nuclear Instrumen-
tation Module Standard) signals, and sending them to a custom-built electronic
delay module with a time resolution of 10 ps. The electronic delay was adjusted
such that the de-exciting STED pulses would follow the excitation laser pulses
immediately to ensure most efficient photophysical switching of fluorescent
molecules. The delay adjustment was performed separately for each excitation
laser and for each fluorescent dye used in the respective experimental sample
using a sample of a fluorescent dye in solution (a so-called “dye sea”) within
the daily microscope alignment routine described in section 2.10.1.
Excitation laser beams at wavelengths of 635 nm and 532 nm, respectively, were
provided by triggerable laser diodes with pulse durations of 120 ps (LDH-
P-635 and LDH-P-FA-530XL, respectively, PicoQuant, Berlin, Germany). The
STED laser pulses stemmed from a tunable Ti:sapphire laser with a repetition
rate of 80 MHz and a 120 fs pulse duration (Chameleon, Coherent LaserSys-
tems GmbH, Dieburg, Germany). For one- and two-color STED imaging of
the biological samples, the STED laser was operated at a wavelength of 750 nm
which was found to yield the highest image quality; optimization of the STED
laser wavelength was performed within a wavelength range of 730− 780 nm.
After passing a Faraday Isolator (FI, FR 500/1100, Linos, Goettingen, Ger-
many) to avoid back reflections into the laser cavity, the STED laser pulses
were stretched to a duration of 300 ps by coupling the STED beam into a 100 m
polarization maintaining single mode optical fiber (SMF1, PM-S630-HP, Thor-
labs GmbH, Munich, Germany) after guiding the beam through 30 cm of SF6
(dense flint) glass rods in order to prevent nonlinear effects in the fiber. The
linear polarization of the STED laser beam was appropriately adjusted with
a half-wave retarder plate (λ/2, AHWP05M-90, Thorlabs, Munich, Germany)
for maximum output before the laser was coupled into the single mode fiber.
After the fiber, the STED beam was collimated and its wavelength cleaned up
using a bandpass filter (F1, F49-755, AHF Analysentechnik, Tuebingen, Ger-
many) with a transmission wavelength range of 755 ± 25 nm. The STED beam
then passed a vortex phase plate (PM, VPP-A1, RPC Photonics, Rochester, NY,
USA) which generated the typical toroidal lateral intensity distribution used in
STED microscopy (the so-called STED “doughnut”).
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The 635 nm excitation laser (also referred to as the “red” excitation) passed
through an electronically adjustable liquid crystal variable retarder (VR1, Mead-
owlark Optics, Frederick, CO, USA) followed by a Glan-Thompson polarizing
prism (GT, PGT 2.10.0, B. Halle Nachfl. GmbH, Berlin, Germany) to allow both
laser power control as well as linear polarization of the laser beam before cou-
pling it into the optical fiber. The red excitation laser wavelength spectrum
was cleaned up by a dielectric filter (F2, z633/10, AHF Analysentechnik, Tue-
bingen, Germany) and the spatial mode profile of the laser was adjusted to
optimal Gaussian shape by coupling the laser beam into a single mode po-
larization maintaining optical fiber (SMF2, P1-630PM-FC-2, Thorlabs, Munich,
Germany). After the fiber, the beam was collimated and passed through a
half-wave retarder plate (λ/2, AHWP05M-600, Thorlabs, Munich, Germany)
to ensure vertical linear polarization. The red excitation laser beam was then
combined with the STED laser beam path by a dichroic mirror (DM1, zt 647
rdc-xxrxt, F48-649, AHF Analysentechnik, Tuebingen, Germany).
The 532 nm excitation laser (also referred to as the “green” excitation) passed
through an electronically adjustable liquid crystal variable retarder (VR2, Mead-
owlark Optics, Frederick, CO, USA) followed by a polarizing beam splitter
(PBS, PTW15, B. Halle Nachfl. GmbH, Berlin, Germany) to allow both laser
power control as well as linear polarization of the laser beam before coupling
it into the optical fiber. The green excitation laser wavelength spectrum was
cleaned up by a dielectric filter (F3, ZET 532/10, F49-532, AHF Analysentech-
nik, Tuebingen, Germany) and the spatial mode profile of the laser adjusted
to optimal Gaussian shape by coupling the laser beam into a single mode po-
larization maintaining optical fiber (SMF3, P1-488PM-FC-2, Thorlabs, Munich,
Germany). After the fiber, the beam was collimated by a lens (L6) and passed
through a half-wave retarder plate (λ/2, AHWP05M-600, Thorlabs, Munich,
Germany) to ensure vertical linear polarization. The green excitation laser
beam was then combined with the STED (and the red excitation) laser beam
path by a dichroic mirror (DM2, HCBS R594, F38-594, AHF Analysentechnik,
Tuebingen, Germany). The two excitation laser beams and the STED beam,
being axially aligned, then passed a resonant beam scanner (as previously de-
scribed in [409]) and, with access from the bottom, was led through the mod-
ified headpiece of an inverted microscope (IRB, Leica, Heidelberg, Germany)
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Figure 2.2.: Scheme of the custom-built, fast scanning STED microscope used for select experiments as indicated in
section 2.1.2. Abbreviations (in alphabetical order): APD - Avalanche Photo Diode; DM - Dichroic Mirror;
Exc - Excitation; F - Filter; FI - Faraday Isolator; FM - Flip Mirror; FPS - Flippable Pellicle Beam Splitter;
GR - Glass Rods; GT - Glan Thompson Polarizer; λ/2 - Half-Wave Retarder Plate; λ/4 - Quarter-Wave
Retarder Plate; L - Lens; M - Mirror; MMF - Multi Mode Fiber; Obj - Objective; PBS - Polarizing Beam
Splitter Cube; PH - Pinhole; PM - Phase Mask; PMT - Photomultiplier Tube; Res - Resonant Scanning
Mirror; SMF - Single Mode Fiber (polarization maintaining); VR - Variable Retarder.
equipped with an oil immersion objective (Obj, HCX PL APO 100x/1.4-0.7 Oil
CS, Leica Microsystems GmbH, Wetzlar, Germany). All three beams were cir-
cularly polarized before passing through the objective by an adjustable quarter-
wave retarder plate (λ/4, WPH05M-670, Thorlabs, Munich, Germany) that was
installed close to the back aperture of the objective and whose position was set
to ensure optimal circular polarization, especially of the STED beam. The bi-
ological sample was imaged laterally by resonantly scanning it in one spatial
dimension (the X-axis), and by stage scanning it along the other spatial dimen-
sion (the Y-axis) with a piezo stage (733-3DD and E-710, Physik Instrumente
GmbH, Karlsruhe, Germany).
The fluorescence signal of the “red” color channel (i.e. of the respective flu-
orophores with an absorption maximum close to the 635 nm laser line of the
“red” excitation laser) passed through the objective, was descanned and even-
tually coupled out of the common laser beam path by a dichroic mirror (DM3,
zt670 rdc-xxrxt, F48-677, AHF Analysentechnik, Tuebingen, Germany). The
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fluorescence signal of the red channel was cleaned up by a bandpass filter (F4,
675/67 BrightLine HC, F39-674, AHF Analysentechnik, Tuebingen, Germany)
that removed unwanted scattered light. Confocal detection of the red fluores-
cence signal was achieved by imaging the sample plane onto a pinhole with a
diameter of 100 µm (PH, custom-built part) and then collecting the signal with
a free-beam avalanche photo diode (APD red, SPCM-AQRH-13 20220, Perkin
Elmer, Fremont, CA, USA).
The fluorescence signal of the “green” color channel (i.e. of the respective flu-
orophore with an absorption maximum close to the 532 nm laser line of the
“green” excitation laser) was, after being descanned, coupled out of the com-
mon laser beam path by the dichroic mirror DM1. It then passed a flippable
mirror (FM) and a bandpass filter (F5, 630/38 BrightLine HC, F39-633, AHF
Analysentechnik, Tuebingen, Germany). Confocal detection was achieved by
focusing the green channel fluorescence signal into a multi mode fiber with a
core diameter of 62.5 ± 2.5 µm (MMF1, M31L01, Thorlabs, Munich, Germany).
The multi mode fiber was attached to an avalanche photo diode (APD orange,
SPCM-AQRH-13-FC, Perkin Elmer, Fremont, CA, USA).
For further improvement of achievable image resolution, the fluorescence sig-
nals of both the “red” color channel (detected by “APD red”) and the “green”
color channel (detected by “APD orange”) in STED imaging mode was time-
gated using the STED laser pulses as internal trigger signals. To this end, the
two APDs were each connected to custom-built time gating electronics which
recorded the fluorescence signal following the individual STED laser pulses (cf.
[410, 405]). The ranges of the time gates for the respectively used fluorescent
dyes were optimized to yield the best STED images.
Since the green channel fluorescence signal was coupled out of the common
beam path with the red excitation laser via a flippable mirror, the two color
channels (i.e. the “red” and the “green” color channels) could only be recorded
in consecutive scans. Yet, as the resonant scanner of this STED microscope
setup provided very fast image scanning, effects of sample drift could be ne-
glected when overlaying the two-color images for analysis. This procedure
was controlled and justified after imaging samples that were labeled with the
respective fluorophores coupled to two primary antibodies against the same bi-
ological structure and finding complete colocalization when performing sam-
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ple scans in an analogous fashion as for the actual investigated samples.
As part of the daily microscope alignment routine to ensure proper beam align-
ment, proper synchronization of the excitation and STED pulses, and optimal
illumination of the detection devices (see section 2.10.1), the setup also com-
prised a Photomultiplier Tube (PMT, MD 963CPM D, Perkin Elmer, Fremont,
CA, USA) as a diagnostic unit. The PMT was used to record the backscat-
tered light from a sample of  80 nm gold beads (see section 2.5.1). To this end,
the reflected light from the gold beads scanned with the respective laser beam
was coupled out of the common laser beam path via a flippable pellicle beam
splitter (FPS, BP145B1, Thorlabs, Munich, Germany) and focused with a lens
(L14) onto a multi mode fiber (MMF2, M31L01, Thorlabs, Munich, Germany)
to which the PMT was attached.
2.1.3. STED microscope Leica TCS SP8 STED 3X
The following experiments were conducted using the commercially available
STED microscope system Leica TCS SP8 STED 3X (Leica Microsystems GmbH,
Wetzlar, Germany):
• STED imaging of human adipocytes and ventricular induced pluripotent
stem cells stained with Cholesterol-PEG-KK114 (employing a live-cell la-
beling protocol, see section 3.2) and respectively stained for Caveolin-1
and Caveolin-3 (via indirect immunofluorescence, see section 3.5).
• Two-color STED imaging of living VM stained with Chol-KK114 and ei-
ther Di-8-ANEPPS or Cholesterol-BODIPY (see sections 2.3.2 and 3.3).
• Two-color STED imaging of Cholesterol and Ganglioside GM1 structures
in living VM labeled with the dye conjugates Chol-KK114 and Cholera
Toxin Subunit B (see sections 2.3.2 and 3.6).
• Three-color STED imaging of fixed VM stained for Dystrophin and/or
Caveolin-3 at different epitopes along the respective proteins via indirect
immunofluorescence (see section 3.8).
The STED microscope was equipped with a white light laser source operated in
pulsed mode (78 MHz repetition rate) for fluorophore excitation and two STED
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lasers for fluorescence inhibition: one STED laser with a wavelength of 775 nm
operated in pulsed mode with pulse trains synchronized to the white light laser
pulses, and one continuous-wave STED laser with a wavelength of 592 nm.
Excitation wavelengths between 470 − 670 nm were selected from the white
light laser emission spectrum via an acousto-optical beam splitter (AOBS). All
laser beams were focused into the cell sample with a wavelength corrected,
1.40 numerical aperture oil immersion objective (HC PL APO 100x/1.40 OIL
STED WHITE). The samples were scanned using the field-of-view beam scan-
ner at a scanning rate of 600 lines per second, resulting in a pixel dwell time
of 0.4 µs, and within a scan format of (1024 × 1024) pixels, and a pixel size
of (22.73 × 22.73) nm2. The fluorescence light emitted from the samples was
detected by the two built-in GaAsP hybrid detectors set to the respective de-
tection windows appropriate for the fluorescent dyes used in the samples. For
imaging three-color samples (see section 3.8), a photomultiplier tube (PMT)
was additionally used to record the third color channel. The recorded fluores-
cence signal in the STED imaging mode was time-gated using the white light
laser pulses as internal trigger signals. The fluorescence images were obtained
with 16-fold line averaging but no frame accumulation.
The explicit imaging parameters used for individual samples - especially exci-
tation wavelengths, detection channels, and time gating windows - are speci-
fied in the sections discussing the respective experiments.
2.1.4. STED microscope Abberior 2C STED 775 QUAD Scan
The following experiments were conducted using the commercially available
STED microscope system Abberior 2C STED 775 QUAD Scan (Abberior Instru-
ments GmbH, Goettingen, Germany):
• STED imaging of living culture cell lines (U2OS, HeLa, HEK-293, Vero)
stained with Cholesterol-PEG-KK114 (Chol-KK114) (see section 3.2).
• STED imaging of living HeLa cells overexpressing a Caveolin-3-SNAP
construct and stained with the dye compound SiR-SNAP (see sections
2.4.1 and 3.5).
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• Two-color STED imaging of living HeLa cells overexpressing a Caveolin-
3-SNAP construct and stained with the dye compound 580CP-BG(SNAP)
and Chol-KK114 (see sections 2.4.1 and 3.5).
The microscope was built around an Olympus IX83 microscope stand (Olym-
pus Deutschland GmbH, Hamburg, Germany) and was used in a configura-
tion employing excitation lasers with wavelengths of 561 nm (LightUp561, Ab-
berior Instruments GmbH, Goettingen, Germany) and 640 nm (PiL063X, Ad-
vanced Laser Diode Systems GmbH, Berlin, Germany), respectively, as well as
a pulsed STED laser at a wavelength of 775 nm (Nanosecond pulsed fiber laser,
MPB Communications Inc., Pointe-Claire, Canada). All three lasers were oper-
ated in pulsed mode at a repetition rate of 40 MHz. Lasers were focused into
the sample plane by a 1.40 numerical aperture oil immersion objective (UP-
lanSApo 100x/1.40 Oil 8/0.17/FN26.5, Olympus Deutschland GmbH, Ham-
burg, Germany). Fluorescence of the respective color channels was detected
with avalanche photo diodes (APD, SPCM-AQRH, Excelitas Technologies Corp.,
Fremont, CA, USA). The red fluorescent color channel (i.e. for the dyes Chol-
KK114 and SiR-SNAP) was recorded within a detection window of (685 ±
35) nm; the green fluorescent color channel (i.e. the dye compound 580CP-
BG(SNAP)) was recorded within a detection window of (615 ± 10) nm. Sam-
ples were scanned using the Abberior QUAD beamscanner with a constant
pixel size of of (20 × 20) nm2 and a typical pixel dwell time of 30 µs. Two-
color STED images (see section 3.5) were recorded in pixel interleaved mode
with a pixel dwell time of 40 µs and 20 µs for the green and the red color chan-
nel, respectively. The recorded fluorescence signal in the STED imaging mode
was time-gated using the STED laser pulses as internal trigger signals. The
time gates for the respectively used fluorescent dyes were optimized to yield
the best STED images and could be set explicitly in the microscope’s software.
For the detection of Chol-KK114 signals, the time gate was optimized to a delay
of 2.813 ns and a width of 5.391 ns. For the detection of SiR-SNAP signals, the
time gate was optimized to a delay of 3.438 ns and a width of 5.859 ns. For the
detection of 580CP-BG(SNAP) signals, the time gate was optimized to a delay
of 2.656 ns and a width of 8.047 ns.
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2.2. Synthesis of fluorescent Cholesterol analogs
Fluorescent Cholesterol analogs were prepared by coupling the respective fluo-
rescent dye compound to a Cholesterol-Polyethylene Glycol (Chol-PEG) deriva-
tive. 1.0 mg of the NHS ester of the dye compound were solved in 50 µl of
dry N,N-dimethylformamide (DMF). A solution of 3 mg (2.9 µmol) of Chol-
PEG(1k)-amine (PG2-AMCS-1k, Nanocs via Scholz GmbH, Neubiberg, Ger-
many) in 50 µl dry DMF and 2 µl triethylamine was added gradually in an
argon atmosphere and stirred overnight at room temperature. The reaction
was controlled by thin-layer chromatography (TLC). The volatile components
were removed under vacuum. The product was purified by flash column chro-
matography (CHCl3/MeOH/(H2O+1% AcOH), 80:20:2) and stored as a solid.
For the preparation of stock solutions, the solid fluorescent Cholesterol analog
was dissolved in methanol to arrive at a concentration of 2 mg/ml. The so-
lution was vortexed and was stored air-tight and protected from light at -20
°C.
For the preparation of working solutions, the methanol was evaporated from
the stock solution using N2. Phosphate-Buffered Saline (PBS, pH 7.4) was
added to arrive at a concentration of 2 mg/ml. The working solution could
be stored air-tight and protected from light at 8 °C for several months without
loss in quality.
2.3. Mouse ventricular cardiomyocyte samples
All animal procedures were carried out in accordance with the German animal
welfare act (TierSchG) and in agreement with the animal welfare committee
at both the Max Planck Institute for Biophysical Chemistry, and the Univer-
sity Medicine Goettingen. During every procedure performed on the animals,
i.e. sacrifice for tissue and organ harvesting, the individuals carrying out the
procedures took greatest care to ensure the humane treatment and use of lab-
oratory animals and to ensure the greatest possible avoidance of harm to the
animals.
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MW [g/mol] Final concentration
[mM]
10× Perfusion buffer
NaCl 58.4 120.4
KCl 74.6 14.7
KH2PO4 136.1 0.6
Na2HPO4 × 2 H2O 177.99 0.6
MgSO4 × 7 H2O 246.5 1.2
Na−HEPES 238.31 10
Ad. H2O; adjust pH to 7.4 at 37 °C with NaOH [1M]
1× Perfusion buffer
NaHCO3 84 4.6
Taurin 125.1 30
2, 3-Butanedione monoxime 101.1 10
Glucose 180.2 5.5
Ad. 10× Perfusion buffer (diluted 1:10 in H2O)
Concentration Final concentration
Digestion buffer
Collagenase Type II 340 units/mg 2 mg/ml
CaCl2 100 mM 40 µM
Ad. 1× Perfusion buffer
Stopping buffer
Bovine Calf Serum (BCS) 100% 10%
CaCl2 100 mM 12.5 µM
Ad. 1× Perfusion buffer
Blocking buffer
Bovine Calf Serum (BCS) 100 % 10 %
Triton X-100 10 % 0.2 %
Ad. Phosphate-Buffered Saline (PBS, pH 7.4)
Table 2.1.: Perfusion buffer, digestion buffer, and stopping buffer for isolation of mouse ventricular cardiomyocytes
as described in section 2.3.1; blocking buffer for blocking and permeabilization of fixed mouse ventricular
cardiomyocytes as described in section 2.3.3. Providers and order numbers of the used chemicals are given
in the Appendix A.1.
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2.3.1. Isolation of mouse ventricular cardiomyocytes
The isolation of adult mouse ventricular cardiomyocytes was performed ac-
cording to the protocol published by Wagner et al. [22, 23, 411]. In brief, mice
were anesthetized with Isoflurane (3 % in O2) and sacrificed by cervical dislo-
cation. Hearts were extracted and their proximal aorta connected to a 21 gauge
cannula (clipped to about 0.5 mm in length and roughened around its outer
surface). Cannulas were connected to a modified Langendorff perfusion sys-
tem [412] and the cannulated hearts were perfused with Ca2+-free perfusion
buffer (see Table 2.1) for 4 min at 37 °C and at a flow rate of 4 ml/min. The per-
fusion buffer was then replaced by digestion buffer (see Table 2.1) containing
2 mg/ml Collagenase Type II and 40 µM CaCl2. Hearts were perfused with the
digestion buffer for 8 min at 37 °C and at a flow rate of 4 ml/min. After 5 min
of perfusion with digestion buffer, about 2 ml of the digestion buffer that had
passed through the heart was collected in a Petri dish. After 8 min of perfu-
sion, hearts were cut off the perfusion cannula below the atria, the ventricles
collected in the Petri dish and manually dissected. Possibly remaining blood
clots were removed. Digestion was stopped by adding to the Petri dish 5 ml of
perfusion buffer containing 10 % Bovine Calf Serum (BCS) and 12.5 µM CaCl2
(see “Stopping buffer” in Table 2.1). The entire content of the Petri dish was
transferred to a 15 ml conical centrifuge tube and was left to sediment very
briefly. The supernatant was transferred into another tube and filled to a final
volume of 10 ml with stopping buffer. The isolated ventricular cardiomyocytes
were left to sediment for 8 min, then washed with 10 ml of fresh stopping buffer
and left to sediment for another 8 min. The supernatant was then discarded
and the cell pellet was resuspended in fresh perfusion buffer. For staining and
imaging experiments, the cell pellet was split to ensure a cell density of about
1500 cells/cm2 when plating on 42 mm laminin coated glass cover slips (#1.0,
MARI011199039234, VWR International GmbH, Darmstadt, Germany). Imag-
ing experiments of living mouse ventricular cardiomyocytes were conducted
within 5 h after isolation. High cell quality was ensured by verifying the fol-
lowing traits of intact living cardiomyocytes: rod shape, even/sharp cell edges,
regular striations, no signs of aberrant contractions, and no membrane blebs.
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2.3.2. Live cardiomyocyte samples
Staining with fluorescent Cholesterol analogs
Cholesterol rich membrane domains within the extracellular leaflet of the plas-
ma membrane of living isolated mouse ventricular cardiomyocytes (VM) were
stained with the fluorescently labeled Cholesterol constructs Cholesterol-PEG-
KK114 (Chol-KK114) [100], Cholesterol-PEG-DY380XL (Chol-DY380XL), Cho-
lesterol-PEG-AF488 (Chol-AF488), Cholesterol-PEG-STAR488 (Chol-STAR488),
and Cholesterol-PEG-OG488 (Chol-OG488) (see also section 2.2 for the synthe-
sis of the respective fluorescent Cholesterol analogs). For labeling VM,  42
mm glass cover slips were coated with mouse laminin (2 mg/ml, 354232, BD
Biosciences, Heidelberg, Germany) diluted 1:10 in perfusion buffer. The coated
cover slips were either placed inside an open cell imaging chamber (POC-R2,
PeCon GmbH, Erbach, Germany) for immediate experiments or placed inside
disposable Petri dishes that were then sealed with Parafilm and set aside for
later use. Freshly isolated living cardiomyocytes were resuspended in Ca2+
free perfusion buffer and sedimented by gravity for 10 min. The supernatant
was carefully removed and the cells were resuspended in perfusion buffer with
added Chol-KK114 in different concentrations, specified in the corresponding
sections, and ranging from 5 µM to 25 mM. Cells were incubated in the dye so-
lution for 8 min while sedimenting by gravity. The supernatant was then care-
fully removed and the cells were resuspended in perfusion buffer and trans-
ferred onto the coated cover slips mounted inside the cell chamber. Cells were
left to attach to the coated cover slips for 5 min, then washed three times to re-
move excess dye. Cells were covered with perfusion buffer and imaged inside
the imaging chamber using one of the respective STED microscope systems
(see section 2.1.1). For labeling living VM with the fluorescent Cholesterol ana-
log Cholesterol-BODIPY (Chol-BODIPY, 810255, Avanti Polar Lipids, Inc., Al-
abaster, AL, USA), a Chol-BODIPY working solution was prepared. To that
end, 10 µl Chol-BODIPY from a 0.3125 mM stock were dried under N2. A solu-
tion of 40 mg Methyl-β-Cyclodextrin and 1 mg Bovine Serum Albumine (BSA)
in 2 ml Phosphate-Buffered Saline (PBS) was prepared and added to the dried
Chol-BODIPY. The mixture was continuously shaken for 5 min. Freshly iso-
lated living cardiomyocytes were resuspended in perfusion buffer with added
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Chol-BODIPY working solution at a concentration of 1:20. The ensuing incuba-
tion and plating procedure was the same as for labeling with Chol-KK114 (as
described in this section). Double stains of living VM with both Chol-KK114
and Chol-BODIPY were prepared by simultaneously labeling cells with the
two fluorescent analogs following the protocols described in this section. Con-
focal images of these double stains are presented in section 3.3, Fig. 3.8. Dou-
ble stains were recorded using the STED microscope Abberior 2C STED 775
QUAD Scan, operated in confocal mode. The Chol-BODIPY signal was excited
at a wavelength of 485 nm and detected within a region of (525 ± 25) nm. The
Chol-KK114 signal was excited at a wavelength of 640 nm and detected within
a region of (685 ± 35) nm. The pixel size was set to (20× 20) nm²; the pixel
dwell time was set to 0.05 ms.
Staining with Di-8-ANEPPS
The plasma membrane of living isolated cardiomyocytes was stained with the
voltage-sensitive membrane marker dye Di-8-ANEPPS [413, 414] (D-3167, Mo-
lecular Probes, Life Technologies, Darmstadt, Germany). For this,  42 mm
glass cover slips were coated with mouse laminin (2 mg/ml, 354232, BD Bio-
sciences, Heidelberg, Germany) diluted 1:10 in perfusion buffer. The coated
cover slips were either placed inside an open cell imaging chamber (POC-R2,
PeCon GmbH, Erbach, Germany) for immediate experiments or placed inside
disposable Petri dishes that were then sealed with Parafilm and set aside for
later use. Freshly isolated living cardiomyocytes were resuspended in Ca2+
free perfusion buffer and sedimented by gravity for 10 min. The supernatant
was carefully removed and the cells were resuspended in perfusion buffer with
added Di-8-ANEPPS in a 50 µM concentration. The mixture of cells and dye-
containing perfusion buffer was transferred onto the coated cover slips and
incubated for 15 min at room temperature and in the dark. Cells were washed
three times with perfusion buffer, then the imaging chamber was filled with 1 -
2 ml perfusion buffer and cells were imaged using the Leica TCS SP8 STED 3X
(see section 2.1.3).
For dual-labeled living cardiomyocyte samples stained with Di-8-ANEPPS and
Cholesterol-PEG-KK114 (Chol-KK114), cells were resuspended in perfusion
buffer containing both Di-8-ANEPPS (50 µM) and Chol-KK114 (5 µM), trans-
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ferred into the imaging chamber and incubated for 15 min, then washed three
times and imaged in perfusion buffer using the Leica TCS SP8 STED 3X STED
microscope.
Staining with fluorescence labeled Choleratoxin B
Ganglioside GM1 (Monosialotetrahexosylganglioside) within the outer mem-
brane leaflet of living mouse ventricular cardiomyocytes was stained using re-
combinant Cholera Toxin Subunit B fluorescently labeled with the dye Alexa
Fluor 594 (CtB-AF594, C34777, Molecular Probes via ThermoFisher Scientific,
Dreieich, Germany; see Appendix A.3). For this, freshly isolated mouse ven-
tricular cardiomyoctes (see section 2.3.1) were slowly cooled down to 10 °C.
The dye-labeled CtB conjugate (1.0 mg/ml stock solution prepared following
the supplier instructions) was diluted 1:500 in perfusion buffer (see Table 2.1)
containing 2 % Bovine Calf Serum (BCS) and cooled to 10 °C. Cells were resus-
pended in the CtB-AF594 solution and incubated for 20 min at 10 °C, inverting
the solution twice manually during incubation to gently mix the cells with the
dye solution. Cells were resuspended in cooled (10 °C) perfusion buffer con-
taining 2 % BCS and left at 10 °C for another 2 min before being resuspended in
cooled (10 °C) perfusion buffer. Cells were plated on  42 mm laminin coated
cover slips placed inside an open cell imaging chamber and left to warm up to
room temperature for 5 min. Cells were imaged using the Abberior 2C STED
775 QUAD Scan microscope with the specific imaging parameters described in
section 2.1.4.
For dual-labeled living cardiomyocyte samples stained with both CtB-AF594
and Cholesterol-PEG-KK114 (Chol-KK114), cells were incubated with Chol-
KK114 at a concentration of 2.5 µM as described in section 2.3.2 prior to incu-
bation with CtB-AF594. Dual-labeled samples were imaged using the Abberior
2C STED 775 QUAD Scan microscope (see section 2.1.4).
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2.3.3. Fixed cardiomyocyte samples
Immunofluorescence-labeling of cardiomyocytes
For immunofluorescence stains, freshly isolated mouse ventricular cardiomy-
ocytes were plated on laminin coated glass cover slips (10 µM laminin per
 18 mm cover slip from a 2 mg/ml stock solution, diluted 1:10 in perfusion
buffer) for 30 min prior to fixation with 4 % Paraformaldehyde (PFA, in PBS,
pH 7.4) for 10 min at room temperature. PFA was removed and cells were cov-
ered with blocking buffer containing 0.2 % Triton X-100 and 10 % bovine calf
serum (see Table 2.1) for blocking and permeabilization (1 h at 4 °C). Primary
antibodies were diluted 1:500 in blocking buffer and cells incubated with the
primary antibody overnight at 4 °C. Cells were washed three times with PBS
(twice for 1 min, once for 10 min). Secondary antibodies were diluted 1:1000 in
blocking buffer and cells incubated with the secondary antibody for 2 h in the
dark at room temperature. Cells were washed three times with PBS (twice for
1 min, once for 10 min) and samples mounted on coverslides (631-1551, VWR
International GmbH, Darmstadt, Germany) in polyvinyl alcohol (Mowiol 4-
88, Sigma-Aldrich, Taufkirchen, Germany) containing 2.5 % DABCO (see Ap-
pendix A.1). Samples were left to dry in the dark overnight, sealed with clear
nail polish, and used for respective microscopic imaging. An overview of the
respectively used primary and secondary antibodies can be found in the Ap-
pendix A.3.
Staining with fluorescence labeled Choleratoxin B
To stain for Ganglioside GM1 (Monosialotetrahexosylganglioside) within the
outer membrane leaflet of fixed mouse ventricular cardiomyocytes, freshly iso-
lated cardiomyocytes were incubated with CtB-AF594 as described in section
2.3.2. Cells were then plated on glass cover slips, fixed, blocked, permeabilized,
and mounted on coverslides as described in section 2.3.3.
For fixed cardiomyocyte samples dual-labeled with CtB-AF594 and Caveolin-
3-STAR635P (see section 3.6), cardiomyocytes were incubated with CtB-AF594
as described in section 2.3.2, then fixed and further stained via indirect im-
munofluorescence as described in section 2.3.3. Dual-labeled samples were
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imaged using the Abberior 2C STED 775 QUAD Scan microscope with the spe-
cific imaging parameters described in section 2.1.4.
Cholesterol depletion with Methyl-β-Cyclodextrin
For the treatment of freshly isolated mouse ventricular cardiomyocytes (VM)
with Methyl-β-Cyclodextrin (M-β-CD), VM were typically incubated in VM
culture medium (see Table 2.2) in a humidified incubator (37 °C, 5 % CO2).
Final concentration
VM culture medium
HEPES 10 mM
2, 3-Butanedione monoxime 10 mM
Penicillin-Streptomycin (PenStrep):
Penicillin 100 units/ml
Streptomycin 100 µg/ml
Bovine Serum Albumin (BSA) 0.2 %
Insulin-Transferrin-Sodium Selenite supplement (ITS):
Recombinant human insulin 10 µg/ml
Human transferrin 5.5 µg/ml
Sodium selenite 5 ng/ml
Ad. 1×Minimum Essential Medium (MEM)
Table 2.2.: Culture medium for mouse ventricular cardiomyocytes (VM). Providers and order numbers of the used
chemicals are given in Appendix A.1.
VM were treated with M-β-CD to investigate the cardiac membrane architec-
ture as well as sarcolemmal Caveolin-3, and Dystrophin protein arrangements
upon extraction of Cholesterol (Chol) from the membrane (see section 3.5.1).
To this end, mouse ventricular cardiomyocytes (VM) were isolated as described
in section 2.3.1. Reintroduction of Calcium (Ca2+) to the suspension of iso-
lated VM in stopping buffer (see Table 2.1) was performed in the following
four steps. First, the Ca2+-free cell suspension was left to sediment for 8 min,
the supernatant discarded, and the cell pellet resuspended in stopping buffer
containing 12.5 µM Ca2+. Next, the cell suspension was left to sediment for an-
other 8 min, the supernatant discarded, and the cell pellet resuspended in per-
fusion buffer (see Table 2.1) containing 100 µM Ca2+. This step was repeated
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two more times with resuspension in perfusion buffer containing 400 µM Ca2+,
and 900 µM Ca2+, respectively.
After Ca2+ reintroduction, cells were resuspended in VM culture medium (see
Table 2.2) to which M-β-CD was added at a concentration of 5 mM. VM were
incubated in this solution in a humidified incubator for 1 h, carefully mixing
the solution by manually turning it upside-down every 20 min.
For staining Cav-3 and Dyst structures in Chol-depleted fixed VM via indirect
immunofluorescence, cells were removed from the incubator, the supernatant
discarded and the fixation and staining protocol was carried out as described
in section 2.3.3.
For the visualization of membrane structures in Chol-depleted living VM, cells
were stained with Di-8-ANEPPS according to the protocol described in section
2.3.2 (with the slight alteration that 900 µM Ca2+ containing perfusion buffer
was used instead of Ca2+-free perfusion buffer for incubation).
For reintroduction of Chol (“Cholesterol-repletion”) and simultaneously stain-
ing Chol structures in Chol-depleted living VM, VM were incubated at very
high concentrations of the membrane marker Cholesterol-PEG-KK114 (Chol-
KK114). To this end, cells were removed from the incubator, the supernatant
discarded and the cells resuspended in perfusion buffer containing 900 µM
Ca2+ and 1 µM Chol-KK114, and incubated at room temperature for 10 min.
Cells were washed twice with Ca2+-containing perfusion buffer, plated on
laminin-coated coverslips placed inside an open cell imaging chamber for 5 min,
washed once more with Ca2+-containing perfusion buffer, and imaged using
the custom-built fast scanning STED microscope described in section 2.1.2.
2.3.4. The mdx 5cv mouse model of muscular dystrophy
Mice of the Dystrophin (Dyst) deficient strain B6Ros.Cg-Dmdmdx-5Cv/J [288]
were purchased from The Jackson Laboratory, Bar Harbor, ME, USA. The strain
was maintained and cared for in the animal facility of the University Medicine
Goettingen according to the German animal welfare act (TierSchG) and in agree-
ment with the animal welfare committee at the University Medicine Goettin-
gen. Male mice at an age ranging from 12 to 16 weeks were used. Male wild-
type C57BL/6N mice at a similar age served as control.
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2.4. Samples of culture cell lines
2.4.1. U2OS, HeLa, HEK-293, and Vero cells
U2OS, HeLa, HEK-293 (referred to as HEK), and Vero cell lines were cultured
on glass cover slips in immortal cell line culture medium (see Table 2.3) and
typically seeded one day prior to further experiments (i.e. transfection and/or
staining for STED imaging); all incubation protocols were carried out in a hu-
midified incubator (37 °C, 5 % CO2). For STED imaging, adherent cells were
covered with colorless immortal cell line imaging medium (see Table 2.3).
For staining living culture cells with Cholesterol-PEG-KK114 (Chol-KK114),
cells were freshly seeded one day before being incubated with imaging medium
containing 5 µM Chol-KK114. After three washing steps with imaging medium,
imaging was performed using the commercial STED microscope Abberior 2C
STED 775 QUAD Scan (see section 2.1.4).
For staining living HeLa cells overexpressing a human-Caveolin-3-SNAP con-
struct (see Appendix C, and [415, 416]) and stained, via SNAP-tagging, with
either the dye Silicon-Rhodamine (SiR, S9102S, New England Biolabs, Ipswich,
MA, USA), or the dye compound 580CP-BG(SNAP) (the dye 580CP [344] was
conjugated to a SNAP-tag and kindly provided by Dr. A. Butkevich from
the MPICBPC in Göttingen, Germany; see also section 3.5), HeLa cells were
seeded one day prior to being transfected. For transfection, serum-free DMEM
medium (see Table 2.3) containing 0.7 µg/ml DNA of the Caveolin-3-SNAP
construct, and 1.5 % transfection agent (TurboFect, R0531, ThermoFisher Scien-
tific, Dreieich, Germany) was left to incubate at room temperature for 20 min
before being added to the cells. Cells were incubated for 24 h. For staining
with SiR or 580CP-BG(SNAP), respectively, cells were incubated with imaging
medium (see Table 2.3) containing 1 µM of the respective fluorescent SNAP-
dye for 30 min. After three short washing steps with imaging medium, cells
were used for STED imaging with the STED microscope Abberior 2C STED
775 QUAD Scan (see section 2.1.4).
For two-color stains of living HeLa cells overexpressing the aforementioned
human-Caveolin-3-SNAP construct and stained with the dye compound 580CP-
BG(SNAP) and with Chol-KK114 (see section 3.5), HeLa cells were seeded,
transfected, and incubated with 580CP-BG(SNAP) as described in the last para-
2.4. SAMPLES OF CULTURE CELL LINES 79
graph. Cells were stained with Chol-KK114 according to the protocol described
in section 2.3.2 and used for STED imaging with the STED microscope Abbe-
rior 2C STED 775 QUAD Scan (see section 2.1.4).
Concentration Final concentration
Immortal cell line culture medium
Fetal Bovine Serum (FBS) 100 % 10 %
Sodium pyruvate 100 mM 1 mM
Penicillin-Streptomycin (PenStrep):
Penicillin 10, 000 units/ml 100 units/ml
Streptomycin 10,000 µg/ml 100 µg/ml
Ad. DMEM (4.5 mg/ml Glucose, Glutamax, Phenol red)
Immortal cell line imaging medium
HEPES – 10 mM
Penicillin-Streptomycin (PenStrep):
Penicillin 10, 000 units/ml 100 units/ml
Streptomycin 10,000 µg/ml 100 µg/ml
Ad. DMEM (4.5 mg/ml Glucose, no Phenol red)
Table 2.3.: Culture and imaging media for U2OS, HeLa, HEK, and Vero cells. Providers and order numbers of the used
chemicals are given in Appendix A.1.
2.4.2. Ventricular induced pluripotent stem cells
Human induced pluripotent stem cells (iPSC, cell line: iWT.D2.1o) were main-
tained under feeder-free and serum-free culture conditions with E8 medium
(A1517001, Gibco via ThermoFisher Scientific, Dreieich, Germany) on plates
coated with Geltrex (12760021, ThermoFisher Scientific, Dreieich, Germany).
Directed ventricular cardiomyocyte differentiation of iPSC was initiated at con-
fluence of 90− 100 % via Wingless-related integration site (Wnt) signaling mod-
ulation with cardio differentiation medium. The cardio differentiation medium
consisted of RPMI 1640 medium that was modified with HEPES and Gluta-
max (72400021, Gibco via ThermoFisher Scientific, Dreieich, Germany) as well
as 0.5 mg/ml human recombinant albumin (A9731, Sigma-Aldrich, Taufkir-
chen, Germany), and 0.2 mg/ml L-ascorbic acid 2-phosphate (A8960, Sigma-
Aldrich, Taufkirchen, Germany). Cells were progressively treated with 4 µM
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CHIR99021 (SML1046, Sigma-Aldrich, Taufkirchen, Germany) for 48 h (inhibit-
ing Glycogen Synthase Kinase 3) and with 5 µM IWP-2 (I0536, Sigma-Aldrich,
Taufkirchen, Germany) for an additional 48 h (inhibiting Wnt production). The
medium was changed to cardio culture medium at day 10 after initiation of dif-
ferentiation. Cardio culture medium consisted of RPMI 1640 medium contain-
ing 2 % B-27 serum-free supplement (17504001, Gibco via ThermoFisher Scien-
tific, Dreieich, Germany). Metabolic cardiomyocyte selection was performed
using cardio selection medium for 5 days. Cardio selection medium consisted
of Glucose-free RPMI 1640 medium (11879020, Gibco via ThermoFisher Scien-
tific, Dreieich, Germany) and 4 mM Lactate (L7022, Sigma-Aldrich, Taufkirchen,
Germany). Cardiomyocytes were cultured in cardio culture medium for 60-120
days after initiation of differentiation to enhance maturation. Differentiated
iPSC will now be referred to as Ventricular iPSC (ViPSC). ViPSC were trypsi-
nated and seeded on  25 mm glass cover slips coated with basement mem-
brane matrix, growth factor reduced, Phenol Red-free (BD Matrigel, BD 356231,
BD Biosciences, Heidelberg, Germany), and cultivated for 10 days before being
used for the fluorescence staining techniques described in the following.
For staining ViPSC with Cholesterol-PEG-KK114 (Chol-KK114), the adherent
ViPSC growing on  25 mm glass cover slips were mounted in an open cell
imaging chamber, incubated with Phenol Red-free cardio culture medium con-
taining 5 µM Chol-KK114 for 10 min at room temperature, and washed three
times with PBS before being imaged using the Leica TCS SP8 STED 3X STED
microscope with the specific imaging parameters described in section 2.1.3.
For stainingα-Actinin (α-Act), Caveolin-3 (Cav-3) and Dystrophin (Dyst) struc-
tures in ViPSC, adherent ViPSC growing on  25 mm glass cover slips were
fixed with 4 % Paraformaldehyde (PFA, in PBS, pH 7.4) for 5 min at room tem-
perature. PFA was removed, cells were washed twice with blocking buffer (see
Table 2.1) and incubated in blocking buffer for blocking and permeabilization
(2 h at room temperature). The primary antibodies for each α-Act, Cav-3, and
Dyst were respectively diluted 1:500 in blocking buffer and ViPSC incubated
with the primary antibodies overnight at 4 °C. ViPSC were washed twice (once
with PBS, pH 7.4, for 5 min, once with blocking buffer for 1 h). The secondary
antibodies, respectively coupled to the fluorescent dyes Abberior STAR635P
and Abberior STAR488, were diluted 1:1000 in blocking buffer and ViPSC in-
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cubated with the secondary antibodies for 2 h in the dark at room tempera-
ture. Cells were washed three times (once with PBS, pH 7.4, for 5 min, once
with blocking buffer for 1 h, and once with PBS, pH 7.4, for 5 min) and sam-
ples mounted on coverslides (631-1551, VWR International GmbH, Darmstadt,
Germany) in an antifade reagent (ProLong Gold P36934, Molecular Probes via
ThermoFisher Scientific, Dreieich, Germany). Samples were left to dry in the
dark overnight, sealed with clear nail polish and imaged using the Leica TCS
SP8 STED 3X STED microscope with the specific imaging parameters described
in section 2.1.3.
An overview of the used primary and secondary antibodies can be found in
Appendix A.3.
2.4.3. Human adipocytes
Cryopreserved human preadipocytes (HPAd) derived from human heart adi-
pose tissue were purchased from Cell Applications (802hK-05a, Cell Applica-
tions Inc., San Diego, CA, USA) and cultured according to the supplier instruc-
tions. In brief, cryopreserved HPAd were thawed and cultured in Preadipocyte
Growth Medium (811-500, Cell Applications Inc., San Diego, CA, USA) in a 37
°C, 5 % CO2 humidified incubator, changing the growth medium every other
day. For differentiation, HPAd were trypsinated and seeded on  32 mm glass
cover slips (in a 6-well culture plate) and on 18 mm glass cover slips (in a 12-
well culture plate), respectively. To facilitate the adhesion of HPAd [417, 418],
the glass cover slips were coated with basement membrane matrix, growth fac-
tor reduced, Phenol Red-free (BD Matrigel, BD 356231, BD Biosciences, Heidel-
berg, Germany) diluted in PBS at a protein concentration of 10 mg/ml. When
cells reached 100 % confluency after about 1-2 days, the Preadipocyte Growth
Medium was replaced by Adipocyte Differentiation Medium (811D-250, Cell
Applications Inc., San Diego, CA, USA) and cultured in a 37 °C, 5 % CO2 humi-
dified incubator for about 15 days, changing to fresh Adipocyte Differentiation
Medium every 3 days. Fully differentiated human adipocytes will be referred
to as HAd throughout this work.
For staining living HAd with Cholesterol-PEG-KK114 (Chol-KK114), adherent
adipocytes growing on 32 mm glass cover slips were mounted in an open cell
imaging chamber, incubated with PBS (pH 7.4) containing 5 µM Chol-KK114
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for 10 min at room temperature, and washed three times with PBS before being
imaged using the Leica TCS SP8 STED 3X STED microscope with the specific
imaging parameters described in section 2.1.3.
For staining Caveolin-1 (Cav-1) structures in differentiated fixed HAd, adher-
ent adipocytes growing on  18 mm glass cover slips were fixed with 4 %
Paraformaldehyde (PFA, in PBS, pH 7.4) for 10 min at room temperature. PFA
was removed, cells were washed twice with adipocyte blocking buffer (PBS
pH 7.4 containing 0.1 % Saponin and 10 % Bovine Calf Serum (BCS)), and in-
cubated in adipocyte blocking buffer for 30 min at room temperature. The pri-
mary antibody for Cav-1 was diluted 1:500 in adipocyte blocking buffer and
cells incubated with the primary antibody overnight at 4 °C. HAd were washed
three times with adipocyte blocking buffer (twice for 1 min, once for 10 min).
The secondary antibody coupled to the fluorescent dye Abberior STAR635P
was diluted 1:500 in adipocyte blocking buffer and cells incubated with the sec-
ondary antibody for 1.5 h in the dark at room temperature. HAd were washed
three times with PBS (twice for 1 min, once for 10 min) and samples mounted
on coverslides (631-1551, VWR International GmbH, Darmstadt, Germany) in
an antifade reagent (ProLong Gold P36934, Molecular Probes via ThermoFisher
Scientific, Dreieich, Germany). Samples were left to dry in the dark overnight,
sealed with clear nail polish and imaged using the Leica TCS SP8 STED 3X
STED microscope with the specific imaging parameters described in section
2.1.3.
An overview of the used primary and secondary antibodies can be found in
Appendix A.3.
To control for proper cell differentiation, human preadipocytes and HAd were
stained with the lysochrome diazo dye Oil Red O (ORO, C26H24N4O). ORO is
a well-established marker of triglycerides and neutral lipids [419]. The preva-
lence of lipid droplets indicates the full differentiation of preadipocytes into
mature adipocytes [420]. Staining was carried out similarly to the protocol de-
scribed in [421]. Explicitly, adherent preadipocytes and adipocytes respectively
growing on  18 mm glass cover slips were washed twice with 1× Dulbecco’s
Phosphate-Buffered Saline (DPBS, no Calcium, no Magnesium, 14200-067, Life
Technologies via ThermoFisher Scientific, Dreieich, Germany) prior to fixation
with 4 % Paraformaldehyde (PFA, in PBS, pH 7.4) for 30 min at room tempera-
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ture. A 3 % stock solution of ORO was prepared by dissolving 300 mg ORO
powder (O0625-25G, Sigma-Aldrich, Taufkirchen, Germany) in 100 ml 99 %
Isopropanol. A working solution of ORO was prepared by adding 1.5 parts of
the ORO stock solution to 1 part of deionized water, letting the solution stand
at 4 °C for 10 min and filtering it through a grade 4 paper filter (pore size ca. 25
µm). PFA was removed from the cells, the cells were washed once with deion-
ized water and once with 60 % Isopropanol for 3 min prior to incubation with
the ORO working solution for 5 min. Cells were then washed with deionized
water until the formerly red supernatant became clear. Samples were mounted
on coverslides (631-1551, VWR International GmbH, Darmstadt, Germany) in
an antifade reagent (ProLong Gold P36934, Molecular Probes via ThermoFisher
Scientific, Dreieich, Germany), left to dry in the dark overnight, sealed with
clear nail polish and confocal images were obtained using the Leica TCS SP8
STED 3X STED microscope (see section 2.1.3). The obtained ORO control stains
of undifferentiated vs. differentiated human adipocytes, as well as the specific
imaging settings, are presented in Appendix D.2.
2.5. Calibration samples
2.5.1. Gold beads
Gold bead samples were used to control for the proper alignment of the exci-
tation and STED laser beams both during the first stages of microscope con-
struction as well as within the daily microscope alignment routine (see section
2.10.1). While stirring and heating to 50 °C, 1.5 g polyvinyl alcohol (Mowiol 4-
88, Sigma-Aldrich, Taufkirchen, Germany) was diluted in 10 ml distilled water.
A colloid of gold nanoparticles of 80 nm diameter suspended in water (BBin-
ternational, Cardiff, UK) was sonicated for 10 min. A volume of 10 µl of the
gold colloid was diluted with 100 µl of the Mowiol 4-88 solution and 100 µl of
the dispersion was pipetted onto (22 × 22) mm2 glass coverslips of thickness
# 1.5 (i.e. (0.16 − 0.19) mm thickness; 631-0125, VWR International GmbH,
Darmstadt, Germany)). The coverslips were spincoated for 30 s at 4000 rpm,
covered, and left to dry for 30 min. The coverslips were mounted onto a glass
microscope coverslide (631-1551, VWR International GmbH, Darmstadt, Ger-
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many) in immersion oil appropriate for our imaging system (immersion oil
type F, Leica Biosystems, Nussloch, Germany). The sample was left to dry for
5 min and sealed with nail polish.
2.5.2. Fluorescent Dye Solutions
Fluorescent dye solutions (dye seas) were prepared to control the proper align-
ment of the signal detecting Avalanche Photo Diodes (APD) within the daily
microscope alignment routine (see section 2.10.1) as well as for screening for
proper dyes for use in the Two-Photon-Excitation-CW-STED microscope that
was built within the scope of this thesis (see sections 2.1.1 and 3.4.2). About
20 µg of the respective dye compound in the NHS−ester modification was sol-
vated in 30-60 µl methanol. The less a dye would dissolve in methanol, the
more methanol was applied, yet never exceeding 60 µl. The mixture of dye
in methanol was vortexed vigorously and then filled up with purified water
(Milli-Q, Merck Chemicals GmbH, Darmstadt, Germany) to a final volume of
500 µl. In case the dye was poorly dissolved, the mixture was centrifuged
shortly and only the supernatant used for further sample preparation. Square
((22 × 22) mm2; thickness # 1.5) glass coverslips (631-0125, VWR International
GmbH, Darmstadt, Germany) were moved slowly across a single-well glass
coverslide (5861, GT Vision Ltd, Stansfield, Suffolk, UK) while pipetting about
100 µl of the dye solution into the well avoiding the formation of air pockets
underneath the coverslip. Excess liquid was dabbed off carefully and the sam-
ples sealed with clear nail polish. An overview of the used fluorescent dye
compounds can be found in Appendix A.4.
2.5.3. Fluorescent Beads
Fluorescent bead samples were prepared for use as a benchmark determina-
tion of the image resolution achievable with the used “open” (i.e. user acces-
sible) microscope systems (see sections 2.1.1 and 2.1.2) and measured prior to
every imaging experiment within the daily microscope alignment routine (see
section 2.10.1), thus providing the validation of reproducible microscope per-
formance. For imaging with the Two-Photon-Excitation-CW-STED setup (see
section 2.1.1),  40 nm yellow-green fluorescent beads (FluoSpheres, F8795,
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Molecular Probes via ThermoFisher Scientific, Dreieich, Germany) were used.
For imaging with the custom-built fast scanning STED setup (see section 2.1.2),
 20 nm crimson fluorescent beads (FluoSpheres, F8782, Molecular Probes via
ThermoFisher Scientific, Dreieich, Germany) were used. Square glass cover-
slips ((22 × 22) mm2; thickness # 1.5, 631-0125, VWR International GmbH,
Darmstadt, Germany) were covered with Poly-L-lysine (0.1 % (w/v) in H2O,
P8920-100ML, Sigma-Aldrich, Taufkirchen, Germany) for 10 min, then the ex-
cess Poly-L-lysine was rinsed off with deionized water and blown dry with
compressed air. Fluorescent beads were vortexed and diluted 1:1000 in puri-
fied water (Milli-Q, Merck Chemicals GmbH, Darmstadt, Germany), and the
solution vortexed prior to sonication for 8 min. The bead solution was pipetted
onto the coated coverslips (about 80 µl per coverslip, forming a roughly 1 cm
circle) and left for 10 min, then rinsed off with deionized water and blown
dry with compressed air. The coverslips were mounted onto glass coverslides
(631-1551, VWR International GmbH, Darmstadt, Germany) in polyvinyl al-
cohol (Mowiol 4-88, Sigma-Aldrich, Taufkirchen, Germany) containing 2.5 %
DABCO. Samples were left to dry for 1 h and sealed with clear nail polish.
2.5.4. Standardly prepared fluorescent cell samples
Samples of Vero cells fluorescently labeled for the cytoskeletal protein Tubulin
via indirect immunofluorescence served as standardly prepared specimens for
comparative studies of different fluorescent dyes regarding their spectroscopic
properties and their bleaching behavior. For fluorescence staining, cultured
Vero cells (see section 2.4.1) grown on glass cover slips were fixed with ice-
cold methanol for 4 min. To block unspecific binding, cover slips were washed
three times (for 5 min per step) in 2 % Bovine Serum Albumine diluted in
pH 7.4 PBS (BSA/PBS) at room temperature. The primary antibody against
α-Tubulin (mouse monoclonal, T6074, Sigma-Aldrich, Taufkirchen, Germany)
was diluted 1:50 in 2 % BSA/PBS and cells were incubated with it for 1 hour
in a wet chamber at room temperature, then washed three times (for 5 min
per step) in 2 % BSA/PBS. The secondary antibody, decorated with the respec-
tive fluorescent dye, was diluted 1:50 in 2 % BSA/PBS and cells were incu-
bated with it for 1 hour in a wet chamber at room temperature, then washed
three fast times in PBS. Samples were mounted in polyvinyl alcohol (Mowiol
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4-88, Sigma-Aldrich, Taufkirchen, Germany) containing 2.5 % DABCO (see Ap-
pendix A.1), were left to dry, and sealed with clear nail polish. An overview of
the used primary and secondary antibodies can be found in Appendix A.3.
2.6. Image analysis
2.6.1. General image processing
All acquired images were visualized, processed and analyzed using the soft-
ware package ImSpector [422], Fiji (http://imagej.net/Fiji, [423]), Origin
(OriginLab, Northhampton, MA, USA), and MATLAB (The MathWorks, Inc.,
Natick, Massachusetts, United States).
Image smoothing was performed with the ImSpector software using a low-
pass Gaussian filter with a width of 1.5 times the respective image pixel size
(typically corresponding to 30 nm). If a smoothing step has been applied to the
images, it is stated explicitly in the corresponding figure caption.
Image deconvolution was performed with the ImSpector software using an ex-
perimentally obtained point spread function (from fluorescent bead measure-
ments, see section 2.10.1) of 40 nm full width at half maximum and perform-
ing two iterations of a two-dimensional (2D) Richardson-Lucy deconvolution
[424, 425]; if a deconvolution step has been applied to the images, it is stated
explicitly in the corresponding figure caption.
Images were corrected for background signal with the software Fiji typically
using a rolling ball radius of 30 px, and contrast was enhanced to a saturated
pixel ratio of typically 0.4 %, unless stated otherwise. If a background correc-
tion or contrast enhancement has been applied to the images, it is stated explic-
itly in the corresponding figure caption. In general, the two image processing
steps of background correction and contrast enhancement were only used for
reasons of better visibility.
Three-dimensional (3D) images were obtained from Z-stacks, i.e. successive
scans along the axial direction of two-dimensional (2D) images scanned later-
ally along the imaging plane parallel to the cover slip. 3D image rendering was
performed with the software AMIRA 6.0 (FEI Visualization Sciences Group,
Mérignac, France). For rendering, raw data images were smoothed with the
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software ImSpector using a two-dimensional Gaussian filter with a width of
1.5 pixels and exported to the binary double format. The exported files were
read in with AMIRA 6.0 and displayed in the “Voltex” or “Volren” rendering
modes with adjusted brightness thresholds. Cell sections were obtained by
cutting the rendered 3D images using the “OrthoSlice” mode.
Two-color images were converted to a color map comprising zero signal in
black, the first color channel in cyan, the second color channel in magenta, and
overlap of the first and the second color channel in yellow. The color channel
brightness was normalized to its respective minimum and maximum.
Three color images (see section 3.9, Fig. 3.40) were smoothed using a two-
dimensional Gaussian filter with a width of 1.5 pixels using the software Im-
spector. Image brightness normalized to the respective minimum and maxi-
mum, and converted to an RGB color map using Fiji. This color map comprises
zero signal in black, the first color channel in red, the second color channel in
green, and the third color channel in blue. Overlap of two color channels re-
sults in a cyan, magenta, or yellow signal; overlap of all three color channels
results in a white signal. A summarizing color key is given in the figure.
2.6.2. Determination of image resolution
For the determination of the STED image resolution, I followed a protocol sim-
ilar to the one that I have established, employed and described elsewhere (e.g.
in [426, 427, 343]). For circular signals and structures (e.g. fluorescent beads
or single Caveolin-3 and Dystrophin domains, respectively), a box of between
(200 × 200) nm2 and (400 × 400) nm2 was drawn around a single structure
in the raw data image. The signal intensity was added up along the X-axis of
this box and then graphically displayed against the Y-axis of the boxed region.
For elongated signal structures (e.g. transverse tubules), a line of a width of
at least 5 pixels (typically corresponding to 100 nm) was drawn to perpendic-
ularly cross a selected elongated structure in the raw data image. The signal
intensity was added up parallel to the structure and was displayed against
the position along the drawn line. These plotting procedures for circular and
elongated structures, respectively, were performed using the software package
ImSpector. The signal intensity graphs were exported to the software Origin.
Since the shape of the point spread function (PSF) of a STED microscope de-
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pends on whether the STED laser was operated in pulsed mode or continuous
wave (CW) mode [348], a case differentiation was made for determining the
image resolution depending on the respective STED laser used. Hence, the
signal intensity was normalized and the Origin built-in Lorentzian peak func-
tion was fit to the data if the data was recorded using a STED laser operated
in CW mode, i.e. using the custom-built 2P-Exc-CWSTED setup (see section
2.1.1). A Gaussian function was fit to the data if the data was recorded using a
STED laser operated in pulsed mode, i.e. using the custom-built fast scanning
STED setup (see section 2.1.2), or one of the commercial STED microscope sys-
tems (see sections 2.1.3 and 2.1.4). The upper limit for image resolution was
extracted from these fits as the full width at half maximum of the Lorentzian
or Gaussian curve, respectively. The estimates of the resolution of both circular
and elongated structures that are given in this thesis were obtained from the
arithmetic mean of several such Lorentzian or Gaussian fits of different struc-
tures; the type of the used curves for fitting along with the total number of
evaluated signal structures is denoted explicitly in the sections discussing the
corresponding results.
2.6.3. Determination of bleaching constants
Bleaching under STED imaging conditions of samples fluorescently labeled
with various dye compounds followed a protocol I established and previously
reported in [427]. This protocol is based on the study of bleaching of a sam-
ple under the same image acquisition conditions that are also employed in the
actual imaging experiment. I found this procedure to be the most suitable be-
cause it emulates the bleaching of the actual sample’s region of interest on a
different region in the same sample and thus provides the most realistic assess-
ment of the bleaching process with all its underlying, and, in part, not well-
understood, details. Further, the bleaching constant was determined in units
of imaged frames. The frames were recorded with imaging parameters specific
to the regarding sample. I chose this unit for representation because, in my
experience, when imaging a sample in STED microscopy, the imaging parame-
ters are set such that the best possible STED image is obtained. This procedure
is hardly comparable across different samples and different microscope setups.
Therefore, the most useful measure of bleaching is the number of reasonably
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bright images (i.e. the sample structure must be clearly identifiable) that can
be recorded of a single sample region under optimal imaging conditions. This,
admittedly, very qualitative number should then be compared among sam-
ples where the same structure is labeled with different fluorescent dyes and
imaged using the same microscope. In brief, 20 subsequent frames per sam-
ple spot were obtained under optimized imaging conditions for the respective
fluorescent dye in the sample, i.e. 2P-Exc wavelength, detection window, 2P
and STED illumination powers, and time gating of the fluorescence signal. The
pixel size was kept at 20 nm for all samples and the sample scanning rate was
set to a pixel dwell time of 0.05 ms. The total signal of each acquired frame
was determined, thereby excluding pixels at the image borders as they could
add to an increase in signal over time due to sample drift and therefore de-
tection of signal stemming from an unbleached sample area. Pixel intensities
were plotted against the number of acquired frames. The resulting curves were
normalized to their maximum value and plotted in one graph for comparison
of the bleaching rates. Bleaching rate constants were extracted as the nomi-
nal image frame at which the total fluorescence signal had dropped to half of
its initial/maximum value. The bleaching rate constant was always rounded
down to the next smaller integer. For the characterization of the bleaching
behavior of selected dyes under 2P-Exc-CWSTED conditions, the decrease in
fluorescence intensity was fit to mono- and biexponential decay functions us-
ing the software Origin. The regular residuals per fit function were compared
to each other to evaluate the goodness of fit; this is discussed in Appendix G.3.
2.6.4. Determination of surface signal densities
For the determination of the surface signal densities in filopodia of U2OS,
HeLa, HEK, and Vero cells (see e.g. section 3.3), recorded STED images were
processed with the software Fiji to enhance the contrast (2 % saturated pixels)
and to subtract the background (rolling ball radius: 30 pixels). Filopodial struc-
tures in the images were carefully identified as elongated protrusions from the
basement membrane that showed a fluorescent signal only along their outlines.
Filopodia were outlined manually using the freehand selection tool. The pixel
values outside the outlines were set to zero (Fiji command: “clear outside”) and
the images of the filopodial outlines were saved as separate files and further
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processed in MATLAB. A custom-written MATLAB routine was used to thresh-
old and binarize the images of filopodial outlines. Thresholding was based
on evaluating the value of each pixel in the image and on the comparison of
each pixel with its directly adjacent, and its diagonally neighboring pixels. To
binarize the image, a pixel was set to “1” (positive signal) if its value was 40
% above the mean image brightness and if it was surrounded by both directly
adjacent and diagonally neighboring pixels of values at least equal to the mean
image brightness. The values defininig the binarization thresholds were cho-
sen by iteratively setting different threshold values and examining by eye how
well they would capture the filopodial structures of the original images. The
binarized images were then inverted and further processed, again using Fiji.
The “Analyze Particles” plugin was used to determine the area of positive sig-
nal within the filopodial region of interest (ROI), denoted as Asignal and given
in pixel. In the “Analyze Particles” plugin, the minimum acceptable particle
size was set to 10 pixel to avoid artifacts of falsely positively categorized signal
stemming from the binarization protocol. In a next step, to arrive at the total
area of the filopodial structure, the binarized filopodial ROI was processed us-
ing the Fiji built-in functions 1.) “Dilate”, 2.) “Close”, and 3.) “Open”; this
procedure extends the binary signal in the filopodial ROI to encompass the
complete filopodial structures. Using the “Analyze Particles” plugin on this
dilated and filled binary image of the filopodial ROI yields the total area, de-
noted as Atotal and given in pixel. From the values of Asignal and Atotal, the
surface signal density in filopodia ρFilo was calculated as
ρFilo =
Asignal
Atotal
ρFilo is standardly presented as a percentage. The above described procedure
for the determination of ρFilo is visualized exemplarily in the Appendix F.
For the determination of the surface signal densities at the basement membrane
of culture cell lines, and at the sarcolemma of primary mouse ventricular car-
diomyocytes (VM, see e.g. section 3.3), recorded images were processed with
Fiji to enhance the contrast (0.4 % saturated pixels) and to subtract the back-
ground (rolling ball radius: 30 pixels). Regions of interest for surface density
analysis were carefully selected according to the following criteria. For culture
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cell lines featuring filopodia, only membrane regions that did not show filopo-
dial structures were selected. Additionally, in all investigated cell types, re-
gions of cell borders were not considered for analysis because they are usually
oriented perpendicularly to the focal plane and labeled structures thus tend to
stack on top of each other along the axial direction leading to a fluorescence
signal add-up and thus yielding a disproportionally bright signal compared
to the signal brightness along the “flat” cell membrane. This would compro-
mise the accuracy of the image binarization algorithm based on pixel bright-
ness values. Moreover, it was made sure that the analyzed area of cellular
basement membrane was the same for each cell type to justify comparability
of the calculated surface signal densities. The selected image regions that ful-
filled these criteria were saved as separate files and further processed in MAT-
LAB. A custom-written MATLAB routine was used to threshold and binarize
the image regions following a similar procedure as stated above for binariza-
tion of images of filopodial structures. Explicitly, for the binary thresholding of
signal structures along the cellular basement membrane, pixel brightness was
considered “positive signal” if its value was at least 60 % of the mean image
brightness and if it was surrounded by directly adjacent pixels of at least 40 %
of the mean image brightness, and diagonally neighboring pixels of at least 30
% of the mean image brightness. The binarization algorithm then counted all
the pixels considered to have “positive signal”, divided it by the total amount
of pixels in the selected image and gave out the thus obtained surface signal
density ρSurf. ρSurf is standardly presented as a percentage. The above de-
scribed procedure for the determination of ρSurf is visualized exemplarily in
the Appendix F.
2.6.5. Determination of single domain sizes
For the analysis of single Cholesterol (Chol) and Caveolin-3 (Cav-3) signal
domains (defined and discussed in section 3.5) at the sarcolemma of mouse
ventricular cardiomyoctes (VM), recorded STED images were processed with
MATLAB. Single signal domains were carefully identified by eye and were out-
lined manually. Within this chosen outline, the single signal distribution was
approximated by fitting a Gaussian profile (in case of pulsed STED laser il-
lumination), or a Lorentzian profile (in case of CW STED laser illumination)
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in the X- and the Y-direction, respectively. The full width at half maximum
(FWHM) in the X-direction (FWHMx) and in the Y-direction (FWHMy) was de-
noted. This procedure was carried out for several identified single domains
per image (with one image corresponding to one VM), thereby making sure
that the same amount of single domains per image was evaluated. For each
image the arithmetic mean and the standard deviation of both FWHMx and
FWHMy was calculated to yield the diameter of single signal structures within
one cell. This evaluation was repeated for all obtained STED images of VM.
Finally, the arithmetic mean and the standard deviation of the average domain
diameter obtained from each image was calculated and defined as the overall
single domain size.
2.6.6. Determination of ring structure diameters
For the analysis of ring shaped Caveolin-3 and Cholesterol signal structures
at the sarcolemma of mouse ventricular cardiomyocytes and at the basement
membrane of living HeLa cells (see section 3.5), recorded STED images were
processed with the software Fiji to enhance the contrast (2 % saturated pix-
els) and to subtract the background (rolling ball radius: 30 pixels). Individual
ring structures in the images were carefully identified by eye and were outlined
manually. The pixel values outside the outlines were set to zero (Fiji command:
“clear outside”), and the images of single, isolated ring structures were saved
as separate files and further processed in MATLAB. A custom-written MATLAB
routine was used to smooth the images with a low-pass Gaussian filter with
a width of 2 times the image pixel size (corresponding to 40 nm). Signal in-
tensity peaks along the ring structures were identified with a threshold set to
0.4 times the maximum image brightness. The signal peaks were localized to a
single pixel coordinate. A circle was fit to the positions of all determined signal
peaks using the MATLAB built-in function “circfit.m”, and the corresponding
diameter extracted from the fit.
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2.6.7. Determination of contour densities
To quantify the observed effect of the dissociation of sarcolemmal Caveolin-3
(Cav-3) signal clusters upon Cholesterol depletion of mouse ventricular car-
diomyocytes (VM) by incubation with Methyl-β-CycloDextrin (M-β-CD, see
sections 3.5.1 and 2.3.3), I developed an algorithm that extracted the contour
densities of Cav-3 signal structures from the according STED images as ex-
plained in the following. I defined the signal contour density Γ as the ratio
of the number of boundaries between pixels showing a positive Cav-3 signal
vs. pixels showing no Cav-3 signal, and the total number of possible pixel
boundaries within the image. Γ thus describes the extent of clustering of a sig-
nal structure in an inverse fashion, meaning: the bigger Γ, the less clustered is
the spatial distribution of the signal. The algorithm thresholds and binarizes
the STED images analogous to the procedure described in section 2.6.4. In the
binarized images, pixels are categorized into having “positive signal” if their
brightness is above the binarization threshold and “negative signal” (i.e. back-
ground signal) if their brightness is below the binarization threshold. For every
pixel, the algorithm compares the pixel value with the value of the adjacently
neighboring pixels. If there is a transition from positive to negative signal (or
vice versa) between two pixels, this transition is counted as one signal bound-
ary. The number of the recorded boundaries is halved for the actual analysis
to avoid double counting of redundant boundaries, thus yielding the number
of signal transition boundaries Btrans. Additionally, a 1-pixel wide border is
defined along the edges of each image. Transition boundaries are not counted
for pixels of this border to avoid signal artifacts. The total number of possible
pixel boundaries Btot is given by
Btot = 2 · Atot − (R + C)
where Atot: total area of the image (in pixels), R: number of rows in the image
matrix, and C: number of columns in the image matrix. These three input
parameters were extracted from the image from which the border mentioned
above was already subtracted. The signal contour density is determined by the
ratio
Γ =
Btrans
Btot
.
94 2. EXPERIMENTAL METHODS AND TECHNIQUES
Three exemplary cases of signal distribution and their description by Γ are
schematically sketched in Fig. 2.3 A - C, respectively. Therein, the red boxes
symbolize pixels with a positive signal, the white boxes symbolize pixels with a
negative signal, and the grey boxes define the 1-pixel wide image border. Blue
dots mark the counted pixel boundaries upon a transition between a positive
signal pixel to a negative signal pixel. The total area of the signal is the same
Figure 2.3.: Schematic of the definition of the contour density Γ
in Fig. 2.3 A - C, yet its spatial distribution is different. Fig. 2.3 A illustrates a
totally clustered signal structure, B a ring and a small, singular signal entity (a
“single domain”), and C a completely dispersed signal only consisting of sin-
gle domains. The contour density Γ gradually increases for these three cases
of signal distribution. A complete dissociation of a clustered signal into single
domains, albeit of constant signal area, is here characterized by an increase in Γ
by a factor of almost 3. Γ is typically given in % of the total number of possible
pixel boundaries.
2.7. Colocalization analysis
For the colocalization analysis of sarcolemmal Cholesterol (Chol) and Gan-
glioside GM1 (GM1) clusters in living cardiomyocytes (for sample preparation
see section 2.3.2) as well as sarcolemmal Caveolin-3 (Cav-3) and GM1 clusters
in fixed cardiomyocytes (for sample preparation see section 2.3.3), two-color
STED images of the respective samples were obtained as described in sections
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2.3.2 and 2.3.3. Equally sized regions of interest were extracted from images of
individual cells and used for analysis. The two-color STED images were bina-
rized as described in section 2.6.4. The respective signal in the binarized images
was then converted to a false color scale with one color channel displayed in
magenta (for the Chol and the Cav-3 signal, respectively) and the other color
channel displayed in cyan (for the GM1 signal). Binarized and color-converted
images from the same sample scan were overlaid and the overlap of the two
color channels displayed in yellow. The number of pixels featuring the respec-
tive colors magenta, cyan, and yellow were counted. The relative colocalization
(in %) of the first color channel (e.g. Chol in magenta) with the second color
channel (e.g. GM1 in cyan) was determined by dividing the number of yellow
pixels by the total number of pixels in the respective first color channel (i.e.
all magenta pixels in the image). This relative colocalization thus describes the
ratio of the signal of the first color signal colocalizing with the second color sig-
nal with respect to the total signal of the first color channel (e.g. the percentage
of all Chol clusters that colocalize with GM1 clusters). Results are given and
discussed in section 3.6.
An analogous colocalization analysis was performed to determine the effect of
Chol depletion on the spatial association between Dystrophin (Dyst) and Cav-3
signals in VM (see e.g. section 3.7.1).
2.8. Determination of nearest neighbor distances
To extract the peak-to-peak Nearest Neighbor Distance (NND) from multicolor
STED images (see section 3.7), images were processed and analyzed using
a custom-written routine in MATLAB. Images were smoothed using a two-
dimensional Gaussian filter with a width of 1.5 pixels (corresponding to 30 nm
as all analyzed images were acquired with a pixel size of 20 nm). Local signal
maxima in the smoothed images were identified via a pixel by pixel compar-
ison of a central pixel with its directly adjacent and diagonally neighboring
pixels if they were above a threshold value of about 25 % of the maximum im-
age brightness. Coordinates of the found maxima were extracted and indexed
for each color channel of the multicolor images. NND between nearest neigh-
bors from different color channels were determined using the MATLAB built-in
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function “knnsearch”.
Note that the determined NNDs have a directionality, i.e. there is a distinct
distribution of NNDs between A and B vs. between B and A. In this thesis, the
determination of the distribution of the peak-to-peak NND between a popula-
tion A and a population B means that for a fixed signal spot in A the nearest
signal spot from the whole set of all signals in B is identified; then the distance
to A is extracted and enters the NND distribution. Accordingly, the NND be-
tween B and A means that for every B, the distance to the nearest neighbor in
A is determined and denoted.
2.9. Statistics
Statistical significance of all the obtained quantitative data throughout this
work was tested using the two-sided Mann-Whitney-Wilcoxon U test (MWW)
[428, 429]. Statistical significance testing was performed for all possible per-
mutations of pairs of two sample groups within each complete data set per as-
sessed descriptive quantity. The following properties of the quantitative data
sets presented in this work justify the choice of the two-sided MWW:
• The independent variable, i.e. one of the two sample groups, is categor-
ical and can only take on two values: e.g. “cell type 1” vs. “cell type
2”.
• The dependent variable, i.e. the assessed descriptive quantity, is continu-
ous and ordinal.
• The two sample groups, i.e. the two compared cell types, are indepen-
dent: all descriptive quantities were assessed in individual experiments.
• The ordering of the data for each considered sample group is random.
• The sample sizes per sample group differ and are not paired.
• The data within each sample group are not assumed to be normally dis-
tributed, i.e. the sample data are nonparametric.
• The variances of the data within each sample group are not assumed to
be equal nor homogeneously distributed.
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• There is no initial hypothesis about the nominal direction along which the
data sets of each sample group differ from each other. Thus, a two-sided
MWW is performed.
The U statistic of the MWW was determined by first assigning ranks to all
ordinal sample data and, second, determining the sum of ranks for all data
stemming from sample group 1 and all data stemming from sample group 2,
respectively. The U statistic for each sample group (i.e. U1 for sample group 1
and U2 for sample group 2) is then calculated via
U1 = n1n2 +
(
n1 (n1 + 1)
2
)
− R1
and
U2 = n1n2 +
(
n2 (n2 + 1)
2
)
− R2
where n1 and n2 are the sample data size and R1 and R2 are the sum of ranks
of sample group 1 and sample group 2, respectively. I determined the defining
parameters ni and Ui for each pair of sample groups and therefrom the p-value
of statistical significance of the MWW using the MATLAB script “mwwtest.m”
[430]. The difference between data from different sample groups was consid-
ered statistically significant for p≤ 0.01 (marked with (*)), highly statistically
significant for p≤ 0.001 (marked with (**)) and not significant for p≥ 0.01
(marked with “n.s.”).
The explicit MWW U statistics for the data sets presented in this PhD work are
summarized and displayed in the Appendix I.
2.10. Additional experimental techniques
2.10.1. Daily microscope alignment routine
The performance of the custom-built microscope systems used within the scope
of this thesis - i.e. the two-photon-excitation-CW-STED microscope (see sec-
tion 2.1.1) and the fast scanning STED microscope (see section 2.1.2) - was
controlled on a day-to-day basis using standardized calibration samples (see
sections 2.5.1, 2.5.2 and 2.5.3). To this end, a three-step system alignment pro-
cedure was performed as described in the following.
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First, the mutual spatial alignment of the excitation and STED laser beams was
monitored and adjusted by scanning a sample of  80 nm gold beads (see sec-
tion 2.5.1) with the respective laser beam and recording the point spread func-
tion (PSF) of an individual bead with a PMT in the path of the backscattered
light. The excitation laser beams were aligned to the STED beam as the refer-
ence to achieve maximal overlap of both lateral and axial PSFs, respectively.
Second, the optimal alignment of the fluorescence detection units was adjusted
using a fluorescent dye sea sample (see section 2.5.2) that was illuminated with
the respective excitation laser beam. The sample was scanned axially and the
fluorescence signal at the edge of the dye sea was monitored with the APD of
the respective color channel. The illumination of the APD was optimized by
maximizing the fluorescence signal stemming from the dye sea sample. Addi-
tionally, for the fast scanning STED microscope (see section 2.1.2) with pulsed
excitation lasers, the dye sea fluorescence signal was used to synchronize ex-
citation and STED laser pulses. To this end, the dye sea was illuminated with
both excitation and STED laser light (at very low intensities) and the time delay
between the two laser pulse trains was adjusted such that the recorded signal
became minimal (i.e. resulting in a maximal switch-off effect).
Third, to have a comparative standard for the achievable STED image resolu-
tion on the day of a specific experiment using either the fast scanning STED
microscope setup (see section 2.1.2) or the Two-Photon-Excitation-CW-STED
(2P-Exc-CWSTED) microscope (see section 2.1.1), images of spectrally appro-
priate fluorescent beads (see section 2.5.3) were recorded in both STED and
confocal mode. Based on the obtained images, the achievable object resolu-
tion was determined as is described in section 2.6.2. Experiments were con-
ducted only if the thus determined resolution reached an acceptable value. If
this criterion of image quality could not be met, the system was checked and
re-aligned until appropriate performance was guaranteed. The measured di-
ameter of sample beads served as a control value for the achievable resolution.
The 2P-Exc-CWSTED setup provided a standard lateral bead diameter of ≤ 50
nm (see section 3.4.1); the custom-built fast scanning STED setup provided a
standard lateral bead diameter of ≤ 40 nm .
Further, for image acquisition with the 2P-Exc-CWSTED setup (see section
2.1.1), the correction collar of the used water immersion objective was adjusted
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to match the thickness of the cover slips on which the samples were plated
and/or mounted (typically a thickness of 0.13 - 0.16 mm, i.e. cover slips of type
#1.0). To this end, fluorescent beads were axially scanned and the correction
collar was iteratively adjusted to yield the smallest axial point spread function
free of spherical aberrations. An axial resolution of 450 nm was achieved using
yellow-green fluorescent beads featuring an emission maximum at 515 nm (see
section 2.5.3). The optimal position of the correction collar was controlled from
time to time at an appropriate interval.
2.10.2. Western blots
Caveolin-3 (Cav-3) protein expression in mouse ventricular cardiac tissue and
in Cav-3 overexpressing HeLa cells (via the transfection protocol described in
section 2.4.1) was determined by Western Blotting.
To this end, hearts from four 12-week-old, male C57Bl/6N mice (Charles River,
Sulzfeld, Germany) were excised and the left ventricles were dissected. Left
ventricles were homogenized in 1 ml homogenization buffer (HB, see Table
2.4) using a disperser (Ultra-Turrax, IKA-Werke GmbH, Staufen, Germany).
Tissue homogenates were incubated in an overhead shaker for 30 min at 4 °C
prior to being centrifuged at 5, 000 g for 10 min in a centrifuge cooled to 4 °C.
Homogenates of Cav-3 overexpressing HeLa cells were obtained analogously
after collecting cells from the culture dish with a cell scraper, discarding the
supernatant of culture medium and pelleting the cells at 600 g at 4 °C for 5
min.
For the determination of protein concentrations, 3 µl of the supernatant of the
respective homogenate was diluted in 57 µl H2O (1:20 dilution) and used in
a standard protein detection kit (Pierce BCA Protein Assay Kit, 23227, Ther-
moFisher Scientific, Dreieich, Germany) following the manufacturer’s instruc-
tions. The specific protein concentrations in tissue and cell homogenates are
given in the Appendix, see Table L.1. For the gel preparation, a 12 % Acry-
lamide separating gel (see Table 2.5) was mixed and poured, covered with
water-saturated butanol. The gel was polymerized at room temperature un-
til the aqueous phase between the gel and the butanol became clearly visible.
The butanol was discarded, the separating gel was rinsed with distilled water
and dried with filter paper. The 4 % Acrylamide stacking gel (see Table 2.5)
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MW [g/mol] Final concentration
Homogenization buffer (HB)
HEPES 238.31 10 mM
Sucrose 342.30 300 mM
NaCl 58.44 150 mM
EGTA 380.35 1 mM
CaCl2 110.98 2 mM
Adjust to pH 7.4 at 37 °C with NaOH [1M]
Triton X-100 647 1 % (v/v)
Phosphate inhibitor cocktail (PhosSTOP) – 1 tablet/10 ml
Protease inhibitor cocktail, EDTA free
(cOmplete)
– 1 tablet/10 ml
Ad. H2O
4× Laemmli sample buffer (SB)
Glycerol 92.09 47 % (v/v)
EGTA 380.35 16 mM
Tris/HCl (pH 6.8) 121.14 240 mM
SDS 288.37 4 % (w/v)
Bromophenol blue 669.96 0.05 % (w/v)
TCEP 286.65 10 % (w/v)
Ad. H2O
Transfer buffer (TB)
Tris 121.14 65 mM
Glycine 75.07 380 mM
Methanol 32.04 20 % (v/v)
Ad. H2O
Tris-buffered saline with Tween 20 (TBST)
Tris 121.14 10 mM
NaCl 58.44 170 mM
Tween 20 1227.54 0.05 % (v/v)
Ad. H2O; adjust pH to 7.5
Table 2.4.: Buffers for Western blot analysis. Providers and order numbers of the used chemicals are given in Appendix
A.1.
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was poured on top and the comb was inserted immediately. The gel was poly-
merized at room temperature for 1 h. Protein samples were brought to 90 µg
Absolute amount
12 % Acrylamide separating gel, 15 ml total volume
H2O 5.25 ml
Acrylamide/Bis-acrylamide (30 %/0.8 % w/v) 6.0 ml
1.5 M Tris-HCl, pH 8.8 3.75 ml
10 % (w/v) SDS 150 µl
TEMED 7.5 µl
10 % APS 75 µl
4 % Acrylamide stacking gel, 15 ml total volume
H2O 9 ml
Acrylamide/Bis-acrylamide (30 %/0.8 % w/v) 1.98 ml
0.5 M Tris-HCl, pH 6.8 3.78 ml
10 % (w/v) SDS 150 µl
TEMED 15 µl
10 % APS 75 µl
Table 2.5.: Gels for Western blot analysis. Providers and order numbers of the used chemicals are given in Appendix
A.1.
protein in 45 µl 1x Laemmli sample buffer (SB, see Table 2.4). A prestained
molecular weight marker (Protein-Marker V, 27-2210, Peqlab via VWR Inter-
national GmbH, Darmstadt, Germany) was used as a size standard. Samples
were loaded on the gel and electrophoresis was performed at 70 V for approxi-
mately 15 min, then the voltage was increased to 150 V and electrophoresis was
continued until the first weight marker band reached the bottom of the gel.
For blotting, PVDF membranes were soaked in transfer buffer (TB, see Table
2.4) for 1 min. Proteins were blotted to PVDF membranes in a wet blotting
apparatus consisting of two layers of filter paper, the PVDF membrane, the
protein gel, and another two layers of filter paper. The wet blotting apparatus
was filled with 1× TB (see Table 2.4), put on ice, and blotting was performed
at 100 V for 1 h. After blotting, the membrane was stained in a solution of 0.1 %
Ponceau in 5 % acetic acid (P7170, Sigma-Aldrich, Taufkirchen, Germany) for
5 min to confirm uniform protein transfer onto the membrane. The membrane
was then washed thoroughly with H2O and transferred to Tris-buffered saline
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with Tween 20 (TBST, see Table 2.4) containing 5 % milk powder and blocked
for 1 h to avoid artifacts due to unspecific binding.
The ≈ 36 kDa enzyme Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
was used as a loading control. Primary antibodies were diluted in TBST con-
taining 5 % milk powder in the following concentrations: 1:80, 000 for mouse
anti-GAPDH (5G4 Mab 6C5, Biotrend, Cologne, Germany) and 1:1, 000 for rab-
bit anti-Cav-3 (ab2912, Abcam, Cambridge, UK). After blocking, the mem-
branes were incubated with the primary antibodies overnight at 4 °C. Mem-
branes were washed three times (for 10 min per washing step) with TBST. The
secondary antibodies ECL-HRP-linked sheep anti-mouse for GAPDH detec-
tion, and ECL-HRP-linked donkey anti-rabbit for Cav-3 detection (Enhanced
Chemiluminescence Horse Radish Peroxidase, NA9310/NA9340, GE Health-
care, Munich, Germany) were diluted 1:15, 000 in TBST containing 5 % milk
powder. Membranes were incubated with the secondary antibodies for 1 h at
room temperature, and were washed four times (for 10 min per washing step)
with TBST.
For detection, the chemiluminescense reagents were mixed at a ratio of 1:1
Luminol:Peroxide solution (Immobilon Western HRP Substrate, WBKLS0500,
Merck Millipore, Darmstadt, Germany), pipetted onto the membrane while
tilting it gently in an amount to completely cover the membrane. After a short
incubation time, chemiluminescence was recorded using an appropriate imag-
ing station (Kodak Image Station 4000R Pro, Carestream Health Inc., Rochester,
NY, USA).
One of the obtained Western blots is exemplarily shown and thoroughly dis-
cussed in section 3.5. The complete set of Western blots that were prepared is
shown and described in Figure L.1 in Appendix L.
2.10.3. Electron microscopy
Cardiac samples for electron microscopy
Adult mouse ventricular cardiomyocytes were isolated as described in section
2.3.1.
For electron microscopy (EM) imaging of single cells, isolated cells were care-
fully plated in perfusion buffer on  13 mm ACLAR® foil punch-outs (10501-
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10, Plano GmbH, Wetzlar, Germany) for at least 30 min. The supernatant was
carefully pipetted off and replaced by fixative solution consisting of 2.5 % Glu-
taraldehyde (G5882, Sigma-Aldrich, Taufkirchen, Germany) in 0.1 M Sodium
cacodylate buffer (pH 7.5, C4945, Sigma-Aldrich, Taufkirchen, Germany). Cells
were fixed overnight at 4 °C before being processed further as described in sec-
tion 2.10.3.
For EM imaging of cell pellets, i.e. of cells in a loose cell complex, isolated cells
suspended in perfusion buffer were left to sediment for 10 min to form a visible
cell pellet. For immobilization of the cell pellet, the supernatant was carefully
pipetted off and the pellet resuspended in 4 % warm (max. 60 °C to avoid dam-
age to the sample) Agarose (A9539, Sigma-Aldrich, Taufkirchen, Germany) and
centrifuged immediately. After the Agarose had hardened, the mixture of cell
pellet and Agarose was dissected into small pieces and incubated in fixative
solution for 30 min. Ensuingly, the samples were fixed overnight at 4 °C before
being further processed as described in section 2.10.3.
For EM imaging of tissue sections, mouse hearts were extracted, their proxi-
mal aorta connected to a 21 gauge cannula, and cannulas were connected to
a modified Langendorff perfusion system (see section 2.3.1) placed in a fume
cupboard. The cannulated hearts were perfused with perfusion buffer (see Ta-
ble 2.1) for 4 min at 37 °C and at a flow rate of 4 ml/min. Perfusion buffer
was replaced by fixative solution and the hearts perfusion-fixed for 10 min at
a flow rate of 4 ml/min (total volume of throughput: 40 ml). The hearts were
then transferred into a Petri dish coated with Silicone and filled with fixative
solution. Trabeculae carnae from the left ventricle were excised and transferred
into an Eppendorf cup filled with fixative solution and further processed for
EM sample preparation.
Sample preparation for electron microscopy
After fixation, cell and tissue samples (see section 2.10.3) were washed thor-
oughly with 0.1 M sodium cacodylate buffer (three times for 5 min each). Sam-
ples were transferred into 0.1 M sodium cacodylate buffer containing 1 % OsO4
(75633, Sigma-Aldrich, Taufkirchen, Germany) and incubated on ice for 1 h.
OsO4 containing buffer was removed thoroughly and samples washed several
times with H2O. Samples were transferred into 1 % uranyl acetate (in H2O) and
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incubated in the dark at room temperature for 20 min. For dehydration, sam-
ples were washed according to the following scheme: twice with 30 % ethanol
for 5 min each; three times with 50 % ethanol for 5 min each, three times with
70 % ethanol for 5 min each; three times with 100 % ethanol for 5 min each;
twice with 100 % ethanol for 10 min each; and twice with 100 % propylene ox-
ide (110205, Sigma-Aldrich, Taufkirchen, Germany) for 5 min each (closed lid).
Samples were incubated in a 1:1 mixture of Epon 812 (45345, Sigma-Aldrich,
Taufkirchen, Germany) and propylene oxide for 30 min (closed lid). Samples
were incubated in pure Epon 812 for 60 min (closed lid). Epon 812 was replaced
and samples were incubated overnight on a platform shaker. Samples were let
to polymerize in flat embedding molds at 60 °C for 48 h. Samples of cell pellets
and cardiac tissue embedded in Epon 812 were cut into 70 nm thin slices using
an ultramicrotome (Ultracut UCT, Leica Microsystems GmbH, Wetzlar, Ger-
many) equipped with a 35° ultra diamond knife (Diatome, Hatfield, PA, USA).
All samples were counterstained with 1 % methanolic uranyl acetate (incuba-
tion for 20 min followed by thorough washing with distilled water). Samples
were investigated using a BioTwin CM120 transmission electron microscope
(Philips/FEI, Graefelfing, Germany) equipped with a TemCam F416 CMOS
camera (TVIPS GmbH, Gauting, Germany). Images were taken in a format
of (4000 × 4000) pixels without binning.
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3. Results and discussion
3.1. Cholesterol-PEG-KK114: a novel live-cell
membrane marker for STED microscopy
As mentioned in the introduction (see section 1.1), cardiomyocytes feature an
intricate and complex network of cell-wide membrane invaginations: the Trans-
verse-Axial Tubular System (TATS). The specific architecture of the TATS and
the vast set of proteins and lipids that are associated with it are vital for phys-
iological cell function. Deviations from size, regularity, and molecular compo-
sition of the TATS have been shown to be indicative of cardiac pathophysiol-
ogy. Thus, visualizing the TATS of living cardiomyocytes in different models
of cardiac disease using appropriate membrane labels for optical microscopy is
an important experimental approach to complement and control biochemical
data.
Finding and selecting a suitable membrane label for living cells, especially very
sensitive cells like cardiomyocytes, and specifically for the application in STED
microscopy demand certain basic requirements. These requirements comprise,
but are not restricted to, the following key points:
1. The label must be non-toxic, i.e. it must not cause cell death, cell round-
ing, or membrane blebbing. Specifically, for STED imaging of cardiomy-
ocytes, the labeled cells must stay quiescent during the illumination cyle
and the fluorescence read-out. Therefore, the appropriate membrane la-
bel must not only be non-toxic but also show no signs of possibly illumi-
nation induced toxicity, the so-called “phototoxicity” [431, 432, 433].
2. The staining protocol must be fast and physiological.
3. The membrane label must be cell- and membrane-specific.
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4. Cellular internalization must be slow to ensure a membrane-specific, sta-
ble fluorescence signal over the course of the whole experiment.
5. The fluorophore of the membrane label must be compatible with STED
applications, i.e. the fluorophore must have a high quantum yield when
emitting fluorescence light, and at the same time be efficiently switched
into a dark state by the STED laser. Also, the fluorophore must be both
photophysically (i.e. it must have a low rate of photobleaching) and pho-
tochemically stable (i.e. it must retain its spectral properties even after
multiple cycles of excitation and depletion). Preferably, the fluorophore
would have absorption and emission peaks in the near-infrared spectral
region to reduce imaging artifacts due to intracellular scattering, cellu-
lar autofluorescence, and to achieve higher sample penetration depth. In
short, the fluorophore must provide bright STED images with the highest
possible resolution.
A well-established class of dyes that is typically used for fluorescence micros-
copy of cellular membranes is potentiometric (i.e. voltage-sensitive) mem-
brane markers. Widely used examples of these potentiometric dyes are Ami-
nonaphthylethenylpyridinium (ANEP) dyes, such as Di-4-ANEPPS [434, 435]
and Di-8-ANEPPS [414, 413], the latter being used as the current “gold stan-
dard” for labeling cardiomyocyte and skeletal myocyte membrane structures
and visualizing their action potentials [436, 437, 438, 439, 440]. However, pho-
totoxicity [441, 442, 443] has been reported for Di-8-ANEPPS. And although
Di-8-ANEPPS has been used in STED microscopy studies of the membrane
topology of cardiomyocytes [22], its spectroscopic properties make it less than
ideal for STED applications. Di-8-ANEPPS features a very broad excitation
range between 420 nm and 510 nm paired with a similarly broad emission
range between 560 nm and 720 nm [444, 445, 446]. For one, these broad excita-
tion and emission spectra of Di-8-ANEPPS make it rather unsuited for multi-
color imaging applications employing other fluorescent live-cell labels, such as
fluorescent proteins whose most prominent and most often used representa-
tives cover a similar spectral region as that of Di-8-ANEPPS, e.g. Green Flu-
orescent Protein (GFP) and its spectrally similar, mutation-derived variations
[447, 448, 449]. For the other, Di-8-ANEPPS shows a high rate of photobleach-
ing in STED microscopy of living cardiomyocytes. This could be due to an
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appreciable overlap between the dye’s stimulated emission spectrum and its
excited state absorption spectrum [450, 451]. The non-negligible photobleach-
ing is paired with a relatively low lateral diffusion time [17] between 0.2 µm²/s
[452] and 0.5 µm²/s [453] along the extracellular leaflet of the membrane. This
restricts the applicability of Di-8-ANEPPS for three-dimensional (3D) STED mi-
croscopy to static and rather time-consuming imaging schemes. Specifically,
after having acquired a single two-dimensional image of a live cardiomyocyte
stained with Di-8-ANEPPS, and thus having bleached the dye within the fo-
cal volume, it takes several minutes before enough of the membrane probe has
diffused back into the bleached region before another image at a different axial
position can be acquired with a sufficiently high signal-to-noise ratio. There-
fore, dynamic and video-rate STED image acquisition is not feasible using Di-
8-ANEPPS.
A highly promising alternative to Di-8-ANEPPS is the novel membrane label
Cholesterol-PEG-KK114 (Chol-KK114), a fluorescent lipid compound first pre-
sented by Honigmann et al. in 2014 [100] and which has up to now been mostly
used in STED-FCS applications [100, 454, 455], and for experiments regard-
ing cholesterol partitioning in specially prepared lipid vesicles [456] or sup-
ported lipid bilayers [457]. So far this dye compound has not been exploited to
its full potential in actual subdiffraction cellular membrane structure imaging.
Therefore the motivation was to demonstrate the applicability and versatility
of Chol-KK114 for STED microscopy of membrane structures in living cells. I
will show this applicability and quantify the observed nanometric membrane
patterns for a set of widely used culture cell lines and extend it to primary
mouse ventricular cardiomyocytes with their complex and sophisticated TATS
membrane architecture.
Chol-KK114 features the membrane lipid cholesterol (Chol) labeled with the
organic dye KK114 [458] via a 1 kDa large PolyEthylene Glycol (PEG) linker
molecule. The molecular structure of Chol-KK114 is schematically depicted in
Fig. 3.1 A. The spectroscopic properties of the organic dye KK114 decorating
the Chol-PEG complex in water are displayed in Fig. 3.1 B. The dye has its
absorption and emission maximum around 638 nm and 655 nm, respectively.
KK114 is switched off most efficiently with a STED wavelength between 750
and 800 nm [427]. Regarding the requirements for an optimal STED-compatible
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Figure 3.1.: Structure of Cholesterol-PEG-KK114 (Chol-KK114), and absorbance/emission spectra of the dye KK114.
A Schematics of the molecular structure of the dye compound Cholesterol-PEG-KK114. The fluorescent
dye KK114 is displayed in red, the PolyEthylene Glycol (PEG) linker is displayed in blue (the number 22
indicates the number of repeats of the structure motif in parentheses), and the lipid Cholesterol is displayed
in black. The drawing was adapted with permission from [100]. B Normalized absorbance and emission
spectra of the fluorescent dye KK114 [458], and the spectral region of suitable STED laser wavelengths for
efficient fluorescence switch-off (indicated by the dark red bar).
live-cell membrane label identified above, Chol-KK114 proves most suitable
due to its specific chemical and structural composition. Considering the enu-
meration of criteria introduced above, and explicitly comparing Chol-KK114
and Di-8-ANEPPS as membrane labels for living cardiomyocytes, it can be
summarized that:
1. Membrane labeling with Chol-KK114 according to the herein established
staining protocol (see section 2.3.2) enabled long-term STED imaging ex-
periments without observing any signs of toxicity to cells, i.e. cell round-
ing, membrane blebbing, or, in the case of living cardiomyocytes, cell
contraction. Living cardiomyocytes could be used for STED imaging for
up to 4 hours without signs of compromised cell viability. This is at least
twice as long as a reliable physiological STED imaging session using car-
diomyocytes labeled with Di-8-ANEPPS.
2. Membrane labeling with Chol-KK114 does not rely on any special treat-
ment of the living cell samples (e.g. temperature changes or additional
chemicals for marker delivery). It is thus as physiological as possible.
Further, it is fast: the general staining protocol requires only 1 to 3 min of
incubation with the dye solution followed by a maximum of three wash-
ing steps. Compared to the standard Di-8-ANEPPS staining routine, this
speeds up the sample labeling by at least a factor of 5.
3. Chol-KK114 shows highly cell-specific membrane signals for different
culture cell lines as well as for primary mouse ventricular cardiomyocytes.
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The distinct nanometric membrane patterns will be presented and dis-
cussed in detail in the following sections (see sections 3.2 and 3.3).
4. Chol-KK114, as compared to other fluorescently labeled lipids, features
a very slow rate of internalization into the cell. This is most likely due
to the size of the PEG-linker which - with 1 kDa - is rather bulky and
is thus causing the labeled Cholesterol to “get stuck” in the extracellu-
lar leaflet of the lipid bilayer [459, 100, 460] (cf. Fig. 3.2). Due to steric
hindrance, this suppresses events of flip-flopping [460, 461, 462] or cel-
lular transport processes [463, 464, 465] of the labeled Cholesterol from
the extra- to the intracellular leaflet. Along that line, no indication of
diffusion-mediated internalization of Chol-KK114 in any of the long-term
experiments was observed. Label internalization was always coupled to
endocytotic processes with clearly identifiable inclusion bodies. Before
any signs of Chol-KK114 internalization would be observable, investi-
gated cells would rather start forming vesicles. This would, admittedly,
impair the physiological validity of a live-cell sample but never compro-
mise image quality.
5. The possibility of attaching different organic fluorophores to the Chol-
PEG compound creates a spectrally diverse set of fluorescent membrane
labels that allow optimal STED imaging performance and that fit the re-
spective need of the experiment. The dye compound KK114 [458] has
proven to be one of the most suited fluorescent dyes for STED appli-
cations, enabling the acquisition of images with superior resolution of
down to 20 nm [336]. The spectral properties of Chol-KK114 (see Fig. 3.1)
make it ideal for STED imaging in the red spectral region, thus further
reducing phototoxicity, cellular autofluorescence, and scattering within
thick samples. By labeling living mouse ventricular cardiomyocytes with
Chol-KK114, a resolution of membrane compartments down to 35 nm
was achieved (see section 3.3).
An additional and future-oriented advantage of the dye compound KK114 is
that it can be effectively switched off with STED laser wavelengths ranging
from 750 − 800 nm (see Fig. 3.1 B) as we previously investigated and reported
in [427]. The possible application of STED laser wavelengths in the spectral
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PEG-Linker
KK114
Figure 3.2.: Sketch of the insertion of Chol-KK114 into the cellular membrane. The schematic membrane model is
based on the one introduced in section 1.4. The labeled Cholesterol (in yellow) inserts itself into the outer
leaflet of the lipid bilayer (drawn in light blue). The bulky PEG-linker (in dark blue) prevents the lipid-dye
compound from cellular internalization and keeps the fluorescent dye KK114 (in red) in the extracellular
space (see also Fig. 3.1 A). Abbreviations: Chol. - Cholesterol; GM1 - Monosialotetrahexosylganglioside;
PEG - PolyEthylene Glycol. Not drawn to scale.
region farther red than the 775 nm laser line that is implemented in most com-
mercial STED microscopes is a promising future direction for the improve-
ment of STED image quality regarding increase of image resolution, decrease
of sample bleaching, and suppression of background signal. This is because,
as stated above, the scattering inside thick specimen and photobleaching are
reduced at longer STED laser wavelengths. Further, the use of a fluorescent
lipid analog for live-cell membrane staining instead of a voltage-sensor like
Di-8-ANEPPS has advantages that effectively manifest themselves as brighter
and more stable detectable fluorescence signals. These advantages are that the
lateral diffusion along the cell membrane is faster by a factor of 10 to 50 for
lipid-raft associated fluorescent lipid analogs such as Chol-KK114 than it is for
Di-8-ANEPPS [466, 467]. Also, the above mentioned flexibility in choosing the
organic dye that is coupled to the Chol-PEG construct allows the selection of
fluorophores that offer high photostability and high quantum yields. This en-
ables the quick acquisition of images either at a fixed spot in the sample or
while scanning through the sample, thus facilitating the recording of videos
or 3D stacks, respectively. In the following, I will justify the possibilities for
live-cell membrane imaging using Chol-KK114 in different cell systems and
present its excellent applicability in subdiffraction topological investigations
of the Transverse-Axial Tubular System (TATS) of living cardiomyocytes.
3.2. CELL-SPECIFIC CHOLESTEROL NANOPATTERNS 111
3.2. Cell-specific Cholesterol nanopatterns
To assess the suitability of Chol-KK114 for live-cell STED imaging and the
specificity of membrane labeling, I prepared samples of culture cell lines de-
rived from various tissue types. I stained them with Chol-KK114 and used
them for STED imaging under optimized imaging conditions. These select cul-
ture cell lines were: U2OS, HeLa, HEK, Vero (see section 2.4.1, respectively),
ventricular induced pluripotent stem cells (ViPSC, see section 2.4.2), and hu-
man adipocytes (HAd, from adipose heart tissue, see section 2.4.3). For U2OS,
HeLa, HEK, and Vero cells labeled with Chol-KK114, Figure 3.3 shows exem-
plary overview images and magnifications of regions of interest (ROI) marked
by the yellow boxes therein. U2OS (derived from human osteosarcoma can-
Figure 3.3.: STED images of the cell-specific Cholesterol-PEG-KK114 (Chol-KK114) nanopattern at the basement mem-
brane of living culture cells. The following four culture cell lines were stained with 5 µM Chol-KK114 for
STED microscopy as described in section 2.4.1: U2OS, HeLa, HEK, and Vero. Overview images and mag-
nifications corresponding to the indicated yellow boxed regions are displayed. Scale bars in overview
images: 5 µm; scale bars in magnified insets: 500 nm. Images were smoothed using a two-dimensional
Gaussian filter with a width of 1.5 pixels. Image brightness was adjusted in the magnified insets for vis-
ibility. The color bar indicates the respective image brightness of the magnified images in photon counts
(cts.); for the overview images, the same color code was used but ranging from 0 to 132 cts.
cer), HeLa (derived from human cervical cancer), HEK (Human Embryonic
Kidney cells), and Vero (epithelial cells from African Green Monkey) are cells
that typically feature filopodia. Filopodia are elongated, cytoplasmic mem-
brane protrusions that are involved in cell adhesion, cell migration, and cell
sensing [468, 469]. Filopodia are highly enriched in Cholesterol (Chol) [470]
as has been shown by fluorescence microscopy [471] and immunoelectron mi-
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croscopy [472]. By labeling the extracellular leaflet of the lipid bilayer of the
above mentioned four cell lines with Chol-KK114 for STED microscopy, the
assembly of Chol nanodomains mainly along filopodial structures could be
demonstrated (see Fig. 3.3, top and middle row). With STED microscopy of
the Chol-KK114 membrane label it was possible to precisely outline filopodia
in living cells and show the compartmentalization of Chol alongside the outer
membrane leaflet of these protrusions. To quantify these Chol nanodomain as-
semblies in filopodial structures, I determined the Chol-KK114 signal density
ρ as described in section 2.6.4. In Fig. 3.4, the obtained values of ρ in filopodia
are displayed in percent of the total filopodial area for each cell line. As can
Figure 3.4.: Comparison of the Cholesterol-PEG-KK114 (Chol-KK114) signal density ρ in filopodia of the cultured cell
lines U2OS, HeLa, HEK, and Vero. A STED images of the culture cell lines labeled with Chol-KK114,
corresponding to the magnified insets presented and described in Fig. 3.3. Images were smoothed using
a two-dimensional Gaussian filter with a width of 1.5 pixels. The color bar indicates the respective image
brightness in photon counts (cts.). Scale bars: 500 nm. B Bar graph representation of the Chol-KK114
surface signal density ρ in filopodia. ρ was determined as described in section 2.6.4, is given in % of the
total filopodial area, and is presented as mean ± standard deviation. Number of analyzed cells: U2OS -
13; HeLa - 8; HEK - 24; Vero - 13. Statistical significance is denoted as p> 0.01; (∗): significant, p< 0.01;
(∗∗): very significant, p< 0.001 (see also section 2.9 and Appendix I, Table I.1)
be seen in Fig. 3.4, the Chol-KK114 signal density in filopodia is significantly
different between cell types (see also Appendix I, Table I.1). Notably, the den-
sity of Chol-KK114 structures in filopodia of U2OS, HeLa, HEK, and Vero cells
is profoundly higher (by a factor of 100) than the Chol-KK114 signal density
along the cellular basement membrane (see Fig. 3.7). The mentioned cell lines
show from little to no Chol-KK114 membrane domains that are not associated
to filopodia. An increase in the concentration of Chol-KK114 used for mem-
brane labeling above 5 µM did not increase the amount of Chol-KK114 signal
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at the basement membrane of the cells indicating that with 5 µM Chol-KK114
the labeling saturation concentration is reached. There has so far only been one
study involving subdiffraction imaging of Chol clusters in the cell membrane:
Mizuno et al. [473] used PhotoActivation Localization Microscopy (PALM) to
visualize nanoscopic Chol enriched membrane domains in fixed HeLa cells
and could confirm the prevalence of Chol signal in filopodia. In their publi-
cation however, Chol signal could only be observed at the apical membrane
of the cells and in addition to the filopodial Chol signal, there were circular
Chol structures along the membrane. These findings could not be reproduced
here using Chol-KK114. Yet, Mizuno et al. conducted subdiffraction imaging
experiments using fixed HeLa cells fluorescently labeled via the C-terminal
domain of θ-toxin. Thus, the additionally observed Chol cluster signal at the
apical membrane and the absence of Chol clusters at the basement membrane
might be fixation artifacts. Also, the fluorescent θ-toxin label might either be
internalized by the cells or transferred to the cytosolic membrane leaflet by
flip-flopping, resulting in a possible tagging of Chol structures along the intra-
cellular leaflet.
The here observed preferred assembly of Chol-KK114 in filopodia, as opposed
to along the basement membrane, might be interpreted in two ways. Either
that the cellular basement membrane is fully and stably packed with endoge-
nous Chol which results in a highly reduced possibility of exogenous Chol in-
sertion into the outer leaflet. Or that there is a general absence of large-scale
Chol clusters along the extracellular leaflet of the basement membrane result-
ing in a homogeneous distribution of single Chol-KK114 monomers (or only
small Chol-KK114 assemblies) with an overall brightness that would be too
dim to be detectable by fluorescence recording.
For future studies, an in-depth investigation of the Chol distribution in filopo-
dia of living cells would be of great interest, especially because malformation of
filopodia is associated with many pathologies most prominently in the fields of
cancer [474, 475, 476] and neurological disorders [477, 478]. Using Chol-KK114
together with STED microscopy would definitely be a very valuable method
supporting such research.
Contrary to the above findings in the immortal cell lines, other cell types la-
beled with Chol-KK114 and that typically do not feature filopodia, showed a
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distinct Chol-KK114 signal along their basement membrane with a high de-
gree of signal clustering. Specifically, I used Chol-KK114 to label and image
cultured ventricular induced pluripotent stem cells (ViPSC, see section 2.4.2)
and human adipocytes (HAd, from adipose heart tissue, see section 2.4.3). I
Figure 3.5.: STED images of the cell-specific Cholesterol-PEG-KK114 (Chol-KK114) nanopattern at the basement mem-
brane of living ventricular induced pluripotent stem cells (ViPSC, displayed in A) and living human
adipocytes (HAd, from adipose heart tissue, displayed in B). ViPSC and HAd were stained with 5 µM
Chol-KK114 for STED microscopy as described in section 2.4.1. Overview images and magnifications
corresponding to the indicated yellow boxed regions are displayed. Green arrows point out single Choles-
terol domains; yellow arrows point out exemplary bunchy clusters of Cholesterol; blue arrows point out
Cholesterol ring structures. Images were smoothed using a two-dimensional Gaussian filter with a width
of 1.5 pixels. Image brightness was adjusted in the magnified insets for visibility. The color bar indicates
the image brightness in photon counts (cts.). Scale bars in overview images: 5 µm; scale bars in magnified
insets: 500 nm.
chose to label Chol-rich membrane domains in ViPSC because these cells are
often used as a model system to study molecular mechanisms of cardiac dis-
ease [479, 480]. This is due to the fact that it is much easier to obtain, cultivate,
and control ViPSC than it is for primary living cardiomyocytes [481, 482, 483].
Additionally, ViPSC offer the possibility to study patient-specific diseases and
their potential therapies - recently, they have even been cultured to serve as
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grafts repairing injured, fibrotic hearts [484]. There have been many critical
reviews regarding the aptness of ViPSC as a model system [485, 486]. Most
of these studies conclude that ViPSC should be used with caution and always
in combination with necessary control experiments. To justify the quantitative
comparison of the Chol arrangement at the basement membrane of ViPSC and
at the sarcolemma of mouse ventricular cardiomyocytes (VM), I selected only
those ViPSC for image evaluation that were of a similar size and shape as VM.
Further, I assessed the degree of differentiation of the imaged ViPSC by im-
munofluorescence staining forα-Actinin which is a cardiomyocyte marker pro-
tein [487, 481, 482, 488]. Exemplary images of these control stains that confirm
the virtually population-wide differentiation of ViPSC can be found in the Ap-
pendix D.1. As shown in the overview and magnified images of Chol-KK114
labeled ViPSC in Fig. 3.5, the cells show a dense and characteristic pattern of
Chol clusters at their basement membrane. The quantitative evaluation of the
Chol-KK114 surface signal density will be discussed in detail in section 3.3.
There, it will also be explicitly compared to the Chol-KK114 signal structure
and density in living VM. Note that along the basement membrane of living
ViPSC, the Chol-KK114 signal partitions into single domains (see Fig. 3.5 A,
green arrow), into ring structures with a diameter between approximately 100
and 200 nm (see Fig. 3.5 A, blue arrows), and into bunchy clusters of vari-
able shapes and sizes of several hundred nanometers (see Fig. 3.5 A, yellow
arrows). Further, there are regions devoid of any Chol-KK114 signal.
Finally, as another example to motivate the use of Chol-KK114 in cardiomy-
ocytes and compare the resulting membrane structures and patterns, I chose
to label and image Chol domains in human adipocytes (HAd), derived from
adipose heart tissue. The study of Chol domains in cardiac membranes could
benefit significantly from the assessment of the nanoscale distribution of Chol
in HAd. First, because HAd contain large amounts of Chol that predominantly
accumulate inside lipid droplets which are organelles that are formed to a great
extent by HAd [489, 490]. Second, various clinical studies have shown the
connection between obesity and cardiovascular disease [491, 492]. Both the
size as well as the Chol content in adipocytes has been proportionally asso-
ciated with the risk of cardiac pathologies [493, 494, 495]. Fig. 3.5 displays
the obtained STED images of the basement membrane of Chol-KK114 labeled
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living HAd. Interestingly, the incubation of HAd with Chol-KK114 did not
result in obviously visibly stained lipid droplets as is typically known from
other Chol stains of adipocytes, e.g. by indirect labeling using filipin [496] or
NBD cholesterol [497]. Typical signal of lipid droplets could not be detected
in neither the confocal nor the STED images of Chol-KK114 labeled HAd. In
general, upon the addition of free Chol to the cell membrane, Chol is quickly
recognized by the low-density lipoprotein (LDL) receptor. Together with the
LDL receptor, Chol is endocytosed and, if in excess, either stored in the lipid
droplets, or transported back across the cell membrane [489]. The absence of
lipid droplet labeling could be due to Chol-KK114 not penetrating the cellular
basement membrane but inserting itself stably into the extracellular leaflet and
thus not reaching the lipid droplets via endocytosis. Hence, the Chol-KK114
signal in HAd observed here does not contradict the lipid droplet signal seen
when labeling with filipin or NBD cholesterol because the latter two choles-
terol probes are specific to the cytosolic membrane leaflet. Compared to the
Chol-KK114 signal observed in ViPSC, HAd show a similar arrangement of
basement membrane Chol-KK114. Again, the Chol-KK114 signal partitions
into the above mentioned three characteristic pattern motifs: single domains
(see Fig. 3.5 B, green arrow), ring structures of between 100 and 200 nm in
diameter (see Fig. 3.5 B, blue arrow), and variably shaped bunchy clusters of
several hundred nanometers in size (see Fig. 3.5 B, yellow arrow). Regions
devoid of Chol-KK114 signal can also be observed.
Up to now, there are no reports involving live-cell subdiffraction imaging of
Chol structures at the basement membrane and/or in filopodia of the above
investigated cell lines, although Chol-KK114 has been proposed to be very fea-
sible for such applications [457]. Chol-KK114 has so far been used in STED-
Fluorescence-Correlation-Spectroscopy (STED-FCS) studies of Chol partition-
ing and Chol trapping in cell membranes [100, 460]. Further, Chol-KK114 has
been applied to study Chol partitioning in Giant Unilamellar Vesicles (GUVs)
and Giant Plasma Membrane Vesicles (GPMVs) [456, 457]. Comparative re-
views of different fluorescent Chol analogs as reporters for Chol distribution
in both artificial and cellular membrane systems, especially regarding their
normal insertion, partitioning, and diffusion behavior, have emphasized Chol-
KK114 (and similarly constructed fluorescent Chol-PEG analogs) to be among
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the most suitable labels for the visualization of Chol assemblies in the extra-
cellular leaflet [460, 457]. Further, there have been several studies on the fluo-
rescent Cholesterol analog Cholesterol-BODIPY (Chol-BODIPY [498], commer-
cially distributed by Avanti Polar Lipids, Inc., Alabaster, AL, USA) proving
this compound to behave very similarly to free Chol [499, 500]. Hence, to ex-
amine if Chol-KK114 inserts itself into the extracellular membrane in a similar
fashion as Chol-BODIPY, I prepared samples of living VM double-labeled with
Chol-KK114 and Chol-BODIPY for confocal fluorescence imaging. These dou-
ble stains are presented in section 3.3 and show that, indeed, the Chol-KK114
and the Chol-BODIPY signals colocalize. This signal overlap served as an in-
direct verification that Chol-KK114, just like Chol-BODIPY, can be assumed
to behave like a quasi-physiological membrane lipid probe. Apart from be-
ing a membrane marker, Chol-KK114 is thus also suitable for image-based in-
vestigations of the assembly of exogenous free Chol along the outer leaflet of
the lipid bilayer. These control studies and the high quality, cell-specific, and
quantifiable STED images above confirm the applicability of Chol-KK114 as a
trustworthy exogenous membrane marker for living cells.
When attempting to interpret the observed Chol-KK114 signal patterns at the
basement membrane of U2OS, HeLa, HEK, and Vero cells versus that in ViPSC
and HAd, it should be noted that according to the lipid raft hypothesis, exoge-
nous Chol would preferentially insert itself into those regions of the extracel-
lular leaflet that are enriched with saturated phospholipids and sphingolipids
[501, 502, 503]. The assumption of assemblies of saturated lipids that are het-
erogeneously distributed along the cell membrane and that bind large amounts
of Chol could explain the Chol-KK114 signal structures in ViPSC and HAd,
but cannot explain the absence of basement membrane Chol-KK114 signal in
U2OS, HeLa, HEK, and Vero cells. A further possibility would be the asso-
ciation of the exogenous Chol-KK114 with another membrane compartment
that is more often found in ViPSC and HAd than in the other four immortal
cell lines. This membrane compartment could be caveolae (see also section
1.1) that might form more complex three-dimensional structures at the base-
ment membrane of ViPSC, HAd, and most importantly - as will be shown in
the next section - at the sarcolemma of cardiomyocytes than in the immortal
cell lines where caveolae might be smaller, more solitary, and less branched
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structures. Based on the one- and two-photon-excitation-STED images of Chol
structures in living cardiomyocytes that will be presented in the following sec-
tions, I will motivate this possible direct association between the presented
fluorescent Chol analogs and caveolae. This could make the family of organic
dye labeled Chol-PEG markers an indicator of sarcolemmal caveolae in living
cardiomyocytes. In the following, the unique pattern of Chol nanodomains in
cardiomyocytes is presented.
3.3. Cholesterol nanopatterns in living
cardiomyocytes
The Chol nanopattern at the sarcolemma (i.e. the basement membrane of my-
ocytes) of living mouse ventricular cardiomyocytes (VM) is very distinct. Fig.
3.6 shows a living VM labeled with 5 µM Chol-KK114 as described in section
2.3.2 and imaged using the custom-built fast scanning STED microscope setup
(see section 2.1.2). The additionally shown bright field image of the labeled VM
(Fig. 3.6 B) confirms the cell fitness regarding even striations, no membrane
blebbing, and no cell rounding, and thus validates that the STED image shows
Chol structures under physiological conditions. In the STED image, it can be
seen that the sarcolemmal Chol signal is highly clustered and that it does not
align with the cellular striations. The three reoccurring membrane motifs that
had already been encountered when looking at Chol-KK114 stained ViPSC and
HAd (see last section) are conserved in VM: single Chol domains (Fig. 3.6 B,
green arrow), bunchy Chol clusters of variable sizes (Fig. 3.6 B, yellow arrow),
and Chol ring structures (Fig. 3.6 B, blue arrow).
When quantitatively evaluating the Chol-KK114 surface signal density ρ at the
basement membrane (see section 2.6.4) and comparing it between the here
investigated seven cell types, the expected formation of two groups is con-
firmed. The obtained per cent values of ρ are presented in Fig. 3.7. On the one
hand, the immortal cell lines U2OS, HeLa, HEK, and Vero show only a minor
Chol-KK114 signal at the basement membrane. The area of the Chol-KK114
signal amounts to less than 1 % of the total basement membrane area and is
thus negligible. On the other hand, the terminally differentiated cells ViPSC,
HAd, and VM show a significantly more abundant Chol-KK114 surface sig-
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Figure 3.6.: The distinct Cholesterol-PEG-KK114 (Chol-KK114) nanopattern at the sarcolemma of living primary
mouse ventricular cardiomyocytes (VM). VM were stained with 5 µM Chol-KK114 as described in sec-
tion 2.3.2. The coordinate system indicates the longitudinal (X) and the transverse (Y) cell axes. A bright
field (BF) image of a living primary VM, scale bar: 5 µm. B STED image of the sarcolemma of the same VM
stained with Chol-KK114 within the field of view indicated by the yellow box in the bright field image.
Three distinct membrane motifs can be distinguished: single Chol domains (green arrow), Chol ring struc-
tures (blue arrow), and bunchy clusters of Chol (yellow arrow). The STED image was smoothed using a
two-dimensional Gaussian filter with a width of 1.5 pixels. The color bar indicates the image brightness in
photon counts (cts.). Scale bar: 1 µm
nal that comprises almost 20 % of the cellular basement membrane. Further,
the Chol-KK114 surface signal density does not differ significantly between
ViPSC, HAd, and VM (see Appendix I, Table I.2 for a detailed statistical anal-
ysis). Across ViPSC, HAd, and VM, the complexity and abundance of Chol
structures at the basement membrane is conserved.
Summarizing the above findings, as opposed to U2OS, HeLa, HEK, and Vero
cells, the VM, ViPSC, and HAd show both the Chol membrane motifs of single
domains, bunchy clusters, and ring structures, as well as a significantly high
surface signal density of Chol clusters at the basement membrane. VM, ViPSC,
and HAd seem to feature a complex, probably three-dimensional, arrangement
120 3. RESULTS AND DISCUSSION
Figure 3.7.: Comparison of the Cholesterol-PEG-KK114 (Chol-KK114) signal density ρ at the basement membrane of
different cell types. Cell lines: U2OS, HeLa, HEK, Vero, ventricular induced pluripotent stem cells (ViPSC),
human adipocytes (HAd, from adipose heart tissue), mouse ventricular cardiomyocytes (VM). ρ was deter-
mined along the basement membrane of the cell body of cultured and primary cells as described in section
2.6.4, is given in % of the total area of the basement membrane, and is presented as mean ± standard
deviation. Statistical significance is denoted as p> 0.01; (∗): significant, p< 0.01; (∗∗): very significant,
p< 0.001 (see also section 2.9 and Appendix I, Table I.2). Number of analyzed cells: U2OS - 13; HeLa -
8; HEK - 24; Vero - 13; ViPSC - 16; HAd - 37; VM - 55. STED images of the basement membranes of the
mentioned cells labeled with Chol-KK114 are respectively shown in Fig. 3.3, Fig. 3.5, and Fig. 3.6.
of Chol-rich membrane regions. According to the working model of the cardiac
sarcolemma that wa proposed in this thesis (see section 1.4), the arrangement
of Chol could be mediated by caveolar structures at the cell membrane. In
VM, there is a highly abundant sarcolemmal signal of the caveolae forming
protein Caveolin-3 (Cav-3). This is similar to the abundant signal of Cav-3 and
Caveolin-1 (Cav-1) at the basement membrane of ViPSC and HAd, respectively.
For these three cell types, the mentioned complex Chol-KK114 membrane pat-
tern motifs could be observed. These motifs might coincide with similarly ar-
ranged caveolar structures that could potentially organize and shape the Chol
structures into branched three-dimensional membrane indentations. This pos-
sible association between the membrane structures labeled by Chol-KK114 and
the Caveolin proteins will be investigated in more detail in section 3.5. The val-
idation of Chol-KK114 as a physiological membrane label for living VM and its
superior performance for subdiffraction STED imaging will be shown below.
Since the membrane labeling procedure with Chol-KK114 involves the intro-
duction of a surplus of exogenous Chol to the cell, it has to be controlled that
3.3. CHOLESTEROL NANOPATTERNS IN LIVING CARDIOMYOCYTES 121
Chol-KK114 does not disturb the native membrane arrangement and proper-
ties. To that end, I prepared samples of living cardiomyocytes and labeled them
with both Chol-KK114 and Chol-BODIPY (as described in section 2.3.2). Chol-
BODIPY has been shown to conserve many properties of free Chol upon inser-
tion and partitioning in the cell membrane [499, 500]. The colocalization of the
Chol-KK114 and the Chol-BODIPY signal would thus verify that Chol-KK114
alters the physiological membrane composition as minimally as Chol-BODIPY.
The overlap of the Chol-KK114 signal with that of Chol-BODIPY had to be
verified using confocal microscopy. It was not possible to use Chol-BODIPY
in STED image acquisition because Chol-BODIPY shows an unfortunate addi-
tional absorption peak at 590 nm which coincides with the STED wavelength
used for the BODIPY color channel; using a STED wavelength between 750 -
800 nm did not result in a significant switch-off of the fluorophore. The inappli-
cability of Chol-BODIPY for STED imaging with a 592 nm STED wavelength is
discussed in more detail in the Appendix E. Nevertheless, the confocal inves-
Figure 3.8.: Confocal images of living mouse ventricular cardiomyocytes (VM) double labeled with Cholesterol-PEG-
KK114 (Chol-KK114) and Cholesterol-BODIPY (Chol-BODIPY), see section 2.3.2. A Single color channel
image of the Chol-BODIPY color channel. B Single color channel image of the Chol-KK114 color channel.
C Overlay of the two color channels with the Chol-BODIPY channel displayed in cyan (C) and the Chol-
KK114 channel displayed in magenta (M), yellow signal (Y) indicates signal overlap of the color channels.
The corresponding color map is displayed in the image (bottom right); images were transformed to this
color map as described in section 2.6.1. White arrows indicate the longitudinal (X) and the transverse (Y)
cell axes, respectively. Images were smoothed using a two-dimensional Gaussian filter with a width of 1.5
pixels. Scale bars: 5 µm.
tigation of the colocalization of the Chol-KK114 and the Chol-BODIPY signals
reveals the significant signal overlap of the two membrane markers. This is
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demonstrated in Fig. 3.8 which shows the single color channels (Fig. 3.8 A
and B, respectively) and the overlay thereof (Fig. 3.8 C) with the Chol-BODIPY
signal color-coded in cyan and the Chol-KK114 signal color-coded in magenta.
The abundant yellow signal indicates a profound color channel overlap and
thus confirms that the two Chol analogs label the same structures. This vali-
dates that Chol-KK114 is behaving similarly to Chol-BODIPY and is hence po-
tentially mimicking the behavior of free Chol quite well when inserting itself
into the membrane.
As another control that Chol-KK114 is an apt membrane probe, especially for
cardiomyocytes, it had to be compared with the “gold standard” of cardiomy-
ocyte membrane labels: Di-8-ANEPPS. When comparing the Chol-KK114 to
the Di-8-ANEPPS membrane signal in living VM, one should again expect sig-
nificant colocalization of the two labels since both dye compounds exclusively
label the outer leaflet of the plasma membrane (see section 3.1 and [504]). To
verify this, I prepared samples of living VM and dually labeled them with
both Chol-KK114 and Di-8-ANEPPS following the staining protocols described
in section 2.3.2. These two-color samples were imaged both in confocal and
in STED mode using the commercial STED microscope Leica TCS SP8 STED
3X (see section 2.1.3) with an excitation wavelength of 490 nm at 10 % laser
power, a detection window of (510 − 630) nm, and a fluorescence time gate of
(2.80 − 6.30) ns for the Di-8-ANEPPS color channel. For the Chol-KK114 color
channel, an excitation wavelength of 640 nm at 10 % laser power, a detection
window of (670 − 720) nm, and a fluorescence time gate of (2.00 − 6.00) ns
was used. Both color channels were imaged in STED mode using the 775 nm
STED laser. This justifies that the two color channels, although obtained in two
consecutive scans, can be directly overlaid without an additional image regis-
tration procedure because the use of a single STED beam localizes the signal
stemming from each color channel to the same subdiffraction sized spot. The
spectral crosstalk between the two color channels was negligibly low. Fig. 3.9 A
shows the significant signal overlap of the Di-8-ANEPPS and the Chol-KK114
color channels, both in confocal as well as in STED mode. Especially the signal
overlap in the STED images confirms that Chol-KK114 labels the same struc-
tures as Di-8-ANEPPS. Additionally, using the Chol-KK114 and Di-8-ANEPPS
two-color VM sample, I could directly evaluate the improved STED image res-
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Figure 3.9.: Two-color images of living primary ventricular mouse cardiomyocytes (VM) labeled with the membrane
markers Cholesterol-PEG-KK114 (Chol-KK114, at the saturation labeling concentration of 5 µM) and Di-
8-ANEPPS (at a concentration of 50 µM). Images were taken inside the cell, at least 3 µm beneath the
sarcolemma. Images were smoothed using a two-dimensional Gaussian filter with a width of 1.5 pixels.
The used color map is depicted in A, bottom left. Images were transformed to this color map as described
in section 2.6.1. A Confocal overview image of a VM dual-labeled with Chol-KK114 (color-coded in ma-
genta) and Di-8-ANEPPS (color-coded in cyan); the highly abundant yellow signal indicates the significant
overlap of the Chol-KK114 and the Di-8-ANEPPS signal. White arrows indicate the longitudinal (X) and
transverse (Y) cell axes, respectively. Scale bar: 10 µm. B STED images of the region of interest marked by
the yellow box in the confocal overview image. From top to bottom: single-color Chol-KK114 STED im-
age, single-color Di-8-ANEPPS STED image, and overlay of the two color channels with the Chol-KK114
signal in magenta, the Di-8-ANEPPS signal in cyan and the yellow signal indicating spatial overlap of the
magenta and cyan color channels. Scale bars: 1 µm. C Graphical depiction of the averaged and normal-
ized fluorescence intensity profile (FI, norm.) of both the Chol-KK114 and the Di-8-ANEPPS STED signal
obtained from a line profile through a dual-labeled tubular membrane structure (depicted in the left panel
and corresponding to the yellow boxed region in the overlay image in B; scale bar: 200 nm). Image resolu-
tion was determined as the full width at half maximum (FWHM) of the tubular membrane structure (see
section 2.6.2) and amounts to 100 nm in the Chol-KK114 color channel, and 150 nm in the Di-8-ANEPPS
color channel.
olution achievable with the Chol-KK114 stain mentioned in 3.1. Fig. 3.9 B dis-
plays a highly magnified region of the two-color STED image and the T-Tubule
membrane structure for which the image resolution was determined as de-
scribed in section 2.6.2 (indicated by the two yellow arrows). The determined
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resolution of the T-Tubule structure amounts to 100 nm in the Chol-KK114 color
channel, and 150 nm in the Di-8-ANEPPS color channel. This increase in im-
age resolution of 30 % demonstrates the improved photophysical properties
of Chol-KK114 compared to Di-8-ANEPPS. Regarding image resolution, it has
to be considered, however, that the apparent size of the here measured sig-
nal structures is a convolution of the microscope point spread function (PSF)
with the size of the labeled structure, i.e. the diameter of the T-Tubule (includ-
ing the size of the respective membrane label). When looking at smaller sig-
nal structures, the actually achievable image resolution using Chol-KK114 as a
membrane label for STED microscopy is far better than the above-mentioned
100 nm for T-Tubule cross sections. This is nicely demonstrated when looking
at single Chol domains that assemble along the T-Tubular membrane. Such
single Chol domains can be visualized when decreasing the labeling concen-
tration of Chol-KK114 well below the saturation concentration of 5 µM which
results in the distinct labeling of Chol-rich cardiac membrane compartments.
This membrane compartmentalization is exemplified in Fig. 3.10 which shows
an inner-cell (i.e. at least 3 µm beneath the sarcolemma) STED image of a living
VM labeled with Chol-KK114 at a concentration of 500 nM. At this concentra-
tion, single Chol-domains can be identified (see magnified inset in Fig. 3.10,
corresponding to the yellow boxed region in the overview image) and their
resolution can be determined by fitting a Gaussian curve to the signal intensity
distribution of the Chol domain (see section 2.6.2; the images in Fig. 3.9 were
obtained using a pulsed STED laser, see also Appendix B). Based on the eval-
uation of single Chol domains, the image resolution that is possible with the
Chol-KK114 membrane marker then amounts to ≤ 35 nm.
Additionally to this remarkable achievable object resolution, the low concen-
tration labeling strategy presented in Fig. 3.10 already suggests another ad-
vantage: the high versatility of Chol-KK114 for biological studies. Depending
on the Chol-KK114 concentration used in the staining protocol, it can serve
both as a membrane bulk label as well as a membrane nanodomain label. Fig.
3.11 displays these two possible applications of Chol-KK114 for living VM: for
one, the thorough bulk staining of the membrane at high concentrations of
Chol-KK114 (Fig. 3.11 A), and, for the other, the exclusive staining of Choles-
terol rich membrane nanodomains at very low concentrations, resulting in a
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Figure 3.10.: Inner-cell STED image of a ventricular mouse cardiomyocyte (VM) labeled with Chol-KK114. A
Overview STED image. Scale bar: 2 µm. B Image magnification corresponding to the yellow boxed
region in the overview image. The color bar indicates the respective image brightness of the magnified
images in photon counts (cts.); for the overview images, the same color code was used but, there, ranging
from 0 to 115 cts. Images were smoothed using a two-dimensional Gaussian filter with a width of 1.5
pixels. Scale bar: 100 nm. C Graphical depiction of the averaged and normalized fluorescence intensity
profile (FI, norm.) of the Chol-KK114 single domain signal structure indicated by the two yellow arrows.
The structure resolution was determined as the Full Width at Half Maximum (FWHM) of the circular
Chol-KK114 signal structure, obtained as described in section 2.6.2, and amounts to ≤ 40 nm.
compartmentalized membrane signal (Fig. 3.11 B). A thorough staining of the
Transverse-Axial Tubular System (TATS, see section 1.1) was achieved using
the membrane saturating concentration of ≈ 5 µM (Fig. 3.11 A; the satu-
rating concentration was experimentally identified in a series of Chol-KK114
titrations that I tested for staining living VM). The resulting membrane sig-
nal is bright, stable and shows the typical continuous rectangular arrange-
ment of evenly spaced T-Tubule structures as it is known from comparable
bulk and solution stains, such as immersion stains with dextran-linked fluo-
rescein [21], or topographical near-field imaging of T-Tubules, such as Scan-
ning Ion Conductance Microscopy (SICM, [32]). This possibility of labeling the
cardiac membrane system as an entity proves highly useful for studies of the
cardiac membrane architecture, for example to investigate topological changes
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Figure 3.11.: Chol-KK114 serves as a bulk or compartment specific membrane label in living mouse ventricular car-
diomyocytes (VM), depending on the used labeling concentration. The white arrow coordinate system
indicates the longitudinal (X) and the transverse (Y) cell axes, respectively. STED images of inner-cell
regions in living VM labeled at different concentrations of Chol-KK114. Images were obtained with the
custom-built fast scanning STED microscope described in section 2.1.2. Images were smoothed using a
two-dimensional Gaussian filter with a width of 1.5 pixels. Scale bars in overview images: 2 µm; scale
bars in magnifications: 500 nm. A Inner-cell STED overview image of a living VM labeled with Chol-
KK114 at the saturation concentration of 5 µM. Image magnification corresponding to the yellow boxed
region in the overview image; the yellow arrow indicates a region of very dense signal not associated to
a perpendicular T-Tubule cross section. The color bar indicates the respective image brightness in pho-
ton counts (cts.). B Inner-cell STED overview image of a living VM labeled with Chol-KK114 at the low
concentration of 25 nM; green arrows indicate perpendicular cross sections of T-Tubules. Image magni-
fication corresponding to the yellow boxed region in the overview image; the yellow arrow indicates a
region of Chol-rich compartments along the membrane; the blue arrow indicates a longitudinal section
of a T-Tubule. The color bar indicates the respective image brightness of the magnified images in photon
counts (cts.); for the overview images, the same color code was used but, there, ranging from 0 to 103 cts.
of membrane arrangements in disease models [22, 505, 440], especially in com-
bination with high resolution STED imaging. And with the new membrane
label, these studies are not restricted to only lateral sample recordings but can
be readily extended to a three-dimensional imaging scheme, an application in
which once again the advantages of slow label internalization, high lateral dif-
fusion rate and high photostability offered by Chol-KK114, are of great impor-
3.3. CHOLESTEROL NANOPATTERNS IN LIVING CARDIOMYOCYTES 127
tance. Looking more closely at the saturated Chol-KK114 signal distribution,
there are regions with increased signal brightness. These signal structures are
unlikely to be cross-sections of T-Tubules branching off (magnification of Fig.
3.11 A, yellow arrow). The bright-signal regions might be interpreted as over-
lapping, highly clustered Chol domains accumulating along the TATS. And in-
deed, when applying the very low concentration of 25 nM Chol-KK114 to label
living VM, such label-saturated bright-signal regions appear to actually be an
assembly of smaller sized, Chol-rich membrane compartments (see magnifica-
tion of Fig. 3.11 B, yellow arrow). Since Chol-KK114 inserts itself stably into the
extracellular membrane leaflet and since the lipid raft hypothesis postulates
the heterogeneous distribution of Chol-rich domains along this extracellular
leaflet, the here shown nanometric Chol signal patterns could be a first visual-
ization of Chol islands in the intact cardiac membrane. Further, at the 25 nM
Chol-KK114 labeling concentration, perpendicular cross sections of T-Tubules
could be resolved as hollow ring-like structures (Fig. 3.11 B, green arrows).
The membrane signal stemming from longitudinal sections of T-Tubules could
be resolved as the expected two parallel lines (see magnification of Fig. 3.11 B,
blue arrow).
Finally, the slow rate of cellular internalization of Chol-KK114, as stated in sec-
tion 3.1, makes Chol-KK114 so valuable for labeling cardiac membrane struc-
tures since the fast internalization of membrane and lipid labels into cardiomy-
ocytes is a common problem that has been reported before [23]. To qualita-
tively confirm Chol-KK114 to have one of the slowest internalization times, I
screened a non-exhaustive set of fluorescently labeled lipids and assessed their
suitability for cardiomyocyte membrane labeling. Chol-KK114 proved to be
the most satisfactory marker among the tested lipid labels (cf. Appendix E for
an overview of the tested lipid labels).
Conclusively, the fluorescent Chol analog Chol-KK114 is a trustworthy mem-
brane label for living cardiomyocytes that yields signal structures that are anal-
ogous to well-established membrane probes. So far, Chol-KK114 is the best
performing cardiac membrane stain for live-cell STED microscopy. Further, by
choosing the labeling concentration of Chol-KK114, one can flexibly adjust to
the specific biological questions underlying the experiment. In the next section,
the aim is to realize subdiffraction three-dimensional whole cardiomyocyte
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staining of membrane structures. The concept of the fluorescent Chol-PEG
derivative Chol-KK114 as a cardiomyocyte membrane label will be expanded
to obtain fluorescent Chol analogs that are compatible with Two-Photon-Ex-
citation-CW-STED (2P-Exc-CWSTED) microscopy. I will introduce a custom-
built 2P-Exc-CWSTED microscope system and elaborate on the necessary cri-
teria to find suitable fluorophores for such a system. I will present the novel
compound Chol-PEG-OregonGreen488 as the best fluorescent Chol probe for
2P-Exc-CWSTED and show the three-dimensional membrane architecture of
living cardiomyocytes labeled with Chol-OG488 and imaged via 2P-Exc-CW-
STED.
3.4. Two-Photon-Excitation-STED microscopy of the
cardiac membrane system
3.4.1. Characterization of the custom-built
Two-Photon-Excitation-CW-STED microscope for live
cardiomyocyte imaging
As shown in the previous sections, STED microscopy (with one-photon-exci-
tation) yields superior subdiffraction images of Cholesterol structures in stan-
dard as well as sophisticated live-cell systems. Two-Photon (2P) microscopy
has the benefits of deeper tissue penetration due to the near-infrared excita-
tion wavelengths used and thus less scattering events, and decreased pho-
tobleaching of out-of-focus layers in the sample because of the smaller axial
focal volume stemming from the quadratic dependence of the emitted flu-
orescence intensity on the excitation intensity (see section 1.3). To reap the
benefits of these two microscopy methods and use them to visualize the com-
plex three-dimensional and Cholesterol rich membrane system deep inside liv-
ing cardiomyocytes while at the same time reducing cellular stress and pho-
tobleaching, I designed and built a microscope setup featuring pulsed two-
photon-excitation and a continuous wave (CW) STED laser. This two-photon-
excitation-CW-STED (2P-Exc-STED) setup is schematically depicted and de-
scribed in detail in section 2.1.1.
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Important for 2P-Exc-CWSTED imaging deep inside cells, the microscope was
equipped with a water immersion objective with an adjustable correction col-
lar to compensate for the spherical aberrations. This measure maintained the
quality of the STED PSF, thus yielding a significant image resolution improve-
ment along the whole extent of live cardiomyocytes in aqueous solutions. Fur-
ther, the high numerical aperture (NA) of the water immersion objective (NA
= 1.20) reduced the focal volume, thereby increasing the 2P-Exc efficiency and
collecting more emitted photons from the sample.
As already mentioned in the introduction (see section 1.3), for 2P-Exc-CWSTED,
it is vital to temporally clean up the detected fluorescence signal by time gat-
ing. Setting up a proper time gate for the detected fluorescence signal relies
on two parameters. First, the time delay (TGate) of the accepted fluorescence
signal with respect to the incoming 2P-Exc laser pulses. Second, the width of
the time gate (WGate) defining the duration of recording fluorescence starting
from TGate. The delay and width of the fluorescence time gate should be opti-
mized for an individual sample regarding the highest achievable image quality
considering the most favorable trade-off between image brightness and image
resolution in the 2P-Exc-CWSTED mode. Typically, the time gate settings do
not differ profoundly between similar samples. Yet, important properties of
fluorescent dyes, such as fluorescence lifetime [506], quantum yield [507], and
rate of photobleaching [508, 509], depend on the specific configuration and en-
vironment in which a dye is used, like for example if conjugated to an antibody
or a lipid analog, or if used for indirect immunofluorescence or for live-cell la-
beling approaches. Therefore, special attention should be paid on adjusting the
respective fluorescence time gate for individual samples. The optimal settings
for TGate and WGate are mentioned where appropriate. Unless stated otherwise,
all 2P-Exc-CWSTED images were obtained with an optimally set fluorescence
time gate. The highly enhanced image resolution that is achievable when set-
ting up a time gate for 2P-Exc-CWSTED is demonstrated in the Appendix G.1
for both fluorescent bead samples (yellow-green, 40 nm diameter) as well as
for a sample of fixed Vero cells with immunofluorescently labeled Tubulin.
Additionally, I explored the effect of the 2P-Exc laser’s repetition rate on the
photobleaching rate of the organic fluorophores in 2P-Exc-CWSTED applica-
tions. In a preliminary configuration of the 2P-Exc-STED microscope, I used
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a Ti:Sa laser that provided laser pulses with a repetition rate of 1 GHz (Gi-
gaJet TWIN 20c/20c, Laser Quantum, Konstanz, Germany) for 2P-Exc. This
was to test if there is an effect of reduced photobleaching in the case of 2P-Exc
with very high repetition rates (quasi CW excitation). A number of published
studies point towards such a reduction in photobleaching [510, 511, 368]. For
example, at higher repetition rates, the peak intensities can be reduced while
maintaining the same 2P-Exc efficiency. However, repetition rates above 100
MHz are assumed to counteract the main strength of 2P-Exc, namely the re-
duction in the fluorescing sample volume due to an increased fluorophore duty
cycle [380]. Further, repetition rates above 1 MHz are assumed to transfer too
much thermal load into the specimen [512]. In my studies, I could observe a
profound advantageous reduction of fluorophore bleaching when performing
2P-Exc with 1 GHz instead of 80 MHz repetition rate. A 1 GHz repetition rate
for 2P-Exc yielded a significant improvement in photobleaching in both 2P-Exc
mode as well as in 2P-Exc-CWSTED mode. Fig. 3.12 summarizes these results.
The shown bleaching curves were obtained as described in section 2.6.3 using
a test sample of Vero cells stained for Tubulin via indirect immunofluorescence
using the dye compound STAR 488 (see Appendix A.4). All image acquisition
parameters except for the repetition rate of the 2P-Exc laser were kept con-
stant in the course of the bleaching experiments. The 2P-Exc wavelength was
tuned to 790 nm and the 2P-Exc power set to 10 mW (measured in the back-
focal plane of the objective); the 592 nm CW-STED illumination power was
set to 240 mW and the sample scanned with a 0.05 ms pixel dwell time and
a pixel size of 20 nm. To ensure direct comparability, the fluorescence signal
was not time gated in case of 2P-Exc at 80 MHz repetition rate. In the 2P-Exc
mode (Fig. 3.12 A), the fluorophore bleaching is reduced by approximately a
factor of 10; in the 2P-Exc-CWSTED mode (Fig. 3.12 B) the fluorophore bleach-
ing is reduced by approximately a factor of 5 when employing a 2P-Exc laser
with a repetition rate of 1 GHz instead of 80 MHz. Notably, in both imaging
modes, the fluorophore bleaching behavior at 1 GHz 2P-Exc laser repetition
rate follows a mono-exponential decay (fit shown in red in Fig. 3.12 A and B).
In contrast, the bleaching behavior at 80 MHz repetition rate is best modeled
by a bi-exponential decay (curve fit shown in blue in Fig. 3.12 A and B). A
mono-exponential bleaching behavior typically indicates that the fluorophore
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Figure 3.12.: Photobleaching in two-photon excitation (2P-Exc, in A) and two-photon-excitation-CW-STED (2P-Exc-
CWSTED, in B) microscopy at a 2P-Exc laser repetition rate (rep. rate) of 1 GHz (filled squares) vs. 80
MHz (open squares). Bleaching curves were obtained as described in section 2.6.3 using a sample of fixed
Vero cells immunolabeled with the dye Abberior STAR 488. The normalized fluorescence intensity (FI,
norm.) is plotted against the number of successively acquired image frames. Bleaching curves were fit to
either mono-exponential (in red) or bi-exponential (in blue) decays.
transitions from a defined excited state into the terminally bleached dark state
at a constant rate [513, 514]. A bi- or even multiexponential decay might be
explained by additional, also multi-photon, absorption processes that lead into
the bleached molecular state [515, 516]. The modeling and interpretation of
photobleaching is discussed in more detail later (see e.g. Fig. 3.14) where the
bleaching behavior of suitable dyes for 2P-Exc-CWSTED is further explored.
However, laser pulse repetition rates of 1 GHz pose a profound disadvantage
for 2P-Exc-CWSTED because such a high repetition rate makes fluorescence
time gating impossible since we were not in possession of fast electronics to
pick up the 2P-Exc laser pulses with a time resolution of < 1 ns and provide
them as a reference signal. Hence, the ungated 2P-Exc-CWSTED images from
the configuration with 2P-Exc at 1 GHz repetition rate showed only minor to
no resolution improvement compared to the corresponding 2P-Exc images (see
Appendix G.2). It was thus not feasible to employ a 2P-Exc laser with 1 GHz
repetition rate in 2P-Exc-CWSTED microscopy although the high repetition re-
sulting in lower peak intensities significantly reduces fluorophore bleaching.
Equipped with the 2P-Exc laser at a repetition rate of 80 MHz and the possi-
bility for fluorescence signal time gating, the here described 2P-Exc-CWSTED
microscope system could reliably provide a point spread function (PSF) with a
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Figure 3.13.: Achievable image resolution with the custom-built two-photon-excitation-CW-STED (2P-Exc-CWSTED)
microscope setup. Images show yellow-green (YG) fluorescent beads with an excitation and emission
maximum at 505 nm and 515 nm, respectively, and a diameter of 40 nm. Beads were optimally 2P-excited
at 757 nm and detected at (525 ± 25) nm. Graphs show the normalized fluorescence signal summed up
over the X direction within the image region marked by the yellow box. Image resolution was determined
as the full width at half maximum (FWHM) of the respective fit curve to the fluorescence signal profile
(see section 2.6.2). A Ungated 2P-Exc image of YG fluorescent beads and corresponding normalized
fluorescence signal profile of the bead inside the image region marked by the yellow box. The fluorescence
profile was fit to a Gaussian curve; the thereof extracted image resolution amounts to 140 nm (FWHM). B
Gated 2P-Exc-CWSTED image of YG fluorescent beads with a time gate delay at 3.74 ns, time gate width
at 9.88 ns, and corresponding normalized fluorescence signal profile of the same bead as in A as marked
by the yellow box. The fluorescence profile was fit to a Lorentzian curve; the therefrom extracted lowest
measured bead diameter amounts to < 45 nm (FWHM). Images show unprocessed raw data. The color
bar indicates the image brightness in both A and B in photon counts (cts.). Scale bars: 1 µm.
full width at half maximum (FWHM) of below 50 nm in the 2P-Exc-CWSTED
mode. The system’s intrinsic image resolution was controlled prior to each
experiment by recording yellow-green fluorescent beads (with excitation and
emission maxima at 505 nm and 515 nm, respectively) of 40 nm diameter and
determining their apparent size in both 2P-Exc as well as 2P-Exc-CWSTED
modes. The obtained 2P-Exc and 2P-Exc-CWSTED PSFs are shown in Fig.
3.13. There, a fluorescent bead of apparent size of 140 nm in the 2P-Exc mode
(Fig. 3.13 A) could be resolved to its actual size of below 45 nm in the 2P-Exc-
CWSTED mode (Fig. 3.13 B).
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3.4.2. Screening and evaluation of fluorescent dyes for
2P-Exc-CWSTED
The one-photon-excitation and -emission spectra of commercially available flu-
orescent dyes are usually very well-documented and readily communicated by
the respective suppliers. However, the naive assumption of just doubling the
wavelength of a dye’s absorption maximum to arrive at the ideal wavelength
for Two-Photon-Excitation (2P-Exc) does not necessarily apply. It is known
from the literature that the absorption spectra of many dyes can show mild to
very profound blue-shifts under 2P-Exc conditions [381, 383, 517, 382]. In my
attempts to find suitable fluorophores for Two-Photon-Excitation-CW-STED
(2P-Exc-CWSTED) microscopy, I could qualitatively observe and confirm this
quite unpredictable blue-shift for various organic fluorophores in my experi-
ments. Further, combining 2P-Exc with CW-STED is a balancing act between
two main prerequisites. First, the necessity of efficient two-photon excitation
leading to a sufficiently high molecular state inversion of the fluorophores be-
tween the ground state and the excited state. Second, reducing photobleaching
to its minimum, especially when keeping in mind that both the 2P-Exc laser
as well as the STED laser are operated at high intensities and thus increase the
probability of permanent fluorophore bleaching, and also transfer a high ther-
mal load into the specimen. It is therefore necessary to identify the optimal
wavelength for 2P-Exc of a given fluorophore to obtain the most efficient state
inversion and thus the highest possible fluorescence signal at the lowest possi-
ble 2P-Exc power. Conveniently, the emission spectra of fluorescent molecules
stay the same under one-photon- and two-photon-excitation conditions [381]
and are neither dependent on the 2P-Exc wavelength nor on the 2P-Exc power
[518]. The disclosed one-photon emission spectra of commercially available
dyes can thus be readily assumed when searching for suitable dyes for a given
STED laser wavelength. The stimulated emission cross section of many fluo-
rophores is typically only slightly red-shifted with respect to the dye’s emission
spectrum [329]. This would, in a first approximation, motivate choosing fluo-
rescent dyes with emission spectra close to the employed STED wavelength to
achieve the most efficient effect of stimulated emission. In most applications
of STED microscopy, however, the best performing fluorophores are typically
those for which the STED wavelength is located at the red tail of the emission
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spectrum. Such a configuration reduces unwanted fluorescence background
signal stemming from fluorophore re-excitation due to the residual absorption
cross section at the STED laser wavelength (known as anti-Stokes-excitation
[519, 520]). Also, that way, the largest portion of the fluorescence signal can
be collected without overlap with the STED laser line. Although there have
been implementations of STED microscopy with STED wavelengths close to
the maxima of the fluorophores’ emission spectra [520, 521], these approaches
require additional image acquisition and processing steps that reduce the sig-
nal brightness, possibly increase photobleaching due to a decreased sample
scanning speed, and add complexity and possible sources of artifacts. For
completeness, I investigated fluorophores with emission spectra close to the
employed 592 nm STED laser wavelength - for example the dyes ATTO 542,
Alexa Fluor 555, and DY 555 with emission maxima at 562 nm, 565 nm, and
572 nm respectively. These dyes, however, proved highly unsuitable in the 2P-
Exc-CWSTED setup as they showed the expected anti-Stokes-excitation effect
that outweighed the desired fluorophore switch-off by stimulated emission.
Based on the above mentioned reasons and prerequisites, I screened a reason-
ably large subset of fluorescent dyes that I anticipated to fulfill the following
five criteria:
1.) The fluorophore needs to show a sufficiently large two-photon excita-
tion cross section when illuminated within the available excitation wave-
length range of 740 - 850 nm provided by the Ti:Sa-laser in the 2P-Exc-
STED system.
2.) The fluorophore’s stimulated emission spectrum needs to peak close to
the used STED laser wavelength of 592 nm. That way, the fluorophore,
being in the excited state, returns to its ground state with a high probabil-
ity via stimulated emission. This effect of photoswitching by stimulated
emission will be referred to as “switch-off”.
3.) The fluorophore’s absorption coefficient needs to be very low in the vicin-
ity of the used STED laser wavelength of 592 nm to avoid excitation and
re-excitation [522, 329] by the STED laser.
4.) The fluorophore has to be efficiently switched-off by the STED laser. In
essence, this criterion summarizes the premises 1.), 2.) and 3.) as it re-
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lies on a high efficiency of the inversion between the excited state and
the ground state and thus depends on each the two-photon absorption
spectrum, the stimulated emission spectrum, and the STED wavelength
absorption spectrum.
5.) The fluorophore needs to be photostable to withstand both the high-peak-
power 2P-excitation beam as well as the high-power CW-STED-beam
without bleaching.
In a first round of screening fluorescent dyes for their suitability for 2P-Exc-
STED, I restricted my investigation to criteria 1.) - 4.), i.e. omitting pho-
tobleaching. I decided to do so because photobleaching of dyes is a com-
plex process with many underlying mechanisms. This complexity is observed
in the two fields of 2P-Exc microscopy [371, 523, 516] and STED microscopy
[524, 329], and becomes even more complex for 2P-Exc-STED as a combination
of the two methods [368, 402, 525]. Hence, I chose to decouple the evaluation of
the spectral properties of fluorophores from their bleaching behavior to narrow
down the vast amount of possible dyes to a few, most promising candidates.
For this subset of selected dyes, I performed a more in-depth evaluation of their
bleaching behavior which will be presented later in this section.
To assess the fluorescent dyes with optimal spectral properties for the 2P-Exc-
STED microscope setup, I prepared solutions of various fluorophores (so-called
“dye seas”, see section 2.5.2) which I selected based on their available one-
photon-absorption spectra. A comprehensive list of the tested dyes and their
ordering information is given in the Appendix A.4. Due to fast diffusion of the
fluorescent molecules within the dye sea, effects of photobleaching are negli-
gible. Since the fluorophores are dissolved in purified water, the fast flow of
molecules into and out of the focal volume can reasonably be assumed to be
similar to the self-diffusion rate of water. For example, the self-diffusion rate
of the dye fluorescein in water has been determined to be 760 µm²/s [526].
Principally, the dye seas with their high diffusion rate and their subordinate
photobleaching might be a more suitable model system than the widely used
fixed cell samples stained via indirect immunofluorescence if the aim is to fast
and conveniently mimic the behavior of a fast-diffusing fluorescent lipid ana-
log. However, the lateral diffusion rate of fluorescent lipid analogs in the cell
membrane is still two orders of magnitude lower than that of the freely diffus-
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ing dye in solution. Therefore, having identified suitable dyes for 2P-Exc-STED
applications, additional studies of the bleaching behavior were performed in a
second round of dye screening and are presented further below.
For the characterization of the spectral properties under 2P-Exc-STED condi-
tions, the 2P-Exc and the STED laser beams were axially focused to the edge of
the respective fluorescent dye sea, i.e. the transition between the cover slip and
the solution, and the fluorescence signal recorded with the Avalanche Photo
Diode (APD) in the fluorescence detection path. For simplicity, the phase mask
was removed from the STED laser path and the focused STED beam had a
Gaussian intensity profile. A bandpass filter was installed in front of the APD
that could be easily interchanged to cover the appropriate wavelength range of
the emission spectrum of the fluorophore. The fluorescence photon counts of
the respective dye sea under different illumination conditions were recorded
with a pixel dwell time of 3 ms; this setting was kept constant for all tested
dyes for reasons of comparability. The fluorescence time gate of the APD sig-
nal was globally set for all investigated dye seas. The gate had a time delay
of 1.5 ns with respect to the 2P-Exc laser pulses and a width of 9 ns. The APD
dark counts were taken into consideration by subtraction from the recorded
fluorescence photon counts. For comparative quantification of the fluorescence
response of the tested dyes, I defined three parameters that are described in the
following.
• The ratio α describes the switch-off efficiency of the fluorophore by the
STED laser and is calculated by
α = min
(
C2P-Exc-STED(PSTED)
C2P-Exc
)
with C2P-Exc-STED being the detected fluorescence photon counts under il-
lumination with both the excitation and the STED laser, C2P-Exc being the
detected fluorescence photon counts under illumination with the excita-
tion laser only, and PSTED being the power of the 592 nm STED laser. Note
that the value of C2P-Exc-STED depends on PSTED. The smaller the obtained
α, the more efficient is the switch-off by the STED laser. If α ≥ 1, then the
STED laser does not switch off the fluorophore but is, instead, exciting it
in addition to the excitation laser. When determining α, I optimized the
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2P-Exc wavelength for a given dye within the range of 740 - 850 nm at
a respective laser power of 50 mW. PSTED was tuned in the range of 10 -
240 mW. Both laser powers were measured in the backfocal plane of the
objective. If not stated otherwise in Table 3.1, the maximum STED laser
power of 240 mW yielded the denoted value for α.
• The term β describes the amount of re-excitation of the fluorophore by
the STED laser and is calculated by
β = 1−
(
CSTED
C2P-Exc-STED
)
with CSTED being the detected fluorescence photon counts under illumi-
nation with the STED laser, and C2P-Exc-STED being the detected fluores-
cence photon counts under illumination with both the excitation and the
STED lasers. Generally, it can be stated that the bigger the β, the lower is
the amount of re-excitation by the STED laser and thus the more suitable
is the dye. Optimally, β will become 1. β was determined for the opti-
mal 2P-Exc wavelength for the respective dye at an 2P-Exc power of 50
mW and for the STED laser power that yielded the best switch-off (see
the evaluation of α). β is defined in the above fashion to prevent it from
becoming 0 in case of no re-excitation. This is because the goodness factor
η that is defined next, and which relates α and β to one another, should
not become 0 either so as to not obscure the impact of α.
• The ratio η is a compound expression relating α and β to one another and
is calculated by
η =
β
α
.
This definition of η gives a quick and qualitative estimate of the suitabil-
ity of the spectral properties of a fluorophore. Generally, the bigger the η,
the more promising is the dye.
A comprehensive overview of the dyes tested and evaluated for their appli-
cability in 2P-Exc-STED microscopy is given in Table 3.1. The tested dyes are
listed in order of ascending emission wavelengths. The names of the dye com-
pounds are abbreviated, more detailed information about the tested dyes can
be found in the Appendix A.5. Table 3.1 displays the wavelengths of maximum
138 3. RESULTS AND DISCUSSION
absorption and emission (Abs/Em), respectively in nm, and the fluorescence
lifetimes in ns as provided by the manufacturer, except in the case of the com-
pounds DY 380XL and DY 375XL whose lifetimes were measured in-house for
the dye in solution (PBS, pH 7.4), marked as (*), and for the dye labeling Tubu-
lin in Vero cells via indirect immunofluorescence, marked as (**). For each
dye, I optimized the region of fluorescence detection (Det.) and the 2P-Exc
wavelength (opt. λ2P) for the highest measured signal and determined the de-
scriptive parameters α, β, and η for these settings. To qualitatively assess the
brightness of a given dye, I also recorded the maximum signal brightness as
detected by the APD; this maximum brightness (max. bright.) is displayed in
Table 3.1 and denoted in photon counts. The column ”Comments“ summarizes
the observed dye performance regarding switch-off and re-excitation (re-exc.)
behavior as well as the detected signal brightness and additional noteworthy
remarks for evaluation, e.g. if the dye sea shows any signs of photobleaching.
The spectroscopic suitability of the dye for 2P-Exc-STED is then qualitatively
rated according to: (++) - very suitable; (+) - potentially suitable; (-) - not rec-
ommended; (--) - not suitable.
Based on the mentioned criteria defined above, the following seven dyes could
be identified as being the most promising for application in 2P-Exc-STED: ATTO
390, ATTO 425, DY 380XL, AF 488, ATTO 488, STAR 488, and OG 488. For
these compounds, I conducted a more in-depth study of optimal 2P-Exc-STED
imaging conditions and the resulting photobleaching behavior. To fulfill the
high photostability mentioned above in criterion 5.), the fluorophore needs to
provide a large fluorescence signal in the STED imaging mode at a reasonable
sample scan rate (i.e. a pixel dwell time between 0.05 and 0.6 ms). Additionally,
the fluorophore needs to be photostable to enable the acquisition of multiple
images of the same lateral region of interest along different axial depths for
three-dimensional reconstruction imaging. As stated above, the specific prop-
erties of a fluorophore regarding its photostability cannot be quantified using a
dye solution because due to diffusion of dye molecules the solution is not sub-
ject to photobleaching. Hence, for completeness, I evaluated the bleaching be-
havior of those dyes that I had identified to fulfill the above stated criteria 1.) -
4.). I used standard prepared samples of Methanol fixed Vero cells in which the
cytoskeletal protein Tubulin was labeled with the respective fluorophore via in-
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direct immunofluorescence (see section 2.5.4). I recorded bleaching curves of
the respective fluorophores by consecutively scanning one spot in the cell sam-
ples with a pixel dwell time of 0.05 ms and a pixel size of 20 nm. The resulting
pixel intensity was summed up over each frame and normalized to its maximal
value. It was then plotted against the number of acquired image frames (see
section 2.6.3). The resulting bleaching curves for the above mentioned seven
dye compounds are shown in Fig. 3.14.
Figure 3.14.: Bleaching curves of selected dyes for Two-Photon-Excitation-STED (2P-Exc-STED) microscopy. The in-
vestigated dyes were selected after a first round of dye screening regarding the 2P-Exc-STED behavior,
see Table 3.1, and used for staining the cytoskeletal protein Tubulin in Vero cells via indirect immunoflu-
orescence, see section 2.5.4. The bleaching curves were obtained as described in section 2.6.3 and are
evaluated and discussed in section 3.4.2 and in Table 3.2.
For the dyes DY 380 XL, AF 488, ATTO 488, and STAR 488, the bleaching behav-
ior is best described by a bi-exponential decay. I explored both the goodness
of fit of a mono-, bi- and higher order exponential decays to model the bleach-
ing behavior under 2P-Exc-STED conditions. The residuals of these different
fit functions (see Appendix G.3) clearly show that a bi-exponential decay is
the most adequate model. This bi-exponential decay in fluorescence intensity
is the typical bleaching behavior for most dyes under one-photon-excitation
[513], and two-photon-excitation [516], respectively. A mono-exponential de-
cay in fluorescence intensity would usually indicate that photobleaching is a
single-photon-absorption process and can be described as the transition of the
fluorescent molecule from the excited state to a dark state with a constant rate
[513, 514]. For one-photon-excitation-STED, such a mono-exponential decay
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has been reported [346]. The here observed bi-exponential decay under 2P-
Exc-STED conditions motivates a more complex model of photobleaching com-
prising multiple photon absorption pathways that can lead to photobleaching
[515, 516].
Performing a similar analysis on the bleaching behavior of the dyes ATTO 390
and OG 488 reveals that there a mono-exponential decay is the most adequate
model for photobleaching. Although I could verify that the excitation of these
two fluorophores followed a two-photon absorption process, i.e. there was
a quadratic dependence of the fluorescence signal on the illumination inten-
sity (data not shown), the photobleaching behavior of ATTO 390 and OG 488
resembles that of fluorophores under one-photon-excitation-STED conditions
[346]. This hints towards a single photobleaching process with a constant tran-
sition rate into the terminally bleached molecular state. It is beyond the scope
of this work to investigate the underlying processes of photobleaching for dif-
ferent dyes in detail. The important observation is that ATTO 390 and OG 488
essentially show a much slower rate of photobleaching than the above men-
tioned four investigated dyes and are thus promising candidates for use in 2P-
Exc-STED microscopy of Cholesterol rich membrane structures in cardiomy-
ocytes.
The time development of the fluorescence of the dye ATTO 425 features a
gradual increase in total fluorescence intensity before showing signs of pho-
tobleaching. This somewhat deviant behavior is most likely attributable to
self-quenching of the fluorophores [406, 527, 528], a phenomenon also known
as concentration-quenching. Due to the self-quenching effect, the fluorescence
of ATTO 425 first increases in each image frame since more and more fluo-
rophores are photobleached and thus the concentration of still excitable fluo-
rescent molecule decreases, counteracting the suppression of fluorescence sig-
nal introduced by self-quenching. As soon as photobleaching has irreversibly
reduced the fluorophore concentration necessary for effective self-quenching,
the effect of photobleaching prevails and a monotonous decrease in fluores-
cence signal is observed. For ATTO 425, this is the case starting at about image
frame 8. Although the effect of self-quenching effectively delays the disadvan-
tageous photobleaching of the dye ATTO 425, self-quenching is an undesirable
property of a dye for STED microscopy in general and for gated 2P-Exc-STED
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microscopy specifically. This is because the fluorescence switch-off caused by
the STED laser becomes anisotropic depending on the fluorophore concentra-
tion within the sample. Additionally, in essence, self-quenching creates several
subpopulations of the same dye that feature different fluorescence lifetimes
[406]. This profoundly compromises the advantageous setting of a fluorescence
detection time gate that is necessary for optimal image resolution. For these
reasons, and although the fluorescence signal of ATTO 425 does not nearly
drop to half of its maximal value after 20 acquired frames, ATTO 425 was clas-
sified as unsuitable for gated 2P-Exc-STED applications. This is especially the
case for the finally intended imaging of Cholesterol rich membrane structures
in living cardiomyocytes because Cholesterol is a raft-associated lipid and, as
we have seen in section 3.3, partitions into local membrane clusters. Any con-
centration dependent alterations of dye properties should thus be avoided.
It is important to note that I conducted the bleaching study for optimized imag-
ing parameters for each dye compound. I identified these optimal settings by
iteratively adjusting them during scanning of the actual sample to arrive at
the highest quality STED images before performing the actual bleaching scans.
This qualitative assessment of appropriate imaging conditions provides more
comparability between different dyes than an experiment with constant imag-
ing settings for each fluorescent compound. This is because the best image
is the result of the interplay of several underlying factors that cannot be cat-
egorized isolated but must be customized for individual fluorophores. Ad-
mittedly, the choice of the test sample for a certain study also has a significant
impact on the photophysical behavior of a fluorophore. I therefore chose to im-
age Tubulin structures because such specimen are standardly used in the liter-
ature in proof-of-principle applications [529, 530, 531], and because the sample
preparation protocol is highly reproducible. While keeping the image scan rate
and pixel size constant, I explored several image acquisition parameters (sum-
marized in Table 3.2) to achieve the highest quality images of the test sample.
First, the appropriate detection filter was chosen to efficiently collect the major-
ity of the fluorescence stemming from a given fluorophore. As mentioned pre-
viously, the emission spectra of a fluorophore for one-photon- and two-photon-
excitation are the same. Therefore, the choice of detection window per dye was
readily made according to its disclosed emission spectrum. Nevertheless, hav-
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ing adjusted all the other imaging parameters, I went back and tested different
detection regions for fluorescence recording, namely (490 ± 20); (525 ± 25);
(530 ± 20), to validate my initial choice. Conclusively, the detection windows
chosen based on the one-photon-emission spectra were already optimal for de-
tection which confirms the reported observation of unaltered emission spectra
of most dyes under 2P-illumination conditions.
Second, the optimal 2P-Exc wavelength was identified within the range of 740
- 850 nm by gradually adjusting the excitation wavelength while scanning the
sample in two-photon mode to achieve the highest fluorescence signal. The
thus found 2P-Exc wavelengths corresponded to those that I could identify
previously for in the dyes in solution (see Table 3.1). This hints towards the
dyes’ unaltered 2P-absorption spectra in solution vs. as antibody conjugate.
Third, the 2P-Exc and the STED laser powers were adjusted simultaneously
while scanning the sample. Illumination powers were measured in the back
focal plane of the objective. 2P-Exc powers were tested within a range of 1 -
50 mW. Although the 2P-Exc laser was capable of providing even higher illu-
mination powers, any increase beyond 50 mW would result in instantaneous
sample bleaching rendering the search for an appropriate region of interest for
scanning impossible. STED illumination powers were tested within a range of
10 - 240 mW, optimized for a given 2P-Exc power, and the resulting images
were mutually compared for the different combinations of 2P-Exc and STED
powers. In summary, the dye compounds were most efficiently two-photon-
excited for powers in a range of 7 - 20 mW; fluorescence depletion was most
favorable for STED illumination powers in a range of 150 - 240 mW.
Fourth, the time gating of the fluorescence signal detected by the APD was
optimized for each dye individually while scanning the test sample in 2P-Exc-
STED mode. Both the time delay with respect to the 2P-Exc laser beam pulses
as well as the width of the time gate were adjusted and could be fine-tuned
with a temporal resolution of 40 ps.
For reasons of comparability between the bleaching curves of the different
dyes, I chose to describe the bleaching behavior by the parameter FBleach; 0.5
being the number of image frames taken before the summed fluorescence sig-
nal had decreased to half of its initial/maximal value. Defining this qualitative
parameter circumvents having to make an assumption about the underlying
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model of fluorescence decay and takes into account the optimized image set-
tings for each dye. FBleach; 0.5 is listed in Table 3.2.
In addition to the evaluation of the dye suitability for 2P-Exc-CWSTED based
on the photobleaching behavior, I tested the image quality achievable with each
of the above mentioned seven dye compounds. To this end, I recorded 2P-Exc-
CWSTED images of fixed Vero cells stained for the cytoskeletal protein Tubu-
lin (see section 2.5.4). I focused on the following three criteria to assess image
quality: signal specificity and highest image resolution at a sufficient signal-to-
noise ratio. Looking at the obtained images, the dyes ATTO 390 and ATTO 425,
showed very poor performance in both 2P-Exc and 2P-Exc-CWSTED imaging
as the signal seemed very unspecific (in case of ATTO 425), the signal-to-noise
ratio was low, and the image resolution was not notably increased in 2P-Exc-
CWSTED mode as compared to 2P-Exc mode. Images that were obtained us-
ing ATTO 390 and ATTO 425 are shown in the Appendix G.4 and demonstrate
the unsuitability of these dye compounds for 2P-Exc-CWSTED. For the dye
compounds that were found to be very suitable for 2P-Exc-CWSTED (i.e. DY
380XL, AF 488, ATTO 488, STAR 488, and OG 488), Fig. 3.15 gives an overview
of the 2P-Exc-CWSTED images obtained with the respective dyes and the cor-
responding image resolutions. For comparability, similar spots were recorded
within the sample, i.e. Tubulin structures close to the apical cell membrane and
imaged through the nucleus at an imaging depth of approximately 5 µm. This
region of interest (ROI) was chosen, for one, to demonstrate the achievable 2P-
Exc-CWSTED image quality deep inside a specimen. For the other, such an ROI
facilitates the visualization of 2P-Exc-CWSTED image resolution since Tubulin
is less densely arranged around the nucleus.
All five dye compounds showed superior image resolution between 77 nm (AF
488) and 44 nm (OG 488) which corresponds to an increase in resolution by a
factor of 2 up to 3, respectively, when compared to 2P-Exc microscopy. Espe-
cially the dye compounds DY 380XL, AF 488, and OG 488 show high image res-
olution while also exhibiting high signal specificity and low background signal.
The dye STAR 488 shows some unspecific labeling artifacts which might stem
from antibody clustering. Nevertheless, STAR 488 provided a standardly high
enough signal-to-noise ratio to allow reliable data evaluation. The dye ATTO
488 provided images with an unfavorably low signal-to-noise ratio, resulting
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Figure 3.15.: Two-photon-excitation-CW-STED (2P-Exc-CWSTED) images of fixed Vero cells labeled for the cytoskele-
tal protein Tubulin via indirect immunofluorescence. Tubulin was decorated with the antibody-coupled
dye compounds DY 380XL, AF 488, ATTO 488, STAR 488, and OG 488, respectively. Image settings were
adjusted to yield optimal 2P-Exc-CWSTED images; fluorescence time gates were set individually for each
dye compound and correspond to the ones stated in Table 3.2. Graphs next to the corresponding images
show the normalized fluorescence signal intensity averaged over a width of 5 pixels and obtained from
line profiles along the yellow bars. Image resolution was extracted from the profiles by fitting them to a
Lorentzian curve (red line, see section 2.6.2); image resolution is displayed as the full width at half maxi-
mum (FWHM). Images show raw data with adjusted brightness to facilitate visualization. The color bar
indicates the image brightness in photon counts (cts.). Scale bars: 1 µm.
in blurred sample features. It was thus excluded from further investigations.
Altogether, for membrane labeling of living cardiomyocytes via a fluorescent
Cholesterol analog, the following four dyes showed the highest potential: DY
380XL, AF 488, STAR 488, and OG 488 (ordered by ascending emission wave-
length). These four dyes were coupled to Chol-PEG derivatives as described in
section 2.2. I will hereafter refer to the obtained Chol-PEG-dye compounds as
Chol-DY380XL, Chol-AF488, Chol-STAR488, and Chol-OG488.
I used the obtained Chol-PEG-dye compounds to stain living mouse ventricu-
lar cardiomyocytes (VM) and assessed the compounds’ suitability for applica-
tion in 2P-Exc-CWSTED microscopy. For this suitability assessment, I aimed
at achieving the highest quality membrane specific 2P-Exc-CWSTED image
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stacks - i.e. fast 3D image acquisition with a high signal-to-noise ratio and supe-
rior spatial resolution - while at the same time avoiding unspecific background
signal, and cellular stress due to phototoxicity and thermal energy transfer into
the specimen because of high laser powers.
Employing the four fluorescent lipid analogs Chol-DY380XL, Chol-AF488, Chol-
STAR488, and Chol-OG488 for 2P-Exc-CWSTED imaging of cardiac membrane
structures, Chol-OG488 proved to be the most suitable due to slow cellular in-
ternalization, low phototoxicity and reasonably high photostability.
Unfortunately, labeling cardiomyocytes with Chol-DY380XL yielded a diffuse
and unspecific fluorescence signal. This signal unspecificity seemed to stem
from either a very high degree of cellular internalization, and/or a high affin-
ity of the Chol-DY380XL compound to cardiac mitochondria. Both Chol-AF488
and Chol-STAR488, on the other hand, showed slow cellular internalization, a
membrane-specific signal, and a very good switch-off behavior in STED mode
while maintaining a high signal-to-noise ratio. However, both membrane la-
bels subjected the cells to stress, resulting in membrane blebbing and cell con-
traction soon after staining. Additionally, Chol-AF488 had a seemingly high
potential for phototoxicity as cells could neither sustain extended laser illumi-
nation nor an increase in illumination intensity when they were stained with
Chol-AF488. Similar illumination protocols were far less critical for the cells
when being stained with the other prepared fluorescent Cholesterol analogs.
To demonstrate the unsuitability of Chol-DY380XL, and the less than optimal
performance of Chol-AF488 and Chol-STAR488, an overview of the images ob-
tained with these membrane markers (as negative examples) is given in the
Appendix G.5.
Conclusively, I could identify the membrane marker Chol-OG488 as the opti-
mal probe for the visualization of the membrane system of living cardiomy-
ocytes with the novel approach of 2P-Exc-CWSTED microscopy using a fluo-
rescent Cholesterol analog. The results are presented in the next section.
3.4.3. 2P-Exc-CWSTED of membrane structures in living
cardiomyocytes
The images of living mouse ventricular cardiomyocytes (VM) labeled with the
fluorescent Cholesterol (Chol) analog Cholesterol-PEG-OG488 (Chol-OG488)
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presented below were obtained under standardized conditions after optimiza-
tion of both the staining protocol and the image acquisition parameters. The
cells were stained with 5 µM Chol-OG488 according to the protocol described
in section 2.3.2.
Images of living VM in 2P-Exc mode were obtained with an optimized 2P-Exc
wavelength at 760 nm and with an illumination power of 10 mW measured in
the back focal plane of the objective. The 2P-Exc images were acquired with
a pixel size of (40× 40× 200) nm³ in (X× Y× Z) with a pixel dwell time of
0.02 ms, and without fluorescence time gating. The images of living VM in
2P-Exc-CWSTED mode were obtained with 2P-Exc at 760 nm at 10 mW illumi-
nation power and a STED beam at 592 nm with illumination power between
50 mW and 100 mW (the illumination powers were measured for the 2P-Exc
and for the STED laser, respectively, i.e. appropriately gauged to the respec-
tive laser wavelength). The fluorescence signal in 2P-Exc-CWSTED mode was
time gated with an optimized gate delay TGate = 2.42 ns and an optimized gate
width WGate = 9.80 ns. The 2P-Exc-CWSTED images were acquired with a pixel
size of (20× 20× 200) nm³ in (X× Y× Z) and with a pixel dwell time of 0.05
ms. All deviations from the above stated imaging conditions will be stated
explicitly in the corresponding figure captions. Three-dimensional images of
labeled VM were rendered using the software AMIRA 6.0 (see section 2.6.1) and
are always presented such that the side of the VM with which they attach to
the cover slip (i.e. the basement membrane) is seen at the bottom of the image
and the apical membrane is seen at the top.
Fig. 3.16 displays whole-cell 3D renders obtained from 2P-Exc microscopy
imaging of a living VM labeled with Chol-OG488. A volume of (20× 20× 15)
µm³ along (X× Y× Z) was scanned within≈ 6 min using the above mentioned
imaging parameters; image acquisition had no detrimental effects on the cell
fitness which was assessed based on the bright field images of the respective
cell before and after the 2P-Exc scan. As can be seen in Fig. 3.16 A, using Chol-
OG488 enables thorough staining of both the cellular surface sarcolemma and
the complete Transverse-Axial Tubular System (TATS). Transversely and lon-
gitudinally oriented tubules of the TATS and the junctions between them can
be identified. This characteristic rectangular network of the TATS is shown in
more detail in Fig. 3.16 B, which displays a top view of a lateral cross section of
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Figure 3.16.: Three-dimensional (3D) two-photon excitation (2P-Exc) image renders of a living mouse ventricular car-
diomyocyte (VM) labeled with Chol-OG488. VM were stained as described in section 2.3.2, imaging was
performed as described in this section, and 3D image renders were obtained as described in section 2.6.1.
A 3D render of a VM section with the dimensions of (20× 20× 15) µm³ with the basement membrane
seen in the lower part of the image and the apical membrane seen in the top part. B Rotated view of the
same cell in top view from the basement membrane (which was cut off in the render for visual assessment
of the cell interior). The inserted coordinated systems indicate the longitudinal (X) and the transverse (Y)
cell axes (also defining the imaging plane parallel to the cover slip), and the Z axis corresponding to the
optical axis. Scale bars: 5 µm.
the same cell as in Fig. 3.16 A. The Transverse Tubule (TT) structures are reg-
ularly spaced at a distance of about 2 µm; transversely oriented TT are much
more frequently observed that longitudinally oriented TT.
The whole-cell 3D renders that are presented in Fig. 3.16 and 3.17 visualize
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the complex structure of the TATS in living VM and reveal that the extracel-
lular leaflet of the TATS membrane is rich in Chol. The 3D TATS structure in
living ventricular cardiomyocytes (from rat) had first been shown in a pioneer-
ing study by Soeller and Cannell in 1999 [21] who had used fluorescein-linked
dextran as a solution stain for 2P-Exc microscopy. This study showed the cell-
wide network of membrane invaginations in intact cardiomyocytes, a ramified
arrangement of both transverse and longitudinal tubules as can also be seen
here in Fig. 3.16 and 3.17. Soeller and Cannell showed that the surface open-
ings where the TT join the cellular surface sarcolemma (the so-called “ostia”)
are arranged in a rectangular grid-like fashion across the cardiomyocyte sur-
face sarcolemma. This arrangement of the ostia was reproduced in a similar
follow-up study by Savio-Galimberti et al. in 2008 [532] who used fluorescein-
linked dextran and a fluorescent Wheat-Germ Agglutinin (WGA) conjugate for
3D confocal fluorescence microscopy.
Here, using the fluorescent Chol analog Chol-OG488, I find that the ostia cor-
respond to Chol rich patches at the surface sarcolemma. The budding of these
Chol rich sarcolemmal patches into TT is shown in more detail in Fig. 3.17
wherein VM cross sections are displayed. In Fig. 3.17 C, two exemplary TT that
each bud from a Chol rich assembly at the surface sarcolemma are marked by
pink arrows. Very interestingly, when looking closely at the 3D image renders
of Chol-OG488 labeled VM, another peculiarity becomes apparent - not every
Chol rich patch at the surface sarcolemma buds into a TT. Examining the intra-
cellular side of the surface sarcolemma, little “bumps” can be observed. These
bumps are only small membrane invaginations that vary in diameter and elon-
gation, extend not more than a few hundred nanometers into the cell, and are
distributed irregularly. Note also that longitudinally oriented TT structures are
observed only at positions at least 2 µm (i.e. at least one sarcomere length)
away from the surface sarcolemma. This indicates that longitudinally oriented
TT typically develop from the rectangular branching of transversely oriented
TT and are not formed directly at the surface sarcolemma. The pink arrow
head in Fig. 3.17 C marks such an event of several transversely oriented TT
branching out; the branches then fuse to form an elongated longitudinally ori-
ented TT. Another characteristic of the TATS is the bifurcation of transversely
oriented TT into two branches that then continue to extend along the same di-
3.4. 2P-EXC-STED OF THE CARDIAC MEMBRANE SYSTEM 151
Figure 3.17.: Three-dimensional (3D) Two-Photon-Excitation (2P-Exc) image renders of a living mouse ventricular car-
diomyocyte (VM) labeled with Chol-OG488. VM were stained as described in section 2.3.2, imaging was
performed as described in this section, and 3D image renders were obtained as described in section 2.6.1.
The basement membrane of the VM is seen in the lower part and the apical membrane is seen in the
top part of the respective images. The inserted coordinate systems indicate the longitudinal (X) and the
transverse (Y) cell axes (also defining the imaging plane parallel to the cover slip), and the Z axis corre-
sponding to the optical axis. Scale bars: 5 µm. A 3D render of a VM section displayed in solid mode. B
3D render of the same VM as in A with adjusted signal transparency to allow for better visibility of mem-
brane structures inside the VM. C Rotated view of the same cell in top view from the basement membrane
(which was cut off in the render for visual assessment of the cell interior). T-Tubules (TT, pink arrows)
and smaller membrane invaginations (yellow arrows) bud from Chol rich patches at the sarcolemma.
Branching of TT into longitudinally oriented tubules (pink arrow head) and bifurcation of TT (orange
arrow heads) is observed only inside the VM at least 2 µm away from the sarcolemma.
rection as the initial TT (marked by the orange arrow heads in Fig. 3.17 C).
Similarly to the branching of TT to form longitudinal structures, such a bifur-
cation of TT was only observed at distances at least about 2 µm away from the
surface sarcolemma.
In summary, using Chol-OG488 in a 2P-Exc imaging configuration is excel-
lently suited to highlight the architecture of the TATS throughout whole living
VM. The TT network and its distinct topological features, i.e. bifurcation of
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TT and branching of TT to form longitudinal TT structures, can thus be well
visualized and studied.
However, to investigate the above mentioned sarcolemmal “bumps” which are
shallow sarcolemmal membrane invaginations and which bud from Chol rich
patches along the sarcolemma but never develop into TT, it was necessary to
look at the membrane architecture in the vicinity of the basal sarcolemma with
a much higher resolution. This is because the two questions that come to mind
first are: 1.) Which structural factor decides whether a Chol rich sarcolemmal
patch buds into a full TT or remains a more shallow membrane invagination?
and: 2.) What is the composition of these shallow membrane invaginations?
To shed light on these questions, I recorded 2P-Exc-CWSTED images of living
VM labeled with Chol-OG488, thereby focusing on the region starting from the
basal sarcolemma (i.e. where Chol rich patches were observed) and extending
about 4 µm deep into the cell (i.e. where a clear distinction between TT and
shallow membrane invaginations could be made).
As a first control experiment to demonstrate the ability of 2P-Exc-CWSTED
to resolve the subdiffractional features of the membrane architecture in Chol-
OG488 labeled living VM, I recorded image stacks in 2P-Exc-CWSTED mode,
assessed the effect of the imaging procedure on the cell fitness, and determined
the achievable structure resolution. The intrinsic property of fast diffusion of
the dye compound Chol-OG488 together with the intrinsic property of 2P-Exc
of reduced photobleaching in out-of-focus layers within the scanned sample
proved to be a very favorable combination enabling the fast acquisition of high
quality 3D 2P-Exc-CWSTED scans.
Regarding cell viability in the 2P-Exc-CWSTED imaging scheme, it was possi-
ble to consecutively scan a cellular volume of about (20 × 20 × 5) µm³ in (X
× Y × Z) direction with a corresponding pixel size of (20 × 20 × 200) nm³,
a pixel dwell time of 0.02 ms, and employing a 2P-Exc and STED illumina-
tion power of 10 mW and of 50 - 100 mW, respectively (these settings were
identified to yield optimized images with respect to resolution, signal to noise
ration and signal bleaching). 2P-Exc-CWSTED scans with longer duration of
acquisition and/or higher illumination powers (of either the 2P-Exc laser or
the STED laser) would lead to a fast deterioration of cell fitness. This deteriora-
tion would typically manifest itself in a bulging of the cell very locally around
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the scanned region. Heat generation due to laser light absorption within the
cell might be the main explanation for this observed detrimental effect during
prolonged scanning of the same region of interest within the cell. Yet, when
imaging the cells using the above stated parameters, no adverse effects on the
cell fitness were observed when monitoring the cells in widefield images after
2P-Exc-CWSTED scanning.
Regarding the achievable lateral image resolution in 2P-Exc-CWSTED images
of Chol-OG488 labeled living VM, the upper limit of the possible lateral res-
olution of elongated membrane structures (i.e. longitudinal cross sections of
TT) could be determined to be about 65 nm. For circular membrane structures
(i.e. transverse cross sections of TT), this upper limit of achievable lateral res-
olution was found to be about 83 nm. The individual frames of an exemplary
image stack of a living VM labeled with Chol-OG488 and the therefrom ob-
tained respective structure resolutions are shown in Fig. 3.18. Therein, the VM
was scanned over an axial region extending from 2.0 µm to 0.4 µm below the
sarcolemma.
The achievable lateral resolution of individual elongated and circular mem-
brane structures was determined by fitting a Lorentzian peak function to ex-
tracted signal intensity profiles as described in section 2.6.2. Ensuingly, the Z-
stacks of labeled VM obtained from scanning lateral image frames at different
depths within the cell as shown in Fig. 3.18 were processed with the software
AMIRA 6.0 (see section 2.6.1) and yielded high-detail 3D image renders that
capture the subsarcolemmal architecture of the TATS in living VM with sub-
diffraction resolution. Fig. 3.19 shows such 3D renders of 2P-Exc-CWSTED
images of a single VM seen from two perspectives: first, in a top view looking
from the basement sarcolemma (i.e. at the cover slip) into the inside of the cell
(displayed in Fig. 3.19 A) and second, in a top view looking from the inside of
the cell towards the basement sarcolemma (displayed in Fig. 3.19 B). Both Fig.
3.18 A and B feature magnifications of selected regions in the corresponding
overview 3D renders. In these magnifications, pink arrows indicated Chol rich
patches at the sarcolemma that bud into TT while yellow arrrows mark those
Chol rich sarcolemmal patches that remain such shallow membrane invagi-
nations which had been observed in the 2P-Exc 3D renders and which were
demonstrated in Fig. 3.17 C). The fact that the Chol rich sarcolemmal patches
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Figure 3.18.: Two-Photon-Excitation-CW-STED (2P-Exc-CWSTED) images of a living mouse ventricular cardiomy-
ocyte (VM) stained with Cholesterol-PEG-OregonGreen488 (Chol-OG488). VM were stained as described
in section 2.3.2 and imaged at different depths within the cell. A 2P-Exc-CWSTED depth scan through a
living VM. The imaging depth is indicated in the image frames, refers to µm beneath the sarcolemma and
ranges from 0.4 µm to 2.0 µm beneath the sarcolemma. Images were smoothed using a two-dimensional
Gaussian filter with a width of 1.5 pixels. The color bar indicates the image brightness in photon counts
(cts.). Scale bars: 1 µm. B Normalized fluorescence intensity profiles (FI, norm.) that were obtained
from the yellow line (for the left graph) and yellow box (for the right graph, obtained from the addup of
fluorescence signal along the Y-direction) indicated in the respective image frames (of the raw data) and
marking transverse tubular cross sections. The resolution of transverse tubule structures is denoted as the
full width at half maximum (FWHM) extracted from fitting the intensity data to a Lorentzian curve (see
also section 2.6.2). The resolution was determined using the raw data images that are explicitly displayed
in the Appendix H.1, Fig. H.1.
are either associated with TT or with regions of membrane curvature that pro-
trude far less deeply into the inside of the VM is illustrated once more in Fig.
3.20. Therein, a 3D 2P-Exc-CWSTED image render of a Chol-OG488 labeled
VM is displayed and, on one side, orthogonally sliced which results in a 2D
cross section of the cell (indicated by the dashed blue box in Fig. 3.20). Again,
pink arrows exemplarily mark Chol rich sarcolemmal regions that develop into
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Figure 3.19.: Three-dimensional (3D) Two-Photon-Excitation-CW-STED (2P-Exc-CWSTED) image renders of living
mouse ventricular cardiomyocytes (VM) labeled with Chol-OG488. VM were stained as described in
section 2.3.2, imaging was performed as described in this section, and 3D image renders were obtained
as described in section 2.6.1. The inserted coordinate systems indicate the longitudinal (X) and the trans-
verse (Y) cell axes (also defining the imaging plane parallel to the cover slip), and the Z axis corresponding
to the optical axis. A Top view into VM, looking from the basement sarcolemma into the inside of the cell.
Magnification corresponding to the yellow boxed region with pink arrows indicating Chol rich sarcolem-
mal patches that bud into transverse tubules and yellow arrows indicating Chol rich sarcolemmal patches
that are associated with shallow membrane invaginations at the sarcolemma. B Top view out of the same
VM as in A, looking from inside the cell out towards the sarcolemma. Magnification corresponding to
the yellow boxed region with the pink arrow indicating a Chol rich sarcolemmal patch that buds into a
transverse tubule and the yellow arrow indicating Chol rich sarcolemmal patches that are associated with
shallow membrane invaginations at the sarcolemma. Scale bars in overview 3D renders: 5 µm; scale bars
in magnifications: 1 µm.
TT while yellow arrows mark shallow Chol rich membrane invaginations. All
in all, the 3D renders of Chol structures in living VM revealed that there are
two populations of Chol rich patches at the sarcolemma: one that is TT associ-
ated and one that is not. More stringently, it can be stated that every TT buds
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Figure 3.20.: Three-dimensional (3D) Two-Photon-Excitation-CW-STED (2P-Exc-CWSTED) image renders of a living
mouse ventricular cardiomyocyte (VM) labeled with Chol-OG488 (see section 2.3.2). Imaging was per-
formed as described in this section and 3D image renders were obtained as described in section 2.6.1. The
inserted coordinate systems indicate the longitudinal (X) and the transverse (Y) cell axes (also defining
the imaging plane parallel to the cover slip), and the Z axis corresponding to the optical axis. The image
shows a tilted 3D render of the VM. The dashed blue box indicates an orthogonal slice along the Y-Z-
plane. In both the 3D render and the planar slice, some Cholesterol rich sarcolemmal domains bud into
Transverse Tubules (TT, indicated by pink arrows) and some domains develop into less deeply penetrat-
ing membrane invaginations (indicated by yellow arrows). The image was oversaturated in brightness
to facilitate the identification of the different Chol signal patterns indicated by the respectively colored
arrows. Scale bar: 5 µm.
from a Chol rich sarcolemmal patch but not every Chol rich sarcolemmal patch
develops into a TT. Trying to find a general structural principle that decides
whether a Chol rich patch at the sarcolemma turns into a TT or not, I looked at
the size distribution of Chol patches and the shape distribution of Chol patches
and compared the obtained distributions between TT associated Chol patches
and not TT associated Chol patches. To categorize the patches into TT associ-
ated and not TT associated, I tracked the continuity of the fluorescence signal
of the Chol patches over several consecutive lateral 2P-Exc-CWSTED image
frames within an axial range starting right at the sarcolemma of a respective
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VM and ending about 4 µm deep within the cell. If a Chol signal was clearly
traceable over a range of more than 2 µm, it was considered TT associated. If
a Chol signal was lost after about 500 nm within the cell, it was considered not
TT associated. If a signal could not be clearly classified regarding its continuity,
the corresponding sarcolemmal Chol rich patch was not considered for analy-
sis. Note that I initially planned to also evaluate the spacing between Chol rich
sarcolemmal patches to investigate whether the distance between patches had
an influence on the extent of Chol associated membrane invaginations. Yet,
since not every signal of Chol rich patches could definitely be classified as TT
associated or not, such an analysis of the distance between patches was not
feasible because a significant portion of the sarcolemmal Chol signal had to be
excluded from the analysis. The remaining, categorized sarcolemmal Chol rich
patches were evaluated regarding their size and shape after a binarization step
of the 2P-Exc-CWSTED images obtained in the sarcolemmal plane (i.e. single
2D image frames). Image thresholding for binarization was performed in a pro-
cedure analogous to the one described in section 2.6.4. The binarized images
were evaluated using the software FiJi. The built-in “Analyze Particles” plugin
was used which allowed the distinct numbering of particles in the binarized
image so that the previously classified Chol rich patches (i.e. TT associated or
not) could be identified, addressed, and characterized individually regarding
their shape and size by comparing the enumerated particles in the binarized
image with the original raw data images and the therein categorized Chol rich
patches. The shape of Chol rich sarcolemmal patches was analyzed by determi-
nation of the circularity of individual patches: a circularity of 1 would indicate
a completely circular object while a circularity of 0 would indicate a line. The
circularity Circ is defined as Circ = 4pi × [Area] / [Perimeter]2. The size of the
Chol rich sarcolemmal patches was analyzed by determination of the area of
the individually identified patches.
The determined Chol patch shape and size, respectively showed a very high
variation. This variation was observable for both TT associated Chol rich sar-
colemmal patches and for Chol patches associated to shallow membrane in-
vaginations. The difference between the distributions of patch shape and patch
size was not significant when comparing the two populations of Chol rich sar-
colemmal patches.
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The patch circularity ranged predominantly between about 0.2 and close to
1.0 meaning that most patches were either of elliptical or circular shape. The
area size of the patches ranged between about 1800 nm² up to about 150,000
nm² which corresponds to object diameters of about 50 nm up to about 440
nm, respectively, when assuming a roughly circular object shape. The circular
patches could mostly be identified as those patches which were close to the
smallest object size that was resolvable by the 2P-Exc-CWSTED microscope
system, i.e. about 50 nm in diameter. The most often observed patch area
size for both TT as well as shallow invagination associated Chol patches was
at about 4500 nm², corresponding to a roughly circular object of about 75 nm
in diameter. All in all, while a typical patch size could be identified, neither
a typical patch circularity (i.e. patch shape) nor a characteristic difference be-
tween those Chol patches that bud into TT and those Chol patches that do not
was found. Thus, a clear distinction between Chol rich sarcolemmal patches
that were associated to TT and Chol patches that were associated to shallow
invaginations could not be made based on the obtained distributions of patch
shape and patch size, respectively. The obtained results for the distribution of
the area sizes of Chol rich sarcolemmal patches are presented in the Appendix
H.2. There, a bar graph plots displays the area sizes determined for TT associ-
ated patches vs. patches associated to shallow membrane invaginations.
The high variation in shape and size of the sarcolemmal Chol signal is demon-
strated in Fig. 3.21 for two individual VM that were labeled with Chol-OG488
and imaged in 2P-Exc-CWSTED mode in the plane of the basement sarcolemma.
In both Fig. 3.21 A and B, pink arrows exemplarily indicated Chol rich sar-
colemmal patches that are TT associated while yellow arrows mark Chol rich
sarcolemmal patches that are not TT associated. As can be seen from Fig. 3.21
A and B, the Chol rich sarcolemmal patches present themselves with a highly
variant distribution in patch shape and patch size. Both circular and elongated
patches, as well as patches with a small area size (about 1800 nm², i.e. corre-
sponding to a diameter of about 50 nm when assuming a roughly circular ob-
ject shape) and patches extending over larger areas (up to about 150,000 nm²,
i.e. corresponding to a diameter of about 440 nm when assuming a roughly
circular object shape) can either bud into TT or remain associated to shallow
membrane invaginations, respectively. It is hence not readily predictable from
3.4. 2P-EXC-STED OF THE CARDIAC MEMBRANE SYSTEM 159
Figure 3.21.: Highly clustered nanoscopic sarcolemmal Cholesterol (Chol) structures visualized by Two-Photon-
Excitation-CW-STED (2P-Exc-CWSTED) imaging of a living mouse ventricular cardiomyocyte (VM) la-
beled with Cholesterol-PEG-OregonGreen488 (Chol-OG488). VM were stained as described in section
2.3.2, images were taken at the sarcolemma. White arrows indicate the longitudinal (X) and transverse
(Y) cell axes, respectively. Images were smoothed using a two-dimensional Gaussian filter with a width
of 1.5 pixels. A Overview image of sarcolemmal Chol-OG488 signal in a living VM; image magnification
corresponding to the yellow boxed region. B Sarcolemmal Chol-OG488 signal in a living VM. In both A
and B pink arrows indicated Chol rich sarcolemmal patches that bud into transverse tubules while yellow
arrows indicate Chol rich sarcolemmal patches that are associated to shallow membrane invaginations at
the sarcolemma. The color bars indicate the image brightness in each A and B in photon counts (cts.).
Scale bars: 1 µm.
the heterogeneous appearance where TT mouth into/from the sarcolemma and
where shallow membrane invaginations are located. This confirms the find-
ings of the analysis of the shape and size distribution of Chol rich sarcolemmal
patches. Thus, no general principle could be derived that would allow an in-
ference from the determination of the shape or size of a Chol patch to whether
it is TT associated or not. However, when looking at the ensemble of all Chol
rich sarcolemmal patches, reoccurring patterns could be observed. The distinct
arrangement of Chol rich sarcolemmal clusters is a mosaic composed of three
basic structural elements:
160 3. RESULTS AND DISCUSSION
1.) Small single Chol domains,
2.) Ring structures formed by these single domains,
3.) Bunchy clusters of various sizes also featuring a substructure of single
domains.
These three here-defined “membrane motifs” will be elucidated and discussed
in detail in the next section.
Concluding, using 2P-Exc-CWSTED microscopy to image living VM labeled
with the novel fluorescent Chol analog Chol-OG488, the 3D architecture of the
Chol rich cardiac membrane system with a lateral resolution of about 65 nm
and an axial resolution of about 450 nm could be visualized. This allowed the
visualization of the complex transverse-axial tubular system (TATS) inside the
living VM in relation to a distinct arrangement of Chol rich patches at the sar-
colemma (a signal pattern that had been shown before using Chol-KK114, see
section 3.3). Further, it could be shown that TT emerge from/into sarcolem-
mal membrane regions that are highly enriched in Chol. Chol provides for
membrane stiffness and induces membrane curvature [137, 120]. Specifically,
Chol, with its large hydrophobic tail in proportion to its small hydrophilic head
group, has a high intrinsic negative curvature [95, 138, 118, 139]. Hence, enrich-
ment of Chol at the membrane is typically indicative of concave (i.e. inwardly
curved) membrane regions.
The Chol enrichment of sarcolemmal regions that bud into TT was thus to be
expected. Interestingly, however, the Chol rich patches at the sarcolemma of
VM could actually be categorized into two distinct populations. One portion
of Chol rich patches buds into transverse tubules (TT) which eventually branch
out and/or fuse together to form TATS - the most characteristic and integral
membrane architecture of VM. The other portion of Chol rich patches at the
sarcolemma does not add to the TATS but forms shallow membrane invagina-
tions that do not protrude further than about 500 nm into the inside of the VM
- they probably protrude much less than 500 nm into the inside given the axial
resolution limit of ≈ 450 nm of the microscope. A general principle regard-
ing the size or shape of the individual sarcolemmal Chol patches from which it
could be predicted whether they form either TT or shallow invaginations could
not be derived unequivocally. There might be a tendency that the sarcolemmal
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Chol clusters need a certain minimal size to develop into TT. However, spa-
tially very extended Chol patches that did not form TT but remained rather
flat along the sarcolemma were also observed.
Two additional facts about the distinct sarcolemmal pattern of Chol rich patches
were revealed by successively scanning multiple frames of the same region of
interest along the sarcolemma:
1.) Globally, the Chol rich structures seem to be anchored within the mem-
brane and the Chol signal pattern is temporally stable and conserved;
2.) Locally, there are dynamic fluctuations of influx and efflux of Chol signal
around these invariant Chol rich structures.
Note that the image acquisition procedure can be defined as “quasi-dynamical”
given the pixel dwell time of at least 0.02 ms that is necessary for sufficient
signal brightness. Hence, scanning was possible with a frame rate on the order
of tens of seconds.
It can hence be stated that there are local dynamics of Chol around fixed sar-
colemmal Chol rich structures. This might indicate a transient recruitment and
release of Chol by these spatially highly localized and temporally stable Chol
rich membrane compartments. These specific Chol signal dynamics were ob-
served for both those Chol rich sarcolemmal patches that bud into TT as well as
for those Chol rich patches that remain more shallow membrane invaginations.
So, what are these Chol rich shallow membrane invaginations? It has been
proposed that a large curvature in a membrane bilayer requires a higher con-
centration of lipids with a negative intrinsic curvature (like Chol) in the extra-
cellular vs. the intracellular membrane leaflet [533]. This difference in concen-
tration would probably have to be a protein-mediated process. The most likely
membrane compartments that could match the Chol rich shallow membrane
invaginations would be caveolae. Caveolae are omega-shaped pits at the cel-
lular membrane. They are about 70 nm in size at their neck regions and can
fuse together, thus summarizing sophisticated, branched membrane structures
[140]. Caveolae are highly enriched in the protein family of the Caveolins that
line the caveolae along their cytosolic side. The myocyte-specific isoform of
the caveolins is the protein Caveolin-3 (Cav-3) which is also the most strongly
expressed Caveolin in these cell types. Cav-3 features an intermembrane do-
162 3. RESULTS AND DISCUSSION
main, resides at the intracellular membrane leaflet and presents distinct Chol
binding sites. For a more detailed description of Cav-3, its properties, and its
relation to Chol, please refer to section 1.1.2.
The most obvious next step would thus be the investigation of the possible as-
sociation between the observed sarcolemmal Chol structures and the myocyte
caveolae forming protein Cav-3. For this purpose, the ideal specimen would
be living primary cardiomyocytes from a genetically engineered mouse model
in which the Cav-3 is co-expressed together with a fluorescent protein. Un-
fortunately, such a mouse model was not readily available within the scope of
this thesis. Visualizing the nanoscopic sarcolemmal arrangement of Cav-3 us-
ing STED microscopy was thus only possible in fixed VM that were stained for
Cav-3 via indirect immunofluorescence. The fluorescent Chol analogs, how-
ever, were not compatible with immunofluorescence protocols since the therein
used necessary membrane permeabilization step led to the internalization of
the Chol labels. This resulted in an unspecific fluorescence signal throughout
the whole cell. In the following, I therefore indirectly validated the structural
association of Chol clusters with caveolae. My studies included carefully de-
signed control experiments based on both established and novel control sys-
tems. I quantitatively characterized the sarcolemmal Chol signal in living VM
and compared it to the sarcolemmal Cav-3 signal in fixed VM that were la-
beled via immunofluorescence. I could observe a distinct nanoscopic signal
pattern for both Chol and Cav-3. This signal pattern was also found in Ventric-
ular induced Pluripotent Stem Cells (ViPSC) and in Human Adipocytes (HAd,
derived from heart tissue). Further, the artificial expression of Cav-3 in trans-
fected living HeLa cells led to the formation of the above mentioned signal
patterns of both Chol and Cav-3. Such signal patterns were not seen in the cor-
responding control cells. The dependence of Chol clusters and nanopatterns on
the expression of Cav-3 was thus confirmed. On the other hand, Chol depletion
of VM led to the dissociation of Cav-3 clusters and to the loss of sarcolemmal
nanopatterns. Finally, the two-color STED imaging of Chol structures together
with the extracellular leaflet associated glycosphingolipid Ganglioside GM1
(GM1) in living VM showed significant co-clustering on a nanometric scale.
Two-color STED images of Cav-3 and GM1 in fixed VM showed similar ar-
rangements. These images are presented in the following.
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3.5. Association of Caveolin-3 and Cholesterol
membrane domains at the sarcolemma of living
cardiomyocytes
In a first step to study the association of sarcolemmal Chol structures with sar-
colemmal caveolae, and vice versa, STED images of the sarcolemma of living
VM labeled with Chol-K114 and of fixed VM labeled for Cav-3 via indirect
immunofluorescence were acquired, respectively. Since the focus was laid on
STED imaging of the basement sarcolemma, i.e. of the outer membrane close
to the cover slip, the investigated samples could be simplified to being quasi
two-dimensional. Hence, instead of using 2P-Exc-CWSTED, I decided to con-
duct the experiments using one-photon-excitation (pulsed) STED microscopy
with excitation and depletion lasers in the red spectral region. I prepared the
samples accordingly using Chol-KK114 to label Chol rich membrane structures
in living VM, and using the antibody coupled dye Abberior STAR635P to visu-
alize Cav-3 structures in fixed VM. Using such microscope and sample config-
urations had several major advantages. First, without the immediate necessity
to acquire 3D images, photobleaching of out-of-focus imaging planes is a minor
issue. In a one-photon-excitation configuration, the reduction of the lateral PSF
size due to the shorter wavelength that is used and the highly reduced intensity
that is needed for efficient fluorescence excitation thus outweigh the benefit of
the quadratic dependence of the fluorophore excitation on the illumination in-
tensity in a 2P-Exc configuration which essentially provides a pinhole in the
sample plane. Second, using Chol-KK114 in a STED microscope configuration
with synchronized pulsed excitation and pulsed STED lasers yielded images
with the highest resolution. This was an empirical finding which might be at-
tributable to the properties of Chol-KK114 and/or the nature of fluorophore
off-switching by the pulsed STED laser which is more efficient than with a CW
STED laser [348]. Therefore, the in the following presented and analyzed STED
images were acquired using either the custom-built, fast scanning STED setup
(see section 2.1.2), or the STED microscope system Leica TCS SP8 STED 3X (see
section 2.1.3), or the STED microscope system Abberior 2C STED 775 QUAD
Scan (see section 2.1.4).
The obtained STED images revealed that both the Chol and the Cav-3 signals
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are highly clustered at the cardiac sarcolemma and that both the Chol and the
Cav-3 clusters show a distinct nanopattern that can be categorized into three
re-occurring membrane motifs: 1. single domains of an average diameter of
about 70 nm, 2. ring structures of an average diameter of about 240 nm, and 3.
bunchy clusters of variable sizes. Fig. 3.22 shows exemplary overview images
and corresponding magnifications of the mentioned membrane motifs at the
sarcolemma of living VM labeled with Chol-KK114 and of fixed VM labeled
with the dye STAR635P via indirect immunofluorescence. The sarcolemmal
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Figure 3.22.: STED images of A living mouse ventricular cardiomyocytes (VM) labeled for Cholesterol (Chol) with
Chol-KK114, and B fixed VM labeled for Caveolin-3 (Cav-3) via indirect immunofluorescence using the
antibody-coupled fluorescent dye Abberior STAR635P (see Appendix A.4). Demonstration of the simi-
larity of the following three re-occurring sarcolemmal Cholesterol (Chol) and Caveolin-3 (Cav-3) pattern
motifs in mouse ventricular cardiomyocytes (VM): 1. single domains, 2. ring structures, and 3. bunchy
clusters. Following this enumeration, representative magnifications of exemplary motifs as indicated by
the boxed regions in the overview images are displayed to the right of the corresponding images. Images
were smoothed using a two-dimensional Gaussian filter with a width of 1.5 pixels. The color bars indicate
the image brightness in each A and B in photon counts (cts.). White arrows indicate the longitudinal (X)
and the transverse (Y) cell axes, respectively. Scale bars in the overview images: 1 µm; scale bars in the
magnifications: 100 nm.
signal density ρ, the diameter of single domains, and the diameter of ring struc-
tures of the Chol and Cav-3 signal, respectively, were quantified as described in
sections 2.6.4, 2.6.5, and 2.6.6; the obtained results are summarized in Fig. 3.23.
The quantitative assessment of the sarcolemmal signal density ρ showed that
about on sixth (16.93 %) of the sarcolemma of living VM is covered by the Chol
rich clustered structures that could be detected using Chol-KK114 as a probe.
Regarding the sarcolemmal signal density of the Cav-3 signal in fixed VM, al-
most one quarter (24.13 %) of the sarcolemma is covered by Cav-3 structures.
The difference between the sarcolemmal signal densities of Chol and Cav-3 is
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very significant. Assuming that Chol-KK114, due to its bulky PEG linker, is
confined to the extracellular membrane leaflet (see section 3.1) and knowing
that Cav-3 is an intermembrane protein that resides at the intracellular leaflet
(see section 1.1.2), this discrepancy in ρ might indicate that the sarcolemmal
membrane shows a very high density of the inwardly curved caveolar struc-
tures that create regions of highly negative curvature along the extracellular
leaflet. In these regions, the resident endogenous membrane lipids might move
closely together and thus might prevent the exogenous fluorescenent Chol-
KK114 from inserting itself into the membrane. Chol-KK114 might thus not
be able to detect the “bulbous” body of the flask-shaped caveolar structures.
However, at the caveolar neck region, there should be two kinks in the extracel-
lular membrane leaflet that stem from the inward bend. Here, the endogenous
membrane lipids could be arranged further apart from each other, facilitat-
ing the insertion of Chol-KK114. Regarding the association between Chol and
Cav-3 signal structures, Chol-KK114 might hence be a marker of the caveolar
neck region which has a smaller cross section than the body of the caveolus.
In essence, due to the still limited resolution in the obtained images and due
to the finite size of the Chol-KK114 probe, the precise location of Chol with re-
spect to an individual caveolus cannot be identified. Yet, this consideration of
the effect of the membrane curvature caused by caveolae might be one possi-
ble reason for the lower Chol-KK114 signal density compared to that of Cav-3.
On the intracellular side, the membrane curvature provided by the caveolae
might lead to a more spread distribution of the polar headgroups of intracel-
lular membrane lipids and and would thus allow more space for cytosolic in-
tramembrane proteins, including more Cav-3 proteins, to assemble along the
intracellular leaflet. Of course, it cannot be assumed that the Chol-KK114 and
the Cav-3 signals would be associated in a 1:1 ratio since there are many other
Cav-3-independent membrane structures that are rich in Chol. However, this
would rather fuel the expectation that the observed Chol-KK114 signal density
is significantly higher than the Cav-3 signal density.
With the sarcolemmal signal density a rather global figure for comparison, the
Chol and Cav-3 signal structures are also very similar on a local scale. Both
signal structures form a specific nanopattern comprising the following three
basic motifs that shall be discussed in detail:
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Figure 3.23.: Quantification of the signal density ρ, the diameter () of single domains, and the diameter of rings
structures of Cholesterol (Chol) and Caveolin-3 (Cav-3) signals at the sarcolemma of living and fixed
mouse ventricular cardiomyocytes (VM), respectively. ρ and the diameters of single domains and ring
structures were determined as described in sections 2.6.4, 2.6.5, and 2.6.6. Values are presented as mean
± standard deviation. Statistical significance was tested using the two-sided Mann-Whitney-Wilcoxon U
test as described in section 2.9 (the explicit parameters of the statistical test are presented in Appendix I,
Tables I.3, I.4, and I.5) and is given as: (**) - very significant (p < 0.001), and (n.s.) - not significant (p >
0.01). Number of analyzed cells for determination of ρ: 55 (Chol), 44 (Cav-3). Number of analyzed single
domains for diameter determination: 182 (Chol), 2397 (Cav-3). Number of analyzed ring structures for
diameter determination: 404 (Chol), 80 (Cav-3). The image insets reproduce the respective magnifications
presented in Fig. 3.22. Scale bars: 100 nm.
1. Single domains. As indicated in Fig. 3.22 (green boxes), both the Chol
and Cav-3 signals feature separate, small circular signal entities along the sar-
colemma. These entities shall here be referred to as “single domains” because
they can be seen as the basic building blocks of all higher order structural as-
semblies observed for the Chol and Cav-3 signals. Quantification of the single
domains - as described in section 2.6.5 and as shown in Fig. 3.23 - yielded an
average diameter of about 74 nm (Chol) and 68 nm (Cav-3). The difference be-
tween the diameters of the Chol and the Cav-3 single domains was not signifi-
cant. Since the obtained diameter sizes of both Chol and Cav-3 single domains
is well above the resolution of 40 nm that was achievable with the used STED
microscope, it can be assumed that the actual object forming such a single do-
main would have a diameter of roughly 50 to 60 nm (note that the size of the
fluorescent label has to be considered and adds to the detected single domain
size). Thus, the single domains observed here might be single caveolae because
caveolae have been reported to be of similar sizes as those determined here
and because, as we will see in the following, several caveolae tend to assemble
to form more complex shapes [140]. To verify that the observed sarcolemmal
Cav-3 single domains were not attributable to artifacts of antibody clustering
[534], samples with a fragment antigen-binding (Fab) fragment instead of the
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full length secondary antibody were prepared as a control (cf. [354]). The Fab
fragment was also conjugated to the dye STAR635P and the immunolabeling
protocol was conducted analogous to the one described in section 2.3.3. The
images obtained from the use of the fluorescent Fab fragment are not shown
here since they were of much lower signal brightness and thus less instructive.
However, an image of fixed VM labeled for Cav-3 via a Fab-fragment coupled
to STAR635P is shown in the Appendix J; the image shows Cav-3 single do-
mains of about 65 nm in diameter and thus confirms that the here described
single domains are not artifacts stemming from antibody clustering.
2. Ring structures A very peculiar membrane motif is the observed Chol and
Cav-3 ring structures. These ring structures are typically formed by the assem-
bly of between 4 to 8 single domains of Chol and Cav-3, respectively (data not
shown). These rings are exemplarily shown in Fig. 3.22 and the quantification
of their diameters is graphically displayed in Fig. 3.23. The average diameter
of Chol and Cav-3 ring structures was assessed as described in section 2.6.6
and amounts to about 226 nm (Chol) and 253 nm (Cav-3). The difference be-
tween the diameters of the Chol and Cav-3 ring structures is very significant. A
possible explanation for the larger diameter of the Cav-3 ring structures com-
pared to the Chol-KK114 ring structures - in addition to the above discussed
consideration that membrane labeling using Chol-KK114 might only have ac-
cess to the caveolar neck regions - could be that the Cav-3 antibody construct
is of a larger size than Chol-KK114 and thus increases the size of the detected
structure. It has been shown that the antibody-dye constructs used in an im-
munofluorescence assay increases the detected size of a target protein by about
30 nm [535]. However, such a profound difference in size has not been seen for
the diameters of single domains (see above) which might indicate that Chol-
KK114 and the antibody-based label for Cav-3 do not drastically differ in size.
Therefore, the actual difference in size of the two labels becomes more obvious
for the assembly of many single domains in a ring than for an isolated single
domain.
3. Bunchy Clusters The third membrane motif covers a rather broad range of
possible assemblies of Chol and Cav-3 single domains into higher-order sig-
nal structures: bunchy clusters of various sizes. Such clusters are exemplarily
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shown in Fig. 3.22. Although these bunchy clusters feature a high variety of
shapes and sizes, they can clearly be identified as arrangements of individual
single domains in close proximity which gives the clusters a distinct appear-
ance that might best be described as botryoidal (i.e. “grape like”). The ten-
dency of individual caveolae (i.e. the here defined “single domains”) to fuse
and form higher-order complexes of two or more single caveolae has been re-
ported [175, 140] (see also section 1.1.2) which supports the assumption that the
here observed bunchy clusters of Cav-3 and Chol structures are caveolar super-
complexes. I could confirm that two or more single, omega-shaped, caveolae
would fuse to form branched complexes using Electron Microscopy (EM). I
prepared samples for EM of single VM, VM in a loose cell complex (cell pel-
let) and tissue sections from excised papillary muscle. In all of these samples,
I could observe caveolae being in close proximity to each other and somtimes
fusing to form higher-order complexes. I could find these fused assemblies
most often in the prepared tissue sections, possibly because this kind of sam-
ple preparation provided the most physiological analogy to living cells. An
exemplary overview of the obtained EM images is given in the Appendix K. It
is interesting to note that the here proposed caveolar super-complexes are very
frequently seen in the STED images - much more frequently than has been
reported based on EM. The here observed super-complexes extend over very
large interconnected regions across the sarcolemma. This observation holds
true for both the Cav-3 clusters in fixed VM and for the Chol clusters in liv-
ing VM. The high abundance of bunchy Chol clusters, i.e. possible caveolar
super-complexes, in intact VM might indicate that these assemblies are a phys-
iological characteristic of VM. As mentioned in section 1.1.2, one function of
caveolae is most likely that they serve as reservoirs for membrane proteins,
similar to storage rooms. Additionally, they could serve as reservoirs for cellu-
lar surface area and thus a cell’s capability to stretch (reviewed e.g. in [188]).
Especially cells like VM that undergo constant strain and stress due to contrac-
tion and relaxation need a high degree of elasticity which could be provided
by a dynamically adjustable sarcolemmal surface area. Caveolae and the high
Chol levels associated with them could likely serve the purpose to ensure the
elasticity of VM.
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Based on the above findings, the next question was whether the distinct mem-
brane patterns of Chol and Cav-3 structures and their mutual association found
for VM could also be observed in cell types with similar protein expression pro-
files and/or cell types that feature similar physiological demands. To address
this question, I prepared samples of Ventricular induced Pluripotent Stem Cells
(ViPSC) and Human Adipocytes (HAd, derived from adipose heart tissue)
analogous to the ones of VM. I chose to look at ViPSC because they have a
similar protein expression profile as VM and because they ought to perform
similar physiological tasks, i.e. contraction (see also section 3.2). Additionally,
I decided to look at HAd because, although these cells do not express Cav-3,
HAd express very high amounts of the protein Caveolin-1 (Cav-1, [536, 537])
which was the first identified isoform of the Caveolin protein family and also
forms caveolae. Further, HAd also need an elastic membrane since their func-
tion is to store triglycerides. Thus, to compare Chol and Caveolin nanoscopic
signal structures at the basement membrane of the respective cell types, I pre-
pared samples of living ViPSC and HAd labeled with 5 µM Chol-KK114 and
samples of fixed ViPSC and HAd labeled for Cav-3 and Cav-1, respectively, via
indirect immunofluorescence. All samples were imaged using the STED mi-
croscope system Leica TCS SP8 STED 3X (see section 2.1.3). The STED images
are shown in Fig. 3.24. In ViPSC and HAd, the signal structure of both Chol
and Cav-3 is highly clustered at the cellular basement membrane. In both cell
types, the distinct membrane motifs that had been identified in VM could be
observed as well. In Fig. 3.24, green arrows point out single domains, blue
arrows indicate ring structures, and yellow arrows mark bunchy clusters. The
qualitative comparison of Chol vs. the Cav-3 (or Cav-1, respectively) mem-
brane motifs again shows similarities, although they are not as obvious as it
was in the case of VM. Nevertheless, the association of Chol clusters along the
extracellular membrane leaflet and Cav-3 clusters along the intracellular mem-
brane leaflet seems to follow a more general principle that is not exclusive for
VM. Note here that HAd show a distinct Chol signal at their basement mem-
brane although they do not endogenously express the protein Cav-3. Still, HAd
express high levels of the caveolae forming protein Cav-1 [536, 537] which is
likely to have the same role in the assembly of Chol clusters as does Cav-3 in
VM and ViPSC. Yet, as has been shown in section 3.2, HEK cells do not fea-
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Figure 3.24.: STED images of the basement membrane of ventricular induced pluripotent stem cells (ViPSC) and hu-
man adipocytes (HAd). A and C Live ViPSC and live HAd, respectively, labeled with 5 µM Chol-KK114
as described in sections 2.4.2 and 2.4.3. B and D Fixed ViPSC and fixed HAd stained for Caveolin-3 (Cav-
3) and Caveolin-1 (Cav-1), respectively, via indirect immunofluorescence (see sections 2.4.2 and 2.4.3).
Arrows indicate distinct membrane pattern motifs of the respectively labeled lipid or protein: Green
arrows - single domains; blue arrows - ring structures; yellow arrows - bunchy clusters. Images were
smoothed using a two-dimensional Gaussian filter with a width of 1.5 pixels. The color bars indicate the
image brightness in each A and B, and C and D in photon counts (cts.). Scale bars: 500 nm.
ture Chol clusters at their basement membrane when labeled with Chol-KK114
although HEK cells, being epithelial cells, are known to express Cav-1 very
strongly [538]. Thus, in HAd, additional factors are most likely necessary for
the formation of Chol clusters. These factors, be they proteins or special phys-
ical conditions at the membrane, i.e. curvature or mechanical tension, remain
to be elucidated.
Having shown that clustered Chol signals and analogous Cav-3 signals can
also be found at the basement membrane of cell types other than VM, I was
interested in investigating if a cell system which does not endogenously ex-
press Cav-3 and does not show clustered Chol structures at its basement mem-
brane could be manipulated to form Chol clusters - and probably even form
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the described distinct membrane motifs - upon overexpression of Cav-3. I
chose HeLa cells as the experimental cell system to study the effects of such
an intervention. Opposed to VM and ViPSC, HeLa cells which do not endoge-
nously express Cav-3 show neither clustered Chol structures nor distinct Chol
membrane motifs (see section 3.2). This might indicate that the expression of
Cav-3 (and, in the case of HAd, a significantly high expression level of Cav-1
[536, 537]) is necessary 1. for the general clustering of Chol structures at the cel-
lular basement membrane and 2. for the formation of the specific arrangement
of Chol structures into the nanoscopic membrane motifs that were observed. To
address this hypothesized dependence of the nanoscopic Chol arrangement on
the cellular Cav-3 protein levels, living HeLa cells were transfected with a Cav-
3-SNAP construct to induce simultaneous overexpression of the protein Cav-3
together with a SNAP tag (see section 2.4.1). The transfected living HeLa cells
were stained with either Chol-KK114 or with the fluorescent compound Silicon
Rhodamine SNAP (SiR-SNAP). Live-cell STED imaging of Chol or Cav-3 struc-
tures at the cellular basement membrane was performed using the Abberior 2C
STED 775 QUAD Scan microscope (see section 2.1.4 and the therein specified
imaging parameters). The obtained results are summarized in Fig. 3.25.
As a first control to validate that (a) HeLa cells do not endogenously express
Cav-3 and (b) overexpression of the Cav-3-SNAP construct leads to significant
levels of Cav-3 expression in living HeLa cells, protein expression levels were
assessed by Western blot analysis of homogenates of control vs. Cav-3 over-
expressing HeLa cells. The preparation of Western blots is described in detail
in section 2.10.2 and in the Appendix L. The exemplary Western blot shown in
Fig. 3.25 A, left panel, displays the Cav-3-SNAP bands in four individual sam-
ples of Cav-3-SNAP overexpressing HeLa cells (L5-L8; shown in green); an
antibody directed against Cav-3 (anti-Cav-3) was used for protein detection.
Note that the expressed Cav-3-SNAP construct has a molecular weight of ≈ 40
kDa, a value stemming from the simultaneous expression of the Cav-3 protein
(at ≈ 20 kDa) and the SNAP tag (at ≈ 20 kDa, see also [539]). Therefore, the
green Cav-3 protein band in samples of the Cav-3-SNAP overexpressing HeLa
cells is detected at 40 kDa. Lane 9 (L9) shows the protein signal of a sample of
control HeLa cells, i.e. not overexpressing the Cav-3-SNAP construct; here, no
Cav-3 band is detected which confirms that HeLa cells do not endogenously
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Figure 3.25.: STED images of Cholesterol (Chol) and Caveolin-3 (Cav-3) structures at the basement membrane of con-
trol vs. Cav-3-overexpressing living HeLa cells (Cav-3-SNAP OE). A, left panel: Exemplary Western blot
of HeLa cells overexpressing the Cav-3-SNAP construct (lanes L5 - L8), and of control HeLa cells (lane
L9); see also section 2.10.2 and the Appendix L. Lanes L1 - L4 additionally show Cav-3 protein bands of
samples of heart homogenates from the left ventricle excised from four mice. The Cav-3 band detected
by an anti-Cav-3 antibody is shown in green. GAPDH was used as a load control; the signal form the
anti-GAPDH antibody is shown in red. Yellow grid lines and labels are added to facilitate the identifica-
tion of individual lanes and of the molecular weight marks in the blot; image brightness was deliberately
overshot to facilitate identification of the fluorescent bands. Right panel: STED image of living control
HeLa cells labeled with 5 µM Chol-KK114. B, left panel: Cav-3 signal structure at the basement mem-
brane of living HeLa cells overexpressing a Cav-3-SNAP construct and labeled with a Silicon Rhodamine
SNAP tag (SiR-SNAP). Right panel: Chol-KK114 signal structure at the basement membrane of living
HeLa cells overexpressing a Cav-3-SNAP construct. Image magnifications show the distinct membrane
motifs: 1. single domains; 2. ring structures; 3. bunchy clusters. C Bar graph representation of the quan-
titative analysis of the surface signal densities ρ (in %), the diameter  of single domains (in nm), and the
diameter of ring structures (in nm) of Cav-3 and Chol-KK114 signals, respectively. ρ and are given as
mean ± standard deviation; statistical significance was assessed using a Mann-Whitney-Wilcoxon U test
(see section 2.9) and is displayed as: n.s. - not significant; ** - very significant (p < 0.01). Detailed statistics
including sample sizes are given in the Appendix I, Tables I.6, I.7, and I.8. Images were smoothed using a
two-dimensional Gaussian filter with a width of 1.5 pixels. The color bar in A indicates the image bright-
ness for every fluorescence image in A and B in photon counts (cts.). Scale bars in overview images: 1
µm; scale bars in magnifications: 100 nm.
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express Cav-3. GAPDH was used as a load control (shown in red) and con-
firms the even distribution of protein in the samples. For comparison, lanes
1-4 show the Cav-3 expression levels in heart tissue (protein bands shown in
green and detected by the same antibody used also for the samples of HeLa
cells). Samples of heart tissue homogenates were obtained from left ventricles
excised from four mice, see also section 2.10.2 and Appendix L) and validate
that Cav-3 is endogenously expressed in VM. Note that in the heart tissue sam-
ples, the protein bands of endogenously expressed Cav-3 are located at ≈ 20
kDa since here the protein is not coupled to a SNAP tag.
Fig. 3.25 A, right panel, shows an exemplary STED image obtained at the base-
ment membrane of control HeLa cells, i.e. not overexpressing the Cav-3-SNAP
construct that were labeled with 5 µM Chol-KK114. In the control HeLa cells,
no significant Chol-KK114 signal was observed. This finding has been dis-
cussed previously in sections 3.2 and 3.3 where it could be shown that living
HeLa cells feature high amounts of Chol-KK114 signal along filopodial struc-
tures but little to no Chol-KK114 signal at their basement membrane.
Transfected HeLa cells overexpressing the Cav-3-SNAP construct, however,
feature a membrane architecture that is completely different from that of the
control cells. As can be seen in the STED images in Fig. 3.25 B, overexpression
of Cav-3 leads to a profound signal of Cav-3 as well as Chol-KK114 at the base-
ment membrane of living HeLa cells. Both the Cav-3 and the Chol structures
are highly clustered. Such Chol clusters are not seen in the control cells (see
Fig. 3.25 A vs. B, and also section 3.3). The surface signal density ρ of the Cav-
3 clusters amounts to 8.92 % (see Fig. 3.25 C). This means that almost one tenth
of the cellular basement membrane is covered by Cav-3 rich clusters. The den-
sity of the Chol-KK114 signal at the basement membrane of living HeLa cells
overexpressing Cav-3 amounts to 5.79 % and is thus larger by a factor of 10
compared to the signal density of 0.53 % at the basement membrane of control
HeLa cells (see Fig. 3.25 C).
Further, STED images of living HeLa cells overexpressing the Cav-3-SNAP
construct and labeled with SiR-SNAP or Chol-KK114 show the three distinct
nanoscopic membrane motifs, i.e. 1. single domains, 2. ring structures, and
3. bunchy clusters of various sizes (see Fig. 3.25 B) that have also been ob-
served in VM, ViPSC, and HAd. Magnifications of the STED images presented
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in Fig. 3.25 B exemplarily show these three re-occurring patterns. Again, just
like in VM, the Cav-3 and Chol membrane motifs resemble each other strongly
- qualitatively and quantitatively. Quantification of the diameter of the Cav-3
and Chol single domains (see section 2.6.5 and Fig. 3.25 C) yielded average di-
ameters of 78 nm (Cav-3) and 76 nm (Chol). Hence, the Cav-3 and Chol single
domains do not differ significantly in size. Interestingly, the single domains of
Cav-3 and Chol in HeLa cells overexpressing the Cav-3-SNAP construct have a
similar diameter as the corresponding domains in VM, albeit in HeLa cells they
are slightly larger; in VM the single domains had an average diameter of 68
nm (Cav-3) and 74 nm (Chol). Assessment of the average diameter of the Cav-
3 and Chol ring structures featured by the Cav-3-SNAP overexpressing living
HeLa cells (see section 2.6.6 and Fig. 3.25 C), yielded average diameters of 201
nm (Cav-3) and 218 nm (Chol). Again, these ring structure diameters in liv-
ing HeLa cells are similar, although somewhat smaller than the corresponding
ring structure diameters in VM where they amounted to 253 nm (Cav-3) and
226 nm (Chol). From the statistical analysis using the Mann-Whitney-Wilcoxon
U test for the comparison of the datasets of the acquired Cav-3 and Chol ring
diameters, it was found that the size difference between the ring diameters is
very significant (see also Appendix I). The significant difference between the
measured ring diameters might again be attributable to the size of the used
fluorescence labels, as it might have been the case for VM (see the discussion
further above). The SNAP tag has a molecular weight of about 20 kDa [539]
and the Silicon Rhodamine SNAP construct has a molecular weight of 720 Da
[540]. Since the exact physical dimension of the Chol-KK114 membrane label is
not know, the SiR-SNAP construct might be smaller than Chol-KK114, result-
ing in the smaller observed diameter of Cav-3 ring structures compared to that
of Chol-KK114 ring structures.
From the above findings, two things can be concluded. First, the overexpres-
sion of Cav-3 in a cell type that does not endogenously express Cav-3 induces
the formation of Cav-3 assemblies at the cellular basement membrane; these
Cav-3 assemblies qualitatively and quantitatively resemble those assemblies
seen in VM, ViPSC, and HAd (note that VM and ViPSC endogenously express
Cav-3 and that HAd express very high amounts of Cav-1 [536, 537]). Second,
the Cav-3 structures that form upon Cav-3 overexpression assemble Chol into
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similar arrangements at the basement membrane; these Chol arrangements,
again, qualitatively and quantitatively resemble those in VM, ViPSC, and HAd.
This could mean that it is an intrinsic property of Cav-3 to cluster and form a
very specific nanopattern at the basement membrane. Further, the expression
of the protein Cav-3 may be necessary to induce the clustering of Chol into
specific assemblies that resemble those formed by Cav-3.
Having established the experimental system of Cav-3 overexpressing living
HeLa cells and having observed the emergence of both Cav-3 and Chol struc-
tures that resemble those observed in cell types that endogenously express
Cav-3, I could simultaneously label Cav-3 and Chol in living HeLa cells and
perform two-color STED imaging. To this end, living Cav-3 overexpressing
HeLa cells were labeled for Cav-3 with the fluorescent SNAP-tag 580CP-BG-
(SNAP) and for Chol with Chol-KK114 following the protocol described in
section 2.4.1. Images were acquired using the STED microscope system Abbe-
rior 2C STED 775 QUAD Scan (see section 2.1.4). The two color channels were
simultaneously recorded via laser scanning and fluorescence detection in inter-
leafed mode. The same STED laser at the wavelength of 775 nm was applied so
that registration of the color channels was not required. Fig. 3.26 exemplarily
shows one of the obtained two-color STED images of living HeLa cells. As can
be seen in Fig. 3.26 A, the Chol-KK114 signal (displayed in magenta) predomi-
nantly accumulates along filopodial structures of the cells (see also section 3.2).
However, a profound Chol-KK114 signal is also seen at the basement mem-
brane and in close association with found Cav-3 structures (displayed in cyan).
Both the Cav-3 as well as the Chol-KK114 signal are highly clustered. The im-
age magnifications displayed in Fig. 3.26 B and C reveal a mosaic-like arrange-
ment of Cav-3 and Chol clusters. There are regions of structural colocalization
(displayed in yellow; e.g. in Fig. 3.26 B, yellow arrow heads), but also singular
Chol-KK114 and Cav-3 clusters, respectively (see Fig. 3.26 C, red arrow heads).
Further, there are regions of separate, variously shaped Cav-3 and Chol clus-
ters in close mutual proximity that are arranged in an intermeshed fashion - a
patterning which shall here be referred to as “para-localization” (see Fig. 3.26
C, white arrow heads). The two types of close association between Cav-3 and
Chol-KK114 clusters at the basement membrane - i.e. colocalization and para-
localization - are the most frequently observed structural patterns. Since Cav-3
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Figure 3.26.: Two-color STED images of a living HeLa cell overexpressing the Cav-3-SNAP construct and double-
labeled with the fluorescent SNAP tag 580CP-BG(SNAP) (Cav-3-580CP-BG(SNAP), see section 2.4.1 and
Chol-KK114. HeLa cells were transfected and stained as described in section 2.4.1. The Cav-3-580CP-
BG(SNAP) color channel is displayed in cyan (C), the Chol-KK114 color channel is displayed in magenta
(M), yellow signal (Y) indicates the overlap of the two color channels. A Overview image of a living HeLa
cell overexpressing the Cav-3-SNAP construct and labeled with 580CP-BG(SNAP) and Chol-KK114. Scale
bar: 5 µm. B Magnification of the yellow boxed region in A. Yellow arrow heads indicate regions of
structural colocalization. Scale bar: 1 µm. C Zoom-Ins to the green and blue boxed regions, respectively,
in B. White arrow heads indicate regions of para-localization. Red arrow heads indicate separate Cav-3
and Chol clusters, respectively. Images were smoothed using a two-dimensional Gaussian filter with a
width of 1.5 pixels and transformed to the color map depicted in A as described in section 2.6.1. Scale
bar: 500 nm.
is anchored within the intracellular membrane leaflet and since Chol-KK114
due to its bulky PEG-linker most likely inserts itself specifically in the extra-
cellular leaflet, the observed prevalent co- and para-localization of Cav-3 and
Chol-KK114 suggest that Chol-KK114 is an indirect label of Cav-3 rich mem-
brane clusters - and vice versa. From this, it is arguable that Cav-3 clusters and
Chol rich clusters might mutually influence and mediate each other’s localiza-
tion to and positioning in the same membrane regions. Hence, the data pre-
sented in Fig. 3.26 support the assumption that cluster formation at the plasma
membrane is a cooperative process between both membrane leaflets which has
also been suggested in earlier studies [132]. For completeness, note that not all
observed Cav-3 and Chol-KK114 signals were associated with each other. The
two-color STED images show that, albeit Cav-3 and Chol clusters are closely
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associated at the cellular basement membrane, there is no 1:1 mapping of their
signal patterns (see Fig. 3.26 C, red arrow heads). The observation of stand-
alone Cav-3 signal that is not associated to Chol-KK114 structures could be due
to a partial retention of the overexpressed Cav-3-SNAP construct in the Golgi
apparatus. The membrane permeable dye compound 580CP-BG(SNAP) label-
ing the overexpressed Cav-3-SNAP construct would still access this portion of
Golgi associated Cav-3 proteins and due to the limited axial resolution of the
microscope such structures that are not incorporated into the cellular mem-
brane would still yield a detectable signal in the imaging plane right at the
basement membrane. This would, however, most likely only explain those ob-
served solitary Cav-3 clusters that are low in signal brightness. Further, there
is only little evidence that wild-type, i.e. not mutated, Cav-3 shows a high
colocalization with Golgi markers [541]. The more likely conclusion derived
from the observed Cav-3 and Chol signal patterns in Cav-3 overexpressing liv-
ing HeLa cells is that the Cav-3 signal does not completely colocalize with the
Chol-KK114 signal because Cav-3 partly resides in the intracellular leaflet of
the plasma membrane while Chol-KK114 is most probably exclusively inserted
in the extracellular membrane leaflet. The solitary, i.e. not Chol associated,
portion of the detected Cav-3 proteins might hence reside in regions along the
cellular membrane that would not be readily accessible for Chol-KK114 with
its bulky PEG-linker which could possibly be due to steric hindrance in regions
with high negative membrane curvature (as it is also discussed for VM at the
beginning of this section). In addition, some Cav-3 rich membrane clusters may
have bound sufficient amounts of endogenous Chol so that these membrane
areas are already saturated in Chol when Chol-KK114 is exogenously added
to the membrane; and assuming a possibly slow interchange rate between the
fluorescent Chol analog and the resident endogenous Chol associated to those
Cav-3 clusters, colocalization would not be expected there. On the other hand,
Cav-3 is certainly not the only protein that binds Chol [542] and caveolae are
thus likely not the only Chol rich membrane domains [543, 544] - caveolae in-
dependent Chol clustering in the outer cellular leaflet would hence explain the
solitary Chol signal clusters.
Concluding, it could be shown that Chol structures in the extracellular leaflet
and of structures of the intramembrane protein Cav-3 at the intracellular leaflet
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feature highly similar, distinct nanoscopic arrangements at the sarcolemma of
VM. These sarcolemmal arrangments feature three reoccurring motifs: 1. sin-
gle domains of ≈ 70 nm in diameter, 2. ring structures of ≈ 240 nm in di-
ameter, and 3. bunchy clusters of variable sizes. ViPSC and HAd show an
analogous arrangement of Chol and Cav-3 structures, or Chol and Cav-1 struc-
tures, respectively, at their basement membrane. Further, the overexpression
of Cav-3 in HeLa cells - which do not express endogenous Cav-3 and which,
under physiological conditions, do not show Chol clusters at their basement
membrane (see also section 3.3) - led to the formation of the above-mentioned
distinct basement membrane Chol motifs, i.e. single domains, ring structures,
and bunchy clusters. In two-color STED images of living HeLa cells overex-
pressing Cav-3 and labeled for both Cav-3 and Chol, a close spatial association
between Cav-3 and Chol clusters could be observed at the cellular basement
membrane. However, there was no 1:1 mapping of the protein and lipid clus-
ters but rather a mosaic-like arrangement. Hence, since Cav-3 and Chol show
similar nanopatterns at the sarcolemma of VM, and since the amount of Cav-
3 present at the cellular basement membrane influences the assembly of Chol
clusters, in a next step, the influence of the Chol content at the sarcolemma of
VM on the nanopattern of Cav-3 structures was investigated to verify if there
is a mutual dependence between the sarcolemmal Cav-3 and Chol content. To
this end, living VM were depleted of Chol, then labeled for Cav-3, and imaged
using STED microscopy. The resulting profound changes in the sarcolemmal
Cav-3 arrangements are presented in the next section.
3.5.1. Cholesterol depletion leads to the dissociation of
sarcolemmal Caveolin-3 clusters
Cholesterol depletion by the treatment of cells with Methyl-β-Cyclodextrin (M-
β-CD) is a well-established protocol to achieve disruption of caveolar struc-
tures [190]. Further, apart from caveolae, the extraction of Chol from the cel-
lular membrane using M-β-CD has been shown to cause the dissociation of
the respective complexes of many other typically clustered proteins [545, 546,
454]. M-β-CD features an oligosaccharide ring composed of seven glucose
monomers and is of a toroidal structure with a central cavity. The central cav-
ity of M-β-CD is hydrophobic, the outer surface is polar. When in dimeric
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form, M-β-CD transiently binds to the membrane and can extract membrane
Chol by binding to it with high affinity followed by desorption of the resulting
Chol/M-β-CD complex [547]. Note that M-β-CD does not permanently bind
to the membrane and does not insert itself into the membrane [548].
Here, to extract membrane Chol from the sarcolemma of mouse ventricular car-
diomyocytes (VM), living VM were treated with 5 mM M-β-CD as described
in section 2.3.3. Control cells and M-β-CD cells were fixed and labeled for
Cav-3 via indirect immunofluorescence (see section 2.3.3). STED images of
Cav-3 signal structures at the sarcolemma of control vs. Chol depleted fixed
VM were obtained using the custom-built fast scanning STED microscope that
is described in section 2.1.2. Cell fitness was assessed prior to imaging (i.e.
only intact cells featuring regular striations and no signs of blebbing or con-
traction were chosen). Additionally, the used concentration of 5 mM of M-β-
CD is well below the concentration of M-β-CD at 20 mM for which an onset of
cell toxicity has been reported [549]. Upon Chol depletion, the clustered Cav-
3 signal that was described in detail in the last section changes dramatically.
Fig. 3.27 exemplarily shows STED images of control vs. M-β-CD treated fixed
VM labeled for Cav-3 via indirect immunofluorescence using the antibody cou-
pled dye STAR635P. As can be seen, the highly clustered sarcolemmal Cav-3
pattern is lost in Chol depleted cells. Upon Chol depletion, all higher-order
structural arrangements of Cav-3 single domains dissociate which leads to an
almost isotropic distribution of Cav-3 single domains along the sarcolemma.
Accordingly, the membrane motifs of bunchy clusters and ring structures are
no longer observed in Chol depleted cells. The effect of Chol depletion on the
sarcolemmal Cav-3 signal structure was quantitatively assessed by the deter-
mination of three descriptive figures: 1. the diameter of single domains of Cav-
3  (see section 2.6.5), 2. the Cav-3 signal contour density Γ (see section 2.6.7),
and 3. the sarcolemmal Cav-3 signal density ρ (see section 2.6.4). These figures
are displayed in bar graph notation in Fig. 3.27 for control vs. Chol depleted
VM. From the determination of , Γ , and ρ, three major and very interesting
observations can be made.
First, the diameter of sarcolemmal Cav-3 single domains remains unchanged
upon Chol depletion: for control cells, the Cav-3 single domains are about 68
nm in diameter, in Chol depleted cells the diameter of single domains amounts
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Figure 3.27.: Effect of membrane Cholesterol (Chol) depletion on the Caveolin-3 (Cav-3) signal structure at the sar-
colemma of fixed mouse ventricular cardiomyocytes (VM). Membrane Chol was depleted by incubation
of living VM with Methyl-β-Cyclodextrin (M-β-CD) at a concentration of 5 mM prior to fixation and
staining for Cav-3 (see section 2.3.3). A STED image of a fixed, untreated VM (Control) labeled for Cav-3
(marker dye: STAR635P). B STED image of a fixed, Chol depleted VM (+ 5 mM M-β-CD) labeled for
Cav-3 (marker dye: STAR635P). Images were smoothed using a two-dimensional Gaussian filter with a
width of 1.5 pixels. The color bar in indicates the image brightness for A and B in photon counts (cts.).
Scale bars: 1 µm. C Bar graph representation of quantitative measures describing the Cav-3 signal struc-
tures. Left graph: the diameter () of single Cav-3 domains (see section 2.6.5) in untreated VM (Control,
in black) vs. Chol depleted VM (+ 5 mM M-β-CD, in red); diameters are given in nm and presented
as mean ± standard deviation. Middle graph: the Cav-3 signal contour density Γ (see section 2.6.7) in
untreated VM (Control, in black) vs. Chol depleted VM (+ 5 mM M-β-CD, in red); Γ is given in % of the
total number of possible pixel boundaries and presented as mean ± standard deviation. Right graph: the
Cav-3 surface signal density ρ (see section 2.6.4) in untreated VM (Control, in black) vs. Chol depleted
VM (+ 5 mM M-β-CD, in red); ρ is given in % of the total sarcolemmal area and presented as mean ±
standard deviation. Statistical significance of the variation of the diameter of single domains, the varia-
tion of ρ and the variation of Γ (see section 2.9 and Appendix I, Tables I.9, I.10, and I.11) between control
and Chol depleted VM is displayed as : (n.s) - not significant (p > 0.01), and (**) - very significant (p <
0.001). Number of analyzed single Cav-3 domains for diameter determination: Control - 2397; + 5 mM
M-β-CD - 2360. Number of analyzed cells for determination of Γ: Control - 44; + 5 mM M-β-CD - 38.
Number of analyzed cells for determination of ρ: Control - 44; + 5 mM M-β-CD - 38.
to 66 nm. This minor difference in the single domain diameters is not statisti-
cally significant. Based on this, it can be stated that the identified membrane
motif of single domains which was found to be the main “building block” of
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all higher order sarcolemmal Cav-3 patterns (see section 3.5) is not influenced
by the sarcolemmal Chol content. This “survival” of small membrane protein
clusters has been reported previously [454] and could be attributed to mecha-
nisms that stabilize the clusters and that are independent or Chol.
Second, the Cav-3 signal contour density Γ significantly increases by a factor of
≈ 2.6 upon Chol depletion: while control cells showed a mean Γ of about 3 %, in
Chol depleted cells Γ amounted to about 8 %. Since Γ is a measure of the degree
of clustering of an assembly of individual structural entities (see section 2.6.7),
the doubling in Γ quantitatively describes the dissociation of Cav-3 clusters
into their main building blocks (i.e. single domains) upon Chol depletion. As a
consequence, the area of interconnected sarcolemmal regions that do not show
a Cav-3 signal (i.e. black regions in the STED images in Fig. 3.27 A and B,
from here on referred to as “Cav-3-negative” regions) is reduced. This indicates
that in a Chol depleted VM there are more “borders” between Cav-3-positive
and Cav-3-negative regions at the sarcolemma. A molecule diffusing along the
sarcolemma of a Chol depleted VM would thus encounter Cav-3 rich regions
more frequently than a molecule diffusing along the sarcolemma of a VM with
a physiological Chol content. An effective slowed down molecule diffusion
upon Chol depletion has been reported [546].
Third, the surface signal density ρ significantly increases by a factor of ≈ 2
upon Chol depletion: while in a control VM about one quarter of the sar-
colemma is covered by Cav-3 signal (ρ ≈ 24%), the Cav-3 signal covers about
half of the sarcolemma of a Chol depleted VM (ρ ≈ 51%). The doubling of ρ
indicates that upon Chol depletion, Cav-3 signal is added to the sarcolemma.
This raises the question about where this additional signal is coming from.
One possible explanation could be that the additional Cav-3 signal is com-
ing from the dissociation of Cav-3 clusters that consisted of several densely
packed Cav-3 single domains which could not be resolved individually. The
cluster dissociation would lead to a spatial spreading of these single domains
until their individual resolution would be possible. This case shall here be
referred to as a “lateral increase” in signal. Another possible explanation of
the additional Cav-3 signal could be that upon Chol depletion, Cav-3 domains
from layers deeper below the sarcolemma might be freed from their connec-
tion to the sarcolemma-bound Cav-3 domains and “swim to the surface”. This
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case shall here be referred to as an “axial increase” in signal. This explanation
seems possible because one should also consider that the axial resolution of the
used microscope system is limited to confocal resolution (≈ 700 nm for the dye
STAR635P, see section 1.2), single Cav-3 domains cannot readily be discerned
if they overlap along the axial direction.
Taken together, the sarcolemmal membrane Chol content is not only important
for the lateral assembly and arrangement of Cav-3 structures, i.e. clustering
and formation of higher-order membrane motifs, but also for the axial Cav-3
arrangement at the sarcolemma, i.e. 3D structures that extend perpendicularly
to the sarcolemma. The integrity of such 3D Cav-3 structures seems to be de-
pendent on the available sarcolemmal Chol content and it is possible that Chol
depletion flattens the sarcolemma by disruption of these 3D arrangements.
This would effectively result in a loss of the cellular “surface area reservoir”
that might be formed by extended caveolar structures.
For completeness, another possible factor shaping the sarcolemmal Cav-3 sig-
nal arrangement upon Chol depletion shall be critically discussed here: it has
been reported that Chol depletion leads to a loss of Transverse Tubule (TT)
structures in cardiomyocytes [150]. Hence, the increase in Cav-3 signal at the
sarcolemma of Chol depleted VM might stem from Cav-3 domains that were
formerly associated with TT and lost their confinement to these TT when the TT
were lost/altered due to Chol depletion. However, in the mentioned study, cul-
tured VM were incubated with M-β-CD for 48 h before being stained with Di-
8-ANEPPS and imaged for characterization of their TT. The observed loss of TT
might be an artifact of the cell culture: it has been reported in many studies that
the cell culturing process itself leads to a loss of cardiac TT [151, 152, 153, 32].
To control if the here observed change in sarcolemmal Cav-3 clustering upon
Chol depletion was actually an effect of a loss of TT, I compared the Transverse-
Axial Tubular System (TATS) signal architecture in living control VM to that of
living Chol depleted VM (following the herein used Chol depletion protocol,
see section 2.3.3) by labeling those cells with Di-8-ANEPPS. No alterations of
the TATS in Chol depleted VM could be observed. Further, I replenished the
Chol content of Chol depleted living VM by labeling them with Chol-KK114.
Again, when compared to Chol-KK114 labeled control VM, no alterations of
the TATS was observed. The conducted control experiments and the obtained
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images are presented in detail in the Appendix M. The Chol depletion induced
dissociation of sarcolemmal Cav-3 clusters is thus unlikely caused by a loss in
the TATS integrity.
In summary, the presented image-based comparison between the sarcolemmal
Chol and Cav-3 signal patterns points towards the direct structural associa-
tion of outer leaflet Chol and inner leaflet Cav-3 domains. However, there
remains an unfortunate factor impairing the experimental verification of this
direct association: Chol-KK114 is a feasible fluorescent marker only in living
VM with intact membranes - and without access to genetically modified ani-
mals expressing a fluorescent version of Cav-3, Cav-3 can only be imaged via
immunolabeling, i.e. by fixing and permeabilizing the VM. The straightfor-
ward approach of simply dual-labeling a living (or fixed) VM to simultane-
ously detect Chol-KK114 and Cav-3 was hence not possible. I therefore chose
another, more indirect approach to further motivate the specific connection of
the observed sarcolemmal Chol-KK114 and Cav-3 motifs. In this approach, I
made use of the properties of Ganglioside GM1 (GM1, see section 1.1) which
is a commonly used marker of the liquid ordered phase in the extracellular
membrane leaflet [89]. GM1 offers the great advantage that it can be fluores-
cently labeled both for live-cell as well as fixed cell imaging applications. It
was thus possible to simultaneously label Chol and GM1 in the intact cardiac
membrane, resulting in the first two-color STED images of living VM. Further,
a two-color immunofluorescence assay tagging GM1 and Cav-3 for STED mi-
croscopy enabled additional colocalization studies. The results are presented
in the following section.
3.6. Association of sarcolemmal Cholesterol,
Caveolin-3, and Ganglioside GM1 domains
This section is focusing on the spatial association and colocalization of Choles-
terol (Chol) and Ganglioside GM1 (GM1) clusters at the sarcolemma of living
mouse ventricular cardiomyocytes (VM), and of Caveolin-3 (Cav-3) and GM1
clusters at the sarcolemma of fixed VM. The image based evaluation of the sar-
colemmal mosaic-like membrane lipid and membrane protein nanopatterning,
specifically comparing the two experimental cell systems (i.e. living vs. fixed
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VM) will be presented qualitatively and quantitatively. As a quick recapitula-
tion, Fig. 3.28 schematically shows the possible arrangement and association
of Chol, Cav-3 and GM1 along the cardiac sarcolemma, as proposed in the in-
troduction (see section 1.4, Fig. 1.10). With respect to the model presented in
Figure 3.28.: Schematic of the postulated association of the membrane lipids Cholesterol (Chol), Ganglioside GM1
(GM1), and the membrane associated protein Caveolin-3 (Cav-3). The intramembrane domain of Cav-
3 resides within the lipid bilayer, while its amino-terminus (N) and its carboxyl-terminus (C) face the
cytosol. Approximate sites of possible Chol-binding domains are marked by (+). The scheme does not
provide the correct stoichiometry of the lipid and protein distribution (because it is not precisely known).
Neither drawn to actual proportions nor with correct stoichiometry. See also section 1.4.
Fig. 3.28, three important aspects shall be noted here. First, GM1 resides in the
extracellular leaflet of the lipid bilayer [219, 220, 240] with its sugar group pro-
truding about 2.5 nm into the extracellular space [222, 223] and thus, amongst
other glycolipids and glycoproteins, constituting the glycocalyx [223]. Second,
while Chol is abundantly present within both the extracellular and the intra-
cellular sarcolemmal leaflet, the portion of possible Chol insertion sites into
the membrane that can be assessed using Chol-KK114 as a membrane marker
is most likely exclusive to the extracellular leaflet (see also section 3.1). Third,
the amino-terminus (N) and the carboxyl-terminus (C) of Cav-3 are in the cy-
tosol while its hairpin-like transmembrane region is anchored within the intra-
cellular membrane leaflet. Further, Cav-3 features Chol-binding motifs near its
N-terminus that suggest the connection between Cav-3 and intracellular leaflet
Chol molecules (the Chol-binding motifs have been discussed in detail in the
introduction, section 1.1). Following this membrane model, it can be seen that
there is a Chol/Cav-3 complex along the cytosolic side of the sarcolemma, and
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a possible Chol/GM1 complex along the extracellular sarcolemmal membrane
leaflet. It has been reported that a change in lipid composition of the extra-
cellular leaflet concomitantly changes the lipid composition of the intracellular
leaflet [132, 550]. According to this, lipid and/or protein structures along the
intracellular membrane leaflet can serve as interdependent sensors of the spe-
cific lipid content in the extracellular leaflet, specifically, the content of Chol
and/or GM1 in the extracellular leaflet. For example, caveolae associated pro-
teins (such as the members of the Caveolin protein family) along the intracel-
luar leaflet indicate Chol and GM1 rich domains at the opposing extracellu-
lar leaflet whereas certain prenylated proteins at the intracellular leaflet indi-
cate the liquid disordered phase at the opposing extracellular leaflet [551, 552].
Transitively, this suggests the use of Chol-KK114 as a marker of caveolar struc-
tures in living VM, a possible application which is supported by the findings
presented in section 3.5, i.e. the highly similar sarcolemmal nanopatterning of
cardiac Chol and Cav-3 signals. This possible and very useful correlation be-
tween the cardiac Cav-3 and Chol-KK114 signal motivates the use of GM1 as an
indirect marker to control for the spatial association of Chol at the extracellular
leaflet and Cav-3 along the cytosolic side of the membrane.
First, in search of the above proposed possible outer leaflet Chol/GM1 com-
plex, I incubated living VM with Chol-KK114 and fluorescenctly labeled re-
combinant Choleratoxin subunit B (CtB-AF594) to tag GM1 as described in
section 2.3.2. The dual-labeled samples were imaged using the STED micro-
scope Leica TCS SP8 STED 3X (see section 2.1.3). Specifically, the choice of the
fluorescent dyes KK114 and AF594 for the labeling of the respective membrane
constituents allowed the use of the same STED laser wavelength (at 775 nm) so
that the emergence of the recorded fluorescence signal from each color channel
was confined to the same subdiffractional focal spot (i.e. to the vicinity of the
center of the toroidally shaped STED beam). Thus, both color channels could
be recorded simultaneously and could be readily overlaid for colocalization
analysis without the need of image post processing steps regarding color chan-
nel registration. Figure 3.29 shows the STED image of the sarcolemma of a liv-
ing VM dually labeled with Chol-KK114 and CtB-AF594. Considering the sin-
gle color channels, i.e. the Chol-KK114 and the CtB-AF594 channel, separately
(see Fig. 3.29 C), signal clustering of both Chol and GM1 can be observed. The
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Figure 3.29.: Two-color STED image of a living mouse ventricular cardiomyocyte (VM) labeled for Ganglioside GM1
(GM1) via Choleratoxin subunit B coupled to the dye Alexa Fluor 594 (CtB-AF594) and with Chol-KK114.
VM were stained as described in sections 2.3.2 and 2.3.3. A Two-color overview STED image of the
VM. The two color channels are color coded with the GM1-CtB-AF594 channel displayed in cyan (C)
and the Chol-KK114 channel displayed in magenta (M); yellow signal (Y) indicates signal overlap of the
color channels. The corresponding color map is displayed in the top left corner. White arrows indicate
the longitudinal (X) and the transverse (Y) cell axes, respectively. Scale bar: 5 µm. B Magnification of
the STED overview image corresponding to the yellow boxed region. Scale bar: 1 µm. C Single color
images of the respective GM1-CtB-AF594 and Chol-KK114 signal channels corresponding to the image
magnification shown in B. Images were smoothed using a two-dimensional Gaussian filter with a width
of 1.5 pixels and converted to the displayed color map as described in section 2.6.1. Scale bar: 1 µm.
respective Chol and GM1 signal clusters appear in various shapes and sizes,
with the largest clusters being up to 1 µm in diameter (when approximately
assuming a roughly circular cluster shape) and with the smallest clusters be-
ing approximately 60 - 70 nm in diameter. These smallest clusters resemble the
previously described smallest Chol and Cav-3 signal entities that were defined
as “single domains” (see section 3.5). Note that most larger cluster arrange-
ments can readily be identified as consisting of a substructural arrangement of
Chol and GM1 single domains. Regarding the overlay images of the two color
channels, it can be seen from Fig. 3.29 A and B that GM1 is very tightly associ-
ated with Chol but the two signal structures do not entirely overlap. Both the
colocalization and the gap arrangement (i.e. para-localization, see section 3.5)
of Chol- and GM1-rich sarcolemmal domains were observed. However, GM1
and Chol signals are always in close proximity to each other - within a distance
that hardly ever exceeds about 500 nm. Areas devoid of any signal from either
color channel made up the remaining sarcolemmal space between the labeled
domains. The subdiffraction Chol/GM1 double stains thus reveal the intra-
leaflet registration of Chol and GM1 domains at the sarcolemma of living VM,
i.e. the spatial association of Chol and GM1 structures within the same mem-
brane leaflet (here, the extracellular leaflet). This is in agreement with previ-
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ously reported Atomic Force Microscopy (AFM) based observations that GM1
preferentially partitions into the Chol rich liquid ordered phase when added in
physiological concentrations to artificially prepared supported membranes of
controlled lipid compositions [89, 90, 96]. In their AFM studies of the GM1 dis-
tribution in supported monolayers and bilayers of ternary lipid mixtures, Yuan
et al. [90] found irregularly shaped GM1 rich aggregates that formed patches of
about 40 - 150 nm in size in monolayers and about 100 - 400 nm size in bilayers.
Attempts using conventional fluorescence microscopy have been made to sup-
port these data acquired with near-field microscopy [132, 92, 219], but could
not visualize the assembly of Chol and GM1 clusters along the membrane with
such a level of detail shown in the AFM measurements due to limited achiev-
able feature resolution. The here presented STED images (see Fig. 3.29), how-
ever, reliably reproduce the AFM images of the specific arrangement of GM1
clusters that preferentially assemble in close proximity to Chol clusters (i.e. in
the liquid ordered phase of the sarcolemmal membrane). Further, the possi-
ble visualization of small GM1 domains (i.e. < 100 nm and thus in the range
of the unlabeled GM1 aggregates detected using AFM) also motivates the use
of fluorescent CtB as a fluorescent lipid marker that does not necessarily in-
duce additional - and unphysiological - structural clustering. In summary, the
two-color STED images of the Chol-KK114 and GM1-CtB-AF594 signal at the
sarcolemma of living VM indicate that:
1.) Both Chol and GM1 form spatially closely associated clusters at the sar-
colemma of living VM;
2.) The Chol and GM1 clusters show an intra-leaflet registration along the ex-
tracellular sarcolemmal leaflet motivating the use of the fluorescent GM1
signal as a marker of analogously shaped Chol rich regions in living VM;
3.) Both Chol and GM1 clusters are highly variable in size ranging from
small single domains of about 60 - 70 nm in diameter to variously shaped
clusters of up to 1 µm in diameter;
4.) The here observed Chol/GM1 complexes show an arrangement that is
very similar to the one reported from AFM studies of GM1 rich assem-
blies associated to the liquid ordered phase (i.e. Chol rich) in supported
lipid bilayers.
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In a next step, I investigated the arrangement of Cav-3 and GM1 structures at
the sarcolemma of fixed VM that were labeled for Cav-3 and GM1 via indirect
immunofluorescence. The antibody coupled dye compound STAR635P was
used to label Cav-3 and, like in the two-color stains of Chol and GM1 in living
VM, CtB-AF594 was used to label GM1 (see section 2.3.3). Two-color STED im-
ages were obtained using the STED microscope Leica TCS SP8 STED 3X (see
section 2.1.3). As was the case for the Chol-KK114 and GM1-CtB-AF594 double
stains of living VM, the same STED laser at 775 nm could be used for imaging,
thus enabling the direct overlay of color channels without post-acquisition im-
age registration. The obtained STED images are shown in Fig. 3.30. When
Figure 3.30.: Two-color STED image of a fixed mouse ventricular cardiomyocyte (VM) labeled for Ganglioside GM1
(GM1) via Choleratoxin subunit B coupled to the dye Alexa Fluor 594 (GM1-CtB-AF594) and labeled
for Caveolin-3 (Cav-3) via indirect immunofluorescence using the dye STAR635P (Cav-3-STAR635P). VM
were stained as described in sections 2.3.3 and 2.3.2. A Two-color overview STED image of the VM.
The two color channels are color coded with the GM1-CtB-AF594 channel displayed in cyan (C) and the
Cav-3-STAR635P channel displayed in magenta (M); yellow signal (Y) indicates signal overlap of the
color channels. The corresponding color map is displayed in the top left corner. White arrows indicate
the longitudinal (X) and the transverse (Y) cell axes, respectively. Scale bar: 5 µm. B Magnification of
the STED overview image corresponding to the yellow boxed region. Scale bar: 1 µm. C Single color
images of the respective GM1-CtB-AF594 and Cav-3-STAR635P signal channels corresponding to the
image magnification shown in B. Images were smoothed using a two-dimensional Gaussian filter with a
width of 1.5 pixels and converted to the displayed color map as described in section 2.6.1. Scale bar: 1 µm
looking at the single color channel images displayed in Fig. 3.30 C, the cluster-
ing of both the sarcolemmal Cav-3 and GM1 signal becomes obvious. Again,
similarly to what has been observed in the double stains using Chol-KK114 and
GM1-CtB-AF594 in living VM, the single-color images of immunofluorescently
labeled Cav-3 and GM1-CtB-AF594 in fixed VM reveal typical cluster sizes of
between 60 - 70 nm up to 1 µm. The smallest respective Cav-3 and GM1 clusters
of about 60 - 70 nm diameter are circular and strongly resemble the membrane
motif of “single domains” that has been defined for Chol-KK114 and Cav-3
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clusters in section 3.5. The larger clusters are of various sizes and shapes, yet,
they show an underlying substructure and can be identified as assemblies of
single domains. Note also that the general appearance of the GM1 clusters in
both living VM and fixed VM is very similar. This serves as a valuable control
which confirms that the membrane clustering of GM1 is conserved despite the
cell fixation process and therefore supports the assumption that immunofluo-
rescence imaging of GM1 domains in fixed cells can capture the actual phys-
iological composition of the liquid ordered phase at the sarcolemma of living
VM. This strengthens the here conducted strategy of relating Chol-KK114 sig-
nal structures in living VM with Cav-3 signal structures in fixed VM using the
GM1 signal as a mediator. The color channel overlay images in Fig. 3.30 A and
B demonstrate that, analogously to the Chol-KK114/GM1-CtB-AF594 pattern,
the Cav-3 and the GM1 signal are always in close proximity and feature an
either colocalized or para-localized arrangement. With Cav-3 rich structures
residing at the intracellular membrane leaflet and GM1 rich clusters being lo-
cated at the extracellular leaflet, it can be stated from the here obtained sub-
diffraction two-color STED images that Cav-3 and GM1 show an inter-leaflet
registration along the cardiac sarcolemma, i.e. there is a specific spatial associ-
ation between regions facing each other at the intra- and extracellular leaflets.
This means that the observation of a GM1 rich region along the extracellular
leaflet is likely indicative for a Cav-3 rich region of similar spatial extent at the
opposing intracellular leaflet. In summary, the two-color STED images of the
Cav-3-STAR635P and GM1-CtB-AF594 signal at the sarcolemma of fixed VM
indicate that:
1.) Both Cav-3 and GM1 form spatially closely associated clusters at the sar-
colemma of fixed VM;
2.) The Cav-3 and GM1 clusters show an inter-leaflet registration between
the extracellular and the opposing intracellular leaflet of the sarcolemma
motivating the use of the fluorescent GM1 signal as a marker of analo-
gously shaped Cav-3 rich regions in fixed VM;
3.) Both Cav-3 and GM1 clusters are highly variable in size ranging from
small single domains of about 60 - 70 nm diameter to variously shaped
clusters of up to 1 µm diameter;
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4.) The here observed GM1 clusters (i.e. in fixed VM) are of similar size,
shape and substructure as the GM1 clusters observed in living VM and
are thus likely to represent the physiological arrangement of GM1 in VM
despite the cell fixation process.
The above enumeration was intentionally structured in accordance with the
enumeration for the conclusions drawn from the two-color STED images of
simultaneously labeled Chol and GM1 clusters in living VM. That way, a direct
comparison of the results obtained from the two experimental schemes, i.e.
Chol/GM1 STED imaging in living VM vs. Cav-3/GM1 STED imaging in fixed
VM, is possible. It reveals the profound similarity of the structure and the
specific relationship of Chol and GM1 clusters in living VM, and Cav-3 and
GM1 clusters in fixed VM.
All in all, the here presented two-color STED images of sarcolemmal Chol-
KK114 and GM1 clusters in living VM and of sarcolemmal Cav-3 and GM1
clusters in fixed VM reveal a very distinct mosaic-like nanopattern of mem-
brane constituents belonging to the liquid ordered phase. This nanopattern
was shown here for the first time using subdiffraction optical microscopy. Chol-
KK114 and GM1 clusters in living VM show an intra-leaflet registration while
Cav-3 and GM1 clusters in fixed VM show an inter-leaflet registration. Fluores-
cently labeled GM1 is a highly potent marker of Chol rich regions at the extra-
cellular membrane leaflet in living VM and, likewise, a highly potent marker
of Cav-3 rich regions at the intracellular membrane leaflet in fixed VM. This
further supports the possible application of Chol-KK114 as a direct marker of
caveolae in living VM.
In addition to the mostly qualitative conclusions drawn from the two-color
STED images of cardiac membrane lipid and membrane protein domains that
were presented in the last paragraphs, the spatial association of Chol and GM1
clusters in living VM, and Cav-3 and GM1 clusters in fixed VM was quanti-
tatively characterized and evaluated. To this end, I developed a protocol for
the colocalization analysis of these clusters. It evaluates the relative overlap
of the signal from corresponding single-color channel STED images after im-
age binarization via pixel based thresholding (see section 2.7). A conceptually
similar overlap based colocalization analysis procedure has been presented by
Lachmanovich et al. [553]. This approach was initially developed for the analysis
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of antibody-mediated protein “co-patching” experiments based on diffraction
limited fluorescence microscopy images (cf [91, 554, 555, 556]). In these exper-
iments, signal clusters are typically assumed to be homogeneous and not pos-
sessing any sophisticated substructures. Further, the determination of the de-
gree of colocalization is based on the coincidence of the center of mass of a clus-
ter from one population and the area occupied by a cluster from the other pop-
ulation. Thus, the algorithms employed by Lachmanovich et al. for image bina-
rization use ab initio input parameters such as the estimated patch (i.e. cluster)
size which cannot be readily determined for STED images since here, the possi-
bility of resolving clusters of subdiffractional size that form higher-order clus-
ter superstructures render the average cluster size an imprecise figure. Hence,
to adequately treat and analyze the here obtained two-color STED images, I
employed an image thresholding procedure relying on the relative signal in-
tensity of each defined pixel and its close proximity. The thus binarized images
of corresponding single-color channels were overlaid and the number of over-
lapping pixels was determined and evaluated in relation to the total number
of pixels belonging to the signal in the binary single color image. This resulted
in the abstracted display of the mosaic-like arrangement of Chol clusters (or
Cav-3 clusters) and GM1 clusters at the cardiac sarcolemma. In these abstract
membrane lipid and membrane protein mosaics, four distinct membrane areas
were thus clearly distinguishable: 1.) membrane areas only containing Chol-
KK114 or Cav-3 signal; 2.) membrane areas containing only GM1 signal; 3.)
membrane areas containing both Chol-KK114 (or Cav-3) signal and GM1 sig-
nal; 4.) membrane areas devoid of any Chol-KK114, Cav-3 or GM1 signal. The
obtained membrane lipid and membrane protein mosaics are displayed in Fig.
3.31 together with a bar graph representation of the relative colocalization of
respective clusters that were determined as described in section 2.7 and which
are discussed in the following. In the image overlays in Fig. 3.31 A and B, the
mosaic-like arrangement of the sarcolemmal Chol and GM1 clusters in living
VM, and of the Cav-3 and GM1 clusters in fixed VM is respectively visualized.
Therein, the Chol and Cav-3 signal is displayed in magenta, the GM1 signal is
displayed in cyan and spatial overlap of the signal from the two different color
channels is displayed in yellow. In course of the image binarization, threshold-
ing and the overlap based image analysis, the sarcolemmal signal density of
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Figure 3.31.: Colocalization analysis of sarcolemmal GM1 and Chol-KK114 clusters in living VM as well as GM1 and
Cav-3 clusters in fixed VM. Living VM were dual-labeled for Ganglioside GM1 (GM1) via labeled CtB-
AF594 coupled to the dye Alexa Fluor 594 (GM1-CtB-AF594) and with Chol-KK114 (see section 2.3.2).
Fixed VM were dual-labeled for GM1 (via GM1-CtB-AF594) and for Cav-3 via indirect immunofluores-
cence using the dye STAR635P (Cav-3-STAR635P) (see section 2.3.3). STED images of the respectively
labeled VM samples were binarized and the colocalization of signal structures was analyzed as described
in section 2.7. A Binarized STED image of the sarcolemma of a living VM dual-labeled with GM1-CtB-
AF594 (in cyan) and with Chol-KK114 (in magenta); the signal overlap is displayed in yellow. Bar graph
representation of the relative colocalization (Rel. col., in % of the total signal of the respective color chan-
nel) of GM1 clusters with Chol clusters (GM1→ Chol) and of Chol clusters with GM1 clusters (Chol→
GM1). B Binarized STED image of the sarcolemma of a living VM dual-labeled with GM1-CtB-AF594
(in cyan) and with Cav-3-STAR635P (in magenta); the signal overlap is displayed in yellow. Bar graph
representation of the relative colocalization of GM1 clusters with Cav-3 clusters (GM1→ Cav-3) and of
Cav-3 clusters with GM1 clusters (Cav-3 → GM1). The relative colocalization is presented as mean ±
standard deviation. Number of analyzed cells: GM1-Chol double stains - 38; GM1-Cav-3 double stains -
47. Scale bars: 1 µm.
the Chol and Cav-3 signal structures was respectively determined as a control
and was found to match the signal densities obtained from the respective sin-
gle color samples (i.e. living VM exclusively labeled with Chol-KK114 as well
as fixed VM exclusively labeled via Cav-3-STAR635P as presented in sections
3.3 and 3.5). The sarcolemmal signal density of the Chol signal was determined
to be about 14 % (cf. ≈ 17 % in living VM samples single-labeled with Chol-
KK114, see section 3.3) and the sarcolemmal density of the Cav-3 signal was
determined to be about 22 % (cf. ≈ 24 % in fixed VM samples single-labeled
via Cav-3-STAR635P, see section 3.5). Likewise, the sarcolemmal signal density
of the GM1 signal was determined for both the living VM samples (i.e. when
dual-labeling with Chol-KK114 and via GM1-CtB-AF594) and for the fixed VM
samples (i.e. when dual-labeling via Cav-3-STAR635P and GM1-CtB-AF594).
My expectation was to find approximately the same GM1 signal density for
the living as well as for the fixed VM samples. There was, however, a minor
difference between the determined mean sarcolemmal GM1 signal densities
that laid just outside the respective error margins: in living VM (double-stain
with Chol-KK114), the GM1 signal density amounted to about 7± 2 % while in
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fixed VM (double-stain with Cav-3-STAR635P), it was determined to be about
11 ± 2 %. This slight discrepancy could be attributable to the process of cell
fixation and permeabilization which might cause minor and so far unknown
imaging artifacts. Further, the addition of the primary antibody against Cav-3
could induce additional cross-linking of GM1 molecules and thus increase the
GM1 cluster size and eventually their fluorescence brightness directly mani-
festing itself in the recorded images and the ensuing analysis steps that were
based on relative pixel brightness. However, the mentioned difference in GM1
signal densities found in living vs. fixed VM samples was merely marginal
and very likely not profound enough to influence the performed determina-
tion of the relative colocalization of signal clusters. The relative colocalization
of Chol-KK114 clusters with GM1 clusters (and vice versa) and of Cav-3 clus-
ters with GM1 clusters (and vice versa) was determined as described in section
2.7. At the sarcolemma of living VM, the relative colocalization of Chol clusters
with GM1 clusters was determined to be about 34.6 % while the relative colo-
calization of GM1 clusters with Chol clusters amounts to about 51.9 %. This
means that about one third of all Chol-KK114 clusters is spatially associated
with GM1 clusters while more than half of all GM1 clusters is associated with
Chol-KK114 clusters. At the sarcolemma of fixed VM, the relative colocaliza-
tion of Cav-3 clusters with GM1 clusters is found to be about 26.7 % and the
relative colocalization of GM1 clusters with Cav-3 clusters is at about 50.9 %,
meaning that while roughly only one quarter of all Cav-3 clusters colocalize
with GM1 clusters, half of all GM1 clusters are spatially associated with Cav-3
clusters.
Comparing these relations between sarcolemmal Chol and GM1 clusters in liv-
ing VM and sarcolemmal and Cav-3 and GM1 clusters in fixed VM, it can be
seen that a profound amount of GM1 colocalizes with Chol or Cav-3, respec-
tively. Thus, with a 50 % probability, one would find a Chol (or Cav-3) signal
where there is a GM1 signal. Considering that the determination of the relative
colocalization is based on the pixel-by-pixel comparison of the signal distribu-
tion from the two color channels, it is a rather strict approach and gives a po-
tential lower limit for the degree of colocalization between, in this case, GM1
and Chol (or Cav-3). The GM1 signal can thus arguably be used as a reporter
for colocalized or spatially associated Chol or Cav-3 signal. In conjunction with
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the observation that the spatial relation between Chol and GM1 and the spa-
tial relation between Cav-3 and GM1 share similar features, the use of GM1 as
a reporter matching the live VM Chol signal with the fixed VM Cav-3 signal
is an arguably valid approach - at least for qualitative and comparative inves-
tigations. In any case, here, I could show that there exists a specific type of
sarcolemmal nanodomain that is enriched in Chol, GM1, and Cav-3 and which
is heterogeneously distributed across the cardiac membrane.
Concluding, Cav-3 and Chol both share a similar spatial arrangement with re-
spect to GM1. Since Chol and Cav-3 are associated to the same membrane do-
mains as GM1, it is thus probable, that Chol and Cav-3 also reside in the same
sarcolemmal domains. The use of Chol-KK114 to stain sarcolemmal Chol rich
clusters could hence be a strategy to label Cav-3 clusters in living VM without
having to establish a transgenic mouse line that expresses a fluorescent Cav-3
analog. Accordingly, the Cav-3 signal in fixed VM could be used to indicate
Chol rich sarcolemmal regions and relate them to other membrane associated
proteins to determine their spatial orientation along the sarcolemma and their
dependence on the sarcolemmal Chol content. The next section will take such
an approach to study the positioning of the protein Dystrophin (Dyst, see sec-
tion 1.1.4) along the sarcolemma with respect to Cav-3 and depending on the
membrane Chol abundance.
3.7. Association of sarcolemmal Caveolin-3 and
Dystrophin domains at the sarcolemma of
cardiomyocytes
Based on the cardiac membrane model that was proposed in section 1.4, this
section will elucidate the association between the membrane associated pro-
tein Caveolin-3 (Cav-3) and the cytoskeletal protein Dystrophin (Dyst). To this
end, one-, two- and three-color STED images of immunofluorescently labeled
mouse ventricular cardiomyocytes (VM) will be analyzed to extract the mu-
tual spatial arrangement of sarcolemmal Dyst and Cav-3 signal structures. The
effect of Cholesterol (Chol) depletion on the sarcolemmal Dyst/Cav-3 arrange-
ment will be investigated. Further, the molecular orientation of Dyst and Cav-
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3, and of the entire Dyst protein at the sarcolemma will be studied. For this,
Dyst was simultaneously fluorescently labeled using different primary anti-
bodies that target specific protein domains.
In a first step, for the visualization and quantification of the sarcolemmal Dyst
arrangement, VM were stained via indirect immunofluorescence (see section
2.3.3) using the primary antibody ab7163 which recognizes the amino acids
(aa) ≈ 1400-1505, i.e. the central rod domain. Fig. 3.32 A shows an exemplary
STED images of the obtained VM samples. The sarcolemmal Dyst signal pat-
tern is highly clustered and reproduces the three distinct membrane motifs that
have already been described for Chol and Cav-3 at the sarcolemma: 1.) single
domains, 2.) ring structures, and 3.) bunchy clusters of various sizes. Ring
structures and bunchy clusters could be identified as higher-order arrange-
ments of individual single clusters; ring structures were typically composed of
5 ± 2 single clusters (data not shown). Quantitative analysis of the diameters
of single domains and ring structures (see sections 2.6.5 and 2.6.6) reveals that
single sarcolemmal Dyst domains have an average diameter of about 67 nm,
while ring structures have an average diameter of about 211 nm. In Fig. 3.32
B, the obtained values for single domain diameters and ring structure diame-
ters are compared between the Dyst and the Cav-3 signal (see also section 3.5).
There is no significant difference between the single domain sizes for Dyst vs.
Cav-3. For the Cav-3 single domains, it can be assumed that they correspond to
single caveolae, i.e. assemblies of up to 200 Cav-3 molecules. For the Dyst sin-
gle domains, however, since the Dyst protein has an estimated contour length
of about 150 nm, the single domains probably correspond to individual Dyst
molecules or to Dyst clusters that are attached via their rod domains. The sar-
colemmal Dyst pattern shown in Fig. 3.32 A thus corresponds to the spatial
arrangement of the Dyst rod domain.
The diameter of the sarcolemmal ring structures was found to be 211 nm for
Dyst and 253 nm for Cav-3. The statistical difference between the ring structure
diameters of the two protein signals was very significant. This could on the
one hand be due to the size of the specific antibodies used for labeling Dyst
and Cav-3. On the other hand, this difference in size could be indicative for
the specific mutual arrangement of Dyst and Cav-3 (i.e. caveolae) along the
cardiac sarcolemma. The findings of the structural similarities of the Dyst and
196 3. RESULTS AND DISCUSSION
Figure 3.32.: STED image of the Dystrophin (Dyst) signal pattern at the sarcolemma of a fixed mouse ventricular
cardiomyocyte (VM) and quantitative analysis of Dyst vs. Caveolin-3 (Cav-3) membrane motifs. A STED
image of fixed VM labeled for Dyst via indirect immunofluorescence using the primary antibody ab7163
targeting the Dyst rod domain (see section 2.3.3 and Appendix A.3, and the antibody-coupled fluorescent
dye Abberior STAR635P (see Appendix A.4). Image magnifications are indicated by the colored boxes
and show the three reoccurring sarcolemmal Dyst pattern motifs: 1. single domains, 2. ring structures,
and 3. bunchy clusters. B Bar graph representation of the quantification of the diameter  of single
domains and ring structures, respectively, of the sarcolemmal Dyst signal compared to the corresponding
Cav-3 membrane motifs (see section 3.5). Statistical significance was tested as described in section 2.9 with
the explicit parameters of the statistical test given in Appendix I, Tables I.12 and I.13, and is denoted as:
(n.s.) - not significant (p > 0.01) and (**) - very significant (p < 0.001). Number of analyzed single domains
for diameter determination: 2947 (Dyst), 2397 (Cav-3). Number of analyzed ring structures for diameter
determination: 121 (Dyst), 80 (Cav-3). White arrows indicate the longitudinal (X) and the transverse (Y)
cell axes. Images were smoothed using a two-dimensional Gaussian filter with a width of 1.5 pixels. The
color bar indicates the image brightness in measured photon counts (cts.). Scale bar in overview image:
1 µm; scale bar in magnifications: 100 nm.
the Cav-3 - and also the Chol - signal pattern led to the question if Dyst and
Cav-3 are associated to the same sarcolemmal nanodomains.
To investigate the mutual spatial arrangement of Dyst and Cav-3, two-color
STED images of VM labeled fo Dyst and Cav-3 via indirect immunofluores-
cence were acquired and are presented in Fig. 3.33. Regions of both colocal-
ization and para-localization of Dyst and Cav-3 clusters were observed. Fur-
ther, there were Dyst single domains that were remote from Cav-3 signal and
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Figure 3.33.: Two-color STED image of Dystrophin (Dyst) and Caveolin-3 (Cav-3) at the sarcolemma of a fixed mouse
ventricular cardiomyocyte (VM) and quantification of the peak-to-peak nearest neighbor distance (NND)
between Dyst and Cav-3 (and vice versa). Primary antibodies against Dyst (ab7163) and Cav-3 were
decorated with the fluorescent dye compounds Abberior STAR635P and NS510, respectively (see also
Appendix A.3 and A.4). A Two-color STED image of the sarcolemmal Dyst and Cav-3 signal color coded
in magenta and cyan, respectively. Yellow signal indicates signal overlap. B Single color channel images
corresponding to the overlay in A. C Bar graph representation of the normalized distribution of the peak-
to-peak nearest neighbor distance (NND) between Dyst and Cav-3 signal structures (in magenta), and the
Cav-3 and Dyst signal structures (in cyan). The purple shaded regions of the bar graph representation
indicate overlap of the respective NND data. NNDs were determined as described in section 2.8, are given
in nm and are presented as mean ± standard deviation. Images were smoothed using a two-dimensional
Gaussian filter with a width of 1.5 pixels and converted to the displayed color map as described in section
2.6.1. White arrows indicate the longitudinal (X) and the transverse (Y) cell axes. Scale bars: 1 µm.
seemed to be unassociated with it. Bunchy clusters of Dyst always colocalized
or para-localized with Cav-3 clusters. The majority of the Cav-3 signal (single
domains, rings and bunchy clusters) colocalized or para-localized with Dyst
structures. The two-color STED images thus reveal that while almost every
Cav-3 signal cluster is in close proximity to a Dyst signal structure, there are
two distinct populations of Dyst: one population in the vicinity of Cav-3 signal
and one population remote from Cav-3 signal. The population that is spatially
associated with Cav-3 consists mostly of assemblies of single domains of Dyst
signal. The population that is not associated with Cav-3 consists mostly of
single Dyst domains. To quantify this distinct distribution of the sarcolemmal
Dyst and Cav-3 pattern, I determined the peak-to-peak nearest neighbor dis-
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tances (NND) between Dyst and Cav-3 signal structures and vice versa. NNDs
were determined as described in section 2.8. The obtained results are graphi-
cally displayed Fig. 3.33 C. The average NND between a Cav-3 signal peak and
a Dyst signal peak amounts to about (83 ± 51) nm. This very well describes
the observations made from the two-color STED image in Fig. 3.33 A: Cav-3
structures either colocalize with Dyst within the limits of the achievable maxi-
mum resolution of the microscope or they are in close proximity to Dyst - not
further away than about 130 nm which would still lie within the approximate
length of the Dyst molecule and could thus still be considered a distance in
which direct molecular interactions would be possible. On the other hand, the
average NND between a Dyst signal peak and a Cav-3 signal peak amounts
to (263 ± 229) nm, i.e. the NND is very broadly distributed. This also cap-
tures the observations made from Fig. 3.33 A: there exist both Dyst structures
closely associated to Cav-3 structures as well as Dyst structures far away from
the next Cav-3 signal, in part much further away than the approximate length
of a Dyst molecule. Hence, there is a large population of Dyst molecules for
which, based on spatial association, a direct interaction with Cav-3 is not to
be expected. In summary, it can be stated that while every Cav-3 signal at the
sarcolemma has a neighboring Dyst signal in close proximity, not every Dyst
structure is spatially associated with a Cav-3 structure. This is in contrast to the
observations made by McNally et al. in 1998 [204] who found that in skeletal
muscle, there is one fraction of Cav-3 that co-purifies with Dyst, while another
does not. They concluded that Cav-3 is not exclusively associated with Dyst.
Note that in their studies McNally et al. were considering both the sarcolemmal
and the intracellular Cav-3, i.e. also newly expressed protein that would still
be associated to the Golgi apparatus and would not yet have been recruited
to the sarcolemma. In the image based studies in this thesis, the Dyst signal
inside cardiomyocytes was found to be very low, almost not present (data not
shown). This might explain the Cav-3 fraction that is not associated with Dyst.
Of course, it has to be kept in mind that in the here shown STED images, a
small fraction of sarcolemmal Cav-3 that was not spatially associated with Dyst
could also be identified. Generally, however, the obtained data from two-color
STED images of sarcolemmal Dyst and Cav-3 structures in VM show that the
majority of Cav-3 clusters is closely associated with Dyst. And, refining this
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statement: since the antibody ab7163 was used in this two-color imaging pro-
tocol, the data suggest that the spatial association caveolae and Dyst can be
localized to the central rod domain of the Dyst protein.
To further investigate the association of sarcolemmal Cav-3 and Dyst signal
patterns, more precisely: whether the alteration of caveolar integrity changes
the Dyst pattern or the mutual arrangement of Cav-3 and Dyst structures, VM
were depleted of membrane Chol by treatment with Methyl-β-Cyclodextrin
as described in section 2.3.3 (see also section 3.5.1). Chol depleted VM were
labeled for Dyst and Cav-3 and two-color STED images of the samples were
acquired. The results are presented in the next section.
3.7.1. Cholesterol depletion alters the mutual sarcolemmal
Dystrophin/Caveolin-3 association
Chol depletion disrupts caveolae and thus selectively alters the spatial distri-
bution of Cav-3 clusters at the sarcolemma (see section 3.5.1). In section 3.7, the
similarities between the sarcolemmal Dyst and Cav-3 nanopatterns and their
partial spatial overlap have been shown. It was hence of great interest to know
if the depletion of membrane Chol would alter the sarcolemmal Dyst structure.
Since for immunofluorescence labeling of Dyst the primary antibody ab7163
targeting the Dyst central rod domain was used (see also Appendix A.3), the
two possible effects of Chol depletion on the Dyst nanopattern could be hy-
pothesized to have the following implications: a) If Chol depletion led to a
dissociation of higher order Dyst arrangements, then a close spatial associa-
tion between the Dyst central rod domain and sarcolemmal caveolae would
be expected, i.e. only few intermediate proteins should be assumed to be in-
volved in the mediation of the Dyst–Cav-3 interaction. b) If Chol depletion
had no effect on the sarcolemmal Dyst nanopattern, then a more or less direct
interaction between Dyst and caveolae cannot be assumed - at least not at the
site of the Dyst central rod domain.
STED images of control and Chol depleted VM labeled for both Dyst and Cav-3
are presented in Fig. 3.34 A and B.
While the dissociation of sarcolemmal Cav-3 clusters in Chol depleted VM - as
it has also been shown in section 3.5.1, Fig. 3.27 - is clearly visible, Chol de-
pletion has no distinct effect on the sarcolemmal Dyst pattern. However, the
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dissociation and redistribution of the Cav-3 clusters leads to an altered spatial
association between Cav-3 and Dyst signal structures. With the Cav-3 single
domains (i.e. potential single caveolae) being more isotropically distributed in
Chol depleted VM, the population of Dyst single domains that in control VM is
remote from Cav-3 signal structures (see section 3.7) is lost. There is a profound
decrease in the distance between Dyst and Cav-3. I could quantify this effect in
two ways: by determining the peak-to-peak nearest neighbor distances (NND)
between Dyst and Cav-3 signals (and vice versa), and by evaluation of the rel-
ative colocalization of Cav-3 with Dyst (and vice versa). Fig. 3.34 C shows
a comparison between the respective distributions of the peak-to-peak NND
between the Cav-3 and the Dyst signals, and between the Dyst and the Cav-3
signals for control vs. Chol depleted VM. NNDs were determined as described
in section 2.8, the bar graph representation of the NND for control cells in Fig.
3.34 C is a reproduction of Fig. 3.33 C. Upon Chol depletion, the NND be-
tween the Cav-3 and the Dyst signal increases only slightly regarding mean
and standard deviation: from (83 ± 51) nm in control VM to (89 ± 59) nm in
Chol depleted VM. However, the NND between the Dyst and the Cav-3 signal
changes dramatically upon Chol depletion, decreasing profoundly regarding
both mean and standard deviation: from (263 ± 229) nm to (134 ± 89). Thus,
the average NND decreases by a factor of about two, while the standard de-
viation of the NND decreases by a factor of about 2.5. Another more global
figure confirming the increase in proximity between Dyst and Cav-3 signals is
the relative colocalization of Cav-3 signal with Dyst signal and vice versa in the
two cases of control vs. Chol depleted VM. The relative colocalization was de-
termined after image binarization as described in section 2.7 and is displayed
in Fig. 3.34 D. The relative colocalization indicates which fraction of the to-
tal signal of one species (i.e. Dyst or Cav-3) directly colocalizes with the other
species based on the comparison of the pixel values of the binarized images
from the two color channels. As can be seen from Fig. 3.34 D, about 30 % of
the total Cav-3 signal maps 1:1 to the Dyst signal - a ratio which is basically
constant between control and Chol depleted VM. On the other hand, only 7 %
of the total Dyst signal maps to a coinciding Cav-3 signal in control cells, yet
this ratio changes by a factor of 2 in Chol depleted VM where about 15 % of
the total Dyst signal colocalizes with Cav-3 signal. The here shown decrease
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Figure 3.34.: Effect of Cholesterol (Chol) depletion on the spatial association of sarcolemmal Dystrophin (Dyst) and
Caveolin-3 (Cav-3) signal structures. VM were fluorescently labeled as described in section 2.3.3; Dyst
was labeled using the primary antibody ab7163 targeting the Dyst rod domain (see section A.3). Chol
depletion was performed by treatment of VM with 5 mM Methyl-β-CycloDextrin (M-β-CD, see section
2.3.3). A STED image of Dyst and Cav-3 signal at the sarcolemma of control VM. B STED image of Dyst
and Cav-3 signal at the sarcolemma of Chol depleted VM. C Bar graph representation of the normal-
ized distribution of the peak-to-peak nearest neighbor distance (NND) between Dyst and Cav-3 signal
structures (please refer to Fig. 3.33 C for a more detailed description). D Bar graph representation of the
relative colocalization (rel. coloc.) of Dyst and Cav-3 signal structures (please refer to the main text of
section 3.7.1 for a more detailed description). Statistical significance was tested as described in section 2.9
with the explicit parameters of the statistical test given in Appendix I, Tables I.14 and I.15, and is denoted
as: (n.s.) - not significant (p > 0.01) and (**) - very significant (p < 0.001). Number of analyzed cells: 57
(Control); 41 (+ 5 mM M-β-CD). Images were smoothed using a two-dimensional Gaussian filter with
a width of 1.5 pixels and converted to the displayed color map as described in section 2.6.1. The image
color map is displayed in A: Dyst signal is displayed in magenta; Cav-3 signal is displayed in cyan; signal
overlap is indicated in yellow. White arrows indicate the longitudinal (X) and the transverse (Y) cell axes,
respectively. Scale bars: 500 nm.
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in the mean and standard deviation of the NND between Dyst and Cav-3 sig-
nals (while the mean and standard deviation of the NND between Cav-3 and
Dyst signal stays roughly constant) as well as the increase of the relative colo-
calization of Dyst signal with Cav-3 signal (while the relative colocalization of
the Cav-3 signal with the Dyst signal stays roughly constant) reflect the two
structural changes that are obvious from the STED images in Fig. 3.34 A and
B: 1.) Dyst and Cav-3 move closer together (with the Cav-3 signal actually
approaching the Dyst signal) and 2.) a clear distinction between single Dyst
domains in close proximity to or remote from Cav-3 clusters can no longer be
made. Not that the changes in the mutual arrangement of Dyst and Cav-3 both
arise from the dispersion of caveolae across the sarcolemma. The sarcolemmal
Dyst pattern is not directly altered.
Concluding, the absence of an effect of Chol depletion on the sarcolemmal
Dyst distribution indicates that there is no direct spatial association between
the Dyst central rod domain and sarcolemmal caveolae. However, the nomi-
nal increase of Dyst and Cav-3 structures that are in close proximity may have
functional consequences. These consequences may include additional attach-
ment of the Dyst rod domain to sarcolemmal caveolae, potentially mediated by
several intermediate proteins. This might result in an additional stabilization
between the myofibrils and the sarcolemma but also to a loss in flexibility of
the Dyst molecule.
The potential lack of a direct connection between caveolae and the Dyst cen-
tral rod domain led to the question about the actual orientation of the Dyst
molecule with respect to Cav-3 and, generally, with respect to the sarcolemma.
An attempt to elucidate this question is made in the next section.
3.8. Molecular orientation of Dystrophin and
Caveolin-3 at the cardiac sarcolemma
As mentioned in section 1.1.4, the Dyst protein has an estimated contour length
of about 150 nm. Using subdiffraction STED imaging with a standard lateral
resolution of about 40 nm should allow to resolve different domains along the
protein when labeling them with different fluorescent dyes.
In order to be able to 1.) identify and characterize the spatial association be-
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tween Cav-3 and different domains of the Dyst protein and 2.) simultaneously
label different domains of the Dyst protein in a multicolor immunofluorescence
assay and thus investigate the molecular orientation of the Dyst protein along
the sarcolemma using STED microscopy, I tested a set of different anti-Dyst
primary antibodies targeting specific epitopes. Fig. 3.35 gives an overview of
these tested primary antibodies and the approximate epitopes to which they
bind. Detailed information about the antibodies, including host species and
order information, can be found in Appendix A.3.
Figure 3.35.: Schematic depiction of the Dystrophin (Dyst) protein and a selection of commercially available primary
antibodies and the epitopes they are binding to. These antibodies were tested in this thesis (see also
Appendix N). Antibody name, distributor, and the approximate amino acid (aa) sequence of the targeted
protein epitope are shown. For a description of the Dyst protein structure, please refer to section 1.1.4.
Information about all tested primary antibodies can be found in Appendix A.3.
I chose the following three antibodies for use in this thesis:
1.) 4C7 (host species: mouse), targeting the Dyst N-terminus (≈ aa 1-68),
2.) ab85302 (host species: rabbit), targeting the Dyst central rod domain (≈
aa 1850-1950),
3.) C-20 (host species: goat), targeting the Dyst C-terminus (≈ aa 3361-3685).
I made this choice because these three antibodies - derived from three different
host species and targeting three different protein domains - would eventually
allow three-color immunofluorescence staining of the Dyst protein, i.e. intra-
protein labeling and imaging (see section 3.9).
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To control for the labeling specificity of the antibodies, I prepared single-color
immunofluorescence samples of VM from control mice, i.e. from the wild type
C57BL/6N strain, and from Dyst deficient mice, i.e. from the mdx 5cv strain (see
section 2.3.4), using each of the three chosen antibodies. I imaged these samples
in the region of the sarcolemma using STED microscopy. The used primary an-
tibodies were decorated with different fluorescent dye compounds (coupled to
a secondary antibody): 4C7 was decorated with the dye compound STAR635P,
ab85302 was decorated with the dye compound NS510, and C-20 was deco-
rated with the dye compound STAR580. I chose this set of fluorescent dyes
because of their favorable spectral properties for the three-color STED imaging
protocol using only one STED wavelength (three-color images are shown and
discussed in section 3.9). For detailed information about primary antibodies,
secondary antibodies, and the used dye compounds, please refer to Appendix
A.3 and Appendix A.4.
So, what is to be expected from the prepared control samples? An antibody
that specifically labels Dyst would not yield a fluorescence signal in VM of the
dystrophic mdx 5cv mice while it would yield a fluorescence signal in control
mice. Fig. 3.36 summarizes the obtained STED images of these samples.
For the primary antibodies ab85302 (central rod domain, see Fig. 3.36 A) and
C-20 (C-terminus, see Fig. 3.36 B), the expected fluorescence signal was ob-
served: little to no sarcolemmal signal in VM of mdx 5cv mice and a distinct
sarcolemmal signal pattern in VM of control mice. For the primary antibody
4C7 (N-terminus, see Fig. 3.36 C), however, a characteristic signal can be ob-
served in VM of both mdx 5cv and control mice. The observed signal pattern
shows a dotted structure but also lines along the transverse cell axis. These
lines are evenly spaced at a distance of about 2.1 µm in control VM and at
a slightly shorter distance of about 1.8 µm in mdx 5cv VM. The striped sig-
nal pattern hence strongly resembles that of costameres - protein assemblies
characteristic for striated muscle cells. Costameres are adjacent and parallel
to the Z-lines and comprise protein assemblies that connect the sarcomeres to
the sarcolemma [557, 558]. When taking a closer look at the mdx 5cv mouse
model the signal similarity to the control mouse strain can be explained. The
mdx 5cv mouse model was introduced by Chapman et al. in 1989 [288] and was
generated via an N-ethylnitrosourea (ENU) chemical mutagenesis. This muta-
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Figure 3.36.: STED images of VM from control (wild type C57BL/6N) vs. mdx 5cv mice labeled each with one of the
three antibodies 4C7, ab85302, or C-20. Please refer to Appendix A.3 and Appendix A.4 for detailed infor-
mation about the used antibodies and fluorescent dye compounds. A STED images of VM from control
(top) vs. mdx 5cv (bottom) mice immunofluorescence labeled with the primary antibody 4C7 targeting
the N-terminus (N) of the Dyst protein. The primary antibody was decorated with the dye compound
STAR635P. B STED images of VM from control (top) vs. mdx 5cv (bottom) mice immunofluorescence la-
beled with the primary antibody ab85302 targeting the central rod domain (Rod) of the Dyst protein. The
primary antibody was decorated with the dye compound NS510. C STED images of VM from control
(top) vs. mdx 5cv (bottom) mice immunofluorescence labeled with the primary antibody C-20 targeting
the C-terminus (C) of the Dyst protein. The primary antibody was decorated with the dye compound
STAR580. Images were smoothed using a two-dimensional Gaussian filter with a width of 1.5 pixels.
Color bars indicate the respective image brightness in photon counts (cts.). White arrows indicate the
longitudinal (X) and transverse (Y) cell axes, respectively. Scale bars: 1 µm.
genesis causes the Dyst protein synthesis to stop at base 1416 of the full length
wild type Dyst [559]. The remaining truncated Dyst “stump” comprises aa 1-
381 and has a molecular weight of ≈ 43.7 kDa. Since the N-terminal F-Actin
binding domain of Dyst protein is assumed to be located along aa 14-240 (see
section 1.1.4 and Fig. 3.35), the expressed truncated Dyst is still attached to the
costamere by binding F-Actin. The observed signal pattern of the primary anti-
body 4C7 in VM of mdx 5cv is hence to be expected and confirms the specificity
of the antibody for the Dyst N-terminus.
In summary, it can be stated that, although the primary antibody 4C7 yields
a fluorescence signal in VM of both control and mdx 5cv mice, the antibody
still shows very high specificity because it reproduces the expected costamere
regularity. All three here chosen anti-Dyst primary antibody are thus specific
and suitable for fluorescence labeling of distinct Dyst protein domains.
Being equipped with three specific primary antibodies that respectively target
the N-terminus, the central rod domain, and the C-terminus of the Dyst pro-
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tein, I prepared VM samples dual-labeled for Cav-3 and one of the three Dyst
protein regions. Hence, in order to investigate the spatial association between
Cav-3 and different domains of the Dyst protein, I could compare two-color
STED images of the following three combinations:
1.) Cav-3 and the Dyst N-terminus (N),
2.) Cav-3 and the Dyst central rod domain (Rod),
3.) Cav-3 and the Dyst C-terminus (C).
For reasons of comparability, the anti-Cav-3 primary antibody was always dec-
orated with the dye compound STAR580 and the used anti-Dyst primary an-
tibody was always decorated with the dye compound STAR635P. In Fig. 3.37,
STED images of each of the above combinations are shown. The Cav-3 color
channel is displayed in cyan, the respective Dyst color channel is displayed in
magenta, and overlap of the two color channels is indicated by yellow signal.
For all three two-color combinations (see Fig. 3.37 B, D, and F), both the Cav-
3 and the Dyst signal stemming from the particular protein regions show the
familiar sarcolemmal structures of single domains and bunchy clusters (see e.g.
Fig. 3.22 and Fig. 3.32).
Fig. 3.37 B displays the overlay image of the sarcolemmal Cav-3 signal with
the sarcolemmal signal of the N-terminus (N) of the Dyst protein that was la-
beled using the antibody 4C7. The distinct Dyst N-terminal signal resembling
the costameres which had already been shown in the antibody control stains
displayed in Fig. 3.36 is reproduced. Interestingly, there are only few regions
of yellow signal, i.e. only little overlap between Cav-3 and N-terminal Dyst
structures. Still, the two populations of Dyst - one close to Cav-3 signal and
one further away - can be identified in accordance with the data shown and
discussed in section 3.7.
Fig. 3.37 D presents the overlay image of the sarcolemmal Cav-3 signal with the
sarcolemmal signal of the Dyst central rod domain (Rod) that was labeled us-
ing the antibody ab85302. This two-color combination is already known from
Fig. 3.33 and Fig. 3.34. There are clearly identifiable regions of signal over-
lap between the two color channels. Both colocalization and para-localization
of the signal structures can be observed. The two Dyst populations that were
defined with respect to their distance to the Cav-3 signal are again visible.
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Figure 3.37.: Two-color STED images of the sarcolemma of mouse ventricular cardiomyocytes (VM) immunofluores-
cence labeled for Caveolin-3 (Cav-3) and the Dystrophin(Dyst) N-terminus (N), central rod domain (Rod),
or C-terminus (C), respectively. Cav-3 was decorated with the dye compound STAR580 and is displayed
in cyan; Dyst domains were decorated with the dye compound STAR635P and are displayed in magenta.
The respectively labeled Dyst protein domains and the used primary antibodies are denoted in the corre-
sponding image panels; detailed information about the used antibodies and dye compounds can be found
in Appendix A.3 and Appendix A.4. A, C and E Single color channel images of the Cav-3 signal and the
Dyst N-terminus (N), central rod domain (Rod), or C-terminus (C), respectively. B, D, and F Two-color
overlays of the corresponding single color channels in A, C and E (see image captions). Magnifications
correspond to the yellow boxed regions in the overview images. The image color map is displayed in F:
Cav-3 signal is displayed in cyan; Dyst signal is displayed in magenta; signal overlap is indicated in yel-
low. Raw data images were smoothed using a two-dimensional Gaussian filter with a width of 1.5 pixels
and converted into the two-dimensional color map as described in section 2.6.1. White arrows indicate
the longitudinal (X) and the transverse (Y) cell axes, respectively. Scale bars in overview images: 5 µm;
scale bars in magnifications: 1 µm.
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In Fig. 3.37 F, the sarcolemmal Cav-3 signal in combination with the sar-
colemmal signal of the Dyst C-terminus (C, labeled using the antibody C-20)
is shown. Extended regions of overlapping Cav-3 and C-terminal Dyst struc-
tures can be identified. The combination of Cav-3 and C-terminal Dyst seems
to show the largest fraction of signal colocalization of all three tested two-color
combinations. At the same time, a profound area fraction of the sarcolemma is
occupied by free-standing C-terminal Dyst signal that is mostly composed of
single domains. More clustered Dyst signal appears to be mainly associated to
nearby larger Cav-3 clusters.
From the qualitative comparison between Fig. 3.37 B, D, and F, it can be stated
that the spatial association between Cav-3 and the Dyst depends on the re-
spective region along the Dyst protein that is considered. More precisely, the
degree of colocalization between Cav-3 and Dyst signal structures appears to
be much higher for the two-color combinations of Cav-3 and the Dyst central
rod domain, and Cav-3 and the C-terminal Dyst domain than for Cav-3 and
the N-terminal Dyst domain. When comparing Figs. 3.37 D and F, the signal
overlap for the two-color combination of Cav-3 and the C-terminal Dyst do-
main seems to be slightly higher than the signal overlap for the combination of
Cav-3 and the Dyst central rod domain.
For the quantitative evaluation of the above findings, I analyzed the peak-to-
peak nearest neighbor distance (NND) and the relative colocalization between
the Cav-3 signal and the signal stemming from a particular Dyst protein do-
main. Note that I decided not to analyze the peak-to-peak NND nor the rela-
tive colocalization between a particular Dyst domain and Cav-3 (as it was done
in section 3.7; cf. Fig. 3.33). This is because of the two populations of Dyst that
were identified in section 3.7 when labeling the Dyst central rod domain: one
Dyst population in close proximity to and one Dyst population remote from
Cav-3. These two populations could also be identified when labeling the N-
terminus and the C-terminus of the Dyst protein (see Fig. 3.37). The existence
of the two Dyst populations introduces a large variance to the obtained val-
ues of the relative colocalization and the peak-to-peak NND between the Dyst
domains and Cav-3 and thus render these two figures rather unsuited for com-
parative studies.
The peak-to-peak NND between Cav-3 and the Dyst N-terminus, central rod
3.8. MOLECULAR ORIENTATION OF SARCOLEMMAL DYST AND CAV-3 209
domain, or C-terminus was determined as described in section 2.8; the rel-
ative colocalization was determined as described in section 2.7. For clarity,
the relation between Cav-3 and the particular Dyst protein domains shall here
be referred to as Cav-3−→Dyst(N) (in case the Dyst N-terminus was labeled),
Cav-3−→Dyst(Rod) (in case the Dyst central rod domain was labeled), and
Cav-3−→Dyst(C) (in case the Dyst C-terminus was labeled), respectively. In
Fig. 3.38, a bar graph representation of the obtained results is displayed.
Dyst        Cav-3
(263 ± 229) nm
Cav-3       Dyst
(83 ± 51) nm
Figure 3.38.: Bar graph representation of the determined peak-to-peak nearest neighbor distance (NND, in nm) and
the relative colocalization (rel. coloc., in % of the total Cav-3 signal) between the sarcolemmal Cav-3
signal and the Dyst N-terminus (Dyst(N)), central rod domain (Dyst(Rod)), and C-terminus (Dyst(C))
signal, respectively. The displayed figures were obtained as described in sections 2.8 and 2.7 and sum-
marize the two-color STED images presented in Fig. 3.37. A NND between the Cav-3 signal and each
Dyst(N), Dyst(Rod), and Dyst(C). B Rel. coloc. between the Cav-3 signal and each Dyst(N), Dyst(Rod),
and Dyst(C). NND and rel. coloc are presented as mean± standard deviation. Statistical significance was
tested as described in section 2.9 with the explicit parameters of the statistical test given in Appendix I, Ta-
bles I.16 and I.17, and is denoted as: (n.s.) - not significant (p > 0.01) and (**) - very significant (p < 0.001).
Number of analyzed cells: Cav-3–Dyst(N): 47; Cav-3–Dyst(Rod): 43; Cav-3–Dyst(C): 51.
Both the determination of the NND and of the relative colocalization repro-
duce the qualitative conclusions that could be extracted from Fig. 3.37 B, D,
and F. Fig. 3.38 A shows that there is a very significant decrease between Cav-
3−→Dyst(N) and Cav-3−→Dyst(Rod) (from about 167 nm to about 83 nm),
and between Cav-3−→Dyst(N) and Cav-3−→Dyst(C) (from about 167 nm to
about 70 nm). There is also a decrease in NND between Cav-3−→Dyst(Rod)
and Cav-3−→Dyst(C), yet it is not statistically significant.
Likewise, from Fig. 3.38 B, it can be seen that the relative colocalization be-
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tween Cav-3 and the particular Dyst domains very significantly increases from
Cav-3−→Dyst(N) over Cav-3−→Dyst(Rod) to Cav-3−→Dyst(C) (from ≈ 15 %
to ≈ 32 % to ≈ 39 %). The relative colocalization denotes the percentage the to-
tal observed Cav-3 signal that colocalizes with a Dyst signal. Since the relative
colocalization is obtained from binarized raw data, it captures the one-to-one
pixel overlap of the two considered fluorescence signals. Such a pixel based
approach to evaluate the fluorescence signal overlap is very sensitive and very
strict since it demands a precision of one px (i.e. 20 nm for the here acquired
images). Therefore, the concise values of the percental signal overlap may be
lower than it would be expected when looking at the two-color STED images
presented in Fig. 3.37.
Nevertheless, from the obtained two-color STED images (see Fig. 3.37) and the
found comparative increase in relative colocalization in conjunction with the
observed decrease in NND from Cav-3−→Dyst(N) to Cav-3−→Dyst(Rod) to
Cav-3−→Dyst(C), the following possible conclusions can be drawn:
1.) Both Cav-3 and the Dyst C-terminus, and Cav-3 and the Dyst central
rod domain share a closer spatial association than Cav-3 and the Dyst
N-terminus.
2.) The spatial association between Cav-3 and the Dyst C-terminus is slightly
higher than between Cav-3 and the Dyst central rod domain.
3.) The fluorescence signal of each the Dyst N-terminus, central rod domain,
and C-terminus show the existence of two distinct Dyst populations of
which one is close to and one remote from the Cav-3 signal.
In summary, regarding the cardiac membrane nanodomain model that I pro-
posed in section 1.4, the here presented data and the therefrom derived con-
clusions confirm the postulated orientation of the Dyst protein along the sar-
colemma with respect to the membrane resident Cav-3: the Dyst N-terminus
is located further away from the sarcolemma than the central rod domain and
the C-terminus and does probably not interact with Cav-3. Both the central rod
domain and the C-terminus show a higher degree of spatial association with
Cav-3 and thus seem to be located closer to the sarcolemma, arguably within a
distance of 30-120 nm, and with the C-terminus potentially more strongly asso-
ciated to Cav-3 and the sarcolemma than the central rod domain. As has been
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shown in section 3.7.1, Cholesterol (Chol) depletion and thus dissociation of
caveolae does not alter the sarcolemmal arrangement of the Dyst central rod
domain. This might hint towards an only indirect interaction between Cav-3
and the Dyst central rod domain, possibly mediated by one or more intermedi-
ate proteins (e.g. Nitric Oxide Synthase). The here found closer spatial associa-
tion between Cav-3 and the Dyst C-terminus could indicate a more direct inter-
action between the two proteins at this particular Dyst domain. A similar study
investigating the effect of Chol depletion on the sarcolemmal nanopattern of
the particular Dyst domain signal distribution with respect to the caveolar ar-
rangement would elucidate the questions if and how different Dyst domains
associate with the sarcolemma (see also section 4).
To conclude the studies on the spatial orientation of the Dyst protein along the
cardiac sarcolemma, the next section will present and discuss so-called “Dyst
intra-protein labeling” approaches that allow the simultaneous fluorescence
tagging of different protein domains in order to relate their specific arrange-
ment with respect to each other and identify their similar and different struc-
tural - and thus potentially functional - properties.
3.9. Intra-protein immunofluorescence labeling of
Dystrophin
Using the three distinct anti-Dyst primary antibodies 4C7, ab85302, and C-
20 that respectively target the Dyst N-terminus, central rod domain, and C-
terminus, I could establish the simultaneous fluorescence labeling of different
domains of the Dyst protein in VM. This approach shall here be referred to
as “Dyst intra-protein labeling” which yielded two-color and three-color im-
munofluorescence samples for STED microscopy.
In a first step to investigate the mutual assembly of the Dyst N-terminus, cen-
tral rod domain and C-terminus, two-color fluorescence stains were prepared.
This yielded the following three combinations:
i. Samples of fixed VM simultaneously labeled for the Dyst N-terminus and
the Dyst C-terminus; referred to as (N)/(C).
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ii. Samples of fixed VM simultaneously labeled for the Dyst N-terminus and
the Dyst central rod domain; referred to as (N)/(Rod).
iii. Samples of fixed VM simultaneously labeled for the Dyst C-terminus and
the Dyst central rod domain; referred to as (C)/(Rod).
Fig. 3.39 shows two-color STED images of these three types of samples. For
details regarding the sample preparation, the used antibodies and dyes, and
the image acquisition, please refer to section 2.3.3, Appendix A.3, Appendix
A.4, and Appendix B.
Fig. 3.39 B shows the two-color STED image of the combination i.: (N)/(C).
Most of the (N) signal (displayed in cyan) is highly clustered and reproduces
the cardiac costamere structure that shows even stripes along the transverse
cell axis spaced at a distance of about 1.8-2.0 µm (i.e. one sarcomere length,
see also Fig. 3.36). In addition, some (N) signal structures are not assembled
in higher-order clusters but appear to be single domains. The (C) signal (dis-
played in magenta) is almost entirely dispersed and shows clusters only sel-
dom. It is predominantly composed of smaller, circular single domains. Re-
gions of colocalization are seldom seen and mostly confined to the large (N)
signal clusters.
In Fig. 3.39 D, the spatial arrangement of the signals from the combination ii.:
(N)/(Rod) is presented. Again, like in Fig. 3.39 A, the (N) signal (cyan) mainly
shows elongated clustered structures and a few solitary single domains. The
(Rod) signal (in magenta) is in seemingly equal parts composed of both clusters
that are of no distinct shape - i.e. reproducing the pattern of bunchy clusters of
various shapes that have been described in e.g. Fig. 3.32 - and single domains.
Spatial overlap is observed to a larger extent between clustered structures of
the (N) and the (Rod) signal, while little to no colocalization between (N) and
(Rod) single domains is observable. The (Rod) single domains are distributed
irregularly between clusters of both the (N) and the (Rod) signal.
The combination iii. (C)/(Rod) is displayed in Fig. 3.39 F. Here, both the
(Rod) and the (C) signal patterns (in cyan and magenta, respectively) are pre-
dominantly composed of single domains. However, the (Rod) signal shows a
profoundly higher degree of clustering than the (C) signal which is consistent
with the data shown in Fig. 3.39 B and D. Almost all clusters of the (C) signal
that are observed colocalize with (Rod) clusters. Further, the extent of colocal-
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Dyst-4C7-N-term-STAR580
Figure 3.39.: Intra-protein two-color STED images of Dystrophin (Dyst) at the sarcolemma of mouse ventricular car-
diomyocytes (VM). Dyst was respectively labeled at its N-terminus (N), central rod domain (Rod), and
C-terminus (C) using the primary antibodies 4C7, ab85302, and C-20, decorated with one of the two dye
compounds STAR580 or STAR635P. For detailed information about the used antibodies and dye com-
pounds, please refer to Appendix A.3 and Appendix A.4. A, C and E Single color channel images of
the particularly labeled Dyst protein domains (see corresponding image captions). B, D, and F Two-
color overview images of Dyst labeled at different protein domains (see corresponding image captions).
Image magnifications corresponding to the yellow boxed regions. Images were smoothed using a two-
dimensional Gaussian filter with a width of 1.5 pixels and converted to the color map displayed in B
as described in section 2.6.1.The color map corresponds to the captions of the two-color overlay images.
White arrows indicate the longitudinal (X) and the transverse (Y) cell axes, respectively. Scale bar in
overview image: 5 µm; scale bar in magnification: 500 nm.
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ization of the (Rod) and the (C) signal seems to be of the same order as that for
the (N) and the (Rod) signal (see Fig. 3.39 D).
Note that for all three two-color combinations, sarcolemmal regions devoid of
any Dyst signal can be seen. These regions often resemble circular “openings”
at the sarcolemma, yet the specific nature of these openings remains unclear.
One could reckon they are Transverse Tubule (TT) openings, however, they are
generally not evenly distributed along the sarcolemma at the typical sarcomere
distance, as it would be expected for TT.
Based on the observations made in Fig. 3.39 B, D, and F, the qualitative com-
parison of the spatial association of the combinations (N)/(C), (N)/(Rod), and
(Rod)/(C) leads to the following findings and possible interpretations:
1.) (N) shows the largest signal clusters. While these (N) clusters form stripes
parallel to the transverse axis of the VM and are spaced about one sarcom-
ere length apart, (Rod) and (C) clusters appear to be more bunchy and
rounded and neither show a distinct orientation nor a regular position-
ing along the sarcolemma. This could mean that the Dyst N-termini are
arranged in higher-order complexes at the cardiac costameres, while the
(Rod) and the (C) domains that are in closer proximity to the sarcolemma
are less interconnected and might thus be able to move more freely. Such
an arrangement might provide stability at the attachment point between
Dyst and the cytoskeleton while allowing for a certain flexibility and mo-
bility of the sarcolemma-associated domains of the Dyst protein.
2.) The majority of both the (Rod) and the (C) signal is composed of small,
circular single domains. The (N) signal consists of fewer of such single
domains in comparison to the fraction of total (N) signal that is arranged
in clustered assemblies. This finding is in agreement with 1.) and would
support the assumption that the attachment points between Dyst and
the sarcolemma are more dispersed while the attachment points between
Dyst and the cytoskeleton are more concentrated.
3.) Colocalization is predominantly observed between clustered signal struc-
tures of the respective Dyst signals and not in regions that show higher
densities of single domain structures. This suggests that the spatial ar-
rangement between single Dyst proteins could be mediated by protein
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regions that are preferably assembled in larger complexes (e.g. inter-
connected or cross-linked regions) and unconnected regions that would
rather avoid potential oligomerization.
4.) The degree of colocalization seems to be larger for the two combinations
(C)/(Rod) and (N)/(Rod) than for the combination (N)/(C). This moti-
vates the models of Dyst as an elongated protein that have been discussed
in the introduction of this thesis (see section 1.1.4) and that are based on
biochemical studies and protein sequencing analyses. If Dyst was of a
more rounded or coiled shape, one would expect a higher degree of colo-
calization between the particular protein domains and a more isotropic
signal distribution along the sarcolemma.
In an attempt to quantify the above findings, I assessed many of the standard
figures that are typically used to determine spatial correlation and colocaliza-
tion. A variety of these figures has been presented in this thesis, e.g. the pixel-
based signal overlap (see section 2.7) and the peak-to-peak nearest neighbor
distance (see section 2.8). However, extracting these quantities from the ob-
tained two-color micrographs did not yield definite results regarding the as-
sembly between individual Dyst domains along the sarcolemma. This is be-
cause several factors complicate the quantitative analysis of the here presented
two-color intra-protein stains.
First, it cannot be readily assumed that two signal peaks that stem from differ-
ent color channels belong to the same protein. This would require the Dyst pro-
tein to be distributed only sparsely across the sarcolemma which is obviously
not the case when looking at the microscopy data. In consequence, the deter-
mination of the nearest neighbor distance is intrinsically unreliable: if multiple
proteins are closer together than the approximate length of a single protein, the
fluorescence signal cannot be precisely assigned to one particular protein.
Second, while the assessment of the degree of colocalization between two dis-
tinct protein domains is very valuable for a qualitative estimate of the possible
protein orientation or structural arrangement, concise quantitative figures such
as the number of proteins within the region of colocalization cannot be derived
from it. This is e.g. because of the inaccuracy of the thresholding procedure
used to define the spatial extent of a signal.
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Still, there are other potentially promising approaches to quantitatively eval-
uate the here established intra-protein Dyst stains. Some of these approaches
will be touched upon in section 4.
Nevertheless, despite the difficulties to extract definite quantitative figures from
the here presented two-color intra-protein STED micrographs, the prospect of
achieving three-color subdiffraction intra-protein imaging is very tempting.
Using the combination of all three anti-Dyst primary antibodies, three-color
samples were prepared and imaged.
Fig. 3.40 shows the obtained three-color image data obtained at the sarcolemma
of two different VM (A and B, and C and D, respectively). Here, the (N) signal
is displayed in blue, the (Rod) signal is displayed in red, and the (C) signal is
displayed in green. I chose to use this color map (i.e. different from the one
previously used for two-color images) in order to illustrate sarcolemmal re-
gions that show either single channel signal stemming from a particular Dyst
domain (in red, green, or blue), spatial overlap of two color channels (magenta,
yellow, or cyan), or overlap of all three color channels (white).
Upon first sight, a general principle of arrangement of the domain signal can-
not be derived from the three-color images. When looking at the single color
channel images of the (N) signal (Fig. 3.40 A and C) the assembly parallel to
the transverse cell axis and resembling costameric structures can be identified.
Yet, the (Rod) and (C) signals do not necessarily follow this striated pattern, al-
though Fig. 3.40 D might suggest such a preferential transverse orientation of
all three Dyst domains. But despite the difficulties to infer the concise molecu-
lar orientation of the Dyst protein along the sarcolemma from the image data,
two structural peculiarities of the sarcolemmal Dyst arrangement can be ex-
tracted:
1.) Signal colocalization and para-localization predominantly happens be-
tween clusters of individual Dyst domain signals. The resulting signal
complexes are of various sizes and shapes and do neither show a clearly
identifiable local orientation or positioning with respect to each other nor
a global positioning with respect to the cell axes. Further, the clusters are
seldom surrounded by single signal domains but are rather embedded
within regions that are devoid of any Dyst signal (see also 2.)). Typically,
there is no smooth transition between Dyst clusters and regions without
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Figure 3.40.: Intra-protein three-color STED images of the Dystrophin (Dyst) protein N-terminus (N), central rod do-
main (Rod), and C-terminus at the sarcolemma of mouse ventricular cardiomyocytes (VM). Image data
from two different cells is displayed (A and B, and C and D, respectively). A Single color overview im-
ages of the three labeled Dyst domains (N), (Rod), and (C) (see image captions). B Three-color overlay
image of the (N), (Rod), and (C) signal shown in A. Image magnification corresponding to the yellow
boxed region. C Single color overview images of the three labeled Dyst domains (N), (Rod), and (C) (see
image captions). D Three-color overlay image of the (N), (Rod), and (C) signal shown in C. Image mag-
nification corresponding to the yellow boxed region. E The color key indicates regions of single channel
signal, and signal overlap of two or all three color channels. White arrows indicate the longitudinal (X)
and the transverse (Y) cell axes. Images were smoothed using a two-dimensional Gaussian filter with a
width of 1.5 pixels. For detailed information about the used antibodies and fluorescent dyes, please refer
to Appendix A.3 and Appendix A.4. Scale bar in overview images: 5 µm; scale bar in magnifications: 1
µm.
Dyst signal; the two domains are mostly definitive and form a membrane
mosaic.
2.) Although the density of the fluorescence signal stemming from the la-
beled Dyst domains is very high, the sarcolemma is not entirely covered
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with Dyst signal. There are sarcolemmal regions in the images that are
completely black - i.e. devoid of any Dyst signal. Such empty regions
have been observed in the two-color images of Cav-3 co-labeled with the
particular Dyst domains (see Fig. 3.37) and in the two-color images of the
combinations of two simultaneously Dyst domains (see Fig. 3.39) and
were there referred to as “openings”.
Again, the question remains: what could these openings be? Are they the re-
gions where Transverse Tubules (TT) bud from the sarcolemma? If so, the high
density of Dyst at the TT openings might indicate that these openings could dy-
namically change their diameter, probably depending on the degree of cellular
contraction (i.e. depending on the momentary membrane tension). However,
the openings reach diameter sizes of more than 800 nm - much too big for the
typical diameter of TT, unless one assumes that the invaginating membrane
that eventually forms the TT shows only a small curvature which would result
in the TT having the shape of a funnel at the sarcolemma and thus an increased
diameter. Alternatively, these openings could be sarcolemmal regions that are
independent of the cellular cytoskeleton (i.e. not directly mechanically associ-
ated with the myofibrils). They could thus represent membrane regions that
provide cellular elasticity. Undoubtedly, there is much room for speculation.
In a last step, to most instructively visualize how densely the sarcolemma is
packed with Dyst - and how characteristically - all three Dyst domains (N),
(Rod), and (C) were decorated with the same fluorescent dye and their sig-
nal recorded simultaneously in a single sample scan. This sample preparation
protocol was chosen to rule out any effects of chromatic aberrations or dye
dependent differences in image resolution.
Assuming that in the resulting samples, the full-length Dyst protein and thus
the entire sarcolemmal Dyst population is fluorescently tagged, Fig. 3.41 re-
flects that membrane regions devoid of Dyst signal are a distinct property of
the sarcolemmal Dyst arrangement.
The question about the nature of the Dyst-negative sarcolemmal regions shall
be the final - and unanswered - question in this thesis. Strategies to approach
an answer will be presented in section 4. For now, the images shall have a
merely qualitative purpose and might perhaps serve as an inspiration.
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Figure 3.41.: STED images of the sarcolemma of two individual mouse ventricular cardiomyocytes (VM, A and B, re-
spectively) labeled for the protein Dystrophin (Dyst) via indirect immunofluorescence. Dyst was labeled
along its full length by decorating the specifically targeted protein N-terminus (N), central rod domain
(Rod), and the C-terminus (C) with the same fluorescent dye STAR635P. For detailed information about
the labeling procedure, the used antibodies, and the used dye compounds, please refer to section 2.3.3,
Appendix A.3, and Appendix A.4. Color bars indicate the respective image brightness in photon counts
(cts.). White arrows indicate the longitudinal (X) and the transverse (Y) cell axes. Images were smoothed
using a two-dimensional Gaussian filter with a width of 1.5 pixels. Scale bars: 5 µm.
In summary, the here presented subdiffraction image based findings about
the localization and orientation of Dyst with respect to Cav-3 and the car-
diac sarcolemma are in agreement with the cardiac membrane model proposed
in section 1.4. Dyst is an elongated protein whose N-terminus is located fur-
ther away from Cav-3 rich membrane domains (and thus potentially the sar-
colemma) than its central rod domain and its C-terminus. The Dyst N-terminus
forms regularly spaced striated structures that resemble the myocyte costa-
meres. These costamere-like signal structures confirm the F-Actin binding do-
main located at the Dyst N-terminus. Chol depletion does not alter the signal
distribution of the Dyst central rod domain which indicates that Dyst does not
directly interact with caveolae along this domain. And, last but not least, there
are two distinct Dyst populations observable with respect to their spatial asso-
ciation with Cav-3. The functional properties of these two populations remain
yet to be uncovered.
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4. Conclusion and outlook
In this thesis, experimental and analytical methods were developed and ap-
plied to investigate cardiac membrane nanodomains with STED microscopy.
Comprehensive studies using single- and multicolor, one- and two-photon-
excitation STED microscopy were performed on living and fixed isolated mouse
ventricular cardiomyocytes (VM).
Special emphasis was laid on the visualization of the three-dimensional (3D)
nanoscopic structure of the cardiac Transverse-Axial Tubular System (TATS)
because alterations of the TATS topology are correlated to many cardiovascular
pathologies.
Further, the spatial arrangement of the two sarcolemmal lipids Cholesterol
(Chol) and Ganglioside GM1 (GM1) and of the two sarcolemma-associated
proteins Caveolin-3 (Cav-3) and Dystrophin (Dyst) was investigated in detail.
These molecules play an important role in maintaining membrane integrity, in
cellular signaling processes, and in disease mechanisms and their specific sar-
colemmal topology crucially determines their proper physiological functiona-
lity.
The essential milestones that were reached in this thesis and the key findings
that could be derived therefrom shall here be summarized:
1.) A novel class of fluorescent Cholesterol (Chol) analogs was established
as a live-cell membrane label for STED microscopy. The compound Chol-
KK114 yielded an unprecedented lateral resolution of ≤ 35 nm in living
VM. Chol-KK114 is superior to standard fluorescent membrane markers
in many regards and allows both membrane bulk staining and labeling
Chol rich membrane compartments (see section 3.1).
2.) A Two-Photon-Excitation-CW-STED (2P-Exc-CWSTED) microscope was
built (see section 3.4.1) and a comprehensive quantitative study to iden-
tify and characterize organic fluorophores suitable for 2P-Exc-CWSTED
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imaging was conducted focusing on fluorescence switch-off and blea-
ching behavior (see section 3.4.2). Chol-OG488 was found to be the most
suitable fluorescent Chol analog for 2P-Exc-CWSTED live-cell imaging
and enabled the acquisition of 3D images of the TATS of living VM. These
3D images revealed that (a) Transverse Tubules bud from Chol rich sar-
colemmal patches and (b) Chol rich nanoscopic sarcolemmal patches form
shallow membrane invaginations which were assumed to be caveolae
(see section 3.4.3).
3.) Chol and Cav-3 were found to form similar sarcolemmal signal patterns
comprised of three reoccurring motifs: 1. single domains of ≈ 70 nm di-
ameter, 2. ring structures of ≈ 240 nm diameter and 3. bunchy clusters
of various sizes (see section 3.5). Chol depletion substantially altered the
sarcolemmal Cav-3 signal distribution and led to the quantifiable disso-
ciation of Cav-3 clusters (see section 3.5.1). The use of GM1 for two-color
STED imaging together with each Cav-3 and Chol demonstrated the spa-
tial association of Chol and Cav-3 and their probable localization to the
same sarcolemmal membrane domains (see section 3.6).
4.) Dyst was simultaneously labeled at its N-terminus (N), central rod do-
main (Rod), and C-terminus (C) in a newly established “intra-protein”
labeling protocol for multicolor STED imaging. This yielded image based
evidence that Dyst is an elongated protein attached to the cardiac costa-
meres via (N) and associated with the sarcolemma via (Rod) and (C) (see
section 3.9). Two-color images of Cav-3 and the particular Dyst protein
domains showed distinctly different mutual signal pattern arrangements.
The spatial association between Dyst and Cav-3 was found to be closer
for each (N) and (Rod) than for (C) (see section 3.8). Chol depletion did
not alter the sarcolemmal signal pattern of (Rod) which indicated that the
possible connection between (Rod) and the sarcolemma might be medi-
ated by Cav-3 but is not dependent on it (see section 3.7.1).
5.) A cardiac membrane nanodomain model summarizing the findings of
this thesis was proposed and validated and is recapitulated in Fig. 4.1
(see also section 1.4).
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In conclusion, this thesis visualizes for the first time the arrangement of spe-
cific sarcolemmal lipid/protein nanodomains in healthy cardiomyocytes and
demonstrates their association with the characteristic cardiac membrane topo-
logy.
The established experimental and analytical methods and the therewith ob-
tained results offer plenty of possibilities for further explorations.
Future directions: the great potential of fluorescent Chol analogs
The identification and establishment of the versatile class of fluorescent Chol
analogs featuring organic fluorophores linked to the Chol molecule via PEG as
highly suitable membrane labels for STED microscopy of living VM enables a
variety of customized applications.
For one, the experimenter can freely choose the fluorophore that is coupled
to Chol and thus freely adjust the spectral properties of the membrane label
according to their specific experimental setup. This would for example allow
the simultaneous subdiffraction imaging of the cardiac membrane architecture
and of Calcium signals along the membrane using established Calcium marker
dyes such as Fluo-4 or Oregon Green 488 BAPTA-1 [560, 439].
Further, using the Chol-PEG labels at high concentrations as non-toxic mem-
brane bulk labels to thoroughly stain the entire TATS of the VM allows real-
time live-cell studies of the potential alterations of the TATS during mechanical
stretching of VM, upon administration of drugs, or upon induced membrane
damage. Experiments of stretching cardiomyocytes with control over the ap-
plied stretching force and while imaging Calcium sparks has so far yielded
many novel findings regarding excitation-contraction coupling [561, 562]. The
application of STED microscopy to localize Calcium sparks along the cardiac
membrane system during cellular stretching would open up a fantastic and ex-
citing field of research. Here, one of the first experiments that would come to
mind is investigating whether there is a spatial correlation between Calcium
sparks and Chol rich sarcolemmal patches.
As another interesting application, one could think of monitoring the effect of
pharmaceuticals on the cardiac membrane system in real time and with nano-
metric resolution. For example, the “membrane sealant” Poloxamer P188 has
been shown to stabilize the dystrophic cell membrane and provide for mem-
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brane integrity [563, 564]. 3D 2P-Exc-CWSTED microscopy of the Chol-OG488
labeled TATS of dystrophic VM during the administration of P188 (and maybe
during cell stretch or after induced damage to the cell) would be a wonderful
experimental system to study the mode of action of P188 and potential mem-
brane repair mechanisms. Other interesting processes to record would for ex-
ample be the possible alteration of membrane structures upon incubation of
VM with Latrunculin A which disrupts cytoskeletal structures [565, 566].
Note that the fluorescent Chol analogs that have proven ideal labels for STED
imaging of the VM membrane were originally designed for STED-FCS mea-
surements [100]. Regarding the specific nature of the sarcolemmal Chol nan-
odomains, STED-FCS experiments studying their diffusivity or the effects that
these domains have on the movement of a diffusing lipid or protein could be
set up fast and would provide valuable insights.
Finally, the successful use of the fluorescent Chol analogs in many different
cell systems as demonstrated in this thesis motivates the application of these
membrane labels for fluorescence nanoscopy of basically any cell system of in-
terest. As an example, the dye Chol-STAR580 proved to be feasible for imaging
membrane structures in skeletal muscle cells (data not shown).
Future directions: two-color lipid/protein labeling in living VM
An unfortunate shortcoming of the attempt to associate sarcolemmal Chol and
Cav-3 signal was the incompatibility of Chol-KK114 with cell permeabilization
and of Cav-3 immunofluorescence labeling with live-cell STED microscopy.
Apart from various fluorescent labels that are membrane-specific, there are not
many protein-specific organic dye based fluorescence tags available for live-
cell imaging. An exciting addition to the family of fluorescent live-cell labels
are the cell permeable and fluorogenic Silicon Rhodamine (SiR) dyes SiR and
SiR700 that can be used to target e.g. cellular F-Actin or Tubulin when coupled
to cell toxins [345]. Although in this thesis, these labels have been tested to vi-
sualize cytoskeletal structures in living VM, the attempts were not successful,
yielding unspecific signal probably due to a large degree of fluorophore uptake
by mitochondria (data not shown). Also, it would be of much greater interest
to be able to simultaneously label Chol and Cav-3 or Dyst structures in living
VM.
A promising possibility to achieve two-color STED imaging of sarcolemmal
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Chol and e.g. Cav-3 structures would be the generation and utilization of
transgenic animals that express the protein of interest coupled to a fluorescent
protein with the appropriate spectral properties (for example the green fluo-
rescent protein for the combination with Chol-KK114). Unfortunately, such
animals were not readily available in this thesis. The correlative investigations
of lipid/protein nanodomains at the cardiac sarcolemma would in any case
greatly benefit from transgenic animal models.
Future directions: STED combined with near-field microscopy techniques
Since the heart is essentially a pump, the biomechanical properties of cardiomy-
ocytes also deserve a closer look.
Regarding the assessment of biophysical properties of cardiomyocytes (e.g.
Young’s modulus), Atomic Force Microscopy (AFM) is the method of choice
[567]. In addition, AFM can be used to map the texture of the cellular sur-
face. The combined application of AFM and STED microscopy has already
been shown [364, 365]. And together with the membrane-specific fluorescent
Chol analogs, the simultaneous assessment of cardiac surface texture and the
nanopattern of Chol domains would be possible. Since Chol enriched mem-
brane domains such as caveolae are supposed to provide additional surface
area to ensure cellular elasticity, it would be of great interest to find out whether
the sarcolemmal Chol nanodomains shown in this thesis indicate negatively
curved membrane regions.
Further, the circular regions devoid of Dyst and Cav-3 signal that were demon-
strated in section 3.9 are an interesting feature. As speculated, these “ope-
nings” could be the regions where Transverse Tubules (TT) bud from the sar-
colemma, i.e. membrane regions with a large negative curvature. A combina-
tion of near-field scanning microscopy techniques such as Scanning Ion Con-
ductance Microscopy (SICM) or AFM and STED microscopy would be valuable
to elucidate the nature of these peculiar openings. Since the observed open-
ings strongly vary in diameter (see Fig. 3.41), they could - apart from being
TT openings - also be different membrane structures, potentially serving the
purpose of providing cellular elasticity since they may not be linked directly
to the cytoskeleton via Dyst. Cardiac surface texture mapping using SICM has
been successful at identifying both TT and caveolae at the cardiac sarcolemma
[568, 569, 570]. The possibility of simultaneously assessing cardiomyocyte sur-
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face texture and protein distribution on the nanoscale would open up a vast
field of correlative studies - also extendable to disease models. One caveat ex-
ists, however: to adequately map the cardiac surface, the membrane has to be
intact, i.e. cells cannot be labeled via immunofluorescence. Here again, the
generation and use of transgenic animals that express protein variants coupled
to fluorescent proteins would be a feasible alternative. It has been reported that
the diameter of TT remains unchanged upon cellular contraction [571]. Thus, if
the Dyst negative membrane openings coincide with TT openings, this would
mean that TT are flanked by sarcolemmal Dyst but that they are not directly
associated with it.
The observed openings might also be related to cellular focal adhesion points -
the sites along the cellular membrane that mediate the attachment to the extra-
cellular matrix [572, 558]. Multicolor labeling of Dyst and focal adhesion point
marker proteins such as Vinculin, Paxillin, or the extracellular matrix protein
Laminin could elucidate the possible structural importance of the Dyst nega-
tive membrane regions.
Future directions: strategies for quantitative data analyses
The quantitative analysis of three-color STED images of different Dyst protein
domains (see Fig. 3.40) is complicated by the high fluorescence signal density
and the impossibility of determining whether two signal peaks from different
color channels label the same or two different Dyst proteins.
Potential approaches to still extract information about the molecular orienta-
tion from the data could for example involve the determination of a preferred
directionality of the vectors connecting two labeled protein domains with re-
spect to the longitudinal or transverse cell axes. Since the striated arrangement
of the Dyst N-terminus signal is approximately parallel to the transverse cell
axis, it could likewise be used as an internal reference for the orientation of the
Dyst C-terminus and the Dyst central rod domain along the sarcolemma.
Further, the signal peaks from the three individual color channels could be
treated as “moving” signal peaks from a single channel that were recorded at
three points in time. Based on this abstraction, a correlative image analysis
method - e.g. SpatioTemporal Image Correlation Spectroscopy (STICS, [573]) -
could be used to determine the predominant orientation of the different Dyst
domains with respect to each other and with respect to the sarcolemma.
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Future directions: expansion of the established multicolor immunofluores-
cence labeling protocols
The multicolor immunofluorescence labeling protocols for STED that were es-
tablished in section 3.8 enable very versatile applications. Interesting further
experiments regarding two-color imaging of Cav-3 and different Dyst domains
would comprise studying the effect of Chol depletion on the mutual spatial
arrangement between Cav-3 and the Dyst N-terminus or, primarily, the Dyst
C-terminus. Since the spatial association between Dyst and Cav-3 seems to be
closest at the Dyst C-terminus, Chol depletion might lead to a significant signal
redistribution.
The combination of the three fluorophores NS510 (i.e. STAR520), STAR580, and
STAR635P for STED microscopy with a single STED beam at 775 nm, allows
three-color STED imaging without the need for post-acquisition color channel
registration because the use of only one STED laser intrinsically aligns all three
color channels with subdiffraction precision. Within this labeling scheme, there
are in principle no limits to the choice of the proteins of interest to answer
specific biological questions. Very interesting proteins for three-color STED
imaging would be Cav-3, Dyst and eNOS (see also Fig. 4.1). Their mutual
spatial arrangement could further elucidate the molecular orientation of Dyst
along the cardiac sarcolemma.
Future directions: cardiac membrane nanodomains in disease models
Plenty of published studies using a variety of experimental techniques have
confirmed that cardiac pathologies are closely linked to structural alterations of
the cardiac membrane architecture (see section 1.1). In a side project of this the-
sis, the nanoscopic arrangement of Cav-3 and Dyst structures was investigated
in a mouse model of proliferative cardiac hypertrophy induced by Transverse
Aortic Constriction (TAC) - but no structural changes were observed (data not
shown). Nevertheless, the specific 3D distribution of membrane Chol domains
in VM has so far not been assessed in disease models. Possible and promising
investigations would for example comprise the visualization of Chol nanopat-
terns in disease models of hypertrophy or myocardial infarction. There, one
would expect a decrease in density of the sarcolemmal Chol signal and possi-
bly a dilatation of the observed ring structures formed by Chol.
Further, the Chol nanopattern and the 3D TATS topology in living VM derived
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from Cav-3 knockout mice would be of great interest. Such experiments could
supply valuable information about the interdependence between Cav-3 and
the content and arrangement of Chol within the extracellular membrane leaflet.
In this thesis, I could show that Chol extraction has a profound impact on the
sarcolemmal Cav-3 signal pattern - one would expect that VM devoid of Cav-3
are also devoid of those sarcolemmal Chol nanodomains that are visualized by
Chol-KK114.
Finally, 3D 2P-Exc-CWSTED microscopy of the Chol-OG488 labeled TATS of
mdx or even Dyst knockout mice also enables exciting new experiments. Al-
though it was shown in this thesis that Chol depletion has no effect on the
sarcolemmal signal pattern of the Dyst central rod domain, the 3D structure
of the cardiac membrane system in mdx 5cv mice was not characterized using
a fluorescent Chol analog and the potential importance of Dyst expression for
the specific distribution of membrane Chol remains to be clarified.
Of course, there are many more imaginable future directions to continue the
fascinating studies of the intricate protein and lipid structures and their interac-
tions that allow heart cells to accomplish their demanding and amazing tasks.
Concluding, I can confidently confirm that the heart is an expressive symbol,
an impressive organ - and a huge adventure playground for biophysics.
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A. Lists of materials
A.1. Used chemicals
Chemical/Product Company Order number Application
2, 3-Butanedione
monoxime (BDM)
Sigma-Aldrich,
Munich, Germany
B0753 VM sample prep.;
section 2.3
Bovine Calf Serum (BCS) HyClone via
ThermoFisher
Scientific, Dreieich,
Germany
SH30073 VM sample prep.;
section 2.3
Butanol Merck Chemicals
GmbH, Darmstadt,
Germany
K40272688 Western blots;
section 2.10.2
CaCl2 Sigma-Aldrich,
Munich, Germany
C2661 VM sample prep.;
section 2.3
Collagenase type II Worthington via
Cell Systems,
Troisdorf, Germany
on request VM sample prep.;
section 2.3
cOmplete (protease
inhibitor cocktail)
Roche, Grenzach,
Germany
11836170001 Western blots;
section 2.10.2
Ethylene
Glycol-Tetraacetic Acid
(EGTA)
Sigma-Aldrich,
Munich, Germany
E3889 Western blots;
section 2.10.2
Glucose Carl Roth,
Karlsruhe, Germany
HN06.1 VM sample prep.;
section 2.3
Glycine Carl Roth,
Karlsruhe, Germany
3908.3 Western blots;
section 2.10.2
HEPES Carl Roth,
Karlsruhe, Germany
9105.4 VM sample prep.;
section 2.3
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Chemical/Product Company Order number Application
KCl Carl Roth,
Karlsruhe, Germany
6781.3 VM sample prep.;
section 2.3
KH2PO4 Carl Roth,
Karlsruhe, Germany
3904.2 VM sample prep.;
section 2.3
Laminin (2 mg/ml) BD Biosciences,
Heidelberg,
Germany
354232 VM sample prep.;
section 2.3
Methanol Carl Roth,
Karlsruhe, Germany
8388.6 Western blots;
section 2.10.2
MgCl2 · 6 H2O Carl Roth,
Karlsruhe, Germany
2189.2 VM sample prep.;
section 2.3
MgSO4 · 7 H2O Carl Roth,
Karlsruhe, Germany
8283.2 VM sample prep.;
section 2.3
Milk powder Carl Roth,
Karlsruhe, Germany
T145.2 Western blots;
section 2.10.2
Na2HPO4 · 2 H2O Carl Roth,
Karlsruhe, Germany
4984.2 VM sample prep.;
section 2.3
NaCl Carl Roth,
Karlsruhe, Germany
HN00.2 VM sample prep.;
section 2.3
NaHCO3 Carl Roth,
Karlsruhe, Germany
HN01.1 VM sample prep.;
section 2.3
Paraformaldehyde
(PFA)
Sigma-Aldrich,
Munich, Germany
158127 VM sample prep.;
section 2.3
Phosphate Buffered
Saline (PBS, pH 7.4, w/o
Ca2+ and Mg2+
Life Technologies
via ThermoFisher
Scientific, Dreieich,
Germany
10010 VM sample prep.;
section 2.3
PhosSTOP (phosphatase
inhibitor cocktail)
Roche, Grenzach,
Germany
4906837001 Western blots;
section 2.10.2
Ponceau solution Carl Roth,
Karlsruhe, Germany
5938.2 Western blots;
section 2.10.2
Sodium Dodecyl Sulfate
(SDS)
Carl Roth,
Karlsruhe, Germany
1057.1 Western blots;
section 2.10.2
Taurin Carl Roth,
Karlsruhe, Germany
4721.2 VM sample prep.;
section 2.3
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Chemical/Product Company Order number Application
Tetramethylethylene-
diamine
(TEMED)
Carl Roth,
Karlsruhe, Germany
2367.3 Western blots;
section 2.10.2
Tris Carl Roth,
Karlsruhe, Germany
4855.2 Western blots;
section 2.10.2
Trisphosphine (TCEP) Carl Roth,
Karlsruhe, Germany
HN95.1 Western blots;
section 2.10.2
Triton X-100 Sigma-Aldrich,
Munich, Germany
T9284 VM sample prep.;
section 2.3 and
Western blots;
section 2.10.2
Tween 20 Sigma-Aldrich,
Munich, Germany
P1379 Western blots;
section 2.10.2
Table A.1.: Overview of the chemicals used for the experiments within this PhD work; see also section 2.
A.2. Consumables
Product Company Order number Application
BCA Protein Assay
Kit
ThermoFisher
Scientific, Dreieich,
Germany
#23227 Western blots; section
2.10.2
Chemiluminescent
substrate
Merck Chemicals
GmbH, Darmstadt,
Germany
WKBLSO100 Western blots; section
2.10.2
Protein-Marker V Peqlab via VWR
International GmbH,
Darmstadt, Germany
27-2210 Western blots; section
2.10.2
PVDF Immobilon-FL
transfer membrane
Merck Chemicals
GmbH, Darmstadt,
Germany
IPFL00010 Western blots; section
2.10.2
Table A.2.: Overview of the consumables used for the experiments within this PhD work; see also section 2.
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A.3. Used antibodies
Primary antibodies
Table A.3 gives an overview over the primary antibodies used for the experi-
ments in this thesis. The column “Name” denotes the abbreviation of the spe-
cific antibody as it is referred to in this thesis (mostly in the figure captions);
the column typically reproduces the antibody order number. For staining pro-
tocols, see also sections 2.3.3 and 2.4.
Secondary antibodies
Table A.4 gives an overview over the secondary antibodies used for the ex-
periments in this thesis. Note that most of the compounds of fluorescent dyes
conjugated to secondary antibodies were performed in-house at the MPIBPC
(thanks to Ellen Rothermel) and thus whole compounds were not purchased.
Therefore, the table denotes the species specific secondary antibodies (unla-
beled) that were purchased for conjugation. In combination with the Tables
A.3 and A.5, the possible permutations for the fluorescence labels that were
ultimately used for STED imaging can be derived. For staining protocols, see
also sections 2.3.3 and 2.4.
Species
reactivity
Host
species
Clonality Company Order number
Mouse Goat polyclonal Dianova GmbH,
Hamburg, Germany
115-005-003
Mouse Sheep polyclonal Dianova GmbH,
Hamburg, Germany
515-005-003
Rabbit Goat polyclonal Dianova GmbH,
Hamburg, Germany
111-005-003
Rabbit Sheep polyclonal Dianova GmbH,
Hamburg, Germany
DAB-87967
Goat Donkey polyclonal Dianova GmbH,
Hamburg, Germany
705-005-147
Table A.4.: Overview of the secondary antibodies used for the experiments within this PhD work; for staining proto-
cols, see also sections 2.3.3 and 2.4. Note that most of the compounds of fluorescent dyes conjugated to
secondary antibodies were performed in-house at the MPIBPC (thanks to Ellen Rothermel) and thus whole
compounds were not purchased. Therefore, the table denotes the species specific secondary antibodies
(unlabeled) that were purchased for conjugation. In combination with the Tables A.3 and A.5, the possible
permutations for the fluorescence labels that were ultimately used for STED imaging can be derived.
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308 A. LISTS OF MATERIALS
A.4. Used fluorescent dyes and dye compounds
Dye
(abbreviation)
Company Order number Application
Alexa Fluor 488
(AF488)
ThermoFisher
Scientific, Dreieich,
Germany
A20000 2P-Exc-STED; section
3.4
Alexa Fluor 532
(AF532)
ThermoFisher
Scientific, Dreieich,
Germany
A20001 2P-Exc-STED; section
3.4
ATTO 390 ATTO-TEC, Siegen,
Germany
AD 390-31 2P-Exc-STED; section
3.4
ATTO 425 ATTO-TEC, Siegen,
Germany
AD 425-31 2P-Exc-STED; section
3.4
ATTO 465 ATTO-TEC, Siegen,
Germany
AD 465-31 2P-Exc-STED; section
3.4
ATTO 488 ATTO-TEC, Siegen,
Germany
AD 488-31 2P-Exc-STED; section
3.4
ATTO 495 ATTO-TEC, Siegen,
Germany
AD 495-31 2P-Exc-STED; section
3.4
ATTO 430LS ATTO-TEC, Siegen,
Germany
AD 430LS-31 2P-Exc-STED; section
3.4
ATTO 532 ATTO-TEC, Siegen,
Germany
AD 532-31 2P-Exc-STED; section
3.4
Chromeo 488 Active Motif Inc.,
Carlsbad, CA, USA
15511 2P-Exc-STED; section
3.4
Cholesterol-
BODIPY
Avanti Polar Lipids,
Inc., Alabaster, AL,
USA
810255 775 nm STED; e.g.
section 3.3
Di-8-ANEPPS Molecular Probes, Life
Technologies,
Darmstadt, Germany
D-3167 775 nm STED; e.g.
section 2.1.3
DY 380XL Dyomics GmbH, Jena,
Germany
380XL-01 2P-Exc-STED; section
3.4
DY 505 Dyomics GmbH, Jena,
Germany
505-01 2P-Exc-STED; section
3.4
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Dye Company Order number Application
DY 500XL Dyomics GmbH, Jena,
Germany
On request 2P-Exc-STED; section
3.4
DY 490XL Dyomics GmbH, Jena,
Germany
On request 2P-Exc-STED; section
3.4
NS510 [343] Abberior GmbH,
Goettingen, Germany
(distributed as
STAR520SXP)
1-0101-009-0 Two-color STED;
section 3.7
Oregon Green 488
(OG 488)
ThermoFisher
Scientific, Dreieich,
Germany
O6149 2P-Exc-STED; section
3.4
STAR 440SXP Abberior GmbH,
Goettingen, Germany
1-0101-003-8 2P-Exc-STED; section
3.4
STAR 488 Abberior GmbH,
Goettingen, Germany
1-0101-006-9 2P-Exc-STED; section
3.4
STAR 512 Abberior GmbH,
Goettingen, Germany
1-0101-001-4 2P-Exc-STED; section
3.4
STAR 520SXP Abberior GmbH,
Goettingen, Germany
1-0101-009-0 775 nm STED; e.g.
section 2.1.2
STAR 635P Abberior GmbH,
Goettingen, Germany
1-0101-007-6 775 nm STED; e.g.
section 2.1.2
STAR RED
(KK114)
Abberior GmbH,
Goettingen, Germany
1-0101-011-3 775 nm STED; e.g.
section 2.1.2
Table A.5.: Overview of the fluorescent dye compounds tested and used for the experiments within this PhD work;
see also section 2.
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B. IMAGING SPECIFICATIONS FOR THE PRESENTED FLUORESCENCE
MICROGRAPHS
B. Imaging specifications for the
presented fluorescence
micrographs
Table B.1 lists in detail the following image acquisition parameters for every
fluorescence micrograph obtained and presented in the main text of this thesis:
1.) The microscope used for image acquisition (column “Microscope”): the
custom-built Two-Photon-Excitation-CW-STED (2P-Exc-CWSTED) micro-
scope (see section 2.1.1), the custom-built fast scanning STED (F-Scan
STED) microscope (see section 2.1.2), the commercially available Leica
TCS SP8 STED 3X (Leica STED) STED microscope (see section 2.1.3), or
the commercially available Abberior 2C STED 775 QUAD Scan (Abberior
STED) STED microscope (see section 2.1.4).
2.) The used excitation wavelength (in nm) including the reference to the
corresponding used fluorescent dye or dye compound, and the set laser
power (in µW or mW) in the backfocal plane of the objective, denoted as
λExc [nm] (dye), PExc. For the commercial STED systems (Leica STED and
Abberior STED), the excitation power can only be stated in % of the total
laser output power because this is the standard information about the set
laser power given by the microscope control software. For information
about the used dye compounds, please refer to Appendix A.4.
3.) The used STED wavelength (in nm) and the set laser power (in mW) in
the backfocal plane of the objective, denoted as λSTED [nm], PSTED. For the
commercial STED systems (Leica STED and Abberior STED), the STED
laser power can only be stated in % of the total laser output power be-
cause this is the standard information about the set laser power given by
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the microscope control software. If the image was obtained in the confo-
cal (Conf.) mode or in the Two-Photon-Excitation (2P-Exc) mode, i.e. if
no STED laser was used, it is stated explicitly.
4.) The used fluorescence detection window (in nm), denoted as “Det. [nm]”.
5.) The set pixel dwell time (in ms), denoted as “px DT [ms]”.
6.) The set pixel size (in nm), denoted as “px size [nm]”. For two-dimensional
images, the pixel size is given in (X×Y) direction; for three-dimensional
images, the pixel size is given in (X×Y×Z) direction, i.e. for simplicity,
here, pixels can be both two- and three-dimensional containers, depend-
ing on the type of image for which they are defined.
Figure 1.) 2.) 3.) 4.) 5.) 6.)
Fig. 1.1 B 2P-Exc-
CWSTED
760 (Chol-OG488),
10 mW
2P-Exc (530 ± 20) 0.02 (40× 40× 200)
Fig. 3.3 Abberior
STED
640 (Chol-KK114),
2 %
775, 80 % (675 ± 25) 0.04 (20× 20)
Fig. 3.4 Abberior
STED
640 (Chol-KK114),
2 %
775, 80 % (675 ± 25) 0.04 (20× 20)
Fig. 3.5 Leica STED 640 (Chol-KK114),
1 %
775, 60 % (670-740) 0.017 (20× 20)
Fig. 3.6 B F-Scan STED 638 (Chol-KK114),
5 µW
750, 300 mW (675 ± 30) 0.02 (20× 20)
Fig. 3.8 Leica STED 490/640 (Chol-
BODIPY/Chol-
KK114),
5 %/1 %
Conf. (505-
570)/(670-740)
0.017 (20× 20)
Fig. 3.9 Leica STED 490/640 (Di-8-
ANEPPS/Chol-
KK114),
10 %/1 %
775, 80 % (510-
620)/(670-740)
0.017 (20× 20)
Fig. 3.10 F-Scan STED 638 (Chol-KK114),
5 µW
750, 300 mW (675 ± 30) 0.02 (20× 20)
Fig. 3.11 F-Scan STED 638 (Chol-KK114),
5 µW
750, 300 mW (675 ± 30) 0.02 (20× 20)
Fig. 3.13 A 2P-Exc-
CWSTED
757 (YG
FluoBeads),
20 mW
2P-Exc (525 ± 25) 0.02 (20× 20)
Fig. 3.13 B 2P-Exc-
CWSTED
757 (YG
FluoBeads),
20 mW
592, 240 mW (525 ± 25) 0.05 (20× 20)
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MICROGRAPHS
Figure 1.) 2.) 3.) 4.) 5.) 6.)
Fig. 3.15 2P-Exc-
CWSTED
cf. Table 3.2 592, cf. Table
3.2
cf. Table 3.2 0.05 (20× 20)
Fig. 3.16 2P-Exc-
CWSTED
760 (Chol-OG488),
10 mW
2P-Exc (530 ± 20) 0.02 (40× 40× 200)
Fig. 3.17 2P-Exc-
CWSTED
760 (Chol-OG488),
10 mW
2P-Exc (530 ± 20) 0.02 (40× 40× 200)
Fig. 3.18 2P-Exc-
CWSTED
760 (Chol-OG488),
10 mW
592, 240 mW (530 ± 20) 0.05 (20× 20)
Fig. 3.19 2P-Exc-STED 760 (Chol-OG488),
10 mW
592, 240 mW (530 ± 20) 0.05 (20× 20× 200)
Fig. 3.20 2P-Exc-STED 760 (Chol-OG488),
10 mW
592, 240 mW (530 ± 20) 0.05 (20× 20× 200)
Fig. 3.21 2P-Exc-
CWSTED
760 (Chol-OG488),
10 mW
592, 240 mW (530 ± 20) 0.05 (20× 20)
Fig. 3.22 F-Scan STED 638 (Chol-KK114,
STAR635P), 5 µW
750, 300 mW (675 ± 30) 0.02 (20× 20)
Fig. 3.24 Leica STED 640 (Chol-KK114,
STAR635P), 1 %,
0.8 %
775, 70 %,
100 %
(670-740) 0.017 (20× 20)
Fig. 3.25 Abberior
STED
640 (Chol-KK114,
SiR), 5 %, 12 %
775, 70 %,
80 %
(675 ± 25) 0.04 (20× 20)
Fig. 3.26 Abberior
STED
561/640 (580CP-
BG(SNAP)/Chol-
KK114),
20 %/5 %
775, 60 % (620 ±
10)/(675 ±
25)
0.04 (20× 20)
Fig. 3.27 F-Scan STED 638 (STAR635P),
5 µW
750, 300 mW (675 ± 30) 0.02 (20× 20)
Fig. 3.29 Abberior
STED
561/640
(CtB-AF594/Chol-
KK114),
20 %/10 %
775, 50 % (620 ±
10)/(675 ±
25)
0.05 (20× 20)
Fig. 3.30 Abberior
STED
561/640
(CtB-AF594/Chol-
KK114),
20 %/5 %
775, 70 % (620 ±
10)/(675 ±
25)
0.04 (20× 20)
Fig. 3.32 F-Scan STED 638 (STAR635P),
5 µW
750, 300 mW (675 ± 30) 0.02 (20× 20)
Fig. 3.33 F-Scan STED 532/638
(NS510/STAR635P),
20 µW/5 µW
750, 300 mW (620 ±
30)/(675 ±
30)
0.02 (20× 20)
Fig. 3.34 F-Scan STED 532/638
(NS510/STAR635P),
20 µW/5 µW
750, 300 mW (620 ±
30)/(675 ±
30)
0.02 (20× 20)
Fig. 3.36 A Leica STED 640 (STAR635P),
1 %
775, 80 % (670-740) 0.017 (20× 20)
Fig. 3.36 B Leica STED 530 (NS510), 40 % 775, 40 % (550-650) 0.017 (20× 20)
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Figure 1.) 2.) 3.) 4.) 5.) 6.)
Fig. 3.36 C Leica STED 580 (STAR580),
5 %
775, 100 % (600-650) 0.017 (20× 20)
Fig. 3.37
A-F
Leica STED 580/640
(STAR580/STAR635P),
4 %/2 %
775, 100 % (600-
630)/(670-740)
0.017 (20× 20)
Fig. 3.39
A-F
Leica STED 580/640
(STAR580/STAR635P),
5 %/5 %
775, 80 % (600-
630)/(670-740)
0.017 (20× 20)
Fig. 3.41 Leica STED 640 (STAR635P),
5 %/5 %
775, 80 % (600-
630)/(670-740)
0.017 (20× 20)
Table B.1.: Overview of all fluorescence micrographs that are presented in the main text of this thesis and detailed
information about the corresponding image acquisition procedures. Please refer to the main text of this
section (Appendix B) for the description and explanation of the given parameters and used abbreviations.
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C. Plasmid construction for
transfection of living culture
cells
Fluorescence imaging of living cultured cells overexpressing human Caveolin-
3 was achieved by transfecting cells with the expression plasmid pSEMS-CAV3-
SNAP. This expression plasmid was constructed by Gateway vector conversion
from the donor vector pDONR223-Cav3 ([574]) and the empty destination vec-
tor pSEMS-GATEWAY-SNAP26m (Covalys Biosciences, Witterswil, Switzer-
land) [415, 416]. Cell transfection of living cultured cells with this plasmid,
fluorescent tagging, and imaging was performed as described in section 2.4.1.
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D. Control experiments
D.1. Differentiation of ventricular induced
pluripotent stem cells
To validate that the ventricular induced pluripotent stem cells (ViPSC) stained
with the novel cell-specific membrane marker Cholesterol-PEG-KK114 (Chol-
KK114, see section 3.1) were fully and properly differentiated, a portion of the
cells was stained for α-Actinin via indirect immunofluorescence as described
in section 2.4.2. I chose the indirect immunofluorescence stain of α-Actinin in
fixed ViPSC to motivate the successful differentiation protocol and the struc-
tural similarities between ventricular mouse cardiomyocytes (VM). α-Actinin,
an Actin-binding protein involved in the formation of Z-lines, is widely used
in the literature as a cardiomyocyte marker protein to validate the proper phys-
iological state of cardiomyocytes [487] and the proper differentiation of other
cells types induced to be cardiomyocytes [488, 482]. Surely, some of the ViPSC
in a cell culture have features which distinguish them from fully differentiated,
mature VM: they are of a smaller size, they do not show the characteristic rod-
like shape of mature VM, they lack transverse tubules and have other structural
and functional differences from VM as summarized for example in [480, 485].
Yet, the stain against α-Actinin presented in Figure D.1 for both ViPSC and VM
show that the striated pattern of the cells is well-developed and widespread
over almost all ViPSC in the sample which hints towards a global cytoskeletal
scaffolding comparable to mature VM. Additionally to this control for appro-
priately developed striations in ViPSC, we paid special attention to select only
those ViPSC for image analysis of the nanopatterns of Cholesterol domains at
the basement membrane, as presented in section 3.2, that were of the approxi-
mate same cell size as VM and that had the same rod-shaped appearance. For
example, the ViPSC marked with the yellow box in Figure D.1 A would be
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a candidate for display and analysis of a Chol-KK114 surface signal. Images
were obtained in confocal mode using the Leica TCS SP8 STED 3X (see section
2.1.3). Samples were excited at 635 nm at 2 % laser power and their fluorescence
signal recorded within a detection window of (650 − 750) nm.
Figure D.1.: Verification of the full and proper differentiation of ventricular induced pluripotent stem cells (ViPSC).
Confocal immunofluorescence images of fixed ViPSC and fixed ventricular mouse cardiomyocytes (VM)
stained for α-Actinin. A Confocal immunofluorescence images of ViPSC stained for α-Actinin. Cell line:
iWT.D2.1o; differentiation for 120 days. Primary antibody: monoclonal mouse anti-α-Actinin (A7811,
Sigma-Aldrich GmbH, Munich, Germany); secondary antibody: goat anti-mouse-STAR635P (2-0002-
00705, Abberior GmbH, Goettingen, Germany). Left panel: overview scan (field of view: (150 × 150)
µm2) demonstrating the extent of cell differentiation using the striated α-Actinin signal as a control; scale
bar: 20 µm. Right panel: zoom-in to the yellow boxed region of interest in the overview scan; field of
view: (30 × 30) µm2; scale bar: 5 µm. B Confocal image of one VM stained for α-Actinin; field of view:
(80 × 23) µm2; primary and secondary antibodies as in A; scale bar: 5 µm.
D.2. Differentiation of human adipocytes
To validate that the human adipocytes stained with the novel cell-specific mem-
brane marker Chol-KK114 (see sections 3.2 and 3.5) were fully and properly
differentiated, a portion of the cells was stained with the lipid marker Oil Red
O (ORO) as described in section 2.4.3. Figure D.2 displays the ORO signal in
undifferentiated human preadipocytes (HPAd, derived from adult heart adi-
pose tissue) versus the ORO signal in differentiated human adipocytes (HAd).
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Figure D.2.: Verification of the full and proper differentiation of human adipocytes. Human preadipocytes (HPAd, i.e.
undifferentiated) and fully differentiated human adipocytes (HAd, see section 2.4.3) were stained with
the lipid marker Oil Red O (ORO) as described in section 2.4.3 to detect lipid droplets. Scale bars: 20 µm.
A Confocal image of fixed human preadipocytes (HPAd) from adult heart adipose tissue, stained with
ORO. Accumulations of ORO signal are visible but lipid droplets cannot be identified. B Confocal image
of fixed human adipocytes (HAd) stained with ORO after differentiation following the protocol described
in section 2.4.3. Clearly visible lipid droplets validate the full differentiation of HPAd to HAd.
Images were obtained in confocal mode using the Leica TCS SP8 STED 3X (see
section 2.1.3). Samples were excited at 560 nm at 11 % laser power and their
fluorescence signal recorded within a detection window of (605 − 720) nm.
There was also an attempt to record the ORO signal in STED imaging mode,
yet it did not yield feasible results (data not shown).
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E. Comparison of fluorescent lipids
for membrane labeling
Several fluorescent lipids were screened and tested in search of membrane la-
beling techniques of living mouse ventricular cardiomyocytes (VM) for high-
quality STED imaging. As presented in the main text (cf. section 3.3), Cho-
lesterol-PEG-KK114 (Chol-KK114) proved to be a superior live-cell membrane
label. Here, an overview of additionally tested fluorescent lipids is presented.
VM were labeled with the respective lipids in a protocol similar to the one
described for Chol-KK114 (see section 2.3.2). Fig. E.1 displays the resulting
confocal (Conf.) and STED images of stained VM.
Figure E.1.: Additionally investigated fluorescent lipids for membrane labeling in living mouse ventricular cardiomy-
ocytes (VM). A Top row: Confocal (Conf.) and STED images of a living VM labeled with DPPE-KK114.
Middle row: Conf. and STED images of a living VM labeled with Sphingomyelin-KK114. Bottom row:
Conf. and STED images of a living VM labeled with CPE-ATTO590. Scale bars: 1 µm. B Top: Conf. and
STED images of a living VM labeled with Cholesterol-BODIPY (Chol-BODIPY); scale bars: 10 µm. Bottom:
Absorption (black line) and emission (red line) spectra of the fluorescent lipid Chol-BODIPY.
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Fig. E.1 A shows VM labeled with 1,2-Dipalmitoyl-sn-glycero-3-phosphoetha-
nolamine linked to the dye KK114 (DPPE-KK114, top row), with Sphingomy-
elin linked to the dye KK114 (middle row), and with lipopeptide CPE [575]
linked to the dye ATTO590 (CPE-ATTO590, bottom row), respectively. All
three fluorescent lipid compounds were prepared at the Max Planck Institute
for Biophysical Chemistry (the dye ATTO590 was obtained as carboxylic acid
from Atto-tec GmbH, Siegen, Germany) and were used in a STED imaging
scheme employing a STED laser wavelength of 750 nm (KK114 and ATTO590
were excited at 635 nm and 532 nm, respectively. DPPE-KK114 shows a very
high degree of cellular internalization which makes the identification of a mem-
brane-specific signal impossible for both the confocal as well as the STED im-
age. Sphingomyelin-KK114 shows a low degree of cellular internalization and
a membrane-specific signal (i.e. T-Tubule structures) are visible. However, the
fluorescence images show a nonspecific background signal which is especially
pronounced in the STED image, rendering it unsuitable for nanoscopic studies
of cardiac membrane patterns. CPE-ATTO590 shows insufficient membrane
penetration, cannot access intracellular membrane structures and seems to be
exclusively confined to the sarcolemma.
Fig. E.1 B shows a VM labeled with Cholesterol linked to the dye BODIPY
(Chol-BODIPY, top row). Chol-BODIPY was purchased from Avanti Polar Li-
pids, Inc., Alabaster, AL, USA (order number: 810255) and used in STED imag-
ing scheme with excitation at 490 nm and a CW-STED laser at 592 nm. Al-
though the dye compound seems suitable for confocal imaging, the STED im-
ages show an unfortunate artefact due to the STED laser illumination which
manifests itself as “ripple” around the labeled structures. A more in-depth
investigation of the absorption and emission spectrum of Chol-BODIPY (see
Fig. E.1 B, bottom row) revealed a profound absorption peak at ≈ 580 nm,
i.e. very close to the STED laser wavelength (marked with a dotted purple cir-
cle). Although the reasons for this additional, red-shifted absorption peak of
Chol-BODIPY is not clear, there have been studies reporting the concentration
dependent appearance of an additional red-shifted emission peak of BODIPY
both in its free form [576], and when coupled to membrane lipids [577]. This
additonal, redder emission peak has been attributed to the formation of BOD-
IPY dimers. A red-shifted absorption peak of BODIPY has not yet been re-
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ported, yet dimerization of the compound might play a role in this observed
effect. All in all, labeling VM with Chol-BODIPY is not compatible with CW-
STED imaging at 592 nm. Using a pulsed STED laser 775 nm, however, did not
switch off the dye molecules efficiently enough for a visible increase in image
resolution.
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F. Visualization of surface density
determination
Here, in Fig. F.1, the procedure of image thresholding and binarization that
is described in section 2.6.4 to determine the density of different fluorescence
signal structures at the basement membrane and/or in filopodia of various cell
types (discussed in sections 3.2, 3.3, and 3.5) is illustrated. The obtained surface
signal density is generally denoted as ρ and given in % of the total area of a
specific region of interest (ROI) extracted from a recorded image. Fig. F.1 A ex-
emplarily shows a raw data STED image of the sarcolemmal Cholesterol-PEG-
KK114 (Chol-KK114) signal in a living mouse ventricular cardiomyocyte (VM)
and the binarized image extracted from it after the pixel based thresholding
procedure described in section 2.6.4. Fig. F.1 B illustrates the image processing
steps to arrive at the necessary for the determination of the surface signal den-
sity in filopodia (ρFilo, here, for the Chol-KK114 signal). These steps include:
1.) the manual identification and selection of filopodial structures (Fig. F.1, B,
top row), 2.) the determination of the area of the Chol-KK114 signal within the
filopodial structure (Fig. F.1, B, middle row), and 3.) the determination of the
total area of the respetive filopodial structure (Fig. F.1, B, bottom row). ρFilo
is then calculated as the ratio of the Chol-KK114 signal within the filopodial
structure divided by the total area of that filopodial structure. Fig. F.1 C and
D demonstrate the profound increase in accuracy regarding the determination
of ρdue to the much higher object resolution that is achievable with subdiffrac-
tion STED microscopy opposed to diffraction limited confocal microscopy. Fig.
F.1 C displays the raw data confocal (conf., top row) and STED (bottom row)
image of a fixed VM labeled for Caveolin-3 (Cav-3) via indirect immunofluo-
rescence, respectively, and their corresponding binarized image analogs. From
many such (conf. and STED) binarized images, ρ was determined and its de-
rived arithmetic mean ± standard deviation displayed in the bar graphs in
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Figure F.1.: Schematic of the image thresholding procedure applied for the determination of the surface signal density
ρ (see section 2.6.4) both at the basement membrane and in filopodia of selected cell types, and comparison
between the values of ρ extracted from confocal images and their analogous STED images. A Exemplary
STED image of the sarcolemma of a living primary mouse ventricular cardiomyocyte (VM) stained with
the membrane label Cholesterol-PEG-KK114 (Chol-KK114). The upper panel shows the raw image; the
lower panel shows the corresponding image after performing the thresholding (thr.) procedure described
in section 2.6.4. Scale bars: 1 µm. B Exemplary STED images of filopodial structures in U2OS cells stained
with Chol-KK114 and schematic illustration of the procedure for the determination of ρ in filopodia. Top
row: raw STED overview image of the Chol-KK114 signal in U2OS cells and magnified view of a selected
filopodial region of interest (ROI) marked by the yellow box. The filopodial structures in the ROI are
manually cropped along the marked yellow line in the inset as described in section 2.6.4 Middle row:
schematic illustration of the determination of the area of Chol-KK114 signal (in black in the thresholded
image). Bottom row: schematic illustration of the determination of the total area of filopodia within the
selected ROI. Scale bar in U2OS-Chol-KK114 overview STED image: 10 µm; scale bars in all ROI images:
2 µm. C Exemplary images of a fixed VM stained for Caveolin-3 (Cav-3) via indirect immunofluorescence
(see section 2.3.3). The two panels on the left show the confocal and the corresponding STED image of
a region of interest extracted for the determination of ρ. The two panels on the right show the confocal
and STED image after signal thresholding. All scale bars: 1 µm. D Bar graph representation of the Cav-3
surface signal density ρ in VM determined from confocal images (in black) vs. STED images (in red). The
density ρ is given in % of the total sarcolemmal cell area and is presented as mean ± standard deviation.
Statistical significance of the variation of ρ was determined by a two-sided Mann-Whitney-Wilcoxon U test
(MWW, see section 2.9) and is displayed as: (**) - very significant (p ≤ 0.001). Number of analyzed cells in
confocal imaging mode: 10; number of analyzed cells in STED mode: 44 (MWW U statistic: Uconfocal = 0;
USTED = 710; p-value: 3.59 ± 10-7).
Fig. F.1 D. As can be seen from the results shown in Fig. F.1 D, while the
confocal images suggest that about 42 % of the sarcolemma of a living VM is
covered with Chol rich clusters, the STED images reveal that a mere 24 % of the
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sarcolemma is covered with Chol rich clusters - i.e. only about half of the Chol-
KK114 surface signal density that would be extracted from confocal images.
This demonstrates that only about one quarter of the sarcolemmal of a living
VM features regions with a high Chol content, meaning that the sarcolemma
is probably more heterogeneous regarding its specific lipid content and proba-
bly less curved than it would be expected from purely confocal studies of the
distribution of Chol rich cardiac membrane regions.
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G. Custom-built 2P-Exc-CWSTED
microscope and suitable
fluorescent labels
Please refer to sections 3.4.1 and 3.4.2 for a detailed description and charac-
terization of the custom-built Two-Photon-Excitation-CW-STED (2P-Exc-CW-
STED) microscope, its performance and capabilities as well as the results and
the discussion of the identification and investigation of fluorescent labels suit-
able for 2P-Exc-CWSTED, specifically for the generation of fluorescent Choles-
terol analogs to label membrane structures in living mouse ventricular my-
ocytes.
G.1. Gated vs. un-gated
Two-Photon-Excitation-CW-STED microscopy
The importance of fluorescence signal time gating in two-photon-excitation-
CW-STED (2P-Exc-CWSTED) microscopy is demonstrated in Figure G.1 based
on recording yellow-green fluorescent beads (40 nm diameter) in the follow-
ing three configurations: ungated two-photon-excitation (2P-Exc), ungated 2P-
Exc-CWSTED, and gated 2P-Exc-CWSTED. Images were obtained using the
custom-built 2P-Exc-CWSTED microscope described in section 2.1.1 with the
2P-Exc wavelength set to 760 nm and fluorescence detection within a range of
(530 ± 20 nm). For the gated detection of the fluorescence 2P-Exc-CWSTED
signal, the gate delay was set to 3.74 ns, the gate width was set to 9.88 ns with
respect to the incoming 2P-Exc laser pulses. The image resolution of individ-
ual beads was determined by curve fitting of summed signal intensity profiles
with Gaussian curve fitting for the 2P-Exc case and Lorentzian curve fitting for
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Figure G.1.: Comparison of image resolution for the following three imaging modes: ungated 2P-Exc (left column); un-
gated 2P-Exc-CWSTED (middle column); gated 2P-Exc-CWSTED (right column). Images show overview
scans of the same field of view (top row, scale bars: 2 µm) and exemplary magnifications to individual
fluorescent beads (middle row, scale bars: 100 nm). The graphs of normalized fluorescence intensity (FI,
norm.) profiles below the corresponding image were obtained from the summation of pixel intensity
counts within the yellow boxes indicated in the overview images; profiles were summed over 25 pixels,
corresponding to 500 nm, in the x direction. Image resolutions were determined as the full width at half
maximum from either Gaussian (in the 2P-Exc case) or Lorentzian (in the 2P-Exc-CWSTED case) curve
fitting (see section 2.6.2) and are explicitly stated in the graphs.
the 2P-Exc-CWSTED case (see section 2.6.2). The image resolution was then de-
termined as the FWHM of the fitted PSFs. Comparing the resulting FWHM of
the ungated 2P-Exc-CWSTED PSF (FWHM ≈ 130 nm) with that of the 2P-Exc
PSF (FWHM ≈ 150 nm) brings about only a small increase in image resolution
while by fluorescence time gating the 2P-Exc-CWSTED PSF can be reduced by
a factor of three (FWHM ≈ 45 nm).
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G.2. 2P-Exc-STED at a 1 GHz 2P-Exc repetition rate
To evaluate the achievable image resolution employing a two-photon-excita-
tion (2P-Exc) laser with a repetition rate of 1 GHz (GigaJet TWIN 20c/20c,
Laser Quantum, Konstanz, Germany) for (two-photon-Excitation-CW-STED)
2P-Exc-CWSTED applications, I recorded images of fixed Vero cells immunoflu-
orescently labeled for the cytoskeletal protein Tubulin with the dye compound
DY 380XL (see Appendix A.4) in both 2P-Exc as well as 2P-Exc-STED mode. It
has to be kept in mind, that due to the lack of appropriate electronics, it was not
possible to set up a time gate for the fluorescence signal detected by the APD
with respect to the incoming 2P-Exc laser pulses (i.e. laser pulses of about 300 fs
pulse width at a frequency of 1 pulse per nanosecond). Figure G.2 A compares
the 2P-Exc image and the 2P-Exc-STED image obtained at a 2P-Exc repetition
rate of 1 GHz. The obtained intensity profile in 2P-Exc mode was fitted to a
Gaussian function; the intensity profile in 2P-Exc-STED mode was fitted to a
Lorentzian function (see section 2.6.2). The image resolution was determined
as the full width at half maximum (FWHM) of the respective fit curve. Using
the GigaJet Twin 20c/20c laser for 2P-Exc with a repetition rate of 1 GHz - and
thus no fluorescence signal time gating - yielded the following results for the
image resolution: 2P-Exc image - 190 nm; 2P-Exc-STED image - 140 nm (Fig.
G.2 A). On the other hand, for comparison, Fig. G.2 B shows an analogous
spot in a different cell, yet in the same sample, employing a 2P-Exc laser with a
repetition rate of 80 MHz (Mai Tai, Newport Spectra-Physics, Darmstadt, Ger-
many), see also Appendix G.1. The panels in Fig. G.2 B show, from left to
right, the 2P-Exc image, the ungated 2P-Exc-STED image, and the gated 2P-
Exc-STED image with a time gate delay of 0.86 ns and a time gate width of
9.92 ns. Below each respective panel, the obtained image resolution from curve
fitting analogously to Fig. G.2 A is displayed and amounts to: 2P-Exc image
- 190 nm; ungated 2P-Exc-STED image - 100 nm; gated 2P-Exc-STED image -
45 nm. This demonstrates the non-applicability of a 2P-Exc laser operating at
a repetition rate of 1 GHz which is most likely entirely due to the unrealizable
time gating of the detected fluorescence signal.
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Figure G.2.: Comparison of image resolution for the following 5 imaging modes: 2P-Exc at a laser repetition rate of 1
GHz (A, left panel); ungated 2P-Exc-CWSTED at a laser repetition rate of 1 GHz (A, right panel); 2P-Exc
at a laser repetition rate of 80 MHz (B, left panel); ungated 2P-Exc-CWSTED at a laser repetition rate of
80 MHz (B, middle panel); gated 2P-Exc-CWSTED at laser repetition rate of 80 MHz and with a time
gate delay of 0.86 ns and a time gate width of 9.92 ns (B, right panel). The graphs of normalized intensity
profiles below the corresponding images were obtained from line profiles along the indicated yellow lines
in the image; line profiles were averaged over 5 pixels, corresponding to 100 nm. Image resolutions were
determined as the full width at half maximum from either Gaussian (in the 2P-Exc case) or Lorentzian
(in the 2P-Exc-CWSTED case) curve fitting (see section 2.6.2) and are explicitly stated in the graphs. Scale
bars (in white): 1 µm.
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G.3. Characterization of 2P-Exc-STED bleaching
curves
The bleaching curves of different antibody-conjugated dye compounds, shown
in section 3.4.2, were fit with mono-, bi-, and triexponential decay functions, re-
spectively in order to assess which model would best describe the photobleach-
ing behavior. Curve fitting based on the Levenberg-Marquardt algorithm was
performed in Origin using the standardly built-in exponential decay functions.
Here, the resulting curve fits and the corresponding regular residuals are ex-
emplarily shown for the dye DY 380XL in Fig. G.3. The investigation of dif-
ferent fit functions was analogously performed for the dyes ATTO 488, AF 488,
and STAR 488 and yielded the same qualitative results. While the use of a
bi-exponential decay function (Fig. G.3 B) is clearly more adequate to model
the bleaching behavior than a mono-exponential decay function (Fig. G.3 A),
the introduction of a third exponential term for curve fitting (Fig. G.3 C) does
not notably increase the goodness of fit and would only add unnecessary com-
plexity. Conclusively, the bleaching behavior of dyes under 2P-Exc-STED con-
ditions is most comprehensively described by a bi-exponential decay.
G.4. ATTO 390 and ATTO 425 for 2P-Exc-CWSTED
Figure G.4 demonstrates the unsuitability of the antibody-coupled dye com-
pounds ATTO 390 and ATTO 425 for 2P-Exc-CWSTED applications based on
labeling Tubulin structures in fixed Vero cells via indirect immunofluorescence.
Although the two dyes seemed promising regarding their spectral properties
and their photostability (see section 3.4.2), they did not yield convincing im-
ages. ATTO 390 (Fig. G.4 A) showed a relatively high background signal
and rather blurred structures in 2P-Exc mode. No profound increase in im-
age resolution in 2P-Exc-CWSTED mode was observable. ATTO 425 (Fig. G.4
B) showed highly unspecific structure labeling and both 2P-Exc images and 2P-
Exc-CWSTED images had a low signal-to-noise ratio and were badly resolved.
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Figure G.3.: Comparison mono-, bi- and triexponential curve fits to model the bleaching behavior of the exemplary
antibody-conjugated dye DY 380XL. Bleaching curves were obtained from successively scanning 20 im-
age frames of immunofluorescence labeled Vero cells under two-photon-excitation-STED conditions, see
section 3.4.2. A Mono-exponential curve fit (left, red line) and corresponding residuals (right). B Bi-
exponential curve fit (left, red line) and corresponding residuals (right). C Triexponential curve fit (left,
red line) and corresponding residuals (right). The smaller the residuals, the higher the goodness of the
respective curve fit.
G.5. Performance of the alternative fluorescent
Cholesterol analogs Chol-DY380XL,
Chol-AF488, and Chol-STAR488
The dyes DY 380XL, AF 488, STAR 488, and OG 488 all showed high potential
for membrane labeling of living cardiomyocytes for 2P-Exc-CWSTED - at least
based on their spectroscopic properties, bleaching behavior and performance
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Figure G.4.: Fixed Vero cells stained for the cytoskeletal protein Tubulin via indirect immunofluorescence with the dye
compounds ATTO 390 and ATTO 425. Comparison of images obtained in two-photon-excitation (2P-Exc)
mode and two-photon-excitation-CW-STED (2P-Exc-CWSTED) mode to demonstrate the unsuitability of
the respective dye compounds for 2P-Exc-CWSTED applications. All images show raw data; images were
obtained at the apical cell membrane imaging through the cell nucleus. Scale bars: 1 µm. A 2P-Exc image
(left panel) and 2P-Exc-CWSTED image (right panel) of Tubulin decorated with ATTO 390. There is no
noticeable gain in image resolution in the 2P-Exc-CWSTED image. B 2P-Exc image (left panel) and 2P-
Exc-CWSTED image (right panel) of Tubulin decorated with ATTO 425. The 2P-Exc image is diffuse and
labeling seems to be unspecific. The 2P-Exc-CWSTED image brings about no gain in neither information
nor image resolution.
when imaging fixed cell samples (see section 3.4.2). However, after having cou-
pled these dyes to Cholesterol-PEG derivatives, I could identify the resulting
Chol-OG488 as the most suitable membrane label based on image quality and
cell compatibility. Here, Figure G.5 gives an exemplary overview of the im-
ages membrane structures in living mouse ventricular cardiomyocytes (VM) I
obtained with 2P-Exc-CWSTED microscopy when using Chol-DY380XL, Chol-
AF488, and Chol-STAR488, respectively. These images illustrate why I chose
Chol-OG488 for further investigations (see section 3.4.3). Labeling VM with
Chol-DY380XL (Fig. G.5, upper row) resulted in a diffuse, unspecific signal
which is probably due to a fast cellular internalization of the label, and/or due
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Figure G.5.: Performance of the fluorescent Cholesterol analogs Chol-DY380L, Chol-AF488, and Chol-STAR488 in two-
photon-excitation (2P-Exc) and two-photon-excitation-CW-STED (2P-Exc-CWSTED) microscopy of mem-
brane structures in living mouse ventricular cardiomyocytes (VM). VM were stained with 5 µM of the
respective fluorescent Cholesterol analog according to the protocol described in section 2.3.2. Images
show unprocessed data; scale bars: 1 µm. Chol-DY380XL (upper row) shows a diffuse and unspecific sig-
nal in both 2P-Exc as well as 2P-Exc-CWSTED mode. Chol-AF488 and Chol-STAR488 (middle and bottom
row, respectively), albeit showing a good switch-off behavior and image resolution in 2P-Exc-CWSTED
mode, both membrane labels subject the VM to substantial stress, resulting in membrane blebbing and
vesicle formation (yellow arrows) soon after cell staining.
to a high affinity of Chol-DY380XL to the cardiac mitochondria. Chol-AF488
(Fig. G.5, middle row) and Chol-STAR488 (Fig. G.5, bottom row) both show a
very bright and membrane-specific signal in 2P-Exc mode. In 2P-Exc-CWSTED
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mode, Chol-AF488 shows a good switch-off behavior and high signal-to-noise
ratio resulting in a profound increase in image resolution. Chol-STAR488, on
the other hand, is less suitable for 2P-Exc-CWSTED microscopy as it shows a
poor signal-to-noise ratio with a high amount of unspecific background fluo-
rescence. Both Chol-AF488 and Chol-STAR488 exhibit the living cells to a high
degree of cellular stress which results in membrane blebbing (as marked by
the yellow arrows in the respective images) and cell contraction (not visible in
the images) within a short time after staining, typically within 10 min. Addi-
tionally, Chol-AF488 had a seemingly high potential for phototoxicity as cells
could neither sustain extended laser illumination nor an increase in illumina-
tion intensity when they were stained with Chol-AF488. Similar illumination
protocols were far less critical for the cells when being stained with the other
prepared fluorescent Cholesterol analogs.
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H. Supporting material:
2P-Exc-CWSTED of Chol-OG488
labeled living VM
Please refer to section 3.4.3 for a detailed description of the results and the
discussion of Two-Photon-Excitation-CW-STED (2P-Exc-CWSTED) imaging of
living mouse ventricular cardiomyocytes (VM) labeled with the fluorescent
Cholesterol (Chol) analog Chol-PEG-OregonGreen488 (Chol-OG488).
H.1. 2P-Exc-CWSTED of Chol-OG in live VM - raw
data image stack at different depths in the cell
Figure H.1 shows the raw data of Two-Photon-Excitation-CW-STED (2P-Exc-
CWSTED) images of a living mouse ventricular cardiomyocytes (VM) stained
with Cholesterol-PEG-OregonGreen488 (Chol-OG488) and recorded at differ-
ent depths within the cell. The images are the raw data analogs to the smoothed
images presented in section 3.4.3, Fig. 3.18. The imaging depths are given in
µm beneath the sarcolemma and range from -0.4 µm to -2.0 µm. VM were
stained with Chol-OG488 as described in section 2.3.2 at a concentration of 5
µM of Chol-OG488. 2P-Exc at a wavelength of 760 nm was performed at 10
mW and STED at a wavelength of 592 nm was performed at 50 mW (measured
in a back focal plane of the objective, respectively). The fluorescence signal was
time gated with a delay of 2.42 ns and a gate width of 9.80 ns. The lateral pixel
size was set to 20 nm in the X- and Y-direction, respectively and 200 nm for the
Z-direction; the pixel dwell time was set to 0.05 ms. The resolution of trans-
verse tubular membrane structures (see also section 2.6.2) was determined by
first extracting the summed up fluorescence intensity along the yellow line and
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Figure H.1.: Two-Photon-Excitation-CW-STED (2P-Exc-CWSTED) raw data images of a living mouse ventricular car-
diomyocyte (VM) stained with Cholesterol-PEG-OregonGreen488 (Chol-OG488), see also section 3.4.3.
VM were stained as described in section 2.3.2 and successively imaged at different depths within the cell.
The depth is indicated in the image frames, refers to µm beneath the sarcolemma and ranges from -0.4
µm to -2.0 µm. The imaging parameters are given in this section. Scale bars: 1 µm. Graphs below the
image frames show normalized fluorescence intensity profiles (FI, norm.) obtained from the yellow line
(for the left graph) and yellow box (for the right graph) indicated in the respective image frames and
marking transverse tubular cross sections. The resolution of transverse tubule structures is denoted as the
full width at half maximum (FWHM) extracted from fitting the intensity data to a Lorentzian curve (see
also section 2.6.2).
within the yellow box, respectively, indicated in the respective image frames.
Then, a Lorentzian curve was fit to the normalized fluorescence intensity distri-
bution, and the resolution denoted as the full width at half maximum (FWHM)
of the curve fit.
H.2. QUANTIFICATION OF CHOL RICH SARCOLEMMAL PATCH SIZE 335
H.2. Quantification of the size of Chol rich
sarcolemmal patches
In section 3.4.3, using Two-Photon-Excitation-CW-STED (2P-Exc-CWSTED) mi-
croscopy of living mouse ventricular cardiomyocytes (VM) labeled with the
fluorescent Cholesterol (Chol) analog Chol-PEG-OregonGreen488 (Chol-OG-
488), I could show that Chol rich patches at the sarcolemma of VM could be
categorized into two populations. One population of Chol rich sarcolemmal
patches buds into Transverse Tubules (TT) eventually forming the complex
Transverse-Axial Tubular System (TATS) which is the membrane structure typ-
ical of VM. The other population of Chol rich sarcolemmal patches does not
bud into TT but forms shallow membrane invaginations that do not extend
deeper than about 500 nm into the VM interior. To investigate whether the
area size of the observed Chol rich sarcolemmal patches influences if a Chol
patch buds into a TT or not, I determined the distribution of area sizes of Chol
patches classified to belong to one of the two specific populations (i.e. associ-
ated to TT or associated to shallow membrane invaginations), respectively. To
this end, VM were labeled as described in section 2.3.2. Sample imaging was
performed using the custom-built 2P-Exc-CWSTED microscope (see section
2.1.1) and with the settings specified in section 3.4.3. Chol rich sarcolemmal
patches were classified as associated with Tranverse Tubules (TT) or as associ-
ated with shallow membrane invaginations as described in section 3.4.3. 2P-
Exc-CWSTED images of sarcolemmal Chol-OG488 signals were binarized and
the areas of selected Chol rich patches determined using the “Analyze Parti-
cles” plugin within the FiJi image analysis software (see also sections 2.6.1 and
3.4.3). Fig. H.2 summarizes the area size distribution of Chol rich sarcolem-
mal patches that are either associated to TT (displayed in pink) or associated
to shallow membrane invaginations (displayed in yellow), respectively. As can
be seen from the shown bar graph representation, the area size distributions do
not vary significantly between the two populations of Chol rich sarcolemmal
patches. Both populations show a broad distribution of patch area sizes rang-
ing from 1600 nm² up to about 150,000 nm². Further, both populations feature a
typical area size of about 4500 nm², corresponding to a patch diameter of about
75 nm (thereby assuming the Chol patches to be circular). Conclusively, a gen-
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Figure H.2.: Area size distribution of Cholesterol (Chol) rich patches at the sarcolemma of living mouse ventricular
cardiomyocytes (VM) labeled with the fluorescent Chol analog Chol-PEG-OregonGreen488 (Chol-OG488)
and imaged in Two-Photon-Excitation-CW-STED (2P-Exc-CWSTED) mode. The here displayed bar graph
representation with a bin size of 1600 nm² (i.e. corresponding to an area of 2× 2 px shows the areas of
Chol patches associated with Transverse Tubules (TT) in pink and the areas of Chol patches associated
with shallow membrane invaginations in yellow, respectively. To facilitate the visibility of the area size
distribution, the bars were shaded with a color transparency of 50 % resulting in an orange hue where
pink and yellow bars overlap. The y-axis (“# Observations”) denotes the frequency with which a Chol
patch with a certain area was observed. Number of evaluated Chol rich sarcolemmal patches: patches
associated with TT - 52; patches associated with shallow membrane invaginations - 71. See section H.2 for
further details regarding data acquisition and interpretation.
eral principle that would allow for the inference if a Chol rich sarcolemmal
patch is either associated to TT or associated to shallow membrane invagina-
tions could not be derived based on the determination of the distribution of the
area sizes of the sarcolemmal Chol patches.
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I. Statistical significance testing
Statistical significance testing for the data presented throughout this PhD work
was performed using the two-sided Mann-Whitney-Wilcoxon U test (MWW)
as described in section 2.9. The tables in the following summarize and display
the explicit MWW U statistics for the data sets presented in the main text.
Cell line U2OS HeLa HEK Vero
U2OS
ρU2OS = (47.34 ± 10.17)% ρU2OS = (47.34 ± 10.17)% ρU2OS = (47.34 ± 10.17)%
ρHeLa = (37.81 ± 8.04)% ρHEK = (39.91 ± 7.71)% ρVero = (41.32 ± 8.20)%
— nU2OS = 61; UU2OS = 718 nU2OS = 61; UU2OS = 1421 nU2OS = 61; UU2OS = 700
nHeLa = 52; UHeLa = 2454 nHEK = 85; UHEK = 3764 nVero = 36; UVero = 1496
p = 5.81× 10−7 (∗∗) p = 3.38× 10−6 (∗∗) p = 3.00× 10−3 (∗)
HeLa
ρHeLa = (37.81 ± 8.04)% ρHeLa = (37.81 ± 8.04)% ρHeLa = (37.81 ± 8.04)%
ρU2OS = (47.34 ± 10.17)% ρHEK = (39.91 ± 7.71)% ρVero = (41.32 ± 8.20)%
nHeLa = 52; UHeLa = 2454 — nHeLa = 52; UHeLa = 2480 nHeLa = 52; UHeLa = 1160
nU2OS = 61; UU2OS = 718 nHEK = 85; UHEK = 1940 nVero = 36; UVero = 712
p = 5.81× 10−7 (∗∗) p = 0.232 (n.s.) p = 0.058 (n.s.)
HEK
ρHEK = (39.91 ± 7.71)% ρHEK = (39.91 ± 7.71)% ρHEK = (39.91 ± 7.71)%
ρU2OS = (47.34 ± 10.17)% ρHeLa = (37.81 ± 8.04)% ρVero = (41.32 ± 8.20)%
nHEK = 85; UHEK = 3764 nHEK = 85; UHEK = 1940 — nHEK = 85; UHEK = 1718
nU2OS = 61; UU2OS = 1421 nHeLa = 52; UHeLa = 2480 nVero = 36; UVero = 1342
p = 3.38× 10−6 (∗∗) p = 0.232 (n.s.) p = 0.288 (n.s.)
Vero
ρVero = (41.32 ± 8.20)% ρVero = (41.32 ± 8.20)% ρVero = (41.32 ± 8.20)%
ρU2OS = (47.34 ± 10.17)% ρHeLa = (37.81 ± 8.04)% ρHEK = (39.91 ± 7.71)%
nVero = 36; UVero = 1496 nVero = 36; UVero = 712 nVero = 36; UVero = 1342 —
nU2OS = 61; UU2OS = 700 nHeLa = 52; UHeLa = 1160 nHEK = 85; UHEK = 1718
p = 3.00× 10−3 (∗) p = 0.058 (n.s.) p = 0.288 (n.s.)
Table I.1.: MWW U statistics for Chol-KK114 surface signal densities ρ in filopodia of cultured cell lines. This table
corresponds to the data presented in Fig. 3.4 in the main text. ρ was determined as described in section
2.6.4 and is presented as mean ± standard deviation. The parameters defining the MWW distribution are
presented in the table as ni : the sample size of the respective cell line i and Ui : the MWW statistic U of the
respective cell line i. Further, the p-value of the two-sided MWW is denoted in the table and, in parenthesis,
evaluated as (n.s.): not significant, p> 0.01; (∗): significant, p< 0.01; (∗∗): very significant, p< 0.001.
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ρ
H
A
d
=
( 18.86±
2.54) %
ρ
V
M
=
( 16.93±
4.36) %
—
n
U
2O
S
=
28;U
U
2O
S
=
441
n
U
2O
S
=
28;U
U
2O
S
=
440
n
U
2O
S
=
28;U
U
2O
S
=
186
n
U
2O
S
=
28;U
U
2O
S
=
1008
n
U
2O
S
=
28;U
U
2O
S
=
1400
n
U
2O
S
=
28;U
U
2O
S
=
3500
n
H
eLa
=
33;U
H
eLa
=
483
n
H
EK
=
55;U
H
EK
=
1100
n
Vero
=
18;U
Vero
=
318
n
V
-IPSC
=
36;U
V
-IPSC
=
0
n
H
A
d
=
50;U
H
A
d
=
0
n
V
M
=
125;U
V
M
=
0
p
=
0.767
( n.s.)
p
=
0.0015
( ∗
)
p
=
0.140
( n.s.)
p
=
9.49×
10 −
12
( ∗∗
)
p
=
3.19×
10 −
13
( ∗∗
)
p
=
1.52×
10 −
16
( ∗∗
)
H
eLa
ρ
H
eLa
=
( 0.53±
0.29) %
ρ
H
eLa
=
( 0.53±
0.29) %
ρ
H
eLa
=
( 0.53±
0.29) %
ρ
H
eLa
=
( 0.53±
0.29) %
ρ
H
eLa
=
( 0.53±
0.29) %
ρ
H
eLa
=
( 0.53±
0.29) %
ρ
U
2O
S
=
( 0.52±
0.21) %
ρ
H
EK
=
( 0.37±
0.19) %
ρ
Vero
=
( 0.43±
0.24) %
ρ
V
-IPSC
=
( 18.07±
3.96) %
ρ
H
A
d
=
( 18.86±
2.54) %
ρ
V
M
=
( 16.93±
4.36) %
n
H
eLa
=
33;U
H
eLa
=
483
—
n
H
eLa
=
33;U
H
eLa
=
578
n
H
eLa
=
33;U
H
eLa
=
243
n
H
eLa
=
33;U
H
eLa
=
1188
n
H
eLa
=
33;U
H
eLa
=
1650
n
H
eLa
=
33;U
H
eLa
=
4125
n
U
2O
S
=
28;U
U
2O
S
=
440
n
H
EK
=
55;U
H
EK
=
1237
n
Vero
=
18;U
Vero
=
351
n
V
-IPSC
=
36;U
V
-IPSC
=
0
n
H
A
d
=
50;U
H
A
d
=
0
n
V
M
=
125;U
V
M
=
0
p
=
0.767
( n.s.)
p
=
0.0046
( ∗
)
p
=
0.292
( n.s.)
p
=
1.01×
10 −
12
( ∗∗
)
p
=
1.70×
10 −
14
( ∗∗
)
p
=
1.14×
10 −
18
( ∗∗
)
H
EK
ρ
H
EK
=
( 0.37±
0.19) %
ρ
H
EK
=
( 0.37±
0.19) %
ρ
H
EK
=
( 0.37±
0.19) %
ρ
H
EK
=
( 0.37±
0.19) %
ρ
H
EK
=
( 0.37±
0.19) %
ρ
H
EK
=
( 0.37±
0.19) %
ρ
U
2O
S
=
( 0.52±
0.21) %
ρ
H
eLa
=
( 0.53±
0.29) %
ρ
Vero
=
( 0.43±
0.24) %
ρ
V
-IPSC
=
( 18.07±
3.96) %
ρ
H
A
d
=
( 18.86±
2.54) %
ρ
V
M
=
( 16.93±
4.36) %
n
H
EK
=
55;U
H
EK
=
1100
n
H
EK
=
55;U
H
EK
=
1237
—
n
H
EK
=
55;U
H
EK
=
569
n
H
EK
=
55;U
H
EK
=
1980
n
H
EK
=
55;U
H
EK
=
2750
n
H
EK
=
55;U
H
EK
=
6875
n
U
2O
S
=
28;U
U
2O
S
=
440
n
H
eLa
=
33;U
H
eLa
=
578
n
Vero
=
18;U
Vero
=
421
n
V
-IPSC
=
36;U
V
-IPSC
=
0
n
H
A
d
=
50;U
H
A
d
=
0
n
V
M
=
125;U
V
M
=
0
p
=
0.0015
( ∗
)
p
=
0.0046
( ∗
)
p
=
0.347
( n.s.)
p
=
9.65×
10 −
16
( ∗∗
)
p
=
1.16×
10 −
18
( ∗∗
)
p
=
1.36×
10 −
26
( ∗∗
)
V
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ρ
Vero
=
( 0.43±
0.24) %
ρ
Vero
=
( 0.43±
0.24) %
ρ
Vero
=
( 0.43±
0.24) %
ρ
Vero
=
( 0.43±
0.24) %
ρ
Vero
=
( 0.43±
0.24) %
ρ
Vero
=
( 0.43±
0.24) %
ρ
U
2O
S
=
( 0.52±
0.21) %
ρ
H
eLa
=
( 0.53±
0.29) %
ρ
H
EK
=
( 0.37±
0.19) %
ρ
V
-IPSC
=
( 18.07±
3.96) %
ρ
H
A
d
=
( 18.86±
2.54) %
ρ
V
M
=
( 16.93±
4.36) %
n
Vero
=
18;U
Vero
=
318
n
Vero
=
18;U
Vero
=
351
n
Vero
=
18;U
Vero
=
421
—
n
Vero
=
18;U
Vero
=
648
n
Vero
=
18;U
Vero
=
900
n
Vero
=
18;U
Vero
=
2250
n
U
2O
S
=
28;U
U
2O
S
=
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n
H
eLa
=
33;U
H
eLa
=
243
n
H
EK
=
55;U
H
EK
=
569
n
V
-IPSC
=
36;U
V
-IPSC
=
0
n
H
A
d
=
50;U
H
A
d
=
0
n
V
M
=
125;U
V
M
=
0
p
=
0.140
( n.s.)
p
=
0.292
( n.s.)
p
=
0.347
( n.s.)
p
=
2.92×
10 −
9
( ∗∗
)
p
=
4.14×
10 −
10
( ∗∗
)
p
=
7.73×
10 −
12
( ∗∗
)
V
-IPSC
ρ
V
-IPSC
=
( 18.07±
3.96) %
ρ
V
-IPSC
=
( 18.07±
3.96) %
ρ
V
-IPSC
=
( 18.07±
3.96) %
ρ
V
-IPSC
=
( 18.07±
3.96) %
ρ
V
-IPSC
=
( 18.07±
3.96) %
ρ
V
-IPSC
=
( 18.07±
3.96) %
ρ
U
2O
S
=
( 0.52±
0.21) %
ρ
H
eLa
=
( 0.53±
0.29) %
ρ
H
EK
=
( 0.37±
0.19) %
ρ
Vero
=
( 0.43±
0.24) %
ρ
H
A
d
=
( 18.86±
2.54) %
ρ
V
M
=
( 16.93±
4.36) %
n
V
-IPSC
=
36;U
V
-IPSC
=
0
n
V
-IPSC
=
36;U
V
-IPSC
=
0
n
V
-IPSC
=
36;U
V
-IPSC
=
0
n
V
-IPSC
=
36;U
V
-IPSC
=
0
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V
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=
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=
1041
n
V
-IPSC
=
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V
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U
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=
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=
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n
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=
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eLa
=
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H
EK
=
55;U
H
EK
=
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=
18;U
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=
648
n
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A
d
=
50;U
H
A
d
=
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n
V
M
=
125;U
V
M
=
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p
=
9.49×
10 −
12
( ∗∗
)
p
=
1.01×
10 −
12
( ∗∗
)
p
=
9.65×
10 −
16
( ∗∗
)
p
=
2.92×
10 −
9
( ∗∗
)
p
=
0.219
( n.s.)
p
=
0.294
( n.s.)
H
A
d
ρ
H
A
d
=
( 18.86±
2.54) %
ρ
H
A
d
=
( 18.86±
2.54) %
ρ
H
A
d
=
( 18.86±
2.54) %
ρ
H
A
d
=
( 18.86±
2.54) %
ρ
H
A
d
=
( 18.86±
2.54) %
ρ
H
A
d
=
( 18.86±
2.54) %
ρ
U
2O
S
=
( 0.52±
0.21) %
ρ
H
eLa
=
( 0.53±
0.29) %
ρ
H
EK
=
( 0.37±
0.19) %
ρ
Vero
=
( 0.43,±
0.24) %
ρ
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-IPSC
=
( 18.07±
3.96) %
ρ
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4.36) %
n
H
A
d
=
50;U
H
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0
n
H
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=
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H
A
d
=
0
n
H
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=
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=
0
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H
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=
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H
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=
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=
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n
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=
55;U
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=
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=
900
n
V
-IPSC
=
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=
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=
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=
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( ∗∗
)
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=
1.70×
10 −
14
( ∗∗
)
p
=
1.16×
10 −
18
( ∗∗
)
p
=
4.14×
10 −
10
( ∗∗
)
p
=
0.219
( n.s.)
p
=
0.024
( n.s.)
V
M
ρ
V
M
=
( 16.93±
4.36) %
ρ
V
M
=
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4.36) %
ρ
V
M
=
( 16.93±
4.36) %
ρ
V
M
=
( 16.93±
4.36) %
ρ
V
M
=
( 16.93±
4.36) %
ρ
V
M
=
( 16.93±
4.36) %
ρ
U
2O
S
=
( 0.52±
0.21) %
ρ
H
eLa
=
( 0.53±
0.29) %
ρ
H
EK
=
( 0.52±
0.21) %
ρ
Vero
=
( 0.43±
0.24) %
ρ
V
M
=
( 18.07±
3.96) %
ρ
V
M
=
( 18.86±
2.54) %
n
V
M
=
125;U
V
M
=
0
n
V
M
=
125;U
V
M
=
0
n
V
M
=
125;U
V
M
=
0
n
V
M
=
125;U
V
M
=
0
n
V
M
=
125;U
V
M
=
2509
n
V
M
=
125;U
V
M
=
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—
n
U
2O
S
=
28;U
U
2O
S
=
3500
n
H
eLa
=
33;U
H
eLa
=
4125
n
H
EK
=
55;U
H
EK
=
6875
n
Vero
=
18;U
Vero
=
2250
n
V
-IPSC
=
36;U
V
-IPSC
=
1991
n
H
A
d
=
50;U
H
A
d
=
2440
p
=
1.52×
10 −
16
( ∗∗
)
p
=
1.14×
10 −
18
( ∗∗
)
p
=
1.36×
10 −
26
( ∗∗
)
p
=
7.73×
10 −
12
( ∗∗
)
p
=
0.294
( n.s.)
p
=
0.024
( n.s.)
Table
I.2.:M
W
W
U
statistics
for
C
hol-K
K
114
surface
signaldensities
ρ
atthe
basem
entm
em
brane
ofcultured
celllines
and
prim
ary
ventricular
m
ouse
cardiom
yocytes
(V
M
).This
table
corresponds
to
the
data
presented
in
Fig.3.7
in
the
m
ain
text.
ρ
w
as
determ
ined
as
described
in
section
2.6.4
and
is
presented
as
m
ean±
standard
deviation.The
param
eters
defining
the
M
W
W
distribution
are
presented
in
the
table
as
n
i :
the
sam
ple
size
of
the
respective
cellline
iand
U
i :
the
M
W
W
statistic
U
of
the
respective
cellline
i.
Further,
the
p-value
of
the
tw
o-sided
M
W
W
is
denoted
in
the
table
and,in
parenthesis,evaluated
as
( n.s.) :
notsignificant,p
>
0.01;
( ∗
) :
significant,p
<
0.01;
( ∗∗
) :
very
significant,
p
<
0.001.
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Cell type and labeled
structure
VM, Cav-3
VM, Chol
ρVM, Chol = (16.93 ± 4.36)%
ρVM, Cav-3 = (24.13 ± 4.89)%
nVM, Chol = 125; UVM, Chol = 7634
nVM, Cav-3 = 71; UVM, Cav-3 = 1241
p = 5.62× 10−17 (∗∗)
Table I.3.: MWW U statistics for surface signal
densities ρ of the Cholesterol-PEG-
KK114 (Chol-KK114) signal at the
sarcolemma of living primary ven-
tricular mouse cardiomyocytes (VM,
Chol) and of the Caveolin-3 (Cav-
3) signal at the sarcolemma of fixed
VM (VM, Cav-3). This table corre-
sponds to the data presented in Fig.
3.23 in the main text. ρ was deter-
mined as described in section 2.6.4,
is given in % of the total basement
membrane area and is presented as
mean ± standard deviation. The pa-
rameters defining the MWW distri-
bution are presented in the table as
ni : the sample size of the respective
sample i and Ui : the MWW statis-
tic U of the respective sample i. Fur-
ther, the p-value from the two-tailed
MWW is denoted in the table and, in
parenthesis, evaluated as (∗∗): very
significant, p< 0.001.
Cell type and labeled
structure
VM, Cav-3
VM, Chol
VM, Chol = (74 ± 20) nm
VM, Cav-3 = (68 ± 24) nm
nVM, Chol = 129; UVM, Chol = 134812
nVM, Cav-3 = 2397; UVM, Cav-3 = 174401
p = 0.0142 (n.s.)
Table I.4.: MWW U statistics for the diameter
of single domains of the Cholesterol-
PEG-KK114 (Chol-KK114) signal at
the sarcolemma of living primary
ventricular mouse cardiomyocytes
(VM, Chol) and of the Caveolin-3
(Cav-3) signal at the sarcolemma of
fixed VM (VM, Cav-3). This table
corresponds to the data presented in
Fig. 3.23 in the main text. The di-
ameter of single domains was deter-
mined as described in section 2.6.5,
is given in nm and is presented as
mean ± standard deviation. The pa-
rameters defining the MWW distri-
bution are presented in the table as
ni : the sample size of the respective
sample i and Ui : the MWW statis-
tic U of the respective sample i. Fur-
ther, the p-value from the two-tailed
MWW is denoted in the table and, in
parenthesis, evaluated as (n.s.): not
significant, p> 0.01.
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Cell type and labeled
structure
VM, Cav-3
VM, Chol
VM, Chol = (226 ± 86) nm
VM, Cav-3 = (253 ± 58) nm
nVM, Chol = 404; UVM, Chol = 20253
nVM, Cav-3 = 77; UVM, Cav-3 = 10855
p = 2.63× 10−5 (∗∗)
Table I.5.: MWW U statistics for the diameter
of ring structures of the Cholesterol-
PEG-KK114 (Chol-KK114) signal at
the sarcolemma of living primary
ventricular mouse cardiomyocytes
(VM, Chol) and of the Caveolin-3
(Cav-3) signal at the sarcolemma of
fixed VM (VM, Cav-3). This table
corresponds to the data presented in
Fig. 3.23 in the main text. The di-
ameter of ring structures was deter-
mined as described in section 2.6.6,
is given in nm and is presented as
mean ± standard deviation. The pa-
rameters defining the MWW distri-
bution are presented in the table as
ni : the sample size of the respective
sample i and Ui : the MWW statis-
tic U of the respective sample i. Fur-
ther, the p-value from the two-tailed
MWW is denoted in the table and, in
parenthesis, evaluated as (∗∗): very
significant, p< 0.001.
Cell type, condition, and labeled
structure
HeLa, Chol HeLa OE, Cav-3 HeLa OE, Chol
HeLa, Chol
ρHeLa, Chol = (0.53 ± 0.29)% ρHeLa, Chol = (0.53 ± 0.29)%
ρHeLa OE, Cav-3 = (8.92 ± 2.51)% ρHeLa OE, Chol = (5.79 ± 1.24)%
— nHeLa, Chol = 33; UHeLa, Chol = 957 nHeLa, Chol = 33; UHeLa, Chol = 2277
nHeLa OE, Cav-3 = 29; UHeLa OE, Cav-3 = 0 nHeLa OE, Chol = 39; UHeLa OE, Chol = 0
p = 1.55× 10−11 (∗∗) p = 3.95× 10−16 (∗∗)
HeLa OE, Cav-3
ρHeLa OE, Cav-3 = (8.92 ± 2.51)% ρHeLa OE, Cav-3 = (8.92 ± 2.51)%
ρHeLa, Chol = (0.53 ± 0.29)% ρHeLa OE, Chol = (5.79 ± 1.24)%
nHeLa OE, Cav-3 = 29; UHeLa OE, Cav-3 = 0 — nHeLa OE, Cav-3 = 29; UHeLa OE, Cav-3 = 276
nHeLa, Chol = 33; UHeLa, Chol = 957 nHeLa OE, Chol = 39; UHeLa OE, Chol = 1725
p = 1.55× 10−11 (∗∗) p = 1.75× 10−8 (∗∗)
HeLa OE, Chol
ρHeLa OE, Chol = (5.79 ± 1.24)% ρHeLa OE, Chol = (5.79 ± 1.24)%
ρHeLa, Chol = (0.53 ± 0.29)% ρHeLa OE, Cav-3 = (8.92 ± 2.51)%
nHeLa OE, Chol = 39; UHeLa OE, Chol = 0 nHeLa OE, Chol = 39; UHeLa OE, Chol = 1725 —
nHeLa, Chol = 33; UHeLa, Chol = 2277 nHeLa OE, Cav-3 = 29; UHeLa OE, Cav-3 = 276
p = 3.95× 10−16 (∗∗) p = 1.75× 10−8 (∗∗)
Table I.6.: MWW U statistics for the surface signal density ρ of the Cholesterol-PEG-KK114 (Chol-KK114) signal and
the Caveolin-3 (Cav-3) signal at the basement membrane of control vs. Cav-3 overexpressing HeLa cells.
This table corresponds to the data presented in Fig. 3.25 in the main text. In the table, the data for control
HeLa cells stained with Chol-KK114 is denoted as “HeLa, Chol”; the data for Cav-3 overexpressing HeLa
cells labeled for Cav-3 is denoted as “HeLa OE, Cav-3”; the data for Cav-3 overexpressing HeLa cells stained
with Chol-KK114 is denoted as “HeLa OE, Chol”. ρ was determined as described in section 2.6.4, is given
in % of the total basement membrane area and is presented as mean ± standard deviation. The parameters
defining the MWW distribution are presented in the table as ni : the sample size of the respective sample i
and Ui : the MWW statistic U of the respective sample i. Further, the p-value from the two-tailed MWW is
denoted in the table and, in parenthesis, evaluated as (∗∗): very significant, p< 0.001.
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Cell type, condition, and
labeled structure
HeLa OE, Chol
HeLa OE, Cav-3
HeLa OE, Cav-3 = (78 ± 19) nm
HeLa OE, Chol = (76 ± 23) nm
nHeLa OE, Cav-3 = 426; UHeLa OE, Cav-3 = 61364
nHeLa OE, Chol = 319; UHeLa OE, Chol = 74530
p = 0.0235 (n.s.)
Table I.7.: MWW U statistics for the diam-
eter  of single domains of the
Cholesterol-PEG-KK114 (Chol-
KK114) signal and the Caveolin-3
(Cav-3) signal at the basement
membrane of Cav-3 overexpressing
HeLa cells (HeLa OE). This table
corresponds to the data presented
in Fig. 3.25 in the main text.  was
determined as described in section
2.6.5, is given in nm and is presented
as mean ± standard deviation. The
parameters defining the MWW
distribution are presented in the
table as ni : the sample size of the
respective sample i and Ui : the
MWW statistic U of the respective
sample i. Further, the p-value from
the two-tailed MWW is denoted
in the table and, in parenthesis,
evaluated as (n.s.): not significant,
p> 0.01.
Cell type, condition, and
labeled structure
HeLa OE, Chol
HeLa OE, Cav-3
HeLa OE, Cav-3 = (201 ± 80) nm
HeLa OE, Chol = (218 ± 89) nm
nHeLa OE, Cav-3 = 179; UHeLa, Cav-3 = 17689
nHeLa OE, Chol = 152; UHeLa OE, Chol = 9519
p = 2.50× 10−6 (∗∗)
Table I.8.: MWW U statistics for the diameter
of ring structures of the Cholesterol-
PEG-KK114 (Chol-KK114) signal
and the Caveolin-3 (Cav-3) signal at
the basement membrane of Cav-3
overexpressing HeLa cells (HeLa
OE). This table corresponds to the
data presented in Fig. 3.25 in the
main text.  was determined as
described in section 2.6.6, is given
in nm and is presented as mean ±
standard deviation. The parameters
defining the MWW distribution are
presented in the table as ni : the
sample size of the respective sample
i and Ui : the MWW statistic U of
the respective sample i. Further,
the p-value from the two-tailed
MWW is denoted in the table and,
in parenthesis, evaluated as (∗∗):
very significant, p< 0.001.
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Cell type and condition
(labeled structure: Cav-3)
VM, Control
VM, Chol depl.
VM, Control = (68 ± 24) nm
VM, Chol depl. = (66 ± 23) nm
nVM, Control = 2397; UVM, Control = 2730318
nVM, Chol depl. = 2360; UVM, Chol depl. = 2926602
p = 0.0382 (n.s.)
Table I.9.: MWW U statistics for the diameter of single domains of the Caveolin-
3 (Cav-3) signal at the sarcolemma
of control vs. Chol depleted (Chol
depl.) mouse ventricular cardiomy-
ocytes (VM). Chol depletion was
performed as described in section
2.3.3. This table corresponds to the
data presented in Fig. 3.27 in the
main text.  was determined as
described in section 2.6.5, is given
in nm and is presented as mean ±
standard deviation. The parame-
ters defining the MWW distribution
are presented in the table as ni : the
sample size of the respective sam-
ple i and Ui : the MWW statistic U
of the respective sample i. The p-
value from the two-tailed MWW is
denoted in the table and, in paren-
thesis, evaluated as (n.s.): not signif-
icant, p> 0.01.
Cell type and condition
(labeled structure: Cav-3)
VM, Control
VM, Chol depl.
ΓVM, Control = (3.37 ± 0.55)%
ΓVM, Chol depl. = (7.85 ± 1.04)%
nVM, Control = 44; UVM, Control = 1672
nVM, Chol depl. = 38; UVM, Chol depl. = 0
p = 7.89× 10−5 (∗∗)
Table I.10.: MWW U statistics for the con-
tour density Γ of the Caveolin-3
(Cav-3) signal at the sarcolemma
of control vs. Chol depleted
(Chol depl.) mouse ventricular car-
diomyocytes (VM). Chol depletion
was performed as described in sec-
tion 2.3.3. This table corresponds to
the data presented in Fig. 3.27 in
the main text. Γ was determined as
described in section 2.6.7, is given
in % and is presented as mean ±
standard deviation. The parame-
ters defining the MWW distribu-
tion are presented in the table as
ni : the sample size of the respective
sample i and Ui : the MWW statistic
U of the respective sample i. The p-
value from the two-tailed MWW is
denoted in the table and, in paren-
thesis, evaluated as (∗∗): very sig-
nificant, p< 0.001.
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Cell type and condition
(labeled structure: Cav-3)
VM, Control
VM, Chol depl.
ρVM, Control = (24.13 ± 4.89)%
ρVM, Chol depl. = (50.55 ± 4.67)%
nVM, Control = 44; UVM, Control = 1665
nVM, Chol depl. = 38; UVM, Chol depl. = 0
p = 8.98× 10−15 (∗∗)
Table I.11.: MWW U statistics for the surface
signal density ρ of the Caveolin-
3 (Cav-3) signal at the sarcolemma
of control vs. Chol depleted
(Chol depl.) mouse ventricular car-
diomyocytes (VM). Chol depletion
was performed as described in sec-
tion 2.3.3. This table corresponds to
the data presented in Fig. 3.27 in
the main text. ρ was determined as
described in section 2.6.4, is given
in % and is presented as mean ±
standard deviation. The parame-
ters defining the MWW distribu-
tion are presented in the table as
ni : the sample size of the respective
sample i and Ui : the MWW statistic
U of the respective sample i. The p-
value from the two-tailed MWW is
denoted in the table and, in paren-
thesis, evaluated as (∗∗): very sig-
nificant, p< 0.001.
Cell type and labeled
structure
VM, Cav-3
VM, Dyst
VM, Dyst = (67 ± 27) nm
VM, Cav-3 = (74 ± 20) nm
nVM, Dyst = 2947; UVM, Dyst = 4367022
nVM, Cav-3 = 2397; UVM, Cav-3 = 4317787
p = 0.706 (n.s.)
Table I.12.: MWW U statistics for the diam-
eter  of single domains of the
Dystrophin (Dyst) and Caveolin-3
(Cav-3) signal at the sarcolemma of
mouse ventricular cardiomyocytes
(VM). This table corresponds to the
data presented in Fig. 3.32 in the
main text.  was determined as
described in section 2.6.5, is given
in nm and is presented as mean
± standard deviation. The param-
eters defining the MWW distribu-
tion are presented in the table as
ni : the sample size of the respective
sample i and Ui : the MWW statistic
U of the respective sample i. The p-
value from the two-tailed MWW is
denoted in the table and, in paren-
thesis, evaluated as (n.s.): not sig-
nificant, p> 0.01.
Cell type and labeled
structure
VM, Cav-3
VM, Dyst
VM, Dyst = (211 ± 60) nm
VM, Cav-3 = (253 ± 58) nm
nVM, Dyst = 121; UVM, Dyst = 78068
nVM, Cav-3 = 80; UVM, Cav-3 = 11594
p = 8.03× 10−55 (∗∗)
Table I.13.: MWW U statistics for the diam-
eter  of ring structures of the
Dystrophin (Dyst) and Caveolin-3
(Cav-3) signal at the sarcolemma of
mouse ventricular cardiomyocytes
(VM). This table corresponds to the
data presented in Fig. 3.32 in the
main text.  was determined as
described in section 2.6.6, is given
in nm and is presented as mean
± standard deviation. The param-
eters defining the MWW distribu-
tion are presented in the table as
ni : the sample size of the respective
sample i and Ui : the MWW statistic
U of the respective sample i. The p-
value from the two-tailed MWW is
denoted in the table and, in paren-
thesis, evaluated as (∗∗): very sig-
nificant, p< 0.001.
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Relative colocalization (RC)
between A and B (A−→B),
cell condition
Cav-3−→Dyst, Chol depl.
Cav-3−→Dyst, Control
RCCav-3−→Dyst, Control = (32 ± 2.7)%
RCCav-3−→Dyst, Chol depl. = (29 ± 1.9)%
nCav-3−→Dyst, Control = 57; UCav-3−→Dyst, Control = 1009
nCav-3−→Dyst, Chol depl. = 41; UCav-3−→Dyst, Chol depl. = 1328
p = 0.252 (n.s.)
Table I.14.: MWW U statistics for the relative
colocalization (RC, in %) between
the sarcolemmal Caveolin-3 (Cav-
3) and Dystrophin (Dyst) signal in
control vs. Cholesterol depleted
(Chol depl.) fixed mouse ventricu-
lar cardiomyocytes (VM). Chol de-
pletion was performed as described
in section 2.3.3. This table corre-
sponds to the data presented in Fig.
3.34 in the main text. RC was deter-
mined as described in section 2.7,
is given in % of the total sarcolem-
mal Cav-3 signal and is presented
as mean ± standard deviation. The
parameters defining the MWW dis-
tribution are presented in the table
as ni : the sample size of the respec-
tive sample i and Ui : the MWW
statistic U of the respective sam-
ple i. Further, the p-value from the
two-tailed MWW is denoted in the
table and, in parenthesis, evaluated
as (n.s.): not significant, p> 0.01.
Relative colocalization (RC)
between A and B (A−→B),
cell condition
Dyst−→Cav-3, Chol depl.
Dyst−→Cav-3, Control
RCDyst−→Cav-3, Control = (7.2 ± 0.7)%
RCDyst−→Cav-3, Chol depl. = (15 ± 1.2)%
nDyst−→Cav-3, Control = 57; UDyst−→Cav-3, Control = 2255
nDyst−→Cav-3, Chol depl. = 41; UDyst−→Cav-3, Chol depl. = 0
p = 6.97× 10−17 (n.s.)
Table I.15.: MWW U statistics for the relative
colocalization (RC, in %) between
the sarcolemmal Dystrophin (Dyst)
and Caveolin-3 (Cav-3) signal in
control vs. Cholesterol depleted
(Chol depl.) fixed mouse ventricu-
lar cardiomyocytes (VM). Chol de-
pletion was performed as described
in section 2.3.3. This table corre-
sponds to the data presented in Fig.
3.34 in the main text. RC was deter-
mined as described in section 2.7,
is given in % of the total sarcolem-
mal Cav-3 signal and is presented
as mean ± standard deviation. The
parameters defining the MWW dis-
tribution are presented in the table
as ni : the sample size of the respec-
tive sample i and Ui : the MWW
statistic U of the respective sam-
ple i. Further, the p-value from the
two-tailed MWW is denoted in the
table and, in parenthesis, evaluated
as (∗∗): very significant, p< 0.001.
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Peak-to-peak nearest neighbor
distance (NND) between A and B
(A−→B)
Cav-3−→Dyst(N) Cav-3−→Dyst(Rod) Cav-3−→Dyst(C)
Cav-3−→Dyst(N)
NNDCav-3−→Dyst(N) = (167 ± 37) nm NNDCav-3−→Dyst(N) = (167 ± 37) nm
NNDCav-3−→Dyst(Rod) = (83 ± 51) nm NNDCav-3−→Dyst(C) = (70 ± 27) nm
— nCav-3−→Dyst(N) = 47; UCav-3−→Dyst(N) = 0 nCav-3−→Dyst(N) = 47; UCav-3−→Dyst(N) = 0
nCav-3−→Dyst(Rod) = 43; UCav-3−→Dyst(Rod) = 2021 nCav-3−→Dyst(C) = 51; UCav-3−→Dyst(C) = 2397
p = 3.39× 10−16 (∗∗) p = 1.61× 10−17 (∗∗)
Cav-3−→Dyst(Rod)
NNDCav-3−→Dyst(Rod) = (83 ± 51) nm NNDCav-3−→Dyst(Rod) = (83 ± 51) nm
NNDCav-3−→Dyst(N) = (167 ± 37) nm NNDCav-3−→Dyst(C) = (70 ± 27) nm
nCav-3−→Dyst(Rod) = 43; UCav-3−→Dyst(Rod) = 2021 — nCav-3−→Dyst(Rod) = 43; UCav-3−→Dyst(Rod) = 1023
nCav-3−→Dyst(N) = 47; UCav-3−→Dyst(N) = 0 nCav-3−→Dyst(C) = 51; UCav-3−→Dyst(C) = 1170
p = 3.39× 10−16 (∗∗) p = 0.580 (n.s.)
Cav-3−→Dyst(C)
NNDCav-3−→Dyst(C) = (70 ± 27) nm NNDCav-3−→Dyst(C) = (70 ± 27) nm
NNDCav-3−→Dyst(N) = (167 ± 37) nm NNDCav-3−→Dyst(Rod) = (83 ± 51) nm
nCav-3−→Dyst(C) = 51; UCav-3−→Dyst(C) = 2397 nCav-3−→Dyst(C) = 51; UCav-3−→Dyst(C) = 1170 —
nCav-3−→Dyst(N) = 47; UCav-3−→Dyst(N) = 0 nCav-3−→Dyst(Rod) = 43; UCav-3−→Dyst(Rod) = 1023
p = 1.61× 10−17 (∗∗) p = 0.580 (n.s.)
Table I.16.: MWW U statistics for the peak-to-peak nearest neighbor distance NND (in nm) between the sarcolemmal
Caveolin-3 (Cav-3) signal and the signal of different Dystrophin (Dyst) domains in fixed mouse ventricular
cardiomyocytes (VM). The different Dyst domains are: the N-terminus (Dyst(N)), the central rod domain
(Dyst(Rod)), and the C-terminus (Dyst(C)). This table corresponds to the data presented in Fig. 3.38 A in
the main text. NND was determined as described in section 2.8, is given in nm and is presented as mean
± standard deviation. The parameters defining the MWW distribution are presented in the table as ni : the
sample size of the respective sample i and Ui : the MWW statistic U of the respective sample i. Further,
the p-value from the two-tailed MWW is denoted in the table and, in parenthesis, evaluated as (∗∗): very
significant, p< 0.001 and (n.s.): not significant, p> 0.01.
Relative colocalization (RC) between
A and B (A−→B) Cav-3−→Dyst(N) Cav-3−→Dyst(Rod) Cav-3−→Dyst(C)
Cav-3−→Dyst(N)
RCCav-3−→Dyst(N) = (15 ± 2.5)% RCCav-3−→Dyst(N) = (15 ± 2.5)%
RCCav-3−→Dyst(Rod) = (32 ± 2.7)% RCCav-3−→Dyst(C) = (39 ± 3.1)%
— nCav-3−→Dyst(N) = 47; UCav-3−→Dyst(N) = 1927 nCav-3−→Dyst(N) = 47; UCav-3−→Dyst(N) = 2350
nCav-3−→Dyst(Rod) = 43; UCav-3−→Dyst(Rod) = 0 nCav-3−→Dyst(C) = 51; UCav-3−→Dyst(C) = 0
p = 7.93× 10−16 (∗∗) p = 2.29× 10−17 (∗∗)
Cav-3−→Dyst(Rod)
RCCav-3−→Dyst(Rod) = (32 ± 2.7)% RCCav-3−→Dyst(Rod) = (32 ± 2.7)%
RCCav-3−→Dyst(N) = (15 ± 2.5)% RCCav-3−→Dyst(C) = (39 ± 3.1)%
nCav-3−→Dyst(Rod) = 43; UCav-3−→Dyst(Rod) = 0 — nCav-3−→Dyst(Rod) = 43; UCav-3−→Dyst(Rod) = 250
nCav-3−→Dyst(N) = 47; UCav-3−→Dyst(N) = 1927 nCav-3−→Dyst(C) = 51; UCav-3−→Dyst(C) = 0
p = 7.93× 10−16 (∗∗) p = 3.03× 10−16 (∗∗)
Cav-3−→Dyst(C)
RCCav-3−→Dyst(C) = (39 ± 3.1)% RCCav-3−→Dyst(C) = (39 ± 3.1)%
RCCav-3−→Dyst(N) = (15 ± 2.5)% RCCav-3−→Dyst(Rod) = (32 ± 2.7)%
nCav-3−→Dyst(C) = 51; UCav-3−→Dyst(C) = 0 nCav-3−→Dyst(C) = 51; UCav-3−→Dyst(C) = 0 —
nCav-3−→Dyst(N) = 47; UCav-3−→Dyst(N) = 2350 nCav-3−→Dyst(Rod) = 43; UCav-3−→Dyst(Rod) = 250
p = 2.29× 10−17 (∗∗) p = 3.03× 10−16 (∗∗)
Table I.17.: MWW U statistics for the relative colocalization (RC, in %) between the sarcolemmal Caveolin-3 (Cav-3)
signal and the signal of different Dystrophin (Dyst) domains in fixed mouse ventricular cardiomyocytes
(VM). The different Dyst domains are: the N-terminus (Dyst(N)), the central rod domain (Dyst(Rod)), and
the C-terminus (Dyst(C)). This table corresponds to the data presented in Fig. 3.38 B in the main text.
RC was determined as described in section 2.7, is given in % of the total sarcolemmal Cav-3 signal and is
presented as mean ± standard deviation. The parameters defining the MWW distribution are presented
in the table as ni : the sample size of the respective sample i and Ui : the MWW statistic U of the respective
sample i. Further, the p-value from the two-tailed MWW is denoted in the table and, in parenthesis,
evaluated as (∗∗): very significant, p< 0.001.
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J. Sarcolemmal Cav-3 in fixed
cardiomyocytes labeled with a
fluorescent Fab fragment
As a control that the sarcolemmal Caveolin-3 (Cav-3) signal in fixed and im-
munofluorescently labeled mouse ventricular cardiomyocytes (VM) that was
observed and described in section 3.5 was not an artifact attributable to the
possible clustering of the used secondary antibodies, samples were prepared
of VM labeled for Cav-3 using the fluorescent dye STAR635P conjugated to a
Fragment antigen-binding (Fab) fragment as the secondary antibody (instead
of a full length secondary antibody). STED images of the samples were ac-
quired with the STED microscope system Leica TCS SP8 STED 3X (see section
2.1.3) and using the same imaging parameters as for the standardly prepared
fluorescent samples of fixed VM immunolabeled for Cav-3 using a full length
secondary antibody. Fig. J.1 exemplarily shows the sarcolemmal Cav-3 signal
structure of the Fab fragment labeled fixed VM.
Sarcolemmal Cav-3 clusters could be observed and the same nanoscopic Cav-3
membrane motifs as the ones described in section 3.5 could be identified: 1.
single domains of about 70 nm in diameter, 2. ring structures of about 240 nm
in diameter, and 3. bunchy clusters of various sizes. Specifically, the single
domains were not smaller than the ones observed in the samples with the full
length secondary antibody. If the clustered Cav-3 signal shown in section 3.5
would be due to the clustering of the used antibodies, a reduction in the diam-
eter of the single domains would have been expected in the samples decorated
with the Fab fragment. Since this was not the case, the observed clustered Cav-
3 signal at the sarcolemma of VM is in fact attributable to protein clustering.
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1.
Figure J.1.: STED image of the sarcolemmal Caveolin-3 (Cav-3) signal pattern in a fixed mouse
ventricular cardiomyocyte (VM) labeled via indirect immunofluorescence using the
fluorescent dye STAR635P conjugated to a Fragment antigen-binding (Fab) fragment
as the secondary antibody (instead of a full length secondary antibody). For the
preparation of the fluorescent samples, please refer to section 2.3.3. Image magni-
fications display distinct reoccurring Cav-3 membrane motifs: 1. single domains, 2.
ring structures, and 3. bunchy clusters. The imaged region of the cell did not lie
completely flat on the cover slip, hence the signal along the image diagonal from
top left to bottom right stems from a subsarcolemmal region in the cell where stri-
ated Cav-3 signal patterns can be observed. Therefore, special attention was paid to
only select those Cav-3 membrane motifs for the image magnifications that were lo-
cated at the sarcolemma, i.e. in regions not showing striated Cav-3 signals. Images
were smoothed using a two-dimensional Gaussian filter with a width of 1.5 pixels.
White arrows indicate the longitudinal (X) and the transverse (Y) cell axes, respec-
tively. Scale bar in the overview image: 1 µm; scale bars in the magnifications: 100
nm.
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K. Electron microscopy of caveolae
in differently prepared heart
samples
In section 3.5, using STED microscopy, a distinct membrane motif typical to
both the Cav-3 and the Chol-KK114 signal seen at the sarcolemma of mouse
ventricular cardiomyocytes (VM) is introduced and characterized: bunchy clus-
ters of various sizes that are composed of several single domains in close prox-
imity that assemble to form botryoidal (i.e. “grape like”) superstructures. These
superstructures are likely composed of individual neighboring caveolae or even
of caveolae that have fused, forming intricate structural complexes along the
sarcolemma - similar to the burrow system of moles and rabbits. These sar-
colemmal caveolar complexes have been proposed based on imaging of caveo-
lae using Electron Microscopy (EM) [140]. To confirm the observation of cave-
olar superstructures in VM, I prepared samples of VM for investigation using
EM. The generated samples comprised VM under three different cellular con-
ditions: 1.) single, isolated VM, 2.) VM in a loose cell complex (cell pellet),
and 3.) tissue sections from excised papillary muscle. The preparation of the
respective samples for EM is described in detail in section 2.10.3. Specifically,
the three different cellular conditions 1.), 2.), and 3.) represent a respective
increase in physiological accurateness. Fig. K.1 summarizes exemplary EM
images of caveolar structures in VM samples under each of the above men-
tioned three conditions: 1.) single VM (Fig. K.1 A), 2.) cell pellets (Fig. K.1
B), and 3.) tissue sections (Fig. K.1 C). While the arrangement of caveolae in
close proximity to each other could be observed for each of the three sample
preparations, the fusing of caveolae was most often observed in the tissue sec-
tions (Fig. K.1 C). With the additional presence of e.g. connective tissue and
blood vessels in the tissue sections, these sample preparations represent the
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Figure K.1.: Electron micrographs of caveolar structures along the sarcolemma of primary mouse ventricular car-
diomyocytes (VM) obtained from the following three different sample preparations: single cells, cell
pellets, and tissue sections (see section 2.10.3). The increase in physiological accurateness of these three
preparations is qualitatively demonstrated by the gradient bar to the right of the panels. Overview images
and magnified insets (yellow boxes) showing omega-shaped caveolae along the sarcolemma and opened
towards the extracellular space. Scale bars in overview images: 500 nm; scale bars in magnified insets: 100
nm. A Electron micrographs of two exemplary single VM plated after isolation. B Electron micrographs
of two exemplary regions of interest (ROI) within slices of a cell pellet of isolated VM. C Electron micro-
graphs of two exemplary ROI within perpendicularly cut sections of the papillary muscles from the left
ventricle.
most physiological condition under which the EM images of caveolae could be
obtained. Thus, the EM images of the cardiac tissue sections seem to be most
comparable to a snap shot of an intact, physiological state (of course, it has to
be kept in mind that the sample preparation for EM includes several very harsh
steps that possibly very strongly influence the real physiological state of intact
caveolar structures). Conclusively, EM images of caveolae at the cardiac sar-
colemma under the - comparatively - most physiological conditions show the
highest incidence of fused caveolae. This probably indicates that the forma-
tion of caveolar superstructures is a characteristic feature of intact VM. Given
that the bunchy clusters that were observed for the sarcolemmal Cav-3 and
Chol-KK114 signal using STED microscopy (see e.g. Fig. 3.22 in section 3.5)
correspond to caveolar superstructures, the abundance of complex caveolar
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assemblies is even higher in living VM. Such a distinct and often-seen forma-
tion of caveolae at the sarcolemma almost begs for the hypothesis of serving
an underlying specific function. Such a specific function could e.g. be the ad-
justable provision of a reservoir of additional membrane surface area (see e.g.
[188]) - this could be a big advantage for cells like VM that undergo constant
mechanical stress. STED microscopy using fluorescent Cholesterol analogs to
image caveolar structures in living VM seems to be very well suited to study
the sarcolemmal membrane nanopattern and the functions that it may serve.
Such studies could include the dynamic tracking of nanoscopic changes at the
sarcolemma of living VM under different experimental conditions, e.g. dur-
ing mechanical stress or following the administration of drugs that specifically
alter cellular membrane properties (see also section 4).
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L. Additional information: Western
blot analysis
For the determination of protein expression levels by Western blotting, pro-
tein concentrations in individual samples were assessed using a standard pro-
tein detection kit (see section 2.10.2). The obtained protein concentrations per
sample are displayed in Table L.1. For statistical significance of the Caveolin-
Sample ID Protein concentration [µg/µl]
Samples from mouse left ventricle homogenates
C57Bl/6N #1 11.6
C57Bl/6N #2 10.4
C57Bl/6N #3 10.0
C57Bl/6N #4 11.4
Samples from HeLa cell homogenates
HeLa T- #1 3.28
HeLa T- #2 2.86
HeLa T- #3 2.78
HeLa T- #4 3.06
HeLa C 3.96
Table L.1.: Protein concentrations in samples for Western blot analysis. See section 2.10.2 for details on sample prepa-
ration and specification of buffers. Samples contained a final concentration of 2 µg/µl protein in a final
sample volume of 45 µl (i.e. protein content was brought to 90 g per sample). Abbreviations: C57Bl/6N ##
- respective identification of mouse left ventricle samples; HeLa T- ## - respective identification of samples
of HeLa cells transfected with the Cav-3-SNAP construct (see section 2.4.1); HeLa C - Control sample of
untransfected HeLa cells; HP - Homogenization buffer.
3 (Cav-3) protein expression levels determined by Western blotting, a total
of two Western blots with four individual samples from both left ventricle
homogenates and transfected HeLa cell homogenates, respectively, were pre-
pared. The complete set of prepared Western blots is displayed in Fig. L.1
A.1 and B.1, wherein the signal was adjusted in brightness so as to be able
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to make out the molecular marker bands. The protein marker bands were la-
beled manually according to their molecular weight in kDa. For explanatory
purposes, Fig. L.1 A.2 and B.2 show the same Western blots as Fig. L.1 A.1
and B.1, respectively, but with the lanes in the gel and the protein bands la-
beled in yellow according to the nomenclature explained in the following (for
sample preparation, please refer to section 2.10.2). Lanes 01 to 04 (L01 to L04)
contain the samples from left ventricle homogenates C57Bl/6N mice #1 to #4,
respectively. Lanes 05 to 08 (L05 to L08) contain the samples from homogenates
of HeLa cells transfected with the Cav-3-SNAP construct. Lane 09 (L09) con-
tains the control sample from untransfected HeLa cells. Cav-3 protein bands
(at ≈ 20 kDa) and Cav-3-SNAP bands (at ≈ 40 kDa) are shown in green and
labeled as B01 in the respective lane and with a green underscore. The loading
control protein GAPDH bands (at ≈ 36 kDa are shown in red and labeled as
B01 in the respective lane and with a red underscore.
Complete set of Western blots for protein level determination
Figure L.1.: Determination of Caveolin-3 (Cav-3) protein expression by western blotting and presented in section 3.5.
Western blots were prepared following the protocol described in section 2.10.2 and contained four samples
from left ventricle homogenates and transfected HeLa cell homogenates, respectively, as well as one con-
trol sample from untransfected HeLa cells. Please refer to the text for further details on sample preparation
and description of the Western blots.
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M. Cholesterol depletion does not
change the TATS topology
Control experiments were conducted to confirm that sarcolemmal Cholesterol
(Chol) depletion by Methyl-β-Cyclodextrin (M-β-CD) only affects the degree
of sarcolemmal membrane protein clustering - specifically, the clustering of
Caveolin-3 (Cav-3) - but does not alter the basic architectural structure of the
Transverse-Axial Tubular System (TATS). To this end, living mouse ventricular
cardiomyocytes (VM) were incubated with 5 mM M-β-CD (for 1 h, at 37°C, see
section 2.3.3), stained with the potentiometric membrane dye Di-8-ANEPPS
(see section 2.3.2) and imaged in confocal mode using the STED microscope
system Leica TCS SP8 STED 3X (see section 2.1.3). The obtained images of
the membrane structures were qualitatively compared to Di-8-ANEPPS labeled
control cells (i.e. no treatment with M-β-CD). Fig. M.1 A exemplarily shows the
confocal (conf.) images of the Di-8-ANEPPS signal of the TATS of control VM
(Control) vs. VM incubated with M-β-CD (+ 5 mM M-β-CD). Qualitatively, no
difference between the TATS of control and M-β-CD treated cells regarding the
signal brightness, the amount of detectable tubular structures, their intercon-
nectedness, and their regularity was observed. Further, to validate that after
Chol depletion by M-β-CD, the reintroduction of Chol to the TATS membrane
would lead to a Chol signal that showed a similar arrangement as the Chol sig-
nal in control VM, M-β-CD treated cells were labeled with 5 µM of Chol-KK114
(see section 2.3.2) and STED images obtained using the STED microscope sys-
tem Leica TCS SP8 STED 3X. The acquired images were qualitatively compared
to Chol-KK114 labeled control cells (i.e. no treatment with M-β-CD). Fig. M.1 B
exemplarily shows the signal structure of Chol-KK114 labeled control vs. M-β-
CD treated VM. No difference between control vs. M-β-CD treated cells could
be observed; the TATS showed no alterations in structure and regularity. This
confirms that Chol depletion is a reversible effect as Chol rich regions along
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Figure M.1.: Fluorescent stains of living mouse ventricular cardiomyocytes (VM) before and after Cholesterol deple-
tion (Chol depletion) show that the principal VM membrane architecture remains unaltered upon Chol
depletion. A Confocal images of living VM stained with 50 µM Di-8-ANEPPS (see section 2.3.2) for the
two scenarios: 1. Untreated cells, no Chol depletion (left panel, “Control”); 2. Chol depleted cells via in-
cubation with 5 mM Methyl-β-Cyclodextrin (M-β-CD, see section 2.3.3; right panel, “+ 5 mM M-β-CD”).
Scale bars: 5 µm. B STED images of living VM stained with 5 µM Chol-KK114 for the two scenarios: 1.
Untreated cells, no Chol depletion (left panel, “Control”); 2. Chol depleted cells via incubation with 5
mM M-β-CD (right panel, “5 mM M-β-CD”). Scale bars: 2 µm.
the membrane reform when Chol is added back. This could also mean that the
disruption of caveolae that occurs upon Chol depletion (see section 3.5.1) is re-
versible and that the Chol content along the sarcolemma influences the degree
of caveolar clustering in an adjustable fashion.
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N. Dystrophin antibody control
stains in mdx 5cv cardiomyocytes
This appendix provides an overview over the control experiments for the speci-
ficity of the anti-Dystrophin (Dyst) primary antibodies that are used in this the-
sis (see section 3.7). For these controls, two-color immunofluorescence stains of
mouse ventricular cardiomyocytes (VM) from the Dyst deficient mouse strain
mdx 5cv were prepared (see sections 2.3.4 and 2.3.3). VM were labeled for Dyst
using the different primary antibodies that are presented in the following and
that target specific epitopes of the Dyst protein. The targeted amino acids (aa)
are denoted in the following figures. VM were additionally stained for the
membrane associated protein Caveolin-3 (Cav-3) to provide an internal con-
trol for the cell quality.
The two-color STED images were obtained using the STED microscope system
Leica TCS SP8 STED 3X (see section 2.1.3). For the image acquisition settings,
please refer to the overview given in Appendix B. For the two respective color
channels, the two dyes STAR635P and STAR580 were chosen (see section A.4).
To control that there is no effect of the respective dye compound chosen for
labeling on the protein signal distribution, Dyst and Cav-3 were labeled using
STAR635P and STAR580 and vice versa.
Fig. N.1 shows STED images of the sarcolemma of mdx 5cv VM labeled for Dyst
using the amino-terminus (N-terminus) specific primary antibody 4C7 (Santa
Cruz Biotechnology, see section A.3) that targets aa 1-68. Note that a distinct
Dyst signal can be observed in both color channels despite the fact that the VM
stem from the Dyst deficient mdx 5cv mouse line (and the Cav-3 signal is as
expected and not a possible source of spectral cross talk, as seen in the overlay
images of the two color channels). The presence of a visible N-terminal Dyst
signal stems from the specific mutation of the Dyst gene in the mdx 5cv mouse
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model that causes a truncation of the Dyst protein starting at aa 282 [288, 253].
Thus, the Dyst N-terminus is still expressed in the mdx 5cv mouse and can be
recognized by the 4C7 antibody, thus leading to a Dyst pos signal. The specific
Dyst signal pattern that is seen when using the 4C7 antibody is also discussed
in section 3.8.
Figure N.1.: Two-color STED images of Dystrophin (Dyst) and Caveolin-3 (Cav-3) in mdx 5cv, i.e. Dystrophin deficient,
mouse ventricular cardiomyocytes (VM). Dyst was immunofluorescence labeled via the N-terminus spe-
cific antibody 4C7 (Mouse-anti-Dyst, Santa Cruz Biotechnology, see also section A.3) which is directed
against the amino acids (aa) 1-68 of the Dyst molecule. Dyst was decorated with the fluorophores
STAR635P or STAR580 (see section A.4). Cav-3 was immunofluorescence labeled with the antibody
ab2912 (Rabbit-anti-Cav-3, abcam, see also section A.3) and decorated with the fluorophores STAR635P
or STAR580 (see section A.4). Color bars indicate the respective image intensity value (RGB scale). Scale
bars: 5 µm.
Fig. N.2 shows STED images of the sarcolemma of mdx 5cv VM labeled for
Dyst using the rod domain specific primary antibodies ab85302 (Fig. N.2 A,
from abcam, see also section A.3) and ab7163 (Fig. N.2 B, from abcam, see
also section A.3). The antibody ab85302 recognizes the sequence of the Dyst aa
1850-1950 (ab85302 is also used for the imaging protocols presented in section
3.8). The antibody ab7163 recognizes the sequence of the Dyst aa 1400-1505. As
expected, for both antibodies the sarcolemmal Dyst signal is negative in mdx
5cv VM while the Cav-3 signal looks normal.
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Figs. N.3 and N.4 respectively show STED images of the sarcolemma of mdx
5cv VM labeled for Dyst using the carboxyl-terminus (C-terminus) specific pri-
mary antibodies C-20 (Fig. N.3 A-1, Santa Cruz Biotechnology), ab15277 (Fig.
N.3 A-2, abcam), ab7164 (Fig. N.4 A-2, abcam), and 7A10 (Fig. N.4 B-2, Santa
Cruz Biotechnology). For detailed information on the used Dyst primary anti-
bodies, please refer to section A.3. The antibody C-20 recognizes the sequence
of the Dyst aa 3361-3685; the antibody ab15277 recognizes the sequence of the
Dyst aa 3661-3677; the antibody ab7164 recognizes the sequence of the Dyst aa
3558-3684, and the antibody 7A10 recognizes the sequence of the Dyst aa 3200-
3684.The antibody C-20 was also used for the imaging protocols presented in
section 3.8. As expected, none of the C-terminus specific anti-Dyst primary
antibodies yields a significant Dyst signal in VM of the mdx 5cv mouse strain
while the Cav-3 signal looks normal.
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Figure N.2.: Two-color STED images of Dystrophin (Dyst) and Caveolin-3 (Cav-3) in mdx 5cv, i.e. Dystrophin deficient,
mouse ventricular cardiomyocytes (VM). A Immunofluorescence labeled Dyst via the rod domain specific
antibody ab85302 (Rabbit-anti-Dyst, abcam, see section A.3) which is directed against the amino acids
(aa) 1850-1950 of the Dyst molecule. Immunofluorescence labeled Cav-3 via the antibody BD#610421
(Mouse-anti-Cav-3, BD Biosciences, see section A.3). B Immunofluorescence labeled Dyst via the rod
domain specific antibody ab7163 (Mouse-anti-Dyst, abcam, see section A.3) directed against aa 1400-1505.
Immunofluorescence labeled Cav-3 via the antibody ab2912 (Rabbit-anti-Cav-3, abcam, see section A.3).
Dyst and Cav-3 were respectively decorated with the dyes STAR 635P or STAR 580 (see section A.4). Color
bars indicate the respective image intensity value (RGB scale). Scale bars: 5 µm.
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Figure N.3.: Two-color STED images of Dystrophin (Dyst) and Caveolin-3 (Cav-3) in mdx 5cv, i.e. Dystrophin deficient,
mouse ventricular cardiomyocytes (VM). A-1 Immunofluorescence labeled Dyst via the C-terminus spe-
cific antibody C-20 (Goat-anti-Dyst, Santa Cruz Biotechnology, see section A.3) which is directed against
the amino acids (aa) 3361-3685 of the Dyst molecule. Immunofluorescence labeled Cav-3 via the antibody
BD#610421 (Mouse-anti-Cav-3, BD Biosciences, see section A.3). B-1 Immunofluorescence labeled Dyst
via the C-terminus specific antibody ab15277 (Rabbit-anti-Dyst, abcam, see section A.3) directed against
aa 3661-3677. Immunofluorescence labeled Cav-3 via the antibody BD#610421 (Mouse-anti-Cav-3, BD
Biosciences, see section A.3). Dyst and Cav-3 were respectively decorated with the dyes STAR 635P or
STAR 580 (see section A.4). Color bars indicate the respective image intensity value (RGB scale). Scale
bars: 5 µm.
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Figure N.4.: Two-color STED images of Dystrophin (Dyst) and Caveolin-3 (Cav-3) in mdx 5cv, i.e. Dystrophin defi-
cient, mouse ventricular cardiomyocytes (VM). A-2 Immunofluorescence labeled Dyst via the C-terminus
specific antibody ab7164 (Mouse-anti-Dyst, abcam, see section A.3) which is directed against the amino
acids (aa) 3558-3684 of the Dyst molecule. Immunofluorescence labeled Cav-3 via the antibody ab2912
(Rabbit-anti-Cav-3, BD Biosciences, see section A.3). The panel marked as “Overlay” shows the overlaid
color channels to indicate that the Dyst signal in the mdx 5cv VM is not caused by spectral cross talk
with the Cav-3 signal. B-2 Immunofluorescence labeled Dyst via the C-terminus specific antibody 7A10
(Mouse-anti-Dyst, Santa Cruz Biotechnology, see section A.3) directed against aa 3200-3684. Immunofluo-
rescence labeled Cav-3 via the antibody ab2912 (Rabbit-anti-Cav-3, BD Biosciences, see section A.3). Dyst
and Cav-3 were respectively decorated with the dyes STAR 635P or STAR 580 (see section A.4). Color bars
indicate the respective image intensity value (RGB scale). Scale bars: 5 µm.
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